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Abstract 
 
Antimicrobial resistance presents a serious, worldwide threat to public health. New tools are 
required to combat the evolving problem. Here we report the systematic evolution of nucleic 
acid ligands to live Escherichia coli cells. Two SELEX methods were used to generate aptamers 
to the HB101: pAT153 strain of antibiotic resistant bacterial cells. These different Cell-SELEX 
methods were compared to analyse how DNA adapts to selective evolutionary pressure.  The 
first method was performed using asymmetric PCR as the mechanism of single strand 
regeneration, with target cells taken from bacterial colonies. The second method used a novel 
strand protection exonuclease method for single strand regeneration and target cells taken from 
live cultures.  
Sequences evolved during both methods were analysed and stored in plasmid libraries. 
These methods produced a combined total of fifty-eight putative DNA ligands (aptamers). These 
sequences were analysed using alignment and structural prediction software and six candidate 
molecules were taken for further analysis. Evolved sequences were synthesised and target cell 
binding assays were performed using fluorescence laser-scanning confocal microscopy to 
visualise binding. A number of control sequences were also analysed. These included scrambled 
versions of each aptamer sequence, complementary oligonucleotides to deform binding 
structures and positive control sequences of published cell binding aptamers.  Five of the six 
novel sequences exhibited cell specific localisation. Two of these sequences, named Oligo 3.1 
and Oligo 4.4 (one from each SELEX Method) demonstrated apparent ligand binding affinities 
in the low-micromolar range (KDapp Oligo 3.1= 3.35 μM.  KDapp Oligo 4.4 = 6.69 μM). 
 
ii 
 
 
Contents 
            
Declaration          i 
Abstract          ii 
Table of Contents         iii 
Abbreviations and Units         viii 
Index of Figures          x 
Index of Tables          xii 
 
Chapter 1: Introduction        1 
1.1. Nucleic Acid Chemistry         2 
 
1.1.1. Nucleobases         2 
 
1.1.2. Nucleosides and Sugars        4 
 
1.1.3. Nucleotides and Backbones       6 
 
1.1.4. Synthetic Nucleic Acid Analogues       8 
 
1.2. Intermolecular Nucleic Acid Interactions       10 
 
1.2.1. Base Pairings         10 
  
1.2.2. Duplex Nucleic Acid Structures       12 
 
1.2.3. Triplex Nucleic Acid Structures       14 
 
1.2.4. Quadruplex Nucleic Acid Structures     16 
 
1.2.5. Pentaplex Nucleic Acid Structures       18 
 
1.2.6. Intermolecular Functional RNAs       18 
 
1.3. Intramolecular Nucleic Acid Structures       19 
 
1.3.1. Stem-loops, Pseudoknots and Bulges      20 
 
1.3.2. Intramolecular Triplex Structures       22 
 
1.3.3. Intramolecular Quadruplex Structures      22 
 
1.3.4. Riboswitches and Ribozymes       24 
 
1.3.5. Intramolecular Deoxyribozymes       27 
 
1.4. Molecular Evolution and Genetic Information Systems     29 
 
1.4.1. Strategies for Molecular Evolution       31 
 
1.4.2. The RNA World         34 
 
1.4.3. Directed Molecular Evolution       35 
 
1.5. SELEX           38 
 
1.5.1. A Brief History of SELEX        38 
 
1.5.2. DNA SELEX         41 iii 
 
 
 
1.5.3. Cell SELEX         42 
 
1.6. DNA Aptamers and Ligand-Binding       43 
 
1.7. Aptamers vs. Antibodies        46 
 
1.8. Antibiotic Resistance                     48 
 
1.9. The Gram Negative Bacterial Cell Wall      50 
 
1.10. Purpose of this Work                     53
      
  
Chapter 2: Materials and Methods        54 
 
2.1. Chemicals & Reagents         54 
 
2.2. Buffers           55 
 
2.3. Enzymes           58 
 
2.4. DNA Reagents          61 
 
2.4.1. Plasmids          61 
 
2.4.2. Primers and Nucleic Acid libraries       63 
 
2.5. PCR           66 
 
2.5.1. Symmetric PCR         66 
 
2.5.2. Asymmetric PCR         67 
 
2.5.3. Colony PCR         68 
 
2.5.4. Radiolabelled PCR        69 
 
2.6. Nucleic acid purification methods        69 
 
2.6.1. Ethanol Precipitation        69 
 
2.6.2. Qiagen PCR purification        70 
 
2.6.3. Exonuclease I - Shrimp Alkaline Phosphatase PCR purification   70 
 
2.6.4. GE Healthcare microspin column       70 
 
2.7. Spectrophotometry          70 
 
2.7.1. Nanodrop 2000 UV Spectrophotometry      71 
 
2.7.2. Cell Culture Optical Density       71 
 
2.8. Microbial Techniques         71 
 
2.8.1. Media & Antibiotics        71 
 
2.8.2. Strains of E.coli         72 
 iv 
 
 
2.8.3. Culturing E.coli         72 
 
2.8.4. Preparation of Competent Cells       72 
 
2.8.5. Transformation of Plasmid DNA       73 
 
2.8.6. Mini-preparation of Plasmid DNA       73 
 
2.9. Systematic Evolution of Ligands by Exponential Enrichment     74 
 
2.9.1. SELEX Method I         74 
 
2.9.2. SELEX Method II         75 
 
2.10. Gel Electrophoresis         76 
 
2.10.1. Agarose Gel Electrophoresis       76 
 
2.10.2. Native Polyacrylamide Gel Electrophoresis (N-PAGE)    78 
 
2.10.3. Denaturing Polyacrylamide Gel Electrophoresis (D-PAGE)    79 
 
2.10.4. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE)  79 
 
2.11. Molecular Cloning          80 
 
2.12. Phenol Chloroform Extraction        81 
 
2.13. Restriction Endonuclease Digestion        81 
 
2.14. λ Exonuclease Digestion         81 
 
2.15. DNA Sequencing          82 
 
2.16. Oligonucleotide Annealing        82 
 
2.17. Bioinformatics          82 
 
2.17.1. DNA Sequence Analysis and Alignment      82 
 
2.17.2. mfold Structural Prediction       82 
 
2.17.3. ifold Structural Prediction       82 
 
2.18. Confocal Microscopy         83 
 
2.18.1. Sample Preparation        83 
 
2.18.2. Confocal Microscopy        83 
 
2.18.3. Image Processing         83 
 
2.19. Liquid Scintillation Counting                    86
  
     
Chapter 3: Cell-SELEX using Bacterial Colonies and Asymmetric PCR 87 
  
3.1. SELEX Overview & Rationale        87 
 
3.2. SELEX Primers & Library         89 v 
 
 
 
3.3. SELEX Preliminary Experiments        93 
 
Preliminary Experiment I – Sampling the Initial Library    93 
 
Preliminary Experiment II – Primer Walking Experiment    98 
 
Preliminary Experiment III – ssDNA Production     100 
 
Preliminary Experiment IV – Primer Specificity Experiments   105 
 
Preliminary Experiment V – Target Cell Viability     105 
 
3.4. SELEX Method I          108 
 
3.5. Cloning and Sequencing of the enriched pool of molecules     115 
 
3.6. SELEX Method I Conclusions        119 
 
Chapter 4: Cell-SELEX using Bacterial Cell Cultures  
and Lambda Exonuclease            122 
 
4.1. Introduction and Rationale         122 
 
4.2. SELEX Method II Overview and Strategy       123 
 
4.3. SELEX Preparation and Preliminary Experiments     124 
 
Preliminary Experiment I – PCR Optimisation     124 
 
Preliminary Experiment II – PCR Primer to PCR Template Ratio Experiments 125 
 
Preliminary Experiment III– PCR Primer to PCR Template Ratio Experiments II   129 
 
4.4. λ Exonuclease Digestion of DNA        131 
 
4.5. SELEX Method II          143 
 
4.6. Cloning and Sequencing         146 
 
4.7. SELEX Method II Conclusions       150 
 
 
Chapter 5: Molecular Evolution of DNA during  
SELEX Methods I & II          151 
 
5.1. Introduction          151 
 
5.2. Aberrant SELEX Products from SELEX Method I      152 
 
5.3. Aberrant SELEX Products from SELEX Method II     158 
 
5.4. Development of Homogeneity in SELEX Method I and II    160 
 
Chapter 6: Analysis of Evolved Sequences       161 
 
6.1. Analysis of Individual Selected Sequences       161 
 
6.2. Collective Alignment Analysis of Selected Sequences      167 vi 
 
 
 
6.3. Selection of Sequences for Confocal Microscopy      173 
 
Chapter 7: Binding Analysis of Radioactively  
and Fluorescently Labelled Oligonucleotides          179 
  
7.1. Sample Preparation          179 
 
7.2. Laser Scanning Confocal Microscopy Setup       181 
 
7.3. Laser Scanning Confocal Microscopy       181 
 
7.3.1. Negative Control Experiments       181 
 
7.3.2. LSCM Analysis of Evolved Sequences from SELEX Method I   187 
 
7.3.3. LSCM Analysis of Evolved Sequences from SELEX Method II   196 
OLIGO 4.1 and OLIGO 4.1s      196 
 
OLIGO 4.2 and OLIGO 4.2s      199 
 
OLIGO 4.3 and OLIGO 4.3s      199 
 
OLIGO 4.4 and OLIGO 4.4s      202 
 
7.3.4. LSCM Analysis of Aptamer Sequences from the Literature    206 
 
 OLIGO J and OLIGO Js      206 
 
OLIGO K and OLIGO Ks      206 
 
7.3.5. LSCM Analysis of Evolved Sequences and Human Cells    206 
 
7.3.6. LSCM Analysis of Evolved Sequences and Elongated E.coli cells   210 
 
7.4. Quantitation of LSCM results        210 
 
7.5. Radiolabelled Binding Assay         215 
 
Chapter 8: Discussion             217 
 
8.1. Novel ssDNA Sequences which Interact with Gram Negative Bacteria   217 
 
8.2. Insights into Molecular Evolution of DNA       220 
 
8.3. Development of SELEX Methods       222 
 
8.4. Future Work         222 
 
References 
           
Appendices          
 
  
vii 
 
 
Abbreviations 
1D, 2D, 3D – One, Two or Three
 Dimensional 
3’ – Three prime 
5’ - Five prime 
5mC – 5-methylcytosine 
A - Adenine  
AMR – Anti Microbial Resistance 
APS - Ammonium Persulphate  
BLAST - Basic Local Alignment Search
 Tool 
BSA - Bovine Serum Albumin   
C - Cytosine  
CD – Circular Dichroism 
CPM - counts per minute 
Cot – Copy over template 
CotC - Beta-globin co-transcriptional
 cleavage 
DNA - Deoxyribonucleic Acid  
dNTP - Deoxynucleotide Triphosphate  
D-PAGE – Denaturing PAGE 
dsDNA - double-stranded DNA  
dsRNA - double-stranded RNA  
DTT - Dithiothreitol   
E.coli – Escherichia coli 
EDTA – Ethylene diamine tetra acetic
 acid. 
EtOH - Ethanol 
FAM - Fluorescein amidite 
G - Guanine  
GIS – Genetic Information System 
GlcN6P - glucosamine-6-phosphate 
GNA - Glycol nucleic acid 
GMC – General Medical Council 
H-DNA – Protonated triplex DNA 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1
 yl]ethanesulphonic acid  
HEX - Hexachlorofluorescein 
HIV - Human Immunodeficiency Virus  
I - Inosine 
IgG - Immunoglobulin G 
IPTG - Isopropyl β-D-1
 thiogalactopyranoside  
KD - Dissociation Constant   
KDapp – Apparent Dissociation Constant   
LB - Lysogeny Broth   
LNA – Locked Nucleic Acid 
LPS – Lipopolysaccharide  
LSCM – Laser Scanning Confocal
 Microscopy 
Mr - Molecular Weight  
mRNA – messenger RNA 
MONOLEX- One-step SELEX 
NADH - Reduced β-Nicotinamide adenine
 dinucleotide  
NDP - Nucleotide Diphosphate  
NMR - Nuclear Magnetic Resonance  
N-PAGE – Native PAGE 
NTP - Nucleotide Triphosphate   
PAGE - Polyacrylamide Gel
 Electrophoresis  
PBS - Phosphate Buffered Saline  
PCR - Polymerase Chain Reaction  
PDB - Protein Database  
Pi - Inorganic Phophate  
PNA – Peptide nucleic acid 
Qβ - Bacteriophage Qβ 
Rh - hydrodynamic radius  
rRNA - ribosomal RNA  
RT - Reverse Transcriptase  
SDS - Sodium Dodecyl Sulphate  
SELEX - Systematic Evolution of Ligands
 by Exponential Enrichment  
ssDNA - single-stranded DNA  
ssRNA - single-stranded RNA  
T – Thymine 
TAE – Tris Acetate EDTA  
TBE – Tris Borate EDTA 
TEMED - Tetramethylethylenediamine  
TFO - Triplex Forming Oligonucleotide  
Tris –Tris(hydroxymethyl)aminomethane 
TNA - Threose nucleic acid 
tRNA – transfer RNA 
U - Uracil  
UNA – Unlocked Nucleic Acid 
UTR - untranslated region 
UV - Ultraviolet  
WHO - World Health Organisation 
XNA – Xeno nucleic acids  
 
α - alpha 
β - beta 
γ - gamma 
δ / Δ - delta 
ε – epsilon 
ζ - zeta 
λ - lambda 
υ - upsilon 
σ - sigma 
χ - chi 
μ - mu 
  viii 
 
 
  
Units 
° - Degree(s)  
A - Ampere(s)  
Å - Angstrom(s)  
aa - Amino acid(s)  
AU - Absorbance Unit(s)  
bp - Base pair(s)  
Bq – Becquerel(s)  
C - Celsius/Centigrade  
Ci - Curie(s)  
Da - Dalton(s)  
g - Gram(s)  
g - Gravity 
J– Joules  
K - Kelvin  
L - Litre(s)  
m - Metre(s)  
M - Molar  
min – minute(s) 
mol - Mole(s)  
nt - Nucleotide(s)  
OD - Optical Density 
Pa - Pascal(s)  
Psi - Pounds per square inch 
Rpm –Revolutions per minute 
s – second(s) 
S - Svedberg(s)  
Sv –Sievert(s) 
U – Unit(s) 
V - Volt(s)   
W -Watt(s) 
 
Metric Prefixes  
 
M Mega- × 106 
k Kilo-   × 103  
m Milli-  × 10-3  
µ Micro-  × 10-6  
n Nano-  × 10-9  
p Pico-   × 10-12  
f Femto-  × 10-15 
a Atto-   × 10-18 
z Zepto- × 10-21 
y Yocto- × 10-24 
 
 
 
ix 
 
 
Index of Figures 
Name              Page 
Fig 1.1 The nucleobases of DNA and RNA    3 
Fig 1.2 Structure and conformation of sugars in nucleic acids 5 
Fig 1.3 Torsional flexibility of nucleic acid backbones  7 
Fig 1.4 Watson Crick base pairs and XNA    9 
Fig 1.5 Hydrogen bonding edges and alternative base pairs  11 
Fig 1.6 The major forms of duplex DNA    13 
Fig 1.7  Triplex nucleic acid structures     15 
Fig 1.8 Quadruplex nucleic acid structures    17 
Fig 1.9 Structures of single stranded nucleic acids   21 
Fig 1.10 Short DNA hairpins and triads     23 
Fig 1.11 Purine Riboswitches      26 
Fig 1.12 The first directed molecular evolution experiment  37 
Fig 1.13 Four nucleic acid aptamer structures    40 
Fig 1.14 Four antimicrobial molecules     51 
Fig 2.1 DNA modifying enzymes used in this thesis   59 
Fig 2.2 Plasmids used in this thesis     62 
Fig 2.3 SELEX Method schematics     77 
Fig 2.4  Fluorophores used in this thesis     84 
Fig 2.5 Excitation and emission spectra     85 
Fig 3.1  SELEX Method I diagram     88 
Fig 3.2 SELEX Method I PCR primers and positive control 91 
Fig 3.3 Randomised oligonucleotide library    92 
Fig 3.4 Molecular cloning of PCR products    94 
Fig 3.5 Restriction digestion of recombinant plasmids  95 
Fig 3.6 PCR screening of recombinant plasmids   97 
Fig 3.7 A selection of isolated unevolved sequences   99 
Fig 3.8 Primer walking experiment I     101 
Fig 3.9  Asymmetric PCR       103 
Fig 3.10 Test for false-positive PCR amplification   106 
Fig 3.11 Gram staining of E.coli HB101     107 
Fig 3.12 SELEX Method I        110 
Fig 3.13 Comparison of the enriched and original pools  111 
Fig 3.14 PAGE analysis of evolved PCR products   112 
Fig 3.15 Serial dilution of PCR templates    114 
Fig 3.16 Evolved sequences from SELEX Method I   116 
Fig 3.17 Primer walking experiment II     118 
Fig 4.1 SELEX Method II PCR primers and controls  126 
x 
 
 
Fig 4.2 Template dilution SELEX Method II PCR   128 
Fig 4.3 Primer concentration SELEX Method II PCR  130 
Fig 4.4 SDS PAGE analysis of λ exonuclease    133 
Fig 4.5  ssDNA digestion using λ exonuclease     135 
Fig 4.6 dsDNA digestion using λ exonuclease    137 
Fig 4.7 Removal of the phosphorylated strand from the duplex 139 
Fig 4.8 Digestion of high molecular weight PCR product  142 
Fig 4.9 Analysis of SELEX Method II     145 
Fig 4.10 SELEX Method II PCR for cloning    147 
Fig 4.11 Evolved sequences from SELEX Method II   148 
Fig 5.1 Correct and aberrant replicative mechanisms   154 
Fig 5.2 Long PCR products from SELEX Method I   156 
Fig 5.3 Long PCR products from SELEX Method II   159 
Fig 6.1  Alignments of evolved sequences    168 
Fig 6.2 SELEX Method I sequence identities    170 
Fig 6.3 SELEX Method II sequence identities    171 
Fig 6.4 Primer walking experiment III     172 
Fig 6.5 A selection of mFold predicted structures   177 
Fig 6.6 Annealing of complementary oligonucleotides  178 
Fig 7.1  LSCM negative control experiments    183 
Fig 7.2 LSCM fluorescent negative control experiments  185 
Fig 7.3 LSCM fluorescent negative control experiments II  186 
Fig 7.4 LSCM imaging of Oligo 3.1     188 
Fig 7.5 LSCM imaging of Oligo 3.1 II     189 
Fig 7.6 LSCM imaging of disabled Oligo 3.1    191 
Fig 7.7 Fluorescent quantitation of LSCM images   192 
Fig 7.8 LSCM imaging of Oligo 3.2 and 3.2a    195 
Fig 7.9 LSCM imaging of Oligo 4.1     197 
Fig 7.10 LSCM imaging of Oligo 4.1 and 4.1s    198 
Fig 7.11 LSCM imaging of Oligos 4.2, 4.2s, 4.3 and 4.3s  200 
Fig 7.12 LSCM imaging of Oligo 4.4     203 
Fig 7.13 LSCM imaging of Oligo 4.4 II     204 
Fig 7.14 LSCM imaging of oligo 4.4s     205 
Fig 7.15 LSCM imaging of Oligo J and Js    207 
Fig 7.16 LSCM imaging of Oligo K and Ks    208 
Fig 7.17 LSCM imaging of evolved sequences and HEK 293 cells 209 
Fig 7.18 LSCM imaging of elongated E.coli cells   211 
Fig 7.19 Quantitation of binding from LSCM data   213 
Fig 7.20 ifold structural predictions of Oligo 3.1 and 4.4  214 
Fig 7.21 Radiolabelled binding assays     216 
xi 
 
 
Index of Tables   
Name         Page 
Table 2.1  List of stock reagents      55 
Table 2.2 List of buffers       57 
Table 2.3 PCR primers and random pool of SELEX Method I 64 
Table 2.4 PCR primers and random pool of SELEX Method II 65 
Table 2.5 Cloning and Sequencing Primers    65 
Table 2.6 PCR composition SELEX Method I    66 
Table 2.7 PCR composition SELEX Method II    67 
Table 2.8 PCR protocols        67 
Table 2.9 Asymmetric PCR composition     68 
Table 2.10 Colony PCR protocol      69 
Table 2.11 N-PAGE composition      78 
Table 2.12 D-PAGE composition      79 
Table 2.13A SDS-PAGE resolving gel composition   79 
Table 2.13B SDS-PAGE stacking gel composition    80 
Table 2.14 Cloning reaction composition     81 
Table 6.1 SELEX Method I evolved sequences without primers 162 
Table 6.2 SELEX Method I evolved sequences with primers  163 
Table 6.3 SELEX Method II evolved sequences without primers 165 
Table 6.4 SELEX Method II evolved sequences with primers  166       
Table 6.5 Oligonucleotides selected for confocal microscopy  175
 
xii 
1 
 
Chapter 1: Introduction 
 
The work presented in this thesis explores the use of a technique called the Systematic Evolution 
of Ligands by Exponential Enrichment (SELEX) (Tuerk & Gold, 1990). SELEX is a form of 
directed (artificial) molecular evolution by in vitro selection. Directed molecular evolution can 
be performed on a number of different biopolymers, including nucleic acids, nucleic acid 
analogues with modified bases and/or backbones (Pinheiro et al. 2012) and polypeptides 
(Mascini et al. 2012). This thesis focuses on DNA SELEX (Bock et al. 1992; Huizenga & 
Szostak, 1995), where single strands of DNA (ssDNA) adopt functional structures that may 
permit specific binding to a molecular or cellular target.  
This introductory chapter will initially discuss the chemical nature of nucleic acids and 
how this leads to structural diversity in terms of conformational flexibility and base pairing. This 
is followed by a discussion of nucleic acid structures in which intermolecular base pairing 
(between different strands) is predominant. These include multi-stranded structures such as 
duplex DNA/RNA, triplexes and quadruplexes. The next section deals with intramolecular 
structures, that is, those in which a single polynucleotide chain is able to fold into complex 3D 
structures. These include many examples from nature, often of structured ribonucleic molecules 
(transfer RNAs, ribozymes and small interfering RNAs).   
Molecular evolution will then be discussed. This section includes examples from the 
literature of experiments that demonstrate both natural and artificial evolution of information-
containing molecules. Examples include recent developments in artificial genetic information 
systems (GIS). The emergence of SELEX and the technological advances which catalysed its 
development since 1990 will be discussed, with examples of DNA aptamers and Cell-SELEX 
experiments presented. Finally the development of bacterial antibiotic resistance will be 
discussed and this is brought together with the theme of SELEX in the purpose of this work 
section. 
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1.1. Nucleic Acid Chemistry 
The chemical structure of the nucleic acids allows them to function as a replicable storage system 
for heritable information. All known life stores genetic information using biopolymers of DNA 
or RNA. The chemistry of nucleic acids allows the formation of complex structures that contain 
information in the form of chemical structures, the bases. The combination of these properties 
of nucleic acids allows them to respond to selective pressure and undergo Darwinian evolution. 
1.1.1. Nucleobases 
The fundamental repeating units of DNA and RNA macromolecules are the 
deoxyribonucleotides and ribonucleotides respectively. These monomers are made of three 
subunits: a phosphate backbone, a furanose sugar and a nucleobase. The nucleobase is the main 
chemical difference between the different monomers and therefore acts as the storage system for 
heritable information. The nucleobases commonly found in DNA and RNA are Adenine (A), 
Thymine (T), Guanine (G), Cytosine (C) and Uracil (U). These are based on purine or pyrimidine 
rings (Fig. 1.1 A). Although these nucleobases are commonly found in nature, they may undergo 
a number of chemical modifications, such as methylation, deamination, saturation with hydrogen 
and the addition of other functional groups (Fig. 1.1B). 
The nucleobases provide the first level of structural complexity. The sequence of the 
nucleobases determines the position of hydrogen bond donor and acceptor groups along a 
nucleic acid chain. The nucleobases also have different dipole, hydrophobic and van der Waals 
forces associated with them. The sequence composition of the nucleobases defines both the 
genetic information and the physical properties of a polynucleotide chain. Hence a nucleic acid 
sequence will adopt different secondary structures depending on the sequence of nucleobases. A 
pool of polynucleotide molecules which vary in nucleobase sequences may therefore adopt a 
variety of different folded structures. 
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Figure 1.1 The nucleobases of DNA and RNA A. The Purine, Pyrimidine and nucleobase 
rings commonly found in natural DNA and RNA (Bases are attached to nucleic acids at 
positions 1 (pyr.) or 9 (pur.)). B. Examples of methylated, deaminated, saturated and variant 
nucleobases found in nature. The R groups are attached ribosyl groups. 
A. 
B. 
Pyrimidines 
Purines 
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1.1.2. Nucleosides and Sugars 
The addition of a furanose sugar to the nucleobase adds the next level of structural complexity 
(Fig. 1.2). Where the nucleobases are predominantly planar molecules, the β-D-ribofuranose and 
β-D-deoxyribofuranose rings used commonly in natural nucleic acids can exist as one of many 
conformational isomers. The pentose carbohydrate molecule circularises causing the 5’ carbon 
to be extruded from the plane of the ring. The 5’ carbon extends from the endo face of the ring 
and the other face is the exo. Any of the four carbon atoms or the oxygen atom in the ring can 
be extended into the endo or exo conformation. The predominant conformation in DNA is the C 
2’ endo conformation and in RNA is the C 3’ endo conformation. These are known as the South 
and North conformations respectively (Trantírek et al. 2000; Kypr et al. 2009). 
Sugar puckering can be synthetically fixed into a particular conformation by using 
locked nucleic acid (LNA) analogues, North and South methanocarba-nucleoside analogues, and 
3’ bridging phosphorothioate linkages (Singh et al.1998; Brazier et al. 2005; Aviñó et al. 2012). 
The furanose ring is also completely broken in unlocked nucleic acids (UNA) (Doessing & 
Vester, 2011). The five torsion angles of the chemical bonds that define sugar puckering are 
named υ0, υ1, υ2, υ3 and υ4 (Fig. 1.2A). 
The β anomer is most common in DNA and RNA, although α anomer nucleotides have 
been incorporated into DNA duplexes (Koga et al. 1995). The glycosidic bond linkage between 
the nucleobase and the sugar has a torsion angle named chi (χ). The χ angle determines the syn 
or anti conformation of the nucleobase (Fig 1.2B). The conformation of the nucleobase 
determines which face of the nucleobase is available for binding to chemical partners. 
Nucleobases with the syn conformation are found more prevalently in structured ribonucleic 
acid molecules (Sokoloski, 2011). 
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Figure 1.2 Structure and conformation of sugars in nucleic acids. A. The cyclisation of 
β-D-Ribofuranose and the common nucleosides in DNA and RNA. B. The syn and anti-
conformation of a purine and a pyrimidine. R groups represent a hydrogen in DNA and 
a hydroxyl functional group in RNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
A. 
B. 
Anti-conformation                          Syn-conformation 
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1.1.3. Nucleotides and Backbones 
The lone pair electrons from (oxygen and) the deprotonated phosphate groups in the 
phosphodiester backbone give DNA a net negative charge at physiological pH. This 
characteristic allows a number of complex interactions with positively charged amino acids in 
proteins such as histones, or with cations such as Na+ or Mg2+. The mutual electrostatic repulsive 
force between negatively charged backbones also prevents proximity. The deoxyribose 
phosphate backbone is composed of six torsion angles per repeating unit, named α, β, γ, δ, ε, and 
ζ (Fig. 1.3A). These torsion angles give the phosphate backbone a great deal of flexibility. For 
example, the persistence length of single-stranded DNA (which is a measure of the stiffness of 
a polymer) has been estimated to be much less than that of double-stranded DNA (ssDNA 2.223 
nm and dsDNA 35 nm ± 2.8 nm) (Tinland et al. 1997; Yuan et al. 2008; Brinkers et al. 2009; 
Chi et al., 2013). The repulsive forces observed between the negative charges of phosphodiester 
backbones in DNA and RNA mean different structures may be observed under different ionic 
conditions, specifically the presence of different monovalent and divalent metal cations (Pyle, 
2002; Fedor, 2002; Stahley et al. 2007). 
Due to the many possible backbone conformations, each nucleotide monomer can vary 
in structure in a number of different ways. This variation in monomer structure allows great 
flexibility and versatility in the polymer. As explored later, SELEX is performed on single-
stranded DNA, RNA, peptide and other nucleic acid analogue molecules precisely because these 
molecules have the statistical probability to form a great number of structures. This flexibility 
allows many different parts of the biopolymer to come together and interact. These interactions 
may lead to the formation of intramolecular secondary structures. 
This thesis focuses on the structural diversity of single-stranded DNA molecules. This 
complexity emerges from the flexibility of the phosphate backbone, the multiple conformations 
of the β-D-Deoxyribose sugar group and the orientation and sequence of the nucleobases that 
make up the polynucleotide. These are summarised by showing a short section of a single-strand 
tetranucleotide in Fig 1.3B. 
7 
 
Figure 1.3 Torsional flexibility of nucleic acid backbones. A. Diagram showing the variable 
torsion angles of the sugar-phosphate backbone of a nucleic acid (α, β, γ, δ, ε and ζ) (Image 
adapted from Lu & Olson, 2003; Zheng et al. 2009). B. An example chemical structure of a 
single-strand of DNA. Lone pairs of electrons and negative charges are shown. The theoretical 
isoelectric point of this molecule occurs at pH 1.34. This level of protonation would possibly 
be observed at pH 7.4. (Estimations performed using Chemaxon and Marvin software 
(Manchester et al, 2010)) 
 
 
 
A. 
B. 
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1.1.4. Synthetic Nucleic Acid Analogues 
The code-scripts of DNA and RNA allow the incorporation of any one of the four major 
nucleobases. This naturally evolved genetic information system (GIS) may be expanded through 
the use of synthetic nucleic acid analogues (Betz et al. 2013). Nucleic acids with modified bases, 
backbones or sugars are collectively known as Xeno-nucleic acids (XNA). XNA molecules are 
capable of heredity and evolution. Artificially expanded genetic information systems (AEGIS) 
have been used for both in vitro and in vivo applications.  
In one study (Sefah et al. 2014), a library of polynucleotide molecules containing a 
mixture of G, C, A, T and two artificial bases Z and P (Fig. 1.4A) was described and used for in 
vitro selection experiments. Nucleic acid aptamers containing non-natural nucleobases were 
successfully raised to bind to breast cancer cell lines (MDA-MB-231, Human breast 
adenocarcinoma) and liver cancer cells (Zhang et al. 2015). The use of artificial nucleotides can 
expand the number of functional chemical groups which can be used to make a polynucleotide 
chain. The dNaM and dSICS (Fig. 1.4B) artificial nucleotides have been incorporated into the 
genome of living bacterial cells. These in vivo experiments have demonstrated that, even if the 
organism cannot synthesise these artificial nucleotides, the expanded genomes are able to be 
replicated and passed on to progeny cells. dNaM and dSICS have been given the names X and 
Y (Malyshev et al. 2014).  
Both the G, A, T, C, X, Y AEGIS and the G, A, T, C, Z, P AEGIS can be replicated 
with high fidelity using modified DNA polymerase enzymes (Pinheiro et al. 2012). As 
mentioned previously in section 1.1.2, modified sugar groups may also be used to stabilise or 
modify evolved nucleic acid structures. 4’-thio-CTP and 4’-thio-UTP have also been developed 
for use in SELEX (Kato et al. 2005). LNA, UNA and methanocarba-nucleoside analogues have 
been mentioned. Morpholino-oligonucleotides may also be used. Modified backbone nucleic 
acids such as threose nucleic acid (TNA), Glycol nucleic acid (GNA) and peptide nucleic acids 
(PNA) (Nielsen, 2010; Yu, et al. 2013) may also be used as alternative biopolymers, or used to 
hybridise with DNA and RNA. (Pinheiro & Holliger, 2012).  
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B. 
C. 
A. 
C∙G 
T∙A 
Z∙P 
X∙Y 
Figure 1.4 Natural and Synthetic base pairings.. A. Watson-Crick base pairings found in 
DNA B. The Z∙P synthetic nucleobase pairing used in AEGIS in vitro selection experiments. 
C. The dNaM and d5SICS nucleosides used in in vivo expanded genome experiments. 
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1.2. Intermolecular Nucleic Acid Interactions 
Having briefly explored the chemistry of natural and artificial sugars, backbones and bases, in 
this section the formation of intermolecular nucleic acid structures is described. The structure of 
B-form DNA was first proposed by Watson and Crick and later confirmed by Drew and 
Dickerson (Watson & Crick, 1953; Drew et al. 1981). Native double-stranded DNA is composed 
of two antiparallel polynucleotide chains. Purines and pyrimidines form H-bonded pairs along 
the central axis of the double helix while the phosphate backbones are on the outside. B-form 
DNA is the most common form DNA adopts in nature; however, it is not the only intermolecular 
conformation that duplex polynucleotide chains can (and do) adopt. 
1.2.1. Base Pairings 
Nucleobases can interact with each other along one or more hydrogen-bonding ‘edges’ (Fig. 
1.5A). For purines these are the Watson-Crick edge, the Hoogsteen edge and the sugar edge. In 
pyrimidines these are the Watson-Crick edge, the C-H edge and the sugar edge. The C-H edge 
is composed of the hydrogen bond-forming functional groups at position C4. An alternative base 
pairing system was identified by Karst Hoogsteen, and stable Hoogsteen base pairings have been 
observed in B-form DNA (Hoogsteen, 1963; Aishima et al. 2002). Hoogsteen base pairing is 
one example of the versatility of nucleobase interactions.  Reverse Hoogsteen base pairings are 
also important to the structure and function of tRNA molecules (Zagryadskaya et al. 2003).  
Analysis of crystal structures of RNA molecules reveals a great variety of base pairing 
configurations due possibly to crystal packing energies. Indeed, under appropriate conditions, 
any free ribonucleotide may form stable interactions with any other free ribonucleotide (Leontis 
& Westhof, 2002). Some examples of non-Watson Crick base pairing in DNA are a G∙T base 
pairing and an A+∙C base pairing (A+ represents a protonated form of A). These are known as 
wobble base pairings. These DNA structures coordinate ordered water molecules to resolve 
unpaired hydrogen bonds (Fig 1.5B). The wobble hypothesis, first proposed by Crick in 1965, 
states that non-Watson-Crick base pairings are involved in codon-anticodon interactions (Crick, 
1966; Yu & Li, 2011; Fonseca, 2012).  
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Figure 1.5 Hydrogen-bonding edges and alternative base pairs. A. The interacting faces of 
purine and pyrimidine ribonucleotides. Image taken from Leontis et al. 2002.  B. The 
naturally occurring G.T and A+.C wobble base pairings. These pairings demonstrate non-
Watson-Crick base pairings using the Watson and Crick interacting face of the nucleobases. 
A. 
B. 
G∙T Wobble 
A+∙C Wobble 
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1.2.2. Duplex Nucleic Acid Structures 
DNA exists in various forms depending on a number of factors, including hydration, 
temperature, concentration of ions, supercoiling, and base sequence. Three main forms are 
recognised: B, A and Z (Fig1.6). These forms of DNA are in accordance with Erwin Chargaff’s 
rule which states that in biological tissue the molar amount of A will match the molar amount 
of T and the molar amount of G will match the molar amount of C (Chargaff et al. 1951; Judson, 
1993). The formation of DNA duplexes by the formation of H-bonds between bases on opposing 
strands is assisted by the hydrophobic effect. In this, stacking of aromatic nitrogenous bases 
excludes polar water molecules to create a hydrophobic core along the central axis of the duplex.  
Right handed B-form DNA can transition into A-form DNA upon partial dehydration in 
a structurally reversible reaction (Brandes, et al. 1989; Egli et al. 1998; Lee, et al. 2012).  This 
causes a transition of sugar puckering from the C2’-endo state to the C3’ -endo state, that is, 
from South-conformation in B-form, to the North-conformation in A-form. There are exceptions 
to this rule where alternative sugar puckering is observed (Soliva et al. 1999, Trantírek et al. 
2000). Double-stranded RNA molecules also adopt more A-form like structures (Tanaka et al. 
1999; Varshavsky, 2006). Z-DNA is a left-handed helical structure of DNA. Both A- and Z-DNA 
structures are more likely to form when a duplex comprises particular sequences of nucleotides. 
For Z-DNA these sequences particularly include runs of poly (dG-dC). B and Z DNA transitional 
junctions have also been observed (Zhang, et al. 2006). The C form of DNA is rare and 
dependent on the presence of lithium or magnesium cations (Ashikawa & Ikegami 1984; Egli, 
et al. 1998; Premilat & Albiser, 1995; van Dam & Levitt, 2000).  
The double helix is a thermostable biopolymer which exists in a temperature-dependent 
equilibrium between single- and double- strand forms. The energy required to separate 50% of 
a molar concentration of complementary duplex is the melting temperature (Tm). The two 
complementary strands of DNA can be melted into individual strands as the hydrogen bonds, 
hydrophobic and van der Waals interactions between the complementary bases are broken. 
There are a large number of multi-stranded nucleic acid structures and these are not always  
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Geometry attribute   A-DNA  B-DNA  Z-DNA 
Helix sense  right-handed right-handed left-handed 
Repeating unit  1 bp  1 bp  2 bp 
Rotation/bp  32.7°  34.3°  60°/2 
bp/turn   11  10.5  12 
Inclination of bp to axis +19°  −1.2°  −9° 
Rise/bp along axis  2.3 Å (0.23 nm) 3.32 Å (0.332 nm) 3.8 Å (0.38 nm) 
Pitch/turn of helix  28.2 Å (2.82 nm) 33.2 Å (3.32 nm) 45.6 Å (4.56 nm) 
Mean propeller twist  +18°  +16°  0° 
Glycosyl angle  anti  anti  C: anti, 
G: syn 
Sugar pucker  C3'-endo  C2'-endo  C: C2'-endo, 
G: C2'-exo 
Diameter   23 Å (2.3 nm) 20 Å (2.0 nm) 18 Å (1.8 nm) 
Figure 1.6 The major forms of duplex DNA. Upper elevation is viewed down the duplex axis. 
The second elevation is viewed perpendicular to the duplex axis which is shown with a bold black 
line. Table shows basic DNA form statistics. Images adapted from (Lu & Olson, 2003). 
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comprised of the same biopolymer.  For example, hybrid nucleic acid duplexes and triplexes 
may be formed and perform specific functions; DNA – RNA hybrids play an important role in 
the CRISPR-Cas system (Garneau et al. 2010; Hwang et al. 2013; Dicarlo et al. 2013) and 
artificial biopolymers such as PNA, LNA and UNA  also can by hybridised with DNA to create 
stable duplexes (Langkjær & Wengel, 2009; Nielsen, 2010; Ho & Carter, 2011). 
 Circular Dichroism (CD) spectroscopy is a powerful and particularly useful technique 
which can provide a great deal of information about the nature of nucleic acids in solution. CD 
spectroscopy has been used to analyse the kinetics of B-to-A and B-to-Z form transitions (Ivanov 
& Minyat, 1981; Krylov et al. 1990). This technique has been used to study the formation of 
other nucleic acid structures including triplexes, quadruplexes and parallel DNA (Kypr et al, 
2009). Parallel DNA structures have been revealed by CD, and also demonstrate the amazing 
adaptability and structural versatility of polynucleotides (van de Sande et al. 1988; Parvathy et 
al. 2002). Parallel strands of DNA also play an important role in the formation of some triplex 
DNA structures. 
 
1.2.3. Triplex Nucleic Acid Structures 
Intermolecular triple helical (triplex) nucleic acid structures form in a sequence-dependant 
process. Triplex forming oligonucleotides (TFOs) may enter the major groove of DNA duplexes 
and form Hoogsteen base pairings with the duplex. DNA triplexes may be parallel or antiparallel 
(Frank-Kamenetskii & Mirkin, 1995; Fox & Gowers, 2000; Keppler, & Fox, 2001; Fox & 
Brown, 2011) (Fig 1.7). The ability to design specific triplex forming sequences allows 
manipulation of nucleic acid structures. Triplex affinity capture is one example of this (Ito & 
Cantor, 1992). A number of small molecule nucleic acid aptamers use triplex nucleic acid 
structures to form platforms for small molecule interactions. One example is the RNA flavin 
mononucleotide (FMN) aptamer which forms a triad with an accompanying base pair mismatch 
and is stabilised by the presence of FMN (Fan et al. 1996). 
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1.2.4. Quadruplex Nucleic Acid Structures 
Holliday junctions are four-strand DNA structures which play a role in the recombination of 
DNA duplex structures in vivo. The Holliday junction demonstrates that four polynucleotide 
chains may link two different DNA duplexes (Holliday, 1964; Mao, 2004). 
True DNA base quartets have also been found in vivo (Johnson et al. 2008; Lipps & 
Rhodes, 2009; Tran et al. 2011). The G-quadruplex is a stable nucleic acid structure which 
chelates a cation, usually potassium (K+) (Fig 1.8A). Inter- and intramolecular quadruplexes may 
form with a number of different topologies (Fig 1.8B). Detection of DNA G-quadruplexes is 
facilitated by the availability of a large number of fluorescent quartet-specific intercalating 
molecules such asBRACO-19 and PIPER (Monchaud & Teulade-Fichou, 2008). 
 I-motifs are another four-stranded DNA structural motif. Polycytosine sequences, when 
hemiprotonated by acidic conditions, form C-C+ bonds (Fig 1.8 C). G-quadruplex and I-motif 
structures have been observed in DNA and RNA. It is suspected that if one strand of a DNA 
duplex is extruded to form either a G-quadruplex or an I-motif then the complementary strand 
may adopt the complementary structure (Guéron & Leroy, 2000; Brazier et al. 2012). Both these 
tetraplex structures are believed to be involved in biological processes and structured nucleic 
acids including telomeres (Phan & Mergny, 2002; Randall & Griffith, 2009; Tran & Alberti, 
2011) 
G quadruplex structures may form a stable base structure for nucleic acid aptamers. 
Smart quadruplex aptamer technologies are being developed. For example, using the Thrombin-
binding aptamer as a model system, quadruplex formation is regulated by the presence of 
different cations (K+, NH4+, Ba2+, Cs+, Na+ and Li+). Quadruplex structures possessing a cation 
have a higher minimum diameter, whereas the single-stranded form of the same sequence 
oligonucleotide has a smaller minimum diameter. Folded and unfolded quadruplex structures 
may then be analysed by size exclusion and nanopore sensing technologies (Shim, & Gu, 2009). 
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Figure 1.8 Quadruplex folding A. Guanosine quartet chelating a monovalent cation. B. Guanosine topology 
diagrams, showing intermolecular Guanosine quadruplexes. C. A hemiprotonated C+-C pairing and a 
topology diagram showing the structure of a unimolecular I-motif structure. 
A. 
B. 
C. 
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1.2.5 Pentaplex Nucleic Acid Structures 
DNA pentaplexes have also been observed in crystal structures (Chaput & Switzer, 1999). Five-
stranded DNA structures can self-assemble when strands of poly-isoguanine (poly (iG)) form 
stable hydrogen bonds around a caesium ion. The large ionic radius of the Cs+ cation allows iG 
nucleobases to assemble into a pentad and then a pentaplex. This structure is not thought to be 
biologically significant. 
1.2.6. Intermolecular Functional  RNAs 
One of the most dramatic developments in chemical biology over the last twenty years has been 
the growing appreciation of the many complex functional roles RNA can play in biology, and 
can be made to play in chemical systems. The great variety of complex intermolecular RNA 
interactions within the cell demonstrates the importance of nucleic acid base pairing. The 
expression of genes may be altered by the RNA interference system (Fire et al. 1998). Both 
microRNA and small interfering RNA (siRNA) molecules can be used to induce specific 
changes in cell biology. The RNAi pathway is initiated by the enzyme Dicer, which cleaves long 
double-stranded RNA (dsRNA) molecules into short double-stranded fragments of 
approximately 20 nucleotide RNAs. Alternatively, microRNA molecules may be transcribed 
from the introns or exons of genes. Each RNA is unwound into two single-stranded RNAs, 
termed the ‘passenger’ strand and the ‘guide’ strand. The single guide strand is then incorporated 
into the RNA-induced silencing complex (RISC) (Filipowicz, 2005).  
The Ribosome itself is a complex intermolecular ribonucleic- and peptide-based 
machine. Evidence suggests that ribosomes are descendants of ancient peptide bond-forming 
ribozymes (Noller, 2012). Other large intermolecular functional RNA structures include the X-
chromosome inactivation centre (Xic) (Chow et al. 2005) which contains the X-inactive specific 
transcript (Xist) RNA gene (Penny et al. 1996). Both these examples demonstrate that functional 
RNA molecules have been evolved and utilised by nature to enact essential processes. 
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Ribonuclease P (RNase P) is another ribonucleic- and peptide-based complex which plays an 
important role in tRNA processing (Altman, 1989). 
Several other functional intramolecular RNA molecules exist in nature. These include 
Group I intron ribozymes (Cate et al. 1996; Valadkhan, 2007), the hammerhead ribozyme (the 
smallest known naturally occurring ribozyme) (Scott et al. 1995), the hepatitis delta virus (HDV) 
ribozyme (Ferre-D’Amare et al. 1998) and the hairpin ribozyme (Fedor, 2000). These small 
RNA molecules (between 40 and 90 nt) show that ribozymes are widespread and essential in 
nature. 
1.3. Intramolecular Nucleic Acid Structures 
This thesis focuses on structures created by single nucleic acid molecules and the formation of 
intramolecular nucleic acid interactions. Single polynucleotide chains are governed by the same 
chemical laws that allow the formation of intermolecular duplex, triplex, quadruplex and 
pentaplex DNA structures. A single polymer chain will adopt structures which allow the 
formation of hydrogen bonds and minimise the interaction of hydrophobic nitrogenous bases 
with free water molecules at a given temperature (T). These folding processes are driven by 
enthalpy (ΔH) and entropy (ΔS) (Petruska & Goodman, 1995; Müller et al.  2006).  The nucleic 
acid folding software programs used in this thesis function by calculating the theoretical most 
favourable structure with the minimum free energy (ΔG in J·mol−1) (Hofacker 2003; Sharma  et 
al. 2008). Free energy is defined as ΔG=ΔH–TΔS. Both ssDNA and RNA may adopt complex 
structures depending on the sequence of the nucleotides and several other conditions including 
hydration, temperature, cation concentration, crowding agents, pH etc. This single-strand 
flexibility allows the formation of a number of secondary structures including folds, hairpins, 
pseudoknots, kissing loops etc. The flexibility of these biopolymers allows complex molecular 
structures with even only a few nucleotides. Examples of these include the thrombin-binding 
ssDNA palindromic unimolecular quadruplex (mentioned in section 1.2.4) comprising only 
fifteen nucleotides (Macaya et al. 1993; Paborsky et al. 1993; Fialová et al. 2006), a thirteen-
nucleotide ssRNA sequence that can differentiate between theophylline and caffeine with 
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exquisite specificity (Anderson & Mecozzi, 2005), and also a five-nucleotide RNA molecule 
which catalyses the aminoacylation of a complementary four-nucleotide RNA (Turk et al. 2010).  
Single strand nucleic acid molecules are capable of high affinity and specificity of 
binding and can catalyse complex biological processes. The nucleic acid combinatorial 
chemistry aspect of SELEX relies on the assumption that single-stranded nucleic acid molecules 
will adopt a number of different intramolecular structures if the polymers have different 
monomer sequences. Some of these potential structures are explored below. 
 
1.3.1. Stem-loops, Pseudoknots and Bulges 
Intramolecular hairpin structures are a common sequence motif found in single strand nucleic 
acids. Sometimes called snapbacks or stem-loops, these structures are formed by a nucleic acid 
sequence folding back upon itself and forming intramolecular base pairings. This structure 
allows the formation of a relatively short stable duplex, with base stacking but formed from only 
one strand (Fig 1.9A, Fig 1.10A). Pseudoknots are formed when two adjacent stem-loop 
structures are partially linked together by inter-loop base pairings. Double pseudoknots and 
kissing pseudoknots are common motifs in RNA molecules. Bulges occur between two regions 
of base pairing sequences. Non-complementary regions may symmetrically or asymmetrically 
distort the direction of the axis of the helix, which may lead to kinks in the nucleic acid structure. 
Bulges and kinks in nucleic acid structures often form specific binding pockets for small 
molecules.  
In vitro selection experiments were performed where the initial pool of variable 
sequence polynucleotides had a fixed hairpin-forming loop sequence in the centre. This meant 
that hairpin forming aptamers would be selected (Komatsu et al. 2002). Pseudoknot RNA 
sequences have been shown to interact with human immunodeficiency virus (HIV) reverse 
transcriptase (Kensch et al. 2000). Kissing loop RNA molecules have also been selected to bind 
to the trans-activation responsive (TAR) element of HIV-1 (Ducongé & Toulmé, 1999). 
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Figure 1.9 Schematic representations of base-pairing configurations in single-stranded nucleic acids. A. 2D 
representation of hairpins, pseudoknots and bulges. B. Schematic of an H-DNA protonated triplex. C. 
Diagram of a possible unimolecular quadruplex; a number of other topological states are possible. 
Hairpins Pseudoknots 
Bulges 
Unimolecular 
quadruplex 
H-DNA 
A. 
B. C. 
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1.3.2. Intramolecular Triplex Structures  
H-DNA is a form of protonated triplex DNA (Fig 1.9B). The name H-DNA comes from the 
requirement of H+ ions (Frank-Kamenetskii & Mirkin, 1994) which allow the formation of 
C+∙GC triplets. Single strand DNA has been used to evolve an intramolecular triplex adenosine-
sensitive sensor. These DNA triplex structures contain abasic sites which create a binding pocket 
for the specific binding of adenosine (Patel, & Huang, 2011). Both DNA and RNA triple-
stranded structures may form. Some directed molecular evolution experiments have even been 
used to select triplex-forming sequences from a randomised library of sequences. For example, 
SELEX was used to identify and evolve triplex-forming oligonucleotides which bound within 
the major groove of DNA (Ayel & Escudé, 2009). H-DNA was first described as an 
intramolecular triplex to differentiate it from the triple stranded structures described in Section 
1.2.3. In addition to the triads described in Fig. 1.7, stable guanosine base triplets have also 
recently been described using NMR spectroscopy (Fig 1.10B) (Limongelli et al. 2013). It is 
unclear however as to if these 11 nt triplex forming sequences are simply a transitional state 
which nucleic acids pass through in order to form a more stable G-quadruplex structure. These 
structures only require a single strand to form and demonstrate the flexibility of ssDNA. 
1.3.3. Intramolecular Quadruplex Structures 
Unimolecular quadruplexes may be formed from single nucleic acid strands. The archetype 
fifteen nucleotide unimolecular quadruplex thrombin-binding aptamer has previously been 
mentioned. Quadruplex forming DNA sequences have been used in molecular evolution 
experiments to raise G-quadruplex based DNAzymes (Zhu et al. 2012). The thermodynamic 
stability of unimolecular quadruplex structures may be altered by the incorporation of unnatural 
nucleotide analogues (Pasternak et al. 2011; Aviñó et al. 2012). Unimolecular quadruplex 
forming aptamer structures may also be extended (De Rache et al. 2012) and chimeric linked. 
DNA aptamers may be created which bind to multiple sites on the same protein (Hasegawa et 
al. 2008) 
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Figure 1.10 A. A 15 nt DNA hairpin NMR structure of sequence 5’ CGCGAAGCATTCGCG 3’ (Lim & 
Phan, 2013) (PDB 2M8Y).  B.  An 11 nt DNA triplex NMR structure of sequence 5’ GGTTGGTGTGG 3’ 
(Cerofolini et al. 2014) (PDB 2MKM). 
  
A. 
B. 
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1.3.4. Riboswitches and Ribozymes 
The structural motifs found in single-stranded nucleic acids play important roles in biology. 
These are exemplified by inter- and intramolecular RNA structures. Messenger RNA (mRNA) 
acts as the temporary transporter of genome information and is key in the central dogma of 
molecular biology. It demonstrates that single nucleic acid biopolymers are sufficient to carry 
genetic information. Group II, IV, V and VI viruses also have single strand DNA and RNA 
genomes. The sequence of nucleobases that form a single polynucleotide chain conveys a 
primary or single level of information. Any structures then adopted by specific nucleic acid 
single strands can be classed as a ‘secondary’ level of information and can have particular 
regulatory effects.  
Example of functional single-stranded structures include mRNA postcodes. In these, highly 
structured regions in the 3’ UTR of mRNA have been shown to direct the localisation of some 
mRNA molecules within single developing eukaryotic cells (Singer, 1993; Oleynikov & Singer 
1998). The variety of structural motifs that can be formed by single-stranded nucleic acid 
molecules generates the second level of information that can be conveyed with the molecules. 
Specifically, the nucleic acid sequence of the biopolymer may specify which order of amino 
acids are to be synthesised in translation, but the secondary structures adopted may specify 
where and for how long the molecule is to be expressed or under what conditions.  
Self-folded RNA molecules which encode true catalytic functions are called ribozymes. 
Many natural and artificial ribozymes have been studied (Pyle, 1993; Serganov & Patel, 2007). 
Most ribozyme functions involve catalysing self-splicing or splicing of other nucleic acid 
molecules (Chen et al. 2011), catalysing ligation of nucleic acid molecules (Canny et al. 2007) 
or catalysing aminoacylation (Yarus, 2011). Examples of ribozymes include the beta-globin co-
transcriptional cleavage ribozyme (CotC ribozyme) which may be involved in transcription 
termination of RNA polymerase II at beta-globin genes (Dye & Proudfoot, 2001; Teixeira et al. 
2004). The GIR1 branching ribozyme catalyses the nucleophilic attack of an internal 2’ hydroxyl 
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group at a neighbouring phosphodiester bond, creating a lariat cap which increases the longevity 
of downstream nucleic acids (Nielsen et al. 2005).  
Intramolecular ribonucleic acid structures which respond to or are altered by the binding of 
a cofactor and lead to subsequent effects are called riboswitches. Riboswitches can alter gene 
expression in response to external stimuli, thus creating feedback loops. An example of an RNA 
structure which is both a riboswitch and a ribozyme is the glucosamine-6-phosphate activated 
ribozyme. This ribozyme exists within the 5’ UTR of the GlmS mRNA. The riboswitch responds 
to the presence of glucosamine-6-phosphate. When no GlcN6P is bound, (because intracellular 
levels are low) the ribozyme forms a stable double pseudoknot structure and allows transcription 
of the gene glmS which encodes the synthesis of the GlmS enzyme, which in turn catalyses the 
reaction to synthesize GlcN6P. This causes intracellular levels of the metabolite to increase. 
When GlcN6P is bound, the ribozyme is activated and a self-splicing reaction occurs causing 
degradation of the glmS mRNA. This causes expression of the GlmS enzyme to reduce and 
synthesis of GlcN6P to attenuate. This completes a negative feedback loop which regulates 
intracellular levels of GlcN6P (Klein & Ferré-D’Amaré, 2006, 2009; Xin & Hamelberg, 2010). 
Other examples of a natural riboswitch which regulates intracellular metabolite levels 
include the purine riboswitches (Fig 1.11). These are found to be abundant among many 
prokaryotic species (Singh & Sengupta, 2012). These functional intramolecular nucleic acid 
sequences are associated with a number of genes which encode for proteins which catalyse the 
manufacture or efflux of purines in prokaryotes. The adenine riboswitch specifically binds to 
adenine and alters expression of downstream genes (Fig 1.11A).  Bound adenine is stabilised 
and coordinated by four uracil residues. The addition of adenine induces a conformational shift 
within the nucleic acid structure which subsequently exposes the Shine-Dalgarno sequence and 
start sequence. 
The adenine riboswitch controls expression of the add gene which encodes an adenine 
deaminase enzyme which converts adenine to inosine. When adenine is bound to the riboswitch 
(due to high levels of intracellular adenine) the add gene is expressed, which promotes the   
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Figure 1.11 Purine Riboswitches (adapted from Serganov et al. 2004 and Kim & Breaker, 2008) A. 
Prokaryotic adenine-sensitive riboswitch B. Prokaryotic guanine-sensitive riboswitch. Both structures were 
determined by X-ray crystallography,  
  
  
A. 
B. 
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production of adenine deaminase, which subsequently reduces adenine levels and increases 
levels of inosine, thus completing the feedback loop (Lemay et al. 2006; Lemay & Lafontaine, 
2007). An adenine riboswitch can also regulate the expression of the pbuE gene which encodes 
a purine efflux pump which actively transports purines outside of the cell. In this way, high 
levels of intracellular adenine can lead to adenine being removed from the cell (Nygaard & 
Saxild, 2005; Seif & Altman, 2008). Whereas the adenine riboswitch increases expression of 
enzymes which diminish adenine levels in response to high levels of adenine, the intramolecular 
guanosine riboswitches have been shown to decrease expression of enzymes important to 
guanine synthesis. Binding of guanine to the guanine riboswitch (Fig 1.11B) induces a two-state 
allosteric conformational shift which facilitates greater stability and Mg2+ -binding which 
induces reduced expression of the downstream gene xpt (Brenner et al. 2010). Ribozymes and 
riboswitches both act as regulatory elements in living organisms. Use of functional ribozymes 
gives organisms an evolutionary advantage as it allows the organisms to convey not only which 
sequence of amino acids should be expressed, but where in the cell (spatial control), under which 
conditions (conditional control) and for how long (temporal control) using a single-stranded 
nucleic acid sequence. 
An artificial ribozyme has been evolved which only contains two different 
ribonucleotides. The D-U ribozyme contains only 2,6 diaminopurine and uracil nucleobases and 
is able to catalyse the template-directed ligation of RNA molecules with high efficiency (Reader 
& Joyce, 2002). 
1.3.5. Intramolecular Deoxyribozymes 
Folded ssDNA also has the ability to catalyse reactions under some conditions. Deoxyribozymes 
(DNAzymes) have been shown to possess the same cleavage abilities of ribozymes (Breaker & 
Joyce, 1994, 1995). Many DNAzymes have been described with varying functions. While 
ribozymes are common throughout nature and can be evolved in experimentation, DNAzymes 
are almost universally synthetically evolved (Achenbach et al. 2004; Breaker & Joyce, 2014). 
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DNAzymes can also ligate and cleave DNA molecules (Carmi & Breaker, 1998; 
Sreedhara & Breaker, 2004). A DNA molecule has been evolved using in vitro selection which 
forms a very basic DNA repair mechanism. This DNAzyme uses serotonin as a cofactor and 
catalyses the repair of UV-induced DNA thymine dimer crosslinks (Chinnapen & Sen, 2004). 
Functional RNA molecules may be synthesised using DNA and retain function. One example is 
the dopamine-binding aptamer which was initially evolved as an RNA molecule; the sequence 
was made from deoxyribonucleotides and Uracil monomers were converted to Thymine making 
ssDNA (Walsh & DeRosa, 2009). Ribozymes can also be gradually converted into 
deoxyribozymes using molecular evolution. One example of this is the R3 RNA ligase ribozyme 
which was converted to a deoxyribozyme (Paul & Joyce, 2006). 
 DNAzymes are not just chemical analogues of ribozymes. One example is the G-
quadruplex peroxidase-like DNAzyme named PS2.M (Li et al. 2010). Under certain conditions, 
and in the presence of porphyrin ring compounds and potassium ions, G-quadruplex DNA 
structures can catalyse the breakdown of hydrogen peroxide. This can be detected with high 
sensitivity by the use of colour-changing dyes such as luminol. This reaction is inhibited by the 
presence of Pb2+ ions, as these ions displace the porphyrin ring from the DNA structure. This 
has been used to create a highly sensitive Pb2+ detection system. These peroxidase-like 
DNAzymes can also be stabilised by extending the DNA sequence with thymine residues in the 
5’ and 3’ direction (M. Zhang et al. 2012). 
 DNAzymes have been isolated which catalyse important biochemical reactions, 
including for example the Zn2+-dependent phosphomonoester hydrolysis of tyrosine and serine 
side chains. In this way, DNA can act similarly to a phosphatase enzyme (Chandrasekar & 
Silverman, 2013). This phosphatase mimic can remove phosphates from serine, tyrosine and 
hexapeptide substrates containing both phosphorylated serine and tyrosine simultaneously. A 
thorough review of the chemical catalytic activity of DNAzymes was published in late 2015 
(Hollenstein, 2015). 
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 The first DNAzymes were isolated by modifying the in vitro selection protocols 
(Breaker & Joyce, 1994). Although catalytic RNA molecules had previously been found in 
living organisms (Kruger et al. 1982) DNAzymes were found to be more stable, less expensive 
and were able to be synthesised with greater purity in higher quantities. 
1.4. Molecular Evolution and Genetic Information Systems 
When the phrase ‘molecular evolution’ is used in this thesis, generally it refers to the laboratory 
based evolution of molecules and not to the study of the natural evolution of organisms using 
molecular techniques. However, all life on earth can be described as a mechanism used by 
nucleic acids for increasing their longevity and facilitating replication. All organisms represent 
survival machines evolved and maintained by heritable biopolymers for the purposes of 
protection and propagation, so life can be viewed as a by-product of the evolution of nucleic 
acids.  DNA is one example of a heritable polymer. The nature of DNA was correctly predicted 
in 1944 by Erwin Schrödinger who described the covalent molecule of inheritance as an 
aperiodic crystal containing some kind of code script.  All animate life contains DNA, or its 
analogue RNA. All the diversity of life arises from variations in the sequence of DNA. DNA 
gives life complexity and yet makes all living organisms related (Schrödinger, 1944) 
DNA replication is imperfect. The ability of DNA to encode imperfect self-replication 
systems (enzymes) is the source of the complexity of life. Evolution as described by Darwin is 
the preservation and accumulation of successive slight favourable variations over enormous 
lengths of time. Variation arises from the errors made by genetic polymers in replication. DNA 
strikes a fine balance: Perfect high-fidelity replication causes no genetic diversity and no 
evolution. Too many errors causes genetic nonsense, irreproducibility and decay to 
thermodynamic equilibrium. This scenario is known as an error catastrophe. 
“The capacity to blunder slightly is the real marvel of DNA. Without this special attribute, we 
would still be anaerobic bacteria and there would be no music.” - Lewis Thomas- (1974) 
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It is important to point out that the early nucleic acids that provided the fundamental 
building blocks of evolution on this planet may not be the only polymers capable of molecular 
heredity. All that is required for Darwinian evolution is a method of information storage, such 
as a code or pattern of distinct units, a method of replicating this information with high but 
imperfect fidelity to generate variation, and a form of selective pressure which can stop some 
variant forms of the information replicating and thus provide the “struggle for existence”.  
Darwin demonstrated that the selective pressure put upon organisms can come from different 
sources. Organisms can be put under selective pressure by direct human intervention through 
selective breeding, or pressure can come from the environment (food, prey, climate, mating etc.) 
through natural selection. In the molecular biology era, in vitro Darwinian evolution of 
molecules demonstrates that evolutionary selection can occur without the need of a living 
organism since synthetic polymers are capable of preserving and accumulating favourable traits 
by modifying the primary sequence of monomers. DNA, RNA and peptide molecules with 
identical primary sequences of monomers will adopt similar higher-order structures with 
minimum free energies under identical conditions. A specific sequence of DNA, under a given 
set of experimental conditions, may fold into a number of stable states, governed by 
thermodynamic constraints. Importantly for aptamers, the probability of forming this stable state 
can be modified by the presence or absence of binding ligands. This creates a link between a 
molecule’s heritable primary sequence (‘molecular genotype’) and the final 3D structure created 
by that sequence (‘molecular phenotype’). A polymer’s primary sequence may be copied and 
the new molecule will have similar chemical and structural characteristics to the progenitor 
molecule. If the copying process is imperfect then a number of variant progeny sequences may 
be created. Each of these may possess slightly varied chemical properties meaning they may be 
better or worse at performing certain tasks when compared to ancestor molecules. This makes 
every molecule capable of forming the root of a new phylogenetic tree. Any form of stable 
information which can be imperfectly replicated is a genetic information system (GIS). 
Information is passed from ancestor to progeny. This could be a series of zeros and ones in a 
binary code being copied, photocopying a sheet of paper. In each case there is the transmission 
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of information and the creation of a new generation. SELEX relies on this process. As rounds of 
SELEX progress, information is stored, replicated (imperfectly), selected and transmitted to a 
new generation. Molecular genetic information systems usually come in the form of polymers 
since these represent a single readable and replicable line of information specifically the order 
of monomers. The advantage of ssDNA, RNA, peptide and XNA polymers is that the monomers 
have varied functional groups. If the monomers were similar (or identical) there would be no 
variation in the structure or activity of the molecules and therefore little to no different responses 
to selective pressure. SELEX should not in theory be performed using only one nucleotide as 
this would not generate structural diversity. However, polynucleotides of a single monomer 
sometimes have specific properties. For example, polynucleotides adhere to glass (silicate) 
surfaces (Carlson, & Hall, 2014). 
1.4.1. Strategies for Molecular Evolution 
In the book Genes in Conflict: The Biology of Selfish Genetic Elements, Austin Burt and Robert 
Trivers describe three mechanisms that a selfish gene can use to self-promote across generations 
(Johnson, Burt, & Trivers, 2007). These are relevant to this thesis as synthetic nucleic acids may 
use similar strategies during SELEX.  These are (i) Interference, (ii) Over-replication and (iii) 
Gonotaxis. They are mentioned here, because these strategies used by nucleic acids in vivo 
reflect upon possible strategies used by nucleic acids in vitro. Observing how DNA responds to 
selective pressure in nature may illuminate the evolutionary pathways used by DNA in directed 
molecular evolution. 
(i) Interference is the term used to describe a gene’s direct involvement in the survival 
or destruction of competing genetic elements. Where there is competition for resources, “A” 
may promote its own chances for survival by eliminating “B”. Examples of this include the 
segregation distorter (sd) in Drosophila melanogaster, the t haplotype of chromosome 17 in Mus 
musculus (mouse) and the spore killer (sk) in Neurospora sp (Turner & David, 1991; Ardlie, 
1998; Larracuente & Presgraves, 2012;). These genes eliminate gametes that do not contain 
identical genetic elements. This is done by producing gametocidal chemicals that the producers 
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are themselves immune to. This increases the relative proportion of gametes containing the 
selfish element. This may occur even if the genes are lethal to the organism.  Homozygous t 
haplotype male mice are completely sterile. These genetic elements violate Mendelian laws of 
segregation in order to gain an advantage over competing elements. This strategy is similar to 
that used by fledgling cuckoos, who destroy competing organisms by destroying eggs. The 
Maternal effect dominant embryonic arrest (Medea) gene found in some species of beetle has 
been shown when transferred into Drosophila melanogaster to eliminate all progeny that do not 
contain a copy of the Medea gene. The gene produces a toxic microRNA that blocks the 
expression of the vital gene myd88. The Medea gene also contains the antidote to this toxic 
nucleic acid in the form of a toxin-resistant variant of the myd88 gene. In lab trials where 25% 
of the original members were homozygous for Medea, the gene spread to the entire population 
within 10 to 12 generations. This demonstrates the ability of nucleic acids to promote themselves 
at the expense of others. 
A synthetic polymer could also exhibit this strategy. In a system where two or more 
evolvable polymers were competing for resources, it would be advantageous for one of the units 
to halt the replication of the other. In the case of nucleic acid polymers, this could be done by 
one genetic element being able to catalyse the hydrolysis of the phosphate backbones of the 
competing nucleic acids. Indeed, it has been demonstrated that ribozymes can be evolved which 
can catalyse splicing. Examples include the hammerhead ribozyme, the Hepatitis Delta Virus 
(HDV) ribozyme, and the hairpin ribozyme (Robertson & Joyce, 1990). Would it therefore be 
possible for one nucleic acid sequence to ensure survival by eliminating competition?  
(ii) The second strategy by which a self-promoting genetic element may ensure survival 
is by over-replication. This strategy involves a genetic element replicating more when compared 
to competing genetic elements. Examples include, at the molecular level, the homing 
endonucleases. Homing endonucleases are gene-encoded proteins with highly sequence-specific 
endonuclease activity. Once transcribed and translated the enzyme will catalyse a double-
stranded break at a specific site on the other chromosome (the one not containing the Homing 
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endonuclease genes (HEGs)) using a 15-30 bp DNA recognition sequences. This double-
stranded break (DSB) must then be resolved using the cell’s homologous recombination repair 
mechanism. This requires the original chromosome containing the HEGs to act as the template 
for repair. The result of this is that the HEGs are copied into the other chromosome. The HEGs 
have therefore selfishly doubled the number of HEGs within the cell. It also means that no matter 
which chromosome is selected in meiosis to form a gamete, the HEGs will be present. This is 
an example of a viable strategy in intragenomic conflict (Windbichler et al. 2011; Hafez, et al. 
2012). Transposons and Viruses both use the over-replication strategy to promote genetic 
elements over those of the host organism.   
A synthetic biopolymer may also be able to use this strategy. If the polymer could 
develop a method of catalysing self-replication, then it would potentially have an advantage over 
species which did not use this method. This could be done by decreasing the time or resources 
required to fully replicate a heritable element or by acquiring sequences or characteristic which 
would facilitate replication more easily. This would result in one sequence of nucleotides 
becoming more abundant as generations progressed. The absolute fitness of a genotype can be 
defined as the number of individuals with that genotype in a generation divided by the number 
of individuals with the same genotype in the previous generation. Fitness (w) is a central idea in 
evolutionary theory. It can be defined either with respect to a genotype or to a phenotype in a 
given environment. It describes the ability to both survive and reproduce, and is equal to the 
average contribution to the gene pool of the next generation that is made by an average individual 
of the specified genotype or phenotype. If the average individual with a certain genotype 
survives and reproduces causing the number of progeny with that individual’s genotype to 
increase then the organism is said to have high “Darwinian fitness”.  
wabs is absolute fitness of a genotype or phenotype and N is the number of organisms with that 
genotype or phenotype before and after a replication, i.e. the progeny generation and the ancestor 
𝑤𝑎𝑏𝑠  = 
𝑁𝑎𝑓𝑡𝑒𝑟
𝑁𝑏𝑒𝑓𝑜𝑟𝑒
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generation. Is it possible for a synthetic biopolymer to increase in absolute fitness and therefore 
multiply itself more efficiently? 
(iii) The third method used by selfish genetic elements is Gonotaxis. This method 
requires a selfish genetic element to ensure transmission to the next generation by ensuring that 
(during meiosis) they are selected for the germline rather than non-gametes. This takes place in 
oogenesis where during meiosis chromosomes and chromatids are separated into oocytes and 
polar bodies. The genetic elements that go to make up the polar bodies are essentially doomed 
as they will not go on to the next generation. It is therefore in the interest of selfish genetic 
elements to ensure transport into the germline. This strategy does not fit as well as the other two 
into the sphere of synthetic in vitro Darwinism. Directed molecular evolution does not require 
gametogenesis. Biopolymers can replicate without survival machines. A macromolecule may 
increase its chances of replication by possessing any sequences required for replication (such as 
a primer-binding sequence or promoter). These must not be obscured or occluded by other 
interfering sequences. The biopolymer also may develop mechanisms to ensure that all the 
resources required for replication are available in abundance. A synthetic biopolymer may also 
survive selective pressure, not by adapting to it, but by evolving to connect to molecules which 
are responding successfully to the selective pressure. This could in theory represent a form of 
biopolymer parasitism, where a polymer would ensure survival by latching on to a stronger 
candidate during selection. It is possible that these strategies for ensuring the survivability of 
molecules existed even before the emergence of cellular life. 
1.4.2. The RNA World 
The Central Dogma of molecular biology defines DNA as the storage system of hereditary 
information, RNA as the intermediary messenger and proteins as cellular catalysts. The RNA 
world hypothesis states that on the prebiotic earth, ribonucleic acids likely came soon after the 
first precursor biopolymers and that through natural selective pressure RNA became ever more 
complex and eventually lead to cellular biogenesis. The rise of RNA as the candidate for a 
prebiotic ancestor molecule rests on many studies that demonstrate that RNA was able to both 
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store heritable information and act as a catalyst for many complex functions (Harris, 2010). RNA 
molecules which encode for catalytic functions are called ribozymes (discussed previously in 
section 1.3.4).  
1.4.3. Directed Molecular Evolution 
Charles Darwin found that all living creatures were sculpted by the struggle for existence. 
Darwin compared the selective power of nature with human directed selection of domesticated 
species (Darwin, 1859). This highlights the ability of humans to change not only our 
environment but, through application of selective pressure, the evolutionary pathways of other 
organisms. The same is true of molecules. Humans have evolved the ability to firstly, 
insentiently apply selective pressure to our environment through feeding, hunting and living; 
secondly, to apply consciously selective pressures to species through domestication and selective 
breeding; thirdly, to select premeditatedly for specific target genes through molecular techniques 
and genetic engineering and, most recently, to apply selective pressure to populations of 
synthetic chemicals. As humans advance technologically, the focus of human intervention and 
selective pressure becomes more precise, and yet, in all these human interventions, the same 
Darwinian laws apply. Organisms have a genotype and a phenotype. The genotype is the 
heritable record of the information which defines the organism’s evolutionary history and 
characteristics. The phenotype is the physical manifestation of that information as particular 
characteristics. Nucleic acids and associated epigenetic factors are the carriers of heritable 
information in organisms. The molecules themselves contain information and that is physically 
expressed as a nucleic acid structure. As discussed above, DNA and RNA can act as both 
molecules of heredity and catalysis. 
The first documented case of laboratory-based selective pressure on nucleic acid 
sequences was published in 1967. Dr Sol Spiegelman and colleagues at Columbia University 
worked on the Group IV bacteriophage Qβ. The genome of bacteriophage Qβ is 4217 nt in length 
and made of RNA. The genome is highly structured to protect it from bacterial nucleases. Only 
four proteins are encoded by the genome, one of which is Qβ replicase. This enzyme catalyses 
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the replication of the viral genome. The genome is therefore a macromolecule of heritable 
information shaped by evolution and the replicase a mechanism of replication. 
‘What will happen to the RNA molecules if the only demand made on them is the Biblical 
injunction, multiply, with the biological proviso that they do so as rapidly as possible?’ – Sol 
Spiegelman, 1967. 
The purified viral genome was subjected to multiple rounds of amplification by the 
purified replicase. Ribonucleotides were provided in excess as building blocks for the new 
synthetic progeny molecules. The experiment was carried out in vitro. Crucially, at no point was 
the genome translated into proteins, meaning that the genome no longer had any selective 
pressure to produce these proteins. The rationale was to see whether sub-populations, (20 µl 
aliquots of the 250 µl reaction) of exponentially amplified RNA molecules were taken to be the 
template for the next round of amplification. As this selection method was unbiased, the only 
selective pressure acting on the RNA genomes was to produce as many progeny as possible 
relative to other members of the population. The molecules therefore began to increase in 
replicative fitness over seventy-five generations. The molecules became shorter and replicated 
faster when compared to the original RNA genome (Fig. 1.12). The 74th generation of progeny 
molecules also became more susceptible to nuclease digestion, as the RNA genome no longer 
had a life cycle which involved surviving within a eukaryotic host organism. This meant that 
nuclease resistance was no longer required. This marks the first incidence of human intervention 
directing the evolution of nucleic acids (Mills & Spiegelman, 1967).  
The Qβ genome and replicase then became a model system for the study of molecular 
evolution (Pace et al. 1967). A number of different selective pressure experiments were 
performed. These included studying the replication of the genome when one nucleotide 
concentration was incrementally depleted (Levisohn & Spiegelman, 1969). This imposed a 
selective pressure on the evolving molecules. Molecules that required one or more cytidine 5’-
triphosphate (CTP) molecules were at a significant evolutionary disadvantage when CTP was 
depleted. Another set of experiments studied the incorporation of 7-Deaza-adenosine,   
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Figure 1.12 The first study of human-directed laboratory-based evolution of nucleic acids (taken from Mills 
& Spiegelman, 1967).  The time-course enzymatic amplification experiments demonstrate the increased 
“Darwinian fitness” and replicative ability of the progeny pool of evolved RNA molecules (74th transfer 
primed) when compared with the ancestor (Qβ RNA primed). As the reaction mixtures were identical in all 
aspects apart from the template RNA molecules, the difference in absolute fitness of the molecules is an 
intrinsic characteristic to the template sequences.  
  
Original figure legend: ‘A comparison of the kinetics of synthesis of the 
74th variant and the original Qβ RNA. Two 0.25 ml standard reactions, 
one with gel-purified single-stranded variant RNA (74th transfer) and the 
other with Qβ RNA (both above saturations), were initiated at 35 ˚C. 
Aliquots of 0.02 ml were drawn at times indicated and assayed for 
incorporation of P32 –UTP. Data are represented as cpm/0.02 ml.’  
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a nucleotide analogue in the place of ATP (Levisohn & Spiegelman, 1969). In vitro directed 
evolution of Qβ was also performed in increasing concentrations of ethidium bromide. Ethidium 
ions intercalated and stabilised double-stranded RNA structures so that the sequences become 
inaccessible to the replicase (Kramer et al. 1974). This placed a strong selective pressure against 
sequences which form double-stranded structures. In all cases it was found that after a number 
of generations the original nucleic acid sequence adapted to the conditions imposed upon it. If 
we describe the Qβ genome as the ancestor molecule then the progeny molecules adapted to 
replicate more efficiently when compared to the ancestor, under the conditions described above.  
 
1.5. SELEX 
The nucleic acid chemistry, nucleic acid structure, molecular evolution and genetic information 
systems discussed above are now combined into a discussion of SELEX, the fundamental 
process used in this thesis. 
1.5.1. A Brief History of SELEX 
SELEX is an artificial (and indeed patented) process by which molecules that carry heritable 
information may be placed under selective pressure and undergo continuous generations of 
selection, amplification and mutation until desired characteristics emerge. The idea developed 
in the late 1980s and the fundamental ideas were published by Gerald Joyce and colleagues. 
(Joyce, 1989). Earlier work had demonstrated that the ‘survival of the fittest’ model could be 
applied to molecular evolution.  “The arrival of the fittest” remained a problem.  
Several breakthroughs in molecular biology catalysed the development of SELEX. They key 
issue was the ability to synthesise nucleotide libraries containing many variant sequences. This 
solved the problem of generating initial variation (Beaucage & Iyer, 1992). The polymerase 
chain reaction using thermostable Taq DNA polymerase provided an efficient and partially 
error-prone means of replication (Mullis et al. 1986; Mullis, 1990) and advances in sequencing 
technology and software analysis decreased the cost of nucleotide analysis (Sanger & Coulson, 
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1975; Sanger & Nicklen, 1977; Smith et al. 1986). In vitro transcription of RNA molecules also 
improved (Ling et al. 1989). The combination of these technologies facilitated the advancement 
of the field of synthetic molecular genetics. 
The term SELEX was first used to describe a set of experiments performed to isolate single-
stranded RNA ligands to T4 DNA polymerase (Tuerk & Gold, 1990).  High-affinity nucleic acid 
ligands for the protein were isolated by a procedure of alternate cycles of ligand selection from 
pools of variant RNA sequences and amplification of the bound species. The bound molecules 
were exponentially enriched by reverse transcription and subsequent PCR and the resulting pool 
of molecules was analysed by cloning. Eight randomised nucleotides were used in the initial 
pool, so the initial starting pool theoretically contained 48 (65,536) possible species.  
Intriguingly, on the tenth of June 1991, this process was then patented in both US and 
European patent offices. Larry Gold and Craig Tuerk founded NeXstar Pharmaceuticals in 
Boulder, Colorado, USA which holds the patent for SELEX (PCT/US1991/004078 - 
EP19910912753). 
Other in vitro selection experiments performed at the time also involved the selection of 
RNA molecules which demonstrated strong specific binding to organic dyes. These experiments 
investigated the number of variable RNA sequences (and therefore structures) required to 
generate a molecule capable of specific binding (an aptamer) or catalytic activity (a ribozyme). 
These experiments found that “roughly” 1010 starting molecules were required as a minimum in 
order to isolate a structure with binding or catalytic activity (Ellington & Szostak, 1990).  
Both groups demonstrated that it was possible to isolate RNA sequences with specific 
binding activity from a randomised library using PCR, in vitro transcription, in vitro selection, 
reverse transcription, cloning and sequencing. Darwinian in vitro evolution had led to the 
emergence of nucleic acid sequences which formed structures that had high specificity and  
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Figure 1.13 Four Nucleic Acid Aptamer Structures. A  The Malachite Green RNA Aptamer (Malachite Green 
shown in green) (PDB 1F1T.) B The “Spinach” RNA Aptamer (Fluorophore shown in blue, K+ shown in 
Purple, Mg 2+ shown in Green) (PDB 4Q9Q).  C Thrombin-binding quadruplex DNA aptamer and Thrombin 
(K+ shown in Purple, Thrombin shown in blue) (PDB 4DII). D The Argininamide-binding DNA aptamer 
(Argininamide shown in magenta) (PDB 1DB6). A, B and C are X-ray crystallography structures; D was 
determined by NMR. 
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affinity to a particular target. The term ‘aptamer’ was first coined by Professor Szostak in 1990. 
These nucleic acid sequences were named Aptamers (from the Latin aptus - fit, and Greek meros 
– part). Although nucleic acid sequences with strong specific binding of course exist in nature, 
an aptamer is the product of human-directed evolution of nucleic acid molecules (See Fig 1.13 
for four examples of evolved ssDNA and ssRNA aptamers). Aptamers have been compared to 
antibodies, as both molecules exhibit high specificity and affinity. Aptamers however are more 
heat-stable and less expensive than antibodies (Jayasena, 1999; Khati, 2010) and have great 
therapeutic potential (Keefe, & Ellington, 2010). 
1.5.2. DNA SELEX 
The first in vitro selection experiments were performed using RNA molecules transcribed from 
randomised DNA libraries. Later it was found that single strands of DNA were also capable of 
evolving in response to selective pressure. Shortly after the development of the first RNA 
aptamers, the Szostak lab proceeded to evolve the first ssDNA aptamers against organic dyes, 
adenosine and human thrombin (Huizenga & Szostak, 1995). 
DNA proved to be as versatile as RNA with the added bonus of increased chemical stability. 
DNA SELEX eliminated the need for in vitro transcriptions and reverse transcriptions, with time 
and cost benefits. However, new technologies were required to facilitate the generation of single-
stranded DNA. Since the late 1980s and the development of PCR, a number of methods have 
been used to regenerate a single strand of DNA from a duplex PCR fragment. These include: 
denaturing gel electrophoresis band extraction, which was used to raise enantioselective ssDNA 
aptamers against ibuprofen (Kim et al. 2010), magnetic bead strand separation which was used 
to raise high affinity inhibitory aptamers against Taq DNA polymerase (Dang & Jayasena, 
1996), asymmetric PCR which was used to develop aptamers against chitin (Fukusaki et al. 
2000) and enzyme digestions (Bibby et al. 2008). A number of these techniques have been used 
in SELEX experiments (Marimuthu et al. 2012). 
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Examples of ssDNA aptamers include ssDNA aptamers raised to bind to and inhibit the 
rabies virus (Liang et al. 2012), ssDNA aptamers that bind to oxytetracycline (Niazi et al. 2008), 
and a 15 nt palindromic ssDNA aptamer that binds to human thrombin (Fig 1.13.C) (Fialová & 
Vorlíčková, 2006). 
The Apta-Index database contains 212 registered aptamer DNA structures 
(www.aptagen.com). Targets range from ions to tissues.  A number of review publications have 
also listed published aptamers (Stoltenburg et al. 2007; Bunka et al. 2010; Strehlitz et al. 2012; 
Sun et al. 2014). A table of DNA (and RNA) aptamer publications may be found in Appendix 
I. 
1.5.3. Cell SELEX 
Most of the SELEX experiments discussed so far had a homogeneous target; often a single 
purified protein, or organic molecule. It is possible to modify a SELEX protocol by providing a 
much more complex target. Cell SELEX experiments select molecules which bind to a cell, 
tissue or organ (Sefah, et al. 2010). DNA aptamers have been raised to bind to eukaryotic cells, 
including Glioblastoma cell lines (Gao et al. 2012) and metastatic breast cancer lines (Li et al. 
2014). Cell surface biomarkers have been developed using a range of different cell types (Ali et 
al. 2012). RNA sequences have been evolved which can internalise into specific cell types 
(Hernandez et al. 2013). DNA aptamers have been raised which can differentiate between 
vaccinia virus-infected and uninfected cells (Parekh et al. 2010). Aptamers have been raised to 
bind to specific tissue types which may contain a number of different cell types (Liu et al. 2012). 
Cell SELEX can raise aptamers to common elements found on multiple cells. These include 
pathogenic elements such as those found on bacteria (Hamula, & Li, 2011), lipopolysaccharides 
(LPS) (Ding & Ho, 2008) and peptidoglycan (Ferreira et al. 2014). It is important to note that 
the SELEX experiments performed to raise aptamers against the LPS and peptidoglycan were 
performed using purified macromolecular samples and not living cells. Similarly, aptamers have 
been raised to the purified flagellin proteins which can be used in detection systems for 
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Salmonella paratyphi (Ning et al. 2014). Aptamers can be used to accumulate cells from 
environmental samples (Jyoti et al. 2011) and pathogenic unicellular parasites can be extracted 
from human blood (Nagarkatti et al. 2012).  
These is a growing library of bacterial aptamers raised by Cell-SELEX. These include 
those raised by previously described groups working in Korea (Kim et al. 2014) and Japan 
(Savory et al. 2014). Other research groups around the world are developing novel DNAzyme 
detection systems for sensitive specific identification of Gram-negative bacteria (Aguirre & Li, 
2012; Bruno & Carrillo, 2012;  Bruno, 2014). These emerging bacterial detection and diagnostic 
systems could potentially be adapted to use the sequences evolved in this thesis. Early, specific 
and sensitive detection and identification of bacterial cells using inexpensive DNA-based 
biosensors may improve the quality of life of many people.  
The number of nucleic acid biosensors to bacterial cells increases year on year. Nucleic 
acid ligands to Streptococcus (Hamula & Li, 2011), Mycobacterium tuberculosis (Kinase et al. 
2011), Escherichia coli O157 (Lee & Lee, 2012), Salmonella pyogenes (Yang et al. 2013) Vibrio 
parahaemolyticus (Duan & Wang, 2014) Listeria monocytogenes, and Salmonella enterica ( 
Bruno, 2014) have already been evolved. Ligands to Bacillus anthracis protective antigen (Choi 
et al. 2011) and Shiga toxin (Challa et al. 2014) may also prove to be lifesaving future treatments 
to bacterial infections. The similarities between species of the Gram negative 
Enterobacteriaceae family (including Salmonella, Shigella, and Escherichia) may mean that 
aptamers raised to a target organism may be specific to a single strain, a single species or a 
family of related organisms (Fukushima & Kawaguchi, 2002).  
1.6. DNA Aptamers and Ligand-Binding 
Alongside genomic information storage, DNA can act as a specific, tightly binding ligand to a 
range of targets. This is demonstrated by both SELEX and the evolution of DNAzymes. The 
specific mechanisms by which DNA binds to target molecules will now be discussed.  
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 DNA aptamers have been raised to specifically bind to targets of different sizes, and this 
is reflected in the various ways evolved DNA molecules interact with target surfaces. Due to its 
exquisite strength and specificity of binding, and inexpensive production, the DNA-based 
thrombin-binding aptamer (TBA) has become a highly studied example of how aptamers interact 
with protein ligands (Bock et al. 1992). High-resolution structural analysis has shown how the 
aptamer binds to the epitope (as shown previously in Fig 1.13C). The binding site is exosite I of 
human α-thrombin. This is the site where normally α-thrombin would interact with fibrinogen. 
The exosite is comprised of several hydrophobic amino acid residues. The TBA forms an anti-
parallel G-quadruplex structure with two T-T loops on one side of the quadruplex structure. 
These four T residues (T3, T4, T12 and T13) form the hydrophobic binding face of the TBA. 
The hydrophobic T residues stack onto the aromatic amino acid in exosite I (Russo-Krauss et al. 
2012). A combination of experimental and simulation data were used to calculate the binding 
energy (ΔG) of this interaction was  -279.19 kJmol-1 in the presence of K+ ions (Trapaidze et al. 
2015). 
 The second interaction is exemplified by the AMP DNA aptamer, which allows two of 
the target ligands to intercalate. Interactions between hydrophobic residues such as those 
described above are often seen in aptamer-peptide complexes. They also play an important role 
in the interaction between structured DNAs and small organic molecules. Planar organic 
molecules will often intercalate between the bases of a structured DNA molecule. This is true of 
both DNA duplexes, such as the AMP-binding DNA aptamer which intercalated two distinct 
AMP molecules into the major groove of its hairpin structure (Lin & Patel 1997), or 
quadruplexes, such as the G-quadruplex forming DNAzymes which intercalate porphyrin rings 
to exhibit catalytic activity (Yamashita et al. 2005; M. Zhang et al. 2012). Intercalation of small 
molecules is another way nucleic acids can act as strong ligands to target molecules. (This is 
also shown in Fig 1.13.) 
 Another mechanism by which DNA can interact with a ligand is through 
conformational shifting to allow the formation of hydrogen bonds. This is exemplified by the 
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cocaine-binding aptamer. In this case, the aptamer without ligand forms a stable small hairpin 
structure, while the rest of the DNA molecule remains single-stranded and unstructured 
(Stojanovic et al. 2001). Upon addition of the small molecule ligand, the free DNA strand forms 
a three way junction with G∙A base pairings in the centre forming hydrogen bonds with both the 
complementary strand and the small molecule ligand itself. Mutations of the G∙A base pairings 
at the centre of the binding site greatly decrease the affinity for the ligand (Neves et al. 2010). 
The formation of these hydrogen bonds stabilises the ligand-aptamer complex. Many ribozymes 
and riboswitches also work using this principle, where the addition of a ligand allows 
conformational shifting to a more stable state. This is often facilitated by the formation of a 
greater number of hydrogen bonds (as discussed in section 1.3.4).  
 The next example in this section demonstrates how these above-described interactions 
can occur concurrently. The chemical nature of DNA itself allows multiple distinct chemical 
interactions to occur simultaneously. Fig 1.13 D shows the argininamide-binding DNA aptamer. 
This DNA-ligand interaction is mediated by the intercalation of hydrophobic regions of the L-
argininamide molecule, the displacement of nucleobases into non-Watson-Crick conformations 
and hydrogen-bonding interactions between the ligand and the charged phosphate backbone 
(Robertson et al. 2000). This shows that an aptamer may bind to a ligand by a number of different 
chemical interactions. 
 Chemically modifying DNA can lead to previously unobserved functional DNA 
structures. This is illustrated by the slow-off-rate-modified aptamer (SOMA-mer) raised against 
recombinant human nerve growth factor (Jarvis et al. 2015). This nucleic acid contains 
additional aliphatic side chains on some nucleobases. These chemical modifications have been 
used to augment the nucleic acid’s ability to bind to hydrophobic surfaces. The SOMA-mer 
forms a triplex prism structure with several non-Watson-Crick base pairings. This allows the 
modified nucleobases to interact with the protein ligand. Human nerve growth factor is a 
symmetric homodimer and presents two epitopes to the SOMA-mer, allowing 2:1 (SOMA-mer: 
protein) stoichiometric binding (PDB: 4ZBN).  
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 Raising DNA aptamers against DNA-binding proteins can lead to a phenomenon where 
the recognition DNA sequence is selected by the evolutionary process. This has been demon-
strated most recently by the evolution of ssDNA sequences to bind to the T. aquaticus σA subunit 
and the E. coli σ70 subunit (Miropolskaya & Kulbachinskiy, 2015). These DNA aptamers formed 
unique structures (sTap1 forming a partial hairpin with bulges and sEcap1 forming a suspected 
G-quadruplex). However, both sequences contained predicted single-stranded regions with -10-
like promoter element sequences (commonly referred to as TATA boxes). This indicates that the 
SELEX process has selected for DNA molecules with single-stranded TATA box-like regions 
to bind to the transcription factor target molecules. These DNA aptamers have been shown to 
compete with promoter sequences in vitro by competitively inhibiting assembly of transcription 
complexes. 
 ARC1172 is a 41-mer DNA aptamer selected to bind the A1 domain of von Willebrand 
factor (VWF). In the crystal structure (PDB: 3HXQ) of a VWF A1-ARC1172 complex, the ap-
tamer adopts a three-stem structure of mainly B-form DNA with three non-canonical base pairs. 
The DNA molecule’s interaction with the target protein has been studied in great detail. The 
DNA structure forms 4 salt bridges, 16 hydrogen bonds and 20 van der Waals interaction with 
amino acids in VWF. These interactions are assisted by regions of relative negative electrostatic 
potential on the surface of the aptamer, and positive electrostatic potential on the surface of the 
protein. ARC1172 binds with a KD of approximately 0.6 nM (Huang et al. 2009). 
1.7. Aptamers vs. Antibodies 
Aptamers are comparable to antibodies in both affinity and selectivity. Both nucleic acid 
aptamers and monoclonal antibodies are used as tools of molecular recognition. The 1984 Nobel 
Prize in physiology or medicine was awarded jointly to Niels Jerne, Georges Köhler and César 
Milstein (Nobel Media AB, 2013) for work involving and preceding the development of 
monoclonal antibodies. This technology fundamentally requires the manipulation of the immune 
system of an organism to allow molecules that adhere to a specific epitope to be produced. 
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 Aptamers are capable of being selected both in vitro and in vivo. This has been 
demonstrated recently by experiments performed to select for RNA sequences that permeate the 
blood-brain barrier in living mice (Cheng et al. 2013). Advances in phage display technology 
and in vitro antibody library screening also mean that antibodies can also be selected 
independently of multicellular living organisms (Barbas et al. 1992; Moutel et al. 2009; 
Bradbury et al. 2011; Geyer et al. 2012). Both antibodies and aptamers can be selected in vitro 
and in vivo. It is far more common however, for aptamers to be selected in vitro and antibodies 
in vivo. 
 The use of animals for the development of antibodies is a well-established technology. 
The immunisation of living organisms with an adjuvant-coupled antigen, followed by the 
harvesting of B-cells and the use of hybridoma technology, selective media and screening of 
individual hybridoma colonies for specific activity has led to a great number of powerful 
therapeutic and diagnostic agents (Chernajovsky & Nissim, 2008). The maintenance of animal 
model organisms, myeloma and hybridoma cell lines and expensive selection and screening 
processes do add costs to the selection of specific biomarkers that are not generally incurred in 
in vitro selection of nucleic acid aptamers. 
 In the first SELEX paper, Larry Gold stated “Any partitioning agent may be used to 
educate RNA molecules” (Tuerk & Gold, 1990). This indicates one advantage of aptamers over 
antibody technology. Aptamers can be selected against a molecular or cellular target that might 
not be immunogenic, or that might be lethal to an animal if injected. In vitro selection can be 
performed on substances which cannot be recognised by the immune system. In this thesis, the 
aim is to raise molecular ligands against a living pathogenic organism. This could not be done 
using antibodies without injecting the animal’s bloodstream with living pathogenic cells, which 
may have led to the raising of antibodies, but it would almost certainly have led to septicaemia 
and morbidity. 
 Antibodies generally have higher affinities to targets than aptamers. However, aptamer 
and antibodies can both have low picomolar-range affinities (KD) (Kensch et al. 2000; White et 
48 
 
al. 2001). Importantly, the affinity of an antibody or aptamer can be improved; the antibody’s 
affinity can be enhanced with maturation, and the aptamer’s affinity can be improved using 
continued rounds of SELEX, chemical modifications including dimerisation, or more stringent 
selection and partitioning strategies (Hasegawa et al. 2008; Ahmad et al.2012). 
 Aptamers (< 30 kDa) are usually smaller than antibodies (≈150 kDa) (Ozer et al. 2014). 
This means that they are better at permeating biological tissues (Thiel et al. 2012; Cheng et al. 
2013).  However, they also have lower retention rates in the body as smaller molecules are 
filtered more easily by the renal system. This is countered by the lower production costs of 
aptamers when compared with antibodies. Aptamers also take less time to generate and can be 
selected in greater numbers, whereas only one monoclonal antibody is created per hybridoma 
fusion-cell. SELEX can be automated (Eulberg et al. 2005) and can take less time than the 
immunisation of an animal. However, the screening processes required to determine the 
affinities of both nucleic acid and protein selected molecules are equally laborious and time 
consuming. 
 DNA and RNA are polyanionic, and therefore may have difficulties binding to strongly 
negatively charged targets, whereas the chemical diversity of amino acids can provide both 
acidic and basic residues. Nucleic acids, on the other hand, are able to be chemically modified, 
hybridised and fluorescently labelled with comparative ease, making them versatile tools. The 
whole-cell SELEX approach used in this thesis ensures that the aptamers raised will encounter 
the epitopes of a living bacterial cell under experimental conditions (temperature and buffer 
controls). If antibodies were used, the epitope would probably be a cell fragment encountered 
under the conditions dictated by the animal’s bloodstream. Far more variables can be controlled 
using in vitro selection. Aptamers can also be thermally denatured and re-form active structures. 
1.8. Antibiotic Resistance 
Humanity has become exceedingly efficient at applying selective pressure to nature. This can be 
done through eating particular organisms, breeding particular organisms, destroying the habitats 
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of one organism while providing niches for others. One example of this is through use of 
bacteriostatic and bactericidal antibiotics. The strength of the selection pressure put on bacteria 
by human intervention directly links to the rate at which resistance evolves (Oz et al. 2014). The 
development of antimicrobial resistance has been described as having potentially catastrophic 
consequences for humanity (Davies & Davies, 2010) and has recently been described as a 
“ticking time-bomb” by Dame Sally Davies of the General Medical Council (GMC). Many 
varied mechanisms for antibiotic resistance have emerged (Blair, et al. 2014). Multiple drug-
resistant strains of pathogenic bacteria are becoming common throughout the world (Magiorakos 
et al. 2012). The spreading of antimicrobial resistance genes is accelerated by horizontal gene 
transfer (De la Cruz & Davies, 2000; Palmer & Gilmore, 2010). A recent UK government report 
estimated that more people would die from antibiotic-resistant infections than would die from 
all forms of cancer by the year 2050:  
“Without effective antibiotics, even minor surgery and routine operations could become high-
risk procedures, leading to increased duration of illness and ultimately premature mortality. 
Much of modern medicine (for example, organ transplantation, bowel surgery and some cancer 
treatments) may become unsafe due to the risk of infection.”- Quotation from The National Risk 
Register of Civil Emergencies (2015 edition) 
The British public voted for Antibiotics and antimicrobial resistance (AMR) to be the subject 
of the 2014 Longitude Prize. In order to tackle growing levels of AMR, one challenge set for the 
Longitude Prize is to create a cost-effective, accurate, rapid and easy-to-use test for bacterial 
infections that will allow health professionals worldwide to administer the right antibiotics at 
the right time. 
The recent discovery of teixobactin, a genuinely new antibiotic that kills pathogens without 
detectable resistance, demonstrated that in order to combat the evolution of antibiotic resistance, 
an evolutionary strategy must be used. In this case the antibiotic was isolated from an 
unculturable soil bacteria used in a study to combat Staphylococcus aureus and Mycobacterium 
tuberculosis (Ling et al. 2015). In order to create a sustainable model for antibiotic drug 
development a system of antibiotic discovery must be implemented, whereby new antimicrobials 
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must be generated faster, more frequently. Is it therefore possible to use the evolutionary 
combinatorial chemistry process of SELEX to generate new oligonucleotides with antimicrobial 
properties? Using Cell SELEX it may be possible to evolve functional nucleic acid molecules 
which interact with the cell wall of pathogenic organisms. Glycopeptide and β-lactam antibiotics 
all function by inhibiting cell wall structure, function and metabolism (Fig. 1.14). 
 
1.9. The Gram-Negative Bacterial Cell Wall 
In order to be an effective antibiotic agent, a chemical must interact with the target pathogen 
while doing no harm to the patient. A number of antibiotics do however have side effects. 
Examples include the ototoxicity and nephrotoxicity of gentamycin (Lerner et al. 1977; Sweileh, 
2009) and the chemotherapy-like symptoms of levofloxacin (Carbon, 2001). The selective 
power of antibiotics is based on the chemical’s ability to interact with components which 
exclusively belong to the pathogen. The greatest examples of this are the bacterial ribosome and 
bacterial cell-wall. Both are essential to the continuing survival of the pathogen and completely 
superfluous to the host organism. Most antibiotics in use either interrupt bacterial cell-wall 
biosynthesis (such as β-lactam and glycopeptide antibiotics (Fig 1.14.A, B, and D)) or bacterial 
protein synthesis (such as tetracyclines and streptogramins). This thesis focuses on molecules 
which interact with the intact living bacterial cell wall and outer membranes. 
The Gram-negative cell wall is comprised of an inner phospholipid bilayer membrane 
containing a number of important channel proteins, a layer of cross-linked peptidoglycan which 
provides structural stability and shape to the cell and an outer phospholipid bilayer containing a 
number of lipopolysaccharides and antigens (Gram, 1884; Beveridge, 1999; Huang et al. 2008). 
With the exceptions of Mycoplasma and L-form bacteria, these cell walls are widely conserved 
and essential to bacteria. It is speculated that the peptidoglycan cell wall gives a strong 
evolutionary advantage to bacteria and therefore may have been present in the last common 
ancestor of the bacterial domain (Woese et al. 1990; Errington, 2013). As bacteria are constantly 
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A. 
B. 
C. 
D. 
Figure 1.14 Four antimicrobial agents: A Penicillin, a β-lactam antibiotic which functions by binding to and 
inhibiting the enzyme DD-transpeptidase, halting the formation of peptidoglycan cross-linkages. B 
Amoxicillin, another β-lactam antibiotic with similar structure and function. C Clavulanic acid, a β-lactamase 
inhibitor. D Vancomycin, a glycopeptide antibiotic which functions by binding to the amino acid sidechains 
of peptidoglycan and blocking access to cross-linking enzymes.   
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recycling and remodelling cell walls (Johnson & Mobashery, 2013), interrupting cell-wall 
biosynthesis is a powerful mechanisms for killing bacteria. 
Other structures embedded within the bacterial cell wall may be of interest as potential 
targets for new antimicrobial molecules. These include outer membrane proteins such as the 
OmpA membrane domain, the OmpX protein, phospholipase A, general porins (OmpF, PhoE), 
substrate-specific porins (LamB, ScrY) and the TonB-dependent iron siderophore transporters 
(FhuA and FepA) which play essential roles in intercellular communication and virulence and 
regulation of intracellular metabolites and osmoregulation (Koebnik & Van Gelder, 2000). 
Multidrug efflux pumps would also be an attractive target for potential new therapeutic 
molecules as inhibition of these would render resistant bacteria vulnerable to 1st generation 
antibiotics again. One example of a multidrug efflux pump is the tetracycline efflux pump 
encoded by the tetR section of the plasmids pSC101, pBR322 and pAT153 (Speer & Salyers, 
1992; Levy et al. 1999; Magiorakos et al. 2012). 
The advantages and disadvantages of using the whole-cell-SELEX approach when 
compared to an isolated single molecule SELEX approach will now be listed. While single 
isolated molecular SELEX of cell wall components has been performed in the past (Ding et al. 
2008; Ning et al. 2014), there is no guarantee that aptamers raised against a single molecule will 
also bind to the same molecule in situ. There is no way of assuring that the epitope presented in 
the molecular SELEX experiment will be the same epitope presented at the surface of a living 
cell. One interesting example in which Cell-SELEX demonstrates this advantage is in the 
selection of Aptamers against glycosylated haemagglutinin on the surface of Vaccinia virus 
infected cells (Parekh et al. 2010). As haemagglutinin is a transmembrane protein, many 
potential epitopes for aptamers would be inaccessible during SELEX as they would be buried in 
the membrane. Cell-SELEX ensures that only the accessible portions of the molecule are 
available for the selection of aptamers. 
 A single isolated molecule may also behave differently in solution when compared to 
its functional state in situ. Cell surface components may present different epitopes in solution. 
Proteins and polysaccharides may be misfolded, may aggregate or may form a variety of 
53 
 
different structures. Any aptamers raised against these varying epitopes may not necessarily bind 
to the functional forms of the cellular components. However, one advantage of raising aptamers 
against single molecule cellular components is that if aptamers are successfully isolated then the 
probable target epitope is already known. Isolating single cellular components prior to use in 
SELEX may be expensive. Using bacterial cells is cheaper as these can be cultivated at relatively 
little cost. Using isolated cell wall components may allow for easier intermolecular binding 
experiments where the affinity of selected aptamers against target molecules may be measured 
with greater ease. 
 
1.10. Purpose of this Work 
The aims of the work presented in this thesis are as follows: firstly, to isolate cell-specific single-
stranded DNA aptamers that demonstrate specific binding to E.coli HB101: pAT153, secondly, 
to characterise these interactions and quantify the affinity of binding of successful nucleic acid 
sequences. 
This work follows on from previous work in which RNA aptamers have been isolated that bind 
to E. coli O157:H7 (Lee et al. 2012) and DNA aptamers have been raised against E. coli KCTC 
2571 (Kim et al. 2013) and E.coli NSM59 (Savory et al. 2014). Some of the sequences isolated 
in these SELEX experiments will also be tested for binding with E.coli HB101: pAT153 and 
E.coli DH5α. 
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2. Chapter 2: Materials and Methods 
In this chapter, the methods used during this research project will be described. Some of these 
methods are standard and taken from previously published works including Molecular Cloning 
volumes 1, 2 & 3 (Sambrook & Russell, 2001). Methods such as Qiagen PCR product 
purification and CloneJET molecular cloning were performed according to the manufacturer’s 
instructions. Some methods described in this chapter have been designed and optimised for this 
research project. 
Chemicals, reagents and laboratory consumables were purchased from Fisher Scientific 
(FS), Sigma Aldrich (SA), BioRad (BR), Perkin Elmer (PE), Qiagen (QG), Thermo Scientific 
(TS), Genecraft (GC), Life Technologies (LT) and New England Biolabs (NEB). 
Oligonucleotides were synthesised by ADTBio and Invitrogen. DNA sequencing was performed 
by Source Bioscience. Cloning kits were purchased from TS. PCR purification and plasmid 
preparation kits were purchased from QG. 
2.1.  Chemicals & Reagents 
Stock solutions and biochemical reagents were prepared according to Sambrook and Russell 
(Sambrook & Russell, 2001). The names of these reagents, the stock concentration, storage 
requirements and suppliers are listed below in Table 2.1. Unless stated otherwise, the reagents 
were made up in distilled water. Some stock solutions were sterilised by filtration with a 0.22 
µm filter or autoclaving at 121°C and 15 psi for 20 min. pH was adjusted using calibrated pH 
meters and titrating suitable acids and bases.  
Reagent Concentration Storage Supplier 
[α-32P] dATP  0.37 MBq/µl 4°C PE 
Acetic Acid  10% (v/v) Make fresh SA 
Acrylamide:bis-acrylamide, 19:1 ratio  40% (w/v) 4°C FS/BR 
Agarose (electrophoresis grade) 100% RT FS 
Ammonium acetate  10 M -20°C FS 
Ammonium persulphate (APS)  20% (w/v) 4°C SA 
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Ampicillin sodium salt  100 mg/ml 4°C FS 
β-mercaptoethanol 14.3 M RT SA 
Dithiothreitol (DTT) 1 M RT TS 
Ethylenediaminetetraacetic acid (EDTA), 
pH 8.0 
0.5 M RT SA 
Ethidium Bromide  10 mg/ml 
RT – opaque 
container  
SA 
Ethanol  70%, 100% (v/v) -20°C FS 
Glycerol 100% (v/v) RT SA 
KCl  1 M RT SA 
KOAc 3 M RT SA 
MgCl2  1 M RT SA-TS 
MnCl2 1 M RT SA 
3-(N-morpholino)propansulfonic acid 
(MOPS) 
1 M RT SA 
NaCl 1 M RT SA 
NaOAc, pH 5.5 3 M RT SA 
NaOH  10 M 
RT – plastic 
container  
SA 
Propan-2-ol (Isopropanol) 100% (v/v) RT FS 
RbCl 1 M RT  SA 
SDS  10% or 20% (w/v) RT SA 
SYBR Gold 
10,000× Concentrate 
in DMSO 
4°C – opaque 
container 
LT 
Tetramethylethylenediamine (TEMED)  ~98% w/v 4°C FS 
Tetracycline  15 mg/ml 4°C SA 
Tris(hydroxymethyl)aminomethane Tris-
HCl pH 6.8, 8.0 or 8.8 
1 M or 1.5 M RT SA 
Urea diluent  50% (w/v) RT SA 
 
Table 2.1 A list of stock reagents, concentrations, storage conditions and suppliers used in this 
project. RT = Room Temperature. 
 
2.2.   Buffers 
Multicomponent buffers and solutions were made by dissolving or diluting components in 
distilled water. Some solutions were sterilised by filtration or autoclaving. 
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Reagent Composition Storage Supplier 
Alkaline Lysis Solution I 
50 mM Tris-HCl, 10 mM EDTA, 
pH 8.0 
RT  
Alkaline Lysis Solution II 200 mM NaOH, 1% (w/v) SDS RT  
Alkaline Lysis Solution III 3M NaOAc or 3M KOAc, pH 5.5 RT  
BglII Restriction buffer (1×) 
100 mM NaCl, 50 mM Tris-HCl, 
10 mM MgCl2,100 μg/ml BSA, 
pH 7.9 
-20°C NEB 
BglII storage buffer 
 
10 mM Tris-HCl, 50 mM KCl, 1 
mM DTT, 0.1 mM EDTA, 200 
μg/ml BSA, 50% (v/v) glycerol, 
pH 7.4 
-20°C NEB 
Bromophenol blue Agarose gel 
loading buffer (6×) 
 
40% (w/v) sucrose, ~0.01% (w/v) 
Bromophenol blue  
RT  
Competent Cell Buffer I 
 
100 mM RbCl, 50 mM 
MnCl2·4H2O, 30 mM KOAc, 10 
mM CaCl2·2H2O, 15% (v/v) 
glycerol, pH 5.8 
RT 
Filter 
sterilise 
 
Competent Cell Buffer II 
 
10 mM MOPS, 10mM RbCl, 75 
mM CaCl2·2H2O, 15% (v/v) 
glycerol, pH 6.8 
RT 
Filter 
sterilise 
 
Deoxynucleotide solution mix 
 
10 mM dATP, 10 mM dCTP, 10 
mM dGTP, 10 mM dTTP 
-20°C NEB 
Gram stain - Crystal Violet 
 
10% (w/v) crystal violet in 20 ml 
ethanol, combined with 80 ml of 
1% (w/v) ammonium oxalate.  
RT SA 
Gram stain – Gram’s iodine 
 
0.66% (w/v) KI, 0.33% (w/v) I2  RT SA 
Gram stain – Safranin-O 
 
0.025% (w/v)  Safranin-O in 10% 
(v/v) ethanol  
RT SA 
Lambda Exonuclease Reaction 
Buffer (1×) 
 
67 mM Glycine-KOH, 2.5 mM 
MgCl2, 50 μg/ml BSA, pH 9.4 
-20°C NEB 
Lambda Exonuclease Storage 
Buffer (1×) 
 
25 mM Tris-HCl, 50 mM NaCl, 1 
mM DTT, 0.1 mM EDTA, 50% 
(v/v) glycerol, pH 8.0 
-20°C NEB 
LB growth media (Miller) 
 
10 g/l Yeast tryptone, 5 g/l  yeast 
extract, 10 g/l NaCl, pH 7.0 
RT FS 
LB agar growth media (Miller) 
 
10 g/l Yeast tryptone, 5 g/l  yeast 
extract, 10 g/l NaCl, 15 g/l agar, 
pH 7.0 
RT FS 
Orange-G Loading Buffer (6×) 
 
30% (v/v) glycerol, ~0.01% (v/v) 
Orange-G  
RT SA 
PBS (10×) 
 
10 mM Na2HPO4, 2 mM 
KH2PO4, 2.7 mM KCl, 137 mM 
NaCl, pH 7.2 
RT FS 
Taq PCR buffer (10×) 
 
160 mM (NH4)2SO4, 670 mM 
Tris-HCl, 0.1% (w/v) Tween-20 
-20°C GC 
Phenol:chloroform:isoamyl-
alcohol (PCI) 
25:24:1 ratio 4°C FS 
Qiagen bacterial cell 
resuspension buffer 
50 mM Tris-HCl, 10 mM EDTA, 
100 μg/ml RNaseA, pH 8.0 
4°C QG 
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Qiagen cell lysis buffer 
 
200 mM NaOH, 1% (w/v)  SDS RT QG 
Qiagen neutralisation buffer 
 
4.2 M Guanidinium-HCl, 0.9 M 
potassium acetate, pH 4.8 
RT QG 
Qiagen PCR product 
purification binding buffer 
5 M Guanidinium-HCl, 30% (v/v) 
isopropanol 
RT QG 
Qiagen PCR product wash 
buffer 
 
10 mM Tris-HCl, 80% (v/v) 
ethanol  
RT QG 
SDS gel loading buffer (1×) 
50 mM Tris-HCl, 2% (w/v) SDS, 
10% (v/v) Glycerol, ~0.01% 
(w/v) Bromophenol blue, pH 6.8 
RT 
1.5 ml 
aliquots 
 
SDS Tris-glycine running 
buffer (5×) 
125 mM Tris base, 1.25 M 
glycine, 0.5% (w/v) SDS, pH 8.3 
RT  
Sucrose Tris EDTA 
Bromophenol blue Native 
PAGE loading buffer (STEB) 
 
40% (w/v) sucrose, 10 mM Tris-
HCl, 10 mM EDTA, ~0.01% 
(w/v) Bromophenol blue, pH 7.4 
RT  
Denaturing PAGE loading 
buffer (STOP) 
 
80% (v/v) Formamide, 10 mM 
EDTA, 2 mM NaOH, ~0.01% 
(w/v) Bromophenol blue  
RT  
TAE buffer (50×) Tris-acetate 2 M, EDTA 50 mM RT  
Taq PCR Master-mix (2×) 
 
10 mM Tris-HCl, 50 mM KCl, 
1.5 mM MgCl2, 0.2 mM dNTPs, 
5% (v/v)  glycerol, 0.08% (w/v) 
IGEPAL CA-630, 0.05% (w/v) 
Tween-20, 25 units/ml Taq DNA 
Polymerase, pH 8.6 
-20°C NEB 
Taq polymerase storage buffer 
 
20 mM Tris-HCl, pH 7.2, 100 
mM KCl, 0.1 mM EDTA, 5 mM 
DTT, 50% (v/v)  glycerol, 1% 
(w/v) Triton X-100 
-20°C GC 
TBE electrophoresis buffer 
(10×) 
 
890 mM Tris base, 890 mM Boric 
acid, 20 mM EDTA 
RT  
TBE-urea electrophoresis 
buffer (5×) 
 
450 mM Tris, 450 mM Boric 
acid, 10 mM EDTA, 50% (w/v) 
urea 
RT  
TBS (10×) 
 
50 mM Tris-HCl, 150 mM NaCl, 
pH 7.2 
RT  
TE (1×) 
 
10 mM Tris-HCl, 0.1 mM EDTA, 
pH 7.5 
RT  
TEN buffer 
 
10 mM Tris-HCl, 1 mM EDTA, 
10 mM NaCl, pH 7.5 
RT  
TER buffer 
 
10 mM Tris, 1 mM EDTA, 10 
mM NaCl, 2 μg/ml RNaseA, pH 
7.5 
4°C  
 
Table 2.2 A list of the names, composition, storage conditions and suppliers of buffers used in 
this project. 
 
  
58 
 
2.3. Enzymes  
Several DNA-modifying enzymes were used in this project. Synthetic pools of oligonucleotides 
were amplified by Taq DNA polymerase using PCR. This allowed the amplification (and small 
degree of mutation) of selected DNA molecules. The development of PCR by Kary Mullis 
signified a great advance for directed molecular evolution as it allows primer-directed 
amplification of heterogeneous DNA sequence libraries (Mullis et al. 1986; Mullis, 1990). This 
technique is fundamental to the methods of DNA (and RNA) SELEX described shortly. The Taq 
polymerase used in this thesis was provided by FS or NEB. 
The ligation of purified PCR products into plasmid vectors was catalysed by T4 DNA 
ligase. This technique allowed individual DNA sequences to be cloned and transformed into 
competent bacterial cells (Michelsen, 1995). Prior to blunt-ended ligation, PCR products were 
incubated with a “blunting enzyme”. This enzyme catalysed the removal of 5’ single-strand (ss) 
DNA sticky ends and also catalysed the polymerisation of 3’ ssDNA sticky ends into dsDNA. 
The name and nature of this thermostable enzyme were not revealed by Thermo-Fisher Scientific 
and therefore cannot be described in this chapter. T4 DNA ligase and “blunting enzyme” are 
supplied as part of the Life Technologies CloneJET kit. Site-specific restriction of plasmids 
containing inserted PCR fragments was catalysed by the Type II restriction endonuclease BglII. 
The recognition sequence of BglII is 5’-AGATCT-3’ (arrow indicates cleaved phosphodiester 
bond). This enzyme cleaved the recombinant plasmid in two locations (a target site at each) 
which were positioned either side of the blunt-ended ligation site. The enzyme was originally 
isolated from Bacillus globigii (Lukacs et al. 2000, 2001). The recombinant viral protein 
Lambda exonuclease (λ) is a highly processive enzyme that acts in the 5´ to 3´ direction, 
catalysing the removal of 5´ mononucleotides from duplex and ssDNA. The preferred substrate 
is 5´-phosphorylated double stranded DNA, although it will also degrade single-stranded and 
non-phosphorylated substrates at a greatly reduced rate. λ exonuclease is unable to initiate DNA 
digestion at nicks or gaps (Dapprich, 1999; Kovall & Matthews, 1997; Mitsis & Kwagh, 1999). 
λ exonuclease was provided by NEB.  
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Figure 2.1  
A The structure of the restriction endonuclease BglII homo-dimer co crystallised with a 16 mer DNA 
duplex containing the palindromic recognition sequence 5’-AGATCT-3’. (PDB 1DFM) The BglII 
used in this project was supplied by NEB. One subunit is shown in blue and the other in magenta.  
 
B  The structure of the homo-trimer K131A λ exonuclease bound to a 12 mer DNA duplex. (PDB 
3SLP) In these experiments λ exonuclease was supplied by NEB. Subunits are shown in cyan, 
magenta and yellow. 
 
C   Taq DNA polymerase bound to a DNA duplex containing an artificial dNaM-d5SICS base pairs. 
(PDB 4C8L) Taq polymerase used in this project was supplied by GC and NEB. The Taq polymerase 
enzyme is shown in dark blue.  
 
D  The structure of T4 DNA ligase has not yet been characterised. Here is shown the structure of 
another viral ATP dependant DNA ligase co-crystallised with a nicked DNA duplex. (PDB 2Q2T) 
T4 DNA ligase used in this project was provided by Thermo Fisher Scientific as part of the CloneJET 
cloning kit.  
 
A, B, C and D were all determined by X-ray crystallography. The left view is along the axis of the 
DNA and the right view is perpendicular to the axis of the DNA. 
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B. 
C. 
D. 
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2.4. DNA Reagents  
2.4.1. Plasmids 
Three plasmids have been used extensively during this project. The first, pAT153, is a cloning 
vector which encodes multiple drug resistance. The plasmid contains both the bla-1 β-lactamase 
ampicillin resistance gene (originally taken from pBR322 and pSC101) and a tetracycline 
resistance gene TetRc which encodes a multidrug efflux pump (Brow et al. 1985; Levy et al. 
1999). An overview of plasmid pAT153 is shown in Fig 2.2A. The target bacterial cell for 
SELEX in this thesis was strain HB101 containing the pAT153 plasmid. This was 
unambiguously confirmed by growing HB101: pAT153 in the presence of both tetracycline and 
ampicillin, and also by purifying pAT153 by plasmid minipreparation (see section 2.7.6). 
Untransformed E.coli HB101 is inherently resistant to streptomycin and when transformed with 
pAT153 it is also resistant to β-lactam and tetracycline antibiotics. 
The second plasmid used throughout in this project was the pJET1.2 blunt cloning vector, shown 
in Fig 2.2B. This plasmid also encodes β-lactamase. This positive-selection cloning vector 
encodes a gene for a lethal endonuclease (Eco47IR) which, when expressed, produces an 
enzyme which digests bacterial genomic DNA. The lethal enzyme is called Eco47I, a Type II 
restriction enzyme that recognises the sequence 5’-GGWCC-3’. Cloning fragments of DNA 
into the eco47I gene interrupted correct expression of the protein. The plasmid also contains a 
number of restriction sites. 
The third plasmid was pUC19 (shown in Fig 2.2C) This was used as a template for positive 
control PCRs. The primer sets used in SELEX method I (see section 2.8) were taken from a 
publication in which ssDNA was generated from a 1,888 bp PCR fragment using pUC19 as a 
template (Liang et al. 2007). The sequence of these two primers was incorporated into the 
flanking regions of the random library of oligonucleotides used in SELEX Method I. Correct 
PCR amplification using these primers therefore amplified either the evolving pool of molecules 
in SELEX Method I, or (as a control) the 1,888 bp region of plasmid pUC19. The plasmid also  
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Figure 2.2 The three plasmids used in this project A. pAT153 B. pJET1.2 C. pUC19 The 
sequences of these plasmids are shown in the Appendix III.  
bla gene  
tet gene  
origin  
bla gene  
origin  
eco47IR gene 
bla gene  
origin  
lacZa gene  
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encoded β-lactamase (ampicillin resistance). In summary, pAT153 encodes antibiotic resistance 
in the target HB101 cell strain; pJET1.2 was the cloning vector used to isolate and sequence 
individual DNA molecules from the evolving aptamer pool in SELEX methods I & II; pUC19 
was a template positive control DNA molecule used to ensure correct PCR amplification in 
SELEX method I. Preparation of Plasmid DNA is described in section 2.8.6. 
All DNA standard markers and ladders are described fully with suppliers in Appendix II. 
2.4.2.  Primers and Nucleic Acid libraries 
SELEX requires a statistically large starting number of nucleic acid sequences (Lorsch & 
Szostak, 1996). This is best achieved by synthesising a library of nucleic acid sequences in which 
the identity of any one base within a cassette of length n nucleotides can be any one of the four 
natural bases (N). Therefore the total number of possible unique sequences is Nn (i.e. 4n). In this 
work, two starting pools were used: that in Chapter 3 contained a central cassette of 62 random 
nucleotides, and in Chapter 4 the cassette was 50 nucleotides. Both these cassette lengths were 
flanked by PCR primer sequences which gave a total length of 100 nucleotides. Therefore for 
Chapter 3 the theoretical maximum number of potential sequences was 462 = 21.27 × 1036. In the 
same way for Chapter 4 the total theoretical maximum was 450 = 1.27 ×1030.  Oligonucleotide 
libraries were synthesised by Invitrogen/Life Technologies and ADTBio for SELEX methods I 
and II, respectively.  
Pairs of primers were designed which could amplify the random pool of oligonucleotides by 
binding to known flanking sequences. Primers were synthesised by Eurogentec or 
Invitrogen/Life Technologies. All oligonucleotide stocks were resuspended in nuclease-free 
distilled water to a final concentration of 100 µM and the concentration determined by UV 
spectrophotometry. 
 
 
  
64 
 
SELEX Method I (Chapter 3) 
Random pool (single-stranded 100 mer) 
5’ CGCAAGCATAAAGTGTAAAG (N)62 ACTTTCACCAGCGTTTCT 3’ 
Forward primers (18 nt) Reverse primers (20 nt) 
5’ AGAAACGCTGGTGAAAGT 3’ 5’ CGCAAGCATAAAGTGTAAAG 3’ 
F1A 
5’ GAAACGCTGGTGAAAGTA 3’ 
F1C 
5’ GAAACGCTGGTGAAAGTC 3’ 
F1G 
5’ GAAACGCTGGTGAAAGTG 3’ 
F1T 
5’ GAAACGCTGGTGAAAGTT 3’ 
R1A 
5’ GCAAGCATAAAGTGTAAAGA 3’ 
R1C 
5’ GCAAGCATAAAGTGTAAAGC 3’ 
R1G 
5’ GCAAGCATAAAGTGTAAAGG 3’ 
R1T 
5’ GCAAGCATAAAGTGTAAAGT 3’ 
F2 
5’ AAACGCTGGTGAAAGTAC 3’ 
F3 
5’ AACGCTGGTGAAAGTACA 3’ 
R2 
5’ CAAGCATAAAGTGTAAAGGG 3’ 
R3 
5’ AAGCATAAAGTGTAAAGGGA 3’ 
F6S2 
5’ GCTGGTGAAAGTACAGAG 3’ 
F6S8 
5’ GCTGGTGAAAGTACAACG 3’ 
F6S11 
5’ GCTGGTGAAAGTACACAG 3’ 
R6S2 
5’ CATAAAGTGTAAAGGGTGAA 3’ 
R6S8 
5’ CATAAAGTGTAAAGGGACCA 3’ 
R6S11 
5’ CATAAAGTGTAAAGGGTATG 3’ 
 
Table 2.3 The primary sequences of the Random pool and primer sequences used in SELEX 
method I. Experiments using variant primer sequences were performed. These primers were 
used to interrogate the composition of the random pool and selected pools of molecules. Regions 
where modified sequences vary from the original primers are shown in red. 
 
 The starting random pool and primers used in SELEX method II differed from those used 
in Method I. The primers were redesigned to incorporate fluorophores and the primer sequences 
were elongated to 25 bases to increase stringency by raising the Tm. The new primer sets were 
also designed to contain EcoRI and BamHI restriction sites. 
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SELEX Method II (Chapter 4) 
Random pool (single-stranded 100 mer) 
5’(HEX)GCGACCCAAGGAATTCTGCTGAAGG (N)50 CATCGTACCGGATCCGTCACCAGCC 3’ 
TOP Primers (25 nt) BOT primers (25 nt) 
5’GCGACCCAAGGAATTCTGCTGAAGG 3’ 5’GGCTGGTGACGGATCCGGTACGATG 3’ 
5’(HEX) 
GCGACCCAAGGAATTCTGCTGAAGG 3’ 
5’(PHOS) 
GGCTGGTGACGGATCCGGTACGATG 3’ 
5’(FAM) 
GCGACCCAAGGAATTCTGCTGAAGG 3’  
 
Table 2.4 The nucleic acid sequences used during SELEX method II. EcoRI and BamHI 
restriction sites are shown in bold. 5’ chemical modifications are shown. 
 
 Different primers were also used to amplify a region of the pJET1.2 cloning vector in both 
SELEX methods. This was done to screen for successful recombination and to amplify PCR 
products containing cloned insert sequences for purification and later DNA sequencing. 
pJET1.2 Sequencing primers 
Forward sequencing primer (23 nt) Reverse sequencing primer (24 nt) 
5’ CGACTCACTATAGGGAGAGCGGC 3’ 5’ AAGAACATCGATTTTCCATGGCAG 3’ 
 
Table 2.5 The nucleic acid sequences of the primers used to initiate amplification of the cloning 
site of the pJET1.2 blunt cloning vector. 
 
 These primers were all used in PCR experiments (see section 2.5). The modified primer 
experiments used in SELEX Method I depend upon the ability of Taq polymerase to discriminate 
between a 3’ primer base pair mismatch and a correctly matched Watson-Crick base pair. As 
shown later, Taq polymerase will only efficiently initiate elongation when bound with correctly 
to a Watson-Crick base pairing (Ayyadevara, et al. 2000). This discrimination allows only 
amplification of sub-populations of nucleotides with specific nucleic acid sequences. 
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2.5. PCR 
The polymerase chain reaction (PCR) using thermostable Taq DNA polymerase was the main 
method for both amplifying and incorporating mutations into the evolving pool of DNA 
molecules in both SELEX Methods I & II. PCR is an ideal amplification method as the insertion, 
deletion and substitution of nucleotides generates variation. DNA rehybridisation during PCR 
(also known as “the cot effect”) prevents one sequence from dominating a pool of different 
amplifying sequences (Mathieu-Daudé et al. 1996). This allows competition between different 
amplifying species within the PCR tube. As mentioned previously in section 1.4.8, it is however 
possible for sequences to increase reproductive fitness. PCR does provide a form of selective 
pressure, as any evolving molecules must be able to replicate or they will become extinct.  
2.5.1. Symmetric PCR 
We define symmetric as meaning a PCR with an equimolar concentration of forward and reverse 
primers. A typical PCR used in SELEX Method I or II was a 50 µl reaction volume with the 
following components (Table 2.6). In SELEX method I, the individual components of the 
reaction were added separately. 
Component Stock concentration Volume added (µl) Final concentration 
Taq polymerase buffer (10×) 10× 5 1× 
dNTPs 10 mM 2 0.4 mM 
Forward primer 20 µM 1 0.4 µM 
Reverse  primer 20 µM 1 0.4 µM 
MgCl2 25 mM 3.5 1.75 mM 
Taq DNA polymerase 1000 U/ml 0.5 0.01 U/µl 
dH2O  36  
DNA template  1  
Total  50  
 
Table 2.6 The components and concentrations of a typical PCR used in SELEX method I. The 
components of Taq polymerase buffer are described in Table 2.2.  
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Component Stock concentration Volume added (µl) Final concentration 
PCR 2× master mix 2× 25 1× 
Forward primer 20 µM 1 0.4 µM 
Reverse  primer 20 µM 1 0.4 µM 
dH2O  22  
DNA template  1  
Total  50  
 
Table 2.7 The components and concentrations of a typical PCR used in SELEX Method II. The 
components of Taq polymerase master mix are described in Table 2.2. In SELEX Method II, a 
Taq PCR master mix was used, which included the enzyme buffer, dNTPs; & MgCl2 
 
PCR reactions were performed using a Veriti thermocycler from LT, an Eppendorf 
mastercycler or a Techne thermocycler. PCR mixtures were amplified in thin-walled 0.2 ml 
domed cap PCR tubes. The following PCR conditions were used. The key differences between 
methods I and II are in the annealing temperature used and the number of cycles. 
 
SELEX Method I 
 
SELEX Method II  
Temperature 
(°C) 
Time 
(s) 
Temperature 
(°C) 
Time 
(s) 
 
Denaturation 95 300 95 60  
Melting 95 30 
40 
cycles 
95 30 
30 
cycles 
Annealing 53 30 62 30 
Elongation 72 30 72 30 
Final elongation 72 300 
 
72 300  
Hold 4 ∞ 4 ∞  
 
Table 2.8 PCR protocols or the symmetric PCR amplification used in SELEX method I & II 
 
2.5.2. Asymmetric PCR 
We define asymmetric PCR as a chain reaction with unequal primer concentrations. This 
generates ssDNA, and is also known as the linear after the exponential (LATE) PCR or simply 
Asymmetric PCR method. This was used as the single strand regeneration method in SELEX 
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Method I; during SELEX Method II a lambda (λ) exonuclease digestion method was used (See 
section 2.14). A ten-fold dilution of one of the two primers (in this case the forward primer) was 
used to generate ssDNA. This method was taken from previous published work where ssDNA 
was generated from amplification of the plasmid pUC19 (Liang et al. 2007). The PCR protocol 
used in Asymmetric PCR is the same as the method described in Table 2.8 SELEX Method I. 
The composition of the PCR mixture was as follows: 
Component Stock concentration Volume added (µl) Final concentration 
Taq polymerase buffer (10×) 10× 5 1× 
dNTPs 10 mM 2 0.4 mM 
Forward primer 2 µM 1 0.04 µM 
Reverse  primer 20 µM 1 0.4 µM 
MgCl2 25 mM 3.5 1.75 mM 
Taq DNA polymerase 1000 U/ml 0.5 0.01 U/µl 
dH2O  36.  
DNA template  1  
Total  50  
 
Table 2.9 The components and concentration of an Asymmetric PCR as used to regenerate the 
single strand in SELEX method I. 
 
2.5.3. Colony PCR 
In some cases PCR was performed on live bacterial colonies in order to pre-screen (prior to 
sequencing) for successful transformation of recombinants. Overnight growth colonies grown 
following transformation were picked and streaked onto individual selective agar plates. Colony 
PCR was performed by taking single overnight growth colonies of DH5α cells from these 
individual-clone plates using a sterile pipette tip, resuspending the colony in 50 µl of PCR water 
and boiling the sample for 1 minute. 5 µl of this lysate was used directly as the template in the 
PCR mixture. An initial heating step is incorporated into the PCR protocol to further lyse the 
cells. The primer sequences used in these reactions are shown in Table 2.5 and called the forward 
and reverse sequencing primers. The composition of the PCR reactions was identical to the 
composition described in section 2.5.1. However a slightly different PCR protocol was used 
  
69 
 
(Table 2.10). Multiple colonies were screened and the PCR products of these reactions were 
analysed by Native Polyacrylamide gel electrophoresis (N-PAGE 2.10.2). The length of 
resultant PCR products reflected the nature of the template DNA found within the selected 
colony. Correct insertion of a DNA strand into the blunt-ended ligation site creates a larger 
amplicon.  
Colony PCR  
Step Temperature (°C) Time (s)  
Denaturation 94 300  
Melting 94 30 
25 cycles Annealing 60 30 
Elongation 72 30 
Final elongation 72 300  
Hold 4 ∞  
 
Table 2.10 The PCR protocol used to amplify recombinant plasmids during colony PCR. 
 
2.5.4. Radiolabelled PCR 
A small number of radiolabelled PCRs were used during this project. These are discussed in 
section 4.4. Standard symmetric PCR reactions were set up as described in Tables 2.6 – 2.8. 
These PCR reactions also contained (0.37 MBq/µl) [α-32P] dATP. PCR reactions then proceeded 
as described above. PCR purification was performed using GE healthcare spin columns (2.6.4).  
2.6. Nucleic acid purification methods 
Several DNA purification methods were used during this project, usually prior to sequencing 
or enzyme digestion. 
2.6.1. Ethanol Precipitation 
A volume of DNA in solution was measured and 0.1 equivalent volumes of 10 M ammonium 
acetate was added, followed by 2 total equivalent volumes of ice-cold 100% (v/v) ethanol. The 
solution was mixed and placed in a freezer for 30 min (or overnight).  Precipitated DNA was 
pelleted in an Eppendorf cooled-rotor centrifuge for 20 min at 13,000 rpm.  The supernatant was 
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removed and 1 ml ice-cold 70% (v/v) ethanol was added.  DNA was centrifuged again for 1 min 
and the alcohol removed. The pellet was allowed to air-dry until any remaining solvent had 
evaporated and then resuspended water. Ethanol precipitation was used to desalt, purify and 
concentrate plasmid DNA and PCR products in solution. 
2.6.2. Qiagen PCR purification 
The QIAquick PCR Purification kit contained a silica membrane assembly for binding of DNA 
in high-salt buffer and elution with low-salt buffer or water. The purification procedure removed 
primers, nucleotides, enzymes, salts, ethidium bromide, and other impurities from DNA 
samples. A column can bind up to 10 μg of DNA between 100 bp and 10 kbp. This purification 
method was used for primer removal and buffer exchange. Qiagen buffers are listed in Table 
2.2. Protocols were performed according to the manufacturer’s instructions.  
2.6.3. Exonuclease I - Shrimp Alkaline Phosphatase PCR purification 
EXO-SAP PCR purification (purchased from Affymetrix) was performed prior to sequencing of 
PCR products. This multi-enzyme reagent containes Exonuclease I which specifically degrades 
ssDNA into nucleotides while leaving duplex PCR products unaltered. The other enzyme, 
shrimp alkaline phosphatase, catalyses the hydrolysis of dNTPs. Incubation at 37 °C allows the 
enzymes to remove excess primers and dNTPs. Heat inactivation of the enzymes then allowed 
the sample to be sent directly for sequencing. Protocols were performed according to the 
manufacturer’s instructions. Composition of the buffers were not revealed by the manufacturer. 
2.6.4. GE Healthcare microspin column 
Radiolabelling of oligonucleotide required the removal of unincorporated radioactive dNTPs. 
This was done using a GE illustra MicroSpin G-25 column. The size exclusion chromatography 
method allowed separation of DNA strands from smaller molecules and salts. Protocols were 
performed according to the manufacturer’s instructions. 
2.7. Spectrophotometry 
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Ultraviolet light spectroscopy was used in this project to determine the concentrations of DNA 
molecules. Visible light spectroscopy was used to determine the optical density of bacterial cell 
cultures. Fluorophores and other factors are discussed later in the confocal microscopy section 
2.18. 
2.7.1. Nanodrop 2000 UV Spectrophotometry 
The concentration of DNA in solution was determined by UV spectrophotometry. The 
instrument was calibrated and blanked using a buffer-matched solution containing no DNA and 
then the absorption of light between 220 and 380 nm was measured through the sample 
containing DNA. The instrument used different settings for measuring dsDNA, ssDNA and 
oligonucleotides. DNA concentrations were given in ng/µl and those were converted to molar 
concentrations via molecular mass. This instrument was used and maintained according to the 
manufacturer’s recommendations. 
2.7.2. Cell Culture Optical Density 
The optical density of cell cultures was measured by visual (600 nm) light spectrophotometry. 
A Biowave CO 8000 Cell Density meter was calibrated using a sterile reference sample of cell 
media in a quartz cuvette. The optical density of an inoculated sample was then measured in the 
same way. Results were given in Absorbance units to two decimal places. This instrument was 
used and maintained according to the manufacturer’s recommendations. 
2.8. Microbial Techniques 
2.8.1. Media & Antibiotics 
Solid and liquid cell culture media were used in this project.  E.coli cells were cultivated using 
enriched media. Lysogeny broth (LB) and LB agar plates were used.  The composition of these 
can be found in Table 2.2. Selective media was prepared containing either 100 µg/ml Ampicillin 
or 15 µg/ml Tetracycline. Selective antibiotics were added to media after autoclaving under 
aseptic conditions. 
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2.8.2. Strains of E.coli 
The target cell in this chapter is a multi-drug resistant Gram–negative bacteria: E.coli HB101 
(Boyer & Roulland-Dussoix, 1969). The strain HB101 is a hybrid of E. coli K12 and E. coli B 
strains. When transformed with the pAT153 plasmid it becomes resistant to streptomycin, 
ampicillin and tetracycline. Transformation of recombinant plasmids was performed using 
E.coli DH5α (Taylor, et al. 1993). This strain of E.coli gained resistance to ampicillin when 
transformed with pJET1.2 recombinant cloning vectors. 
2.8.3. Culturing E.coli 
E.coli cultures were prepared by inoculating sterilised media with a single colony taken from a 
selective media LB agar plate under aseptic conditions. These culture vessels were then 
incubated at 37 °C with 200 revolutions per minute agitation, in an agitating incubator. Cells for 
SELEX Method II, and later cell binding experiments, were harvested when the cell culture 
reached an OD600 of 0.45 late-log phase ≈107 c.f.u per cm3). Cell cultures for the preparation of 
plasmid DNA were grown overnight. 
2.8.4. Preparation of Competent Cells 
A frozen stock of E.coli DH5α cells was streaked onto an LB agar plate. This was incubated 
overnight at 37 °C. A single colony taken from this plate was used to inoculate 10 ml of sterile 
LB broth. This starter culture was in turn left to grow overnight at 37 °C. A 5 ml sample of this 
broth was then used to inoculate 500 ml of sterile LB broth. This was then incubated at 37 °C 
for approximately 3 hours until the OD600 was 0.48. The culture was then transferred under 
aseptic conditions to a sterile Beckman centrifuge tube. The medium was then centrifuged at 
6000 g for 30 minutes at 4°C in a refrigerated centrifuge. The supernatant was removed and the 
pelleted cells were then resuspended into 166 ml of chilled Competent cell Buffer I (Table 2.2). 
This chilled mixture was kept on ice for 15 minutes. The cell suspension was then transferred to 
sterile Beckman bottles and centrifuged at 6000 g for 30 minutes at 4 °C. The supernatant was 
again removed and the centrifuged cells were resuspended in 40 ml of competent cell buffer II 
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(Table 2.2) and again chilled on ice for 15 minutes. 300 µl samples of cell suspension were then 
aliquoted under aseptic conditions to micro centrifuge tubes and snap-frozen in liquid nitrogen. 
These frozen cells were then stored at -80 °C ready for immediate use in bacterial 
transformations. 
2.8.5. Transformation of Plasmid DNA 
Recombinant plasmids were inserted into competent bacterial cells by heat shock. Competent 
DH5α cells were thawed on ice and 2 µl of cloning reaction mixture was added and mixed. This 
mixture was incubated on ice for 30 minutes. The sample was then moved to a heat block at 42 
°C for 45 seconds and then returned to ice for 5 minutes. To this, 850 µl of warm LB broth at 37 
°C was added and gently mixed by agitation. This was then transferred to a 37 °C shaking 
incubator for 30 minutes at 300 r.p.m. The tube was then centrifuged at 6,000 g for 10 minutes. 
The supernatant was removed and the pelleted cells were resuspended in 100 µl of warm nutrient 
broth with 100 µg/ml ampicillin. This suspension was spread-plated onto solid LB agar plates 
containing 100 µg/ml ampicillin. This plate was incubated overnight at 37 °C. After 24 hours, 
single colonies were observed. 
2.8.6. Mini-preparation of Plasmid DNA 
A single bacterial colony taken from an LB plate was used to inoculate 5 ml of nutrient broth 
containing a selective antibiotic in a sterile container and incubated at 37 °C overnight. The 
turbid culture was transferred into sterile micro-centrifuge tubes and centrifuged at 6,000 g for 
10 minutes. The supernatant was removed and the cell pellet was resuspended in 200 µl of 
Solution I (Table 2.2). It was important to completely resuspended the cells, since any clusters 
of cells will be protected from the following lysis step. Once the cells were completely 
resuspended by pipetting, 200 µl of Solution II (Table 2.2) was added. The tube was mixed by 
sealing the tube and inverting the mixture. A 200 µl sample of Solution III (Table 2.2) was then 
added and mixed. The supernatant was removed taking care to not to remove any of the pellet. 
The clear solution was added to a clean micro-centrifuge tube. To this clear solution, 900 µl of 
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ice cold absolute ethanol was added and mixed. The sample was then centrifuged at 10,000 g 
for 30 minutes. The supernatant was removed and replaced by 700 µl of 70% (v/v) ethanol. The 
sample was then centrifuged at 10,000 g for 30 minutes and the supernatant carefully removed. 
The tube was left open to allow any leftover ethanol to evaporate away. Once this happened the 
pelleted nucleic acids were resuspended in 50 µl of distilled water or TE buffer (Table 2.2). This 
method was similar to those described by Bimboim & Doly, 1979 and Sambrook & Russell, 
2001. Small scale preparation of plasmid DNA was also performed using Qiagen kits. This 
process was also automated by the use of a Qiacube robot. These processes were performed 
according to the manufacturer’s instructions. 
2.9. Systematic Evolution of Ligands by Exponential Enrichment  
Two different SELEX methods were used in this project and are illustrated in Fig 2.3. 
2.9.1. SELEX Method I  
SELEX Method I is described in Chapter 3 and uses bacterial colonies and asymmetric PCR. A 
colony of E.coli HB101:pAT153 was taken from a selective LB agar plate and resuspended in 1 
ml distilled water (Fig 2.3A). To this a randomised pool of oligonucleotides was added from a 
stock oligonucleotide library (2 µl of 100 µM stock > 1014 individual sequences). The 
concentration of the oligonucleotide in the bacterial mixture was not measured. This mixture 
was then incubated with agitation at RT for 10 minutes. This mixture was subsequently 
centrifuged at 8,000 g for three minutes to pellet the cells. The supernatant was removed and 
discarded leaving only the pellet with any bound oligonucleotides. The cell pellet was then 
resuspended in 100 µl of distilled water. 3 µl of this cell suspension was then used as the template 
DNA in three 40 cycle PCRs (1µl each) described in (Table 2.6).The first step of the PCR 
protocol was an additional denaturing step designed to heat-kill the bacterial cells and elute the 
oligonucleotide molecules. The PCR then proceeded as described in Table 2.8. 5 µl of each 
symmetric PCR product was analysed using agarose gel electrophoresis (2.10.1). 1 µl of the 
three PCR products were then used as the template in a subsequent three asymmetric PCRs as 
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described in Table 2.9. This regenerated single-stranded DNA sequences from the duplex input. 
All the asymmetric PCR products (150 µl (unquantified)) were then added to 1 ml of distilled 
water containing a single colony of resuspended E.coli HB101:pAT153 cells. This completed 
one cycle of SELEX. A total of 15 cycles of SELEX were used for SELEX Method I. After 15 
rounds the selected pool of molecules was symmetrically amplified, PCR purified and used in 
molecular cloning with the pJET1.2 blunt cloning vector. The ligation mixture was then 
transformed into E.coli DH5α. Each recombinant plasmid was transformed into an individual 
cell. This means that each bacterial colony-forming unit will uptake one representative sequence 
in the selected pool of molecules. 
2.9.2. SELEX Method II  
Method II differs significantly from the previously described SELEX Method I. A single colony 
of E.coli HB101: pAT153 was taken from a selective LB agar plate and used to inoculate a 10 
ml culture of LB broth with ampicillin. The sample was incubated until it reached an OD600 of 
0.45. (Sezonov, et al. 2007). A 1 ml sample was then taken and centrifuged at 8,000 g for 3 
minutes. The supernatant was removed, leaving the cell pellet. The cell pellet was carefully and 
fully resuspended in 1 ml of 1X PBS (pH 7.2) (Table 2.2) and 50 μl of HEX ssDNA pool (33.94 
μM) was added (Table 2.4). This was mixed to ensure homogeneity, and incubated at RT for 
exactly 30 minutes. The sample was then centrifuged at 8,000 g for 3 minutes and the supernatant 
was removed and stored. The cell pellet was resuspended in 1ml of 1× PBS (pH 7.2) and 
centrifuged again as above three times. Each time the supernatant was stored. After three washes 
the cell pellet was resuspended in 100 μl dH2O and moved to a new tube. This was then heated 
to 95°C for 5 minutes then cooled on ice for 5 mins to heat-kill the cells.  
The 100 μl of heat-killed cells (and any bound oligonucleotides) was added to a "phase 
lock" tube, and 100 μl of PCI (Table 2.1) was added. The sample was mixed (but not vortexed), 
then centrifuged at 16,000 g for 1 min. The top aqueous layer was pipetted into a fresh tube and 
75 μl of 10 M ammonium acetate was added (Table 2.1). A 350 μl measure of freezer-cold 100% 
ethanol was added (i.e. 2 volumes of 100+75 μl). The sample was mixed and stored at -28 °C 
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for 30 mins. The sample was centrifuged at 16,000 g for 20 mins at 0 °C. The supernatant was 
removed and stored.  Then 500 μl of freezer-cold 70% (v/v) ethanol was added down the side of 
the tube opposite the pellet. The sample was centrifuged at 16,000 g for 5 mins at 0 °C. The 
supernatant was again removed and stored. The pellet was left to air dry for 5 mins at RT. The 
pellet was resuspended in 100 μl of water (taking care to resuspend all the DNA under the hinge). 
This completed one SELEX Method II selection step. 
Individual 1 μl samples of the selected oligonucleotides were used as the template in 12 separate 
PCR amplifications. The PCR conditions and protocols were as described above (Table 2.7 & 
2.8). Negative controls containing no template molecules were also performed. To facilitate the 
recovery of the ssDNA strands, 5’-HEX-modified top primers were used. 5’-phosphorylated 
bottom primers were also used. The PCR products were then pooled and purified using a Qiagen 
PCR purification kit.  
ssDNA was then regenerated by λ exonuclease digestion. The purified PCR products were 
mixed with λ buffer (Table 2.2) and PCR products were digested using 5 U of λ exonuclease for 
2 hours at 37 °C. The enzyme was then denatured by heating the sample to 75°C for 10 mins. 
This sample was then purified by Qiagen PCR purification. 7μl samples were taken before and 
after digestion and analysed by D-PAGE (2.10.3) and Nanodrop UV spectrophotometry (2.7.1). 
2.10. Gel Electrophoresis 
2.10.1. Agarose Gel Electrophoresis 
Typically, DNA samples were mixed with agarose gel loading buffers and analysed on 0.8-3.0% 
agarose gels. 1× TAE and TBE Agarose gels were run at a suitable voltage between 80 V and 
200 V. Gels were supplemented with 0.5 µg/ml ethidium bromide and visualised by UV trans-
illumination. Plasmid minipreparation and restriction digests were visualised on 0.8% (w/v) 
TBE gels. DNA molecules over 100 bp in length were analysed using 2% (w/v) agarose gels.  
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Figure 2.3 Schematics showing the SELEX methods used in this thesis A. Method I used in 
Chapter 3. B. Method II used in Chapter 4. 
A. 
B. 
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Agarose powder was weighed and typically resuspended in a volume of 1× TAE or TBE 
resulting in the desired final concentration of agarose. This mixture was then microwaved in an 
Erlenmeyer flask for 90 seconds or until all the particles had dissolved. (If Ethidium Bromide 
was required, the gel was allowed to cool to ≈ 50 °C, and the required volume of stock EthBr 
was added and mixed before pouring.)  This was then poured into a prepared cast (containing 
combs). The gel was allowed to cool and solidify at room temperature. Once cooled, combs were 
removed and gels were submerged in the appropriate running buffer. The lengths of time gels 
were electrophoresed depended on the individual experiment.  
2.10.2. Native Polyacrylamide Gel Electrophoresis (N-PAGE) 
DNA molecules under 100 bp were analysed using 15% (w/v) native PAGE. The compositions 
of chemicals and reagents required for these gels are described in Tables 2.1 and 2.2. The 
components of these gels are described in Tables 2.11 below. Gel mixtures were prepared in 50 
ml falcon tubes and poured into NOVEX gel casts, and combs were added. Once set, these were 
fitted into the NOVEX gel kit and the combs were removed. The gels were submerged in 1× 
TBE and the samples were loaded. Gels were run typically at 80 V.  
Component Initial concentration Final Concentration Volume added 
40% (v/v) Polyacrylamide 40% (w/v) 15% (w/v) 9.375 ml 
TBE 10× 1× 2.5 ml 
dH2O - - 13 ml 
APS 20% (w/v) 0.08% (w/v) 100 µl 
TEMED 98% (v/v) 0.098% (v/v) 25 µl 
Total   25ml 
 
Table 2.11 The composition of a 15% (w/v) N-PAGE gel used in this project to visualise DNA 
molecules under 100 bp 
 
Once electrophoresis was completed, gels were removed and placed into a staining tray. 
These were then submerged in a 1× SYBR Gold solution for 30 minutes. N-PAGE gels, once 
stained with SYBR Gold, were visualised with a Fujifilm FLA5000 phosphorimager. Gels 
containing fluorescent oligonucleotides were analysed without additional staining. 
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2.10.3. Denaturing Polyacrylamide Gel Electrophoresis (D-PAGE) 
15% (w/v) D PAGE gels were used to analyse single strands of DNA. Increased temperature 
and urea concentrations were used to melt strands of DNA. Gels were mixed and cast using a 
BIO-RAD sequi-gel 45 cm gel system as the manufacturer instructed. Once cast, gels were 
submerged in running buffer and run at 70 W until at ≈ 55 °C. Samples were then loaded and 
run at 80 W until complete. 
Component  Initial concentration Final Concentration Volume added 
Acrylamide 40% (w/v) 15% (w/v) 9.375 ml 
TBE-UREA 5× 1× 5 ml 
UREA  50 % (w/v) 21 % (w/v) 10.5 ml 
APS 20% (w/v) 0.08% (w/v) 100 µl 
TEMED 98% (v/v) 0.098% (v/v) 25 µl 
Total   25 ml 
 
Table 2.12 The composition of 15% (w/v) D-PAGE gels used in this project to visualise ssDNA 
molecules under 100 nt 
D-PAGE gels were visualised using a Fujifilm FLA5000 phosphorimager, using SYBR 
Gold stain or fluorescently-labelled oligonucleotides. 
2.10.4. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein samples were analysed using a 15% (w/v) resolving gel with a 5% (w/v) stacking gel. 
Stacking and resolving gels were prepared as described in Tables 2.13A & B. Gels were mixed 
in separate falcon tubes and poured into NOVEX gel casts. The resolving gel was allowed to set 
before pouring the stacking gel. Combs were removed and the samples were loaded. 
Component Initial concentration Final Concentration Volume added 
Acrylamide 30% (w/v) 15% (w/v) 12.5 ml 
Tris (pH 8.8) 1.5 M 0.378 M 6.3 ml 
SDS 10% (w/v) 0.1%  (w/v) 250 µl 
APS 10% (w/v) 0.1%  (w/v) 250 µl 
TEMED 98% (v/v) 0.039% (v/v) 10 µl 
dH2O - - 5.7 ml 
Total   25.01 ml 
 
Table 2.13 A Composition of a 15% SDS-PAGE resolving gel. 
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Component Initial concentration Final Concentration Volume added  
Acrylamide 30% (w/v) 5% (w/v) 830 µl 
Tris (pH 6.8) 1 M 0.126 M 630 µl 
SDS 10% (w/v) 0.1%  (w/v) 50 µl 
APS 10% (w/v) 0.1%  (w/v) 50 µl 
TEMED 98% (v/v) 0.098% (v/v) 5 µl 
dH2O - - 3.435 ml 
Total   5 ml 
 
Table 2.13 B Composition of a 5% SDS-PAGE stacking gel. 
Protein samples were prepared and heated to 95 °C for two minutes in an equal volume of SDS-
gel loading buffer (Table 2.2). Prior to heating, 10 µl of stock β-mercaptoethanol (Table 2.1) 
was added to a 1.5 ml aliquot of SDS loading buffer. Heated samples were loaded onto the SDS-
PAGE gel and were electrophoresed in SDS Tris-Glycine running buffer (Table 2.2) at 80 volts 
for approximately two hours. Protein gels were stained with protein safe stain, destained in a 
10% (v/v) acetic acid, 10% (v/v) methanol solution overnight and visualised using white light 
trans-illumination (G-BOX). 
2.11. Molecular Cloning 
The vector pJET1.2 blunt is a positive-selection cloning system. The plasmid contains a 
sequence which codes for a lethal restriction enzyme. Only when this gene is interrupted by a 
cloned insert is the construct viable. The β-lactamase gene on the plasmid ensures that all viable 
colonies contain plasmids and the eco47IR gene ensures that all plasmids contain an insert. PCR 
was used to amplify the region of the plasmid which contained the inserted sequence. This 
process of screening for inserts by colony PCR allows the presence of an insert and size of the 
cloned region to be analysed. Compositions and protocols for colony PCR are described in tables 
2.5 and 2.10. PCR screening for recombinants showed that all colonies contained cloned 
plasmids. Blunt-ended ligation of purified PCR products was performed according to the 
manufacturer’s instructions. Insert to vector ratios were typically 1:1, 3:1 or 10:1. The 
composition of a typical cloning reaction is described in Table 2.14. 
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 Initial concentration Final Concentration Volume Added 
Reaction buffer 2× 1× 10 µl 
Purified PCR product - - 1 µl 
dH2O - - 6 µl 
Blunting enzyme - - 1 µl 
pJET1.2 cloning vector 50 ng/µl 2.5 ng/µl 1 µl 
T4 DNA ligase 5 U/µl 0.25 U/µl 1 µl 
Total   20 µl 
 
Table 2.14 The composition of a typical cloning reaction used to ligate PCR products into 
pJET1.2. 
2.12. Phenol-Chloroform Extraction 
Up to 500 µl of a sample was pipetted into a “phase lock” Eppendorf tube. An equal volume of 
Phenol:chloroform:isoamyl-alcohol (PCI) (Table 2.2) was added and mixed. The mixture was 
then centrifuged at 16,000 g for 1 min. The top aqueous layer was then pipetted off and placed 
into a new micro-centrifuge tube. 
2.13. Restriction Endonuclease Digestion 
A solution containing DNA was mixed with a 10× restriction digest buffer (Table 2.2) giving a 
final concentration of 1× buffer. A typical restriction digest had a final volume of 20 µl.  A 
measure containing 5 U of BglII restriction endonuclease was then added and mixed. The sample 
was then incubated at 37 ºC for 2 hours. The enzyme was heat-killed by incubating the sample 
for 10 minutes at 70 ºC. 
2.14. λ Exonuclease Digestion 
Single- and double-stranded DNA samples were mixed with 10× λ exonuclease buffer (Table 
2.2) to give a final concentration of 1×. Reaction volumes of 50 µl and 100 µl were used in this 
project. 5 U of λ Exonuclease were then added and the sample was mixed and incubated at 37 
ºC for varying periods of time. The enzyme was then heat-killed by incubating the sample for 
10 minutes at 70 ºC. This standard reaction composition was used for the digestion of a number 
of different DNA substrates. These included double- and single-stranded DNA, 5’- 
phosphorylated DNA and 5’-HEX-modified samples. λ exonuclease time-course reactions were 
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performed where a master reaction containing substrate, enzyme and buffer was initiated, and 
samples were extracted and mixed with STOP buffer to halt the reaction. 
2.15. DNA Sequencing 
Sanger capillary sequencing of plasmids and PCR products was performed by GATC and Source 
Bioscience. Purified plasmids were sent at a concentration of 100 ng/µl and purified PCR 
products at 1 ng/µl per 100 bp. Primers used to initiate the sequencing reaction were sent at 3.2 
µM. Qiagen or ExoSAP purification was performed prior to sequencing (see sections 2.6.2 & 
2.6.3). 
2.16. Oligonucleotide Annealing 
Complementary single-stranded oligonucleotide solutions were mixed in equimolar quantities 
and heated to 95 ºC in a buffer containing monovalent cations, usually 1× or 0.1× PBS or TEN 
buffer (Table 2.2). The sample was allowed to cool slowly overnight creating double-stranded 
DNA molecules. 
2.17. Bioinformatics 
2.17.1. DNA Sequence Analysis and Alignment  
Nucleotide alignments were performed using Clustal W webservers and Geneious R7. Multiple 
sequences were stored using CLC sequence viewer 7 and Geneious R7. Weblogo was used to 
create nucleotide frequency histograms (Crooks et al. 2004). 
2.17.2. mfold Structural Prediction 
2D DNA secondary structural predictions were performed using Vienna RNA fold webservers 
and Geneious R7. DNA folding parameters were used (Mathews et al. 2004). 
2.17.3. ifold Structural Prediction 
The ifold RNA webservers were used to generate 3D structural predictions for oligonucleotide 
sequences under 57 bp (Ding et al. 2008a; J. L. Ding, et al. 2008b; Sharma et al. 2008).  
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2.18. Confocal Microscopy 
2.18.1. Sample Preparation 
Bacterial cells were prepared as described in section 2.8.2. The bacterial cells (approx. 107) were 
resuspended in either water or 1× PBS, containing a concentration of fluorescently labelled 
oligonucleotide which had previously been heated to 95 ºC for 5 minutes and allowed to cool 
slowly. The cell suspension was then left for 40 minutes. The sample was centrifuged at 8,000 
g for 3 minutes and the supernatant was removed. The cells were washed in 1 ml of 1× PBS or 
water and centrifuged at 8,000 g for 3 minutes. This step removes the unbound oligonucleotides. 
The supernatant was removed and the cells were resuspended in 10 µl of water or PBS. A sample 
of this cell suspension was then placed onto a clean glass microscope slide and covered with a 
cover slip. The coverslip edges were then sealed with Rimmel 60 second clear nail varnish 
supplied by Tescos. 
2.18.2. Confocal Microscopy 
Samples were viewed using a Zeiss 710 laser scanning confocal microscopy system. The system 
was operated and maintained according to the manufacturer’s recommendations. Laser intensity 
was fixed at 40% of maximum laser intensity to prevent overheating. Scanning area was set to 
512 by 512 pixels in each of the brightfield and fluorescent light pathways. Image averaging 
was set to the mean of 16 recorded images. Scanning speed was optimised for each experiment. 
488 nm laser was used to excite fluorescence of FAM (Fig 2.4C & 2.5) and the 514 nm laser 
was used to excite HEX (Fig 2.4B & 2.5). Confocal microscopy experiments are described in 
Chapter 7. 
2.18.3. Image Processing 
Images and z-stacks were exported as .lsm files and later converted into .tif files. Image J was 
used to quantify numbers of cells and fluorescence intensity. 
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Figure 2.4 The fluorophores attached to the 5’ phosphate groups of oligonucleotides used in 
confocal microscopy and other binding assays. A Fluorescein. B Hexachlorofluorescein (HEX). 
C Fluorescein amidite (FAM) protected by tertiary butyl groups.. 
 
A. 
B. 
C. 
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Figure 2.5 The excitation and emission spectra of the major fluorophores used in this 
project. FAM and HEX are used in confocal microscopy and SYBR Gold and Ethidium 
bromide are used in visualisation of nucleic acids in gel electrophoresis. In each case the x-
axis shows the wavelength of light in nanometres and the y-axis shows the normalised 
fluorescent intensity (created using Chroma spectral viewer www.chroma.com/spectra-
viewer). Excitation spectra are shown in blue and emission spectra are shown in red.  
HEX 
Ethidium  
SYBR Gold 
FAM 
λ (nm) 
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2.19. Liquid Scintillation Counting 
Radiolabelled PCR products were created using the protocol described in section 2.5.4. Single 
sequenced plasmids were used as the templates to generate known-sequence ssDNA aptamers. 
These were then λ exonuclease-digested using the protocol described in section 2.14. These 
radiolabelled ssDNA sequences were then used in a pull-down assay using the protocol 
described in section 2.19.1 with one variation. In this protocol there were two PBS wash steps. 
The radioactivity of each fraction was determined by liquid scintillation counting. A 300SL 
liquid scintillation counter was used. 
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Chapter 3: Cell-SELEX using Bacterial Colonies 
and Asymmetric PCR. 
 
3.1.SELEX Overview & Rationale 
Escherichia coli is a bacterial species of global biological and medical significance. This 
eubacterium is an essential constituent of ecosystems both throughout the world and within our 
own microbiome. Strains of this organism can be pathogenic, benign or beneficial (Qadri et al. 
2005; Rodrigues et al. 2013; da Re et al. 2013). The focus of the work presented in this chapter 
was to use SELEX to enrich an initially random pool of 100-mer single-stranded DNA molecules 
for sequences that specifically bind to the cell surface of E.coli HB101. The targets for these 
aptamers were live bacterial cells. The selection method used in this chapter allowed molecules 
to be selected which bind to bacteria at different stages of growth since they were taken from 
colonies.  
A diagram showing an overview of this Cell-SELEX procedure (SELEX Method I) is 
shown in Fig 3.1. In vitro selection was performed by incubating the evolving pool of molecules 
with the target cells in water for 10 minutes and the bound and unbound molecules were then 
separated by centrifugation. The cells used in each round of selection were taken from single 
bacterial colonies grown for 24 hours on LB agar containing ampicillin. Cells were centrifuged 
at 8,000 g for 3 minutes; this centrifugation protocol was used to ensure that the cells remained 
intact and alive during the SELEX procedure. The unbound molecules that remained free in 
solution were removed and then discarded. Symmetric (0.4 µM each primer) PCR (40 cycles, 
53 °C annealing SELEX Method I described in Table 2.8) was then used to amplify the cell-
bound molecules: the bound molecules were eluted from the cells by heat denaturation at the 
start of the PCR protocol. The use of Taq polymerase, which lacks proof-reading activity, 
introduced a small amount of further random variation (Eckert & Kunkel, 1991; McCullum & 
Chaput, 2010). PCR controls without template were performed for each round of SELEX. 
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Figure 3.1. Schematic showing the Systematic Evolution of Ligands by EXponential enrichment 
(SELEX). The initial randomised synthetic oligonucleotide pool (red) flanking primer regions (black). 
These synthetic DNA molecules were then amplified using asymmetric PCR and incubated with the target 
cells (blue circles). Bound and unbound molecules were then separated by centrifugation and the bound 
molecules eluted from the cells by heating. The selected molecules were then exponentially enriched by 
symmetric PCR amplification. Enriched duplex sequences are shown in green. For these experiments 
fifteen cycles of PCR were performed, then the enriched sequences were cloned and sequenced. 
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The evolving ssDNA sequences were converted back to primarily ssDNA by amplifying 
samples of the selected molecules using asymmetric PCR. This is a technique in which one of 
the two primers is present in excess over the other (Sanchez et al. 2004). The rationale for using 
this approach is that it is a simple, single-step method for generating ssDNA during each SELEX 
round. The PCR protocol and primers were taken from published work in which asymmetric 
PCR was used to generate single-stranded DNA from a plasmid (Liang et al. 2007). In this PCR 
protocol, primer concentrations were 0.4 µM Reverse vs. 0.04 µM Forward primer. Also, a high 
number of cycles was used to ensure that the primer-extension stage reached completion; as a 
high number of cycles ensures that the lower concentration primer (Forward primer) was 
exhausted, and that a maximum amount of ssDNA is then generated in the remaining cycles. 
One disadvantage of this method is that double-stranded DNA is initially generated as a by-
product. 
Fifteen rounds of SELEX were conducted. During each of the 15 rounds of SELEX, the 
bacterial cells were incubated with the evolving ssDNA pool from the previous round (starting 
with the random pool). In the final stage, the enriched pool of molecules was amplified by 
symmetric PCR (40 cycles, 53 °C annealing), cloned by blunt-ended ligation into the pJET1.2 
cloning vector (2.11), transformed into competent bacterial cells (2.8.5) and plasmid minipreps 
were produced for sequencing (2.8.6).  These final sequences were analysed by sequence 
alignment and tested for E.coli HB101: pAT153 binding by laser-scanning confocal microscopy 
(LSCM). The long-term aim of this work was to create robust, stable single-stranded DNA 
sequences capable of specific binding to living E.coli cells. Such sequences could then be used 
as leads in new antibacterial drug-development, biotechnology or environmental-testing 
situations. 
3.2. SELEX Primers & Library 
 
The development of single-stranded DNA aptamers using Cell-SELEX is an emerging 
technology (Stoltenburg & Strehlitz, 2007; Sefah et al. 2010).  The initial pool of randomised 
oligonucleotide was generated by solid phase phosporamidite oligonucleotide synthesis 
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(Invitrogen UK/Life Technologies). The synthetic pool was designed with defined flanking 
regions to be amplified with the primers shown in Fig 3.2A. These facilitate the amplification 
of the random pool by both asymmetric and symmetric PCR. These primer sequences also 
amplified an 1,888 bp region of pUC19, which was used as a positive amplification control. The 
amplified segment of pUC19 is shown in Fig 3.2B (in blue). The primers were checked 
experimentally to ensure that they did amplify a pUC19 template (50 ng) as expected (Fig 
3.2C).The same panel includes a DNA marker (lane 2) and a no-template control (NTC, lane 3). 
The pUC19 positive control was used throughout the SELEX process to ensure correct 
amplification of the evolving pool of molecules in both symmetric and asymmetric PCR. 
An oligonucleotide library of 100 nt length was synthesised by Invitrogen. This pool of 
DNA molecules had the 5’ and 3’ flanking regions complementary to the primers shown in Fig 
3.2A and a central region of 62 randomised nucleotides shown in Fig 3.3A. The library was 
resuspended at a final concentration of 100 μM and checked by UV Nanodrop 
spectrophotometry. The pool of molecules contained different sequences; therefore, different 
molecules within the pool would have slightly different molecular weights and extinction 
coefficients. Therefore, in this work, when calculating the molar concentration of random pools 
of ssDNA or duplex DNA  the average expected molecular weights were used. 
Fig 3.3B shows a denaturing PAGE (D-PAGE) of the starting oligonucleotide pool of 
molecules (lane 2, 90 ng) alongside a control 100 nt oligonucleotide of defined sequence (lane 
3, 90 ng). This shows that the major synthesis product in lane 2 was 100 nt in length. The D-
PAGE protocol is described in section 2.9.3. Following on from this, the next stage was to 
demonstrate that the PCR primers (Fig 3.2A) could successfully amplify the randomised 
sequence library. This is shown in Fig 3.3C in which a Symmetric PCR reaction was performed 
for 40 cycles on 10 ng of initial random sequence library. This showed a single band of 100 bp 
on an agarose gel (lane 2, 150 ng loaded): the no-template control (NTC) showed no 
contamination. In order to progress to the next round of SELEX, successful positive and no 
template negative controls must be observed at both PCR stages. 
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SELEX Method I Primer Sequences 
Forward -  5’ AGAAACGCTGGTGAAAGT 3’ – 18mer 
Reverse –  5’ CGCAAGCATAAAGTGTAAAG 3’ – 20mer 
 
 
        
  
 
 
 
 
 
 
 
Figure 3.2 SELEX PCR primers and positive control A. The sequences of the primers used to amplify 
the randomised library for SELEX and the pUC19 cloning vector as a PCR positive control. The “reverse” 
primer is the one used in 10-fold excess in asymmetric PCR B. Plasmid map of pUC19 with the 1,888 bp 
region amplified by the primers shown in blue. C. 1% (w/v) agarose gel stained with ethidium bromide 
showing the PCR amplification of the pUC19 plasmid template.  Lane 1) 1,888 bp PCR product (40 
cycles, 53 °C annealing), 2) 2-Log DNA Ladder (0.1-10.0 kb) supplied by NEB, 3) No template PCR 
control. PCR conditions and protocols are described in Tables 2.6 to 2.8. DNA markers are listed in full 
in Appendix II. 
 
 
 pUC19 
2,686 bp 
A. 
B. 
     1            2            3 
C. 
1,888 bp 
100 bp 
500 bp 
10,000 bp 
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Randomised oligonucleotide library  
5’ CGCAAGCATAAAGTGTAAAG (N)62 ACTTTCACCAGCGTTTCT 3’ – 100mer 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Randomised oligonucleotide library and PCR amplification A. The sequence of the synthesised 
initial random library (random nucleotides shown with the 62 nt cassette in red). B. A 15% (w/v) 
Denaturing PAGE stained with SYBR Gold showing; 1) NEB 50 bp DNA ladder (denatured) 2) The 100 
nt randomised oligonucleotide library (90 ng) 3) A reference 100 nt oligonucleotide with a defined 
sequence (reference sequence* supplied by Dr D Gowers 90 ng). C. A 2 % (w/v) agarose gel stained with 
ethidium bromide showing; 1) Gene Ruler 100 bp DNA ladder supplied by Thermo-Fisher 2) PCR product 
random pool amplification (40 cycles, 53 °C annealing) (150 ng) PCR no template control. 
*5’GCTGCTGCTATGATGCTGGCTTTTTGCCAGCATCATAGCAGCAGCTGAGTGCAGCTGAGAGCAGTCTCCT
CAATCCCGCAGTTCAATCGTCGCACATGGC 3’ 
A. 
B. C.      1            2           3    1                2                 3 
100 nt 
100 bp 
500 bp 
1 kbp 
200 bp 
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3.3.   SELEX Preliminary Experiments 
 
Prior to initiating SELEX, several preparatory experiments were performed. In brief, these were 
to: sample the initial library of sequences, optimise the cloning protocol, assess the production 
of ssDNA, check the specificity of the PCR primers and the viability of the target cells. 
Preliminary Experiment I – Sampling the Initial Library 
Having demonstrated successful PCR amplification of both the pUC19 positive control and 
random pool (Figs 3.2C and 3.3C), the next step involved sampling the oligonucleotide library 
by sequencing to check for sequence diversity (‘randomness’). This simultaneously helped 
optimise the PCR purification, cloning and screening steps. PCR products from the random pool 
were amplified by symmetric PCR as in Fig 3.3C and purified by Qiagen kit according to the 
method described in section 2.6.2 before spectrophotometry using a NanoDrop instrument. 
Molecular cloning was performed using pJET1.2 (Fig 3.4A, Michelsen, 1995). This is a 
linearised vector (restricted at the EcoRV blunt restriction site) that, upon ligation, forms a 
recombinant vector that disrupts a lethal endonuclease gene. Ligation was performed using the 
purified PCR product at different ratios of insert to vector. These ratios were: 1:1, 3:1 and 10:1. 
The resulting ligation mixture was transformed into competent E.coli DH5α. Agar plates 
showing the transformants are shown in Fig 3.4B. The number of transformants per plate are 
tabulated in Fig 3.4C and showed that the ratio of 3:1 insert: vector gave the most colonies. 
Two methods were employed to screen the observed colonies for correct ligation. Both 
worked by measuring the distance in base pairs between two fixed points on either side of the 
blunt-ended ligation site on the pJET1.2 cloning vector. The first method was alkaline lysis 
plasmid minipreparation (2.8.6) followed by restriction digestion using BglII (2.13) and 
subsequent analysis by agarose gel (2.10.1). BglII cuts pJET1.2 at nucleotide positions 12 and 
2940 (Fig 3.5A). If the plasmid successfully recombines with a 100 bp insert at the blunt-ended 
ligation  
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Figure 3.4 Strategy for molecular cloning of random sequence purified PCR products A. Plasmid map of 
the pJET1.2 cloning vector. This plasmid encodes for ß-lactamase ampicillin resistance. The blunt-ended 
ligation site is shown at position 0. Insertion of DNA into the linear form of the plasmid interrupts the 
expression of the lethal eco47IR gene. The position of the forward and reverse sequencing primers is 
shown, these have been underlined in blue. B. LB agar plates containing 50 μg/ml ampicillin showing the 
number of recombinant colonies. C. Table of the number of transformed E.coli DH5α colonies after 24 
hrs of incubation at 37 °C. Different molar ratios of insert to plasmid produced different numbers of 
colonies. It is important to note that no colonies were observed when no insert has been ligated into the 
plasmid, indicating that the lethal gene (eco471) interruption system is functioning. 
Insert : Plasmid 
Molar Ratio 
Number of observed 
colonies 
1:1 33 
3:1 114 
10:1 18 
0:1 0 
pJET1.2 
2,974 bp 
 
B. 
C. 
1:1 3:1 
10:1 0:1 
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Figure 3.5 Restriction digest of recombinant plasmids A. Section of the pJET1.2 blunt cloning vector at 
the cloning site; the blunt-ended ligation cloning site is shown with a dotted line. The two BglII 
endonuclease restriction sites are shown in blue. B. 1.5% (w/v) agarose gel stained with ethidium bromide 
showing in lane 1) A 100 bp - 3 kbp DNA ladder supplied by VWR,  even-numbered lanes from  2 to 14) 
1 μg loadings of isolated recombinant plasmids extracted and purified from bacterial cultures. Odd-
numbered lanes from 3 to15) are the same adjacent plasmids after restriction digest with BglII. Lane 16) 
AccuLadder 1 kb DNA Size Marker supplied by Bioneer. M = Marker, U = Uncut, C = Cut.  
A. 
B. 
Insertion site 
        1         2        3        4       5        6         7       8        9      10      11     12     13      14       15      16              
.      M        U       C       U       C       U        C      U       C       U       C      U       C       U        C       M 
100 bp 
200 bp 
3 kbp 2,961 bp 
500 bp 
1 kbp 
10.2 kbp 
500 bp 
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site, then restriction digest of that plasmid would yield a linearised large fragment of 2901 bp 
and a small fragment of 146 bp. The small fragment would contain the 100 bp insert (containing 
a single sequence duplex). If the cloning vector re-circularises without up taking an insert then 
the same large fragment would be observed but the small fragment would only contain 46 bp. 
Figure 3.5B shows the results of an agarose gel with a total of seven recombinant plasmids. Each 
is shown with an uncut (U) and cut (C) sample (1000 ng loadings). In all cases, successful 
ligation was observed, since 147 bp fragments of DNA were observed with each restriction 
digest. 
The second method used to assay transformed colonies for successful recombination was colony 
PCR (method described in 2.5.3). This method used PCR primers specific to the pJET1.2 
plasmid (Fig 3.6A); note, these primers are different to the SELEX primers. The pJET1.2 
forward sequencing primer is complementary to nucleotide position 2913-2935 and the reverse 
sequencing primer is complementary to positions 34-57. This is shown in Fig 3.6B. In much the 
same way as described in the restriction digest method, this method effectively measures the 
distance in bp between two fixed points on either side of the blunt-ended ligation site. 
Transformed colonies from agar plates were used as the template. The expected size of the 
amplicon created by a PCR using a correctly recombined plasmid as a template was 218 bp (100 
bp of insert plus 118 bp of vector sequence and primers). The amplicons of the colony PCR 
reactions (25 cycles, 60 °C annealing) were analysed by 15% native PAGE (N-PAGE) and eight 
example recombinants are shown in Fig 3.6C alongside an NTC. The higher resolving ability of 
the high-percentage gel allowed the observation of slight variations in the electrophoretic 
mobility of the amplicons. This indicates that each of the observed amplicons had a unique 
molecular weight and likely reflects the diversity in individual sequences. None of the amplicons 
were observed migrating at 118 bp which would be expected if the vector had re-circularised. 
Both the restriction digest method and the colony PCR method of screening for 
recombination successfully identified correct recombination of inserts into the pJET1.2 cloning 
vector. 
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A. 
pJET1.2 sequencing primers 
Forward -  5’ CGACTCACTATAGGGAGAGCGGC 3’ – 23mer 
Reverse -  5’ AAGAACATCGATTTTCCATGGCAG 3’ – 24mer 
 
B. 
 
 
 
  
 
 
 
 
C. 
 
 
 
 
 
 
Figure 3.6 PCR screening analysis of recombinant plasmids A. Sequences of the primers used to amplify 
the blunt-ended ligation site of the pJET1.2 cloning vector. B. Plasmid map of the pJET1.2 blunt cloning 
vector showing the region amplified by the sequencing primers. C. 15% (w/v) Native PAGE gel stained 
with SYBR Gold showing colony PCR reaction of recombinant colonies. 1) NEB 50 bp DNA ladder, 2-
9) PCR products of picked recombinant colonies (25 cycles, 60 °C annealing) (70 ng per lane). 10) PCR 
no template control.  
pJET1.2 Forward 
pJET1.2 Reverse 
 1            2             3            4            5            6           7             8            9          10       
50 bp 
200 bp 
1.35 kbp 
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Finally, identified recombinant plasmids were sequenced using the pJET1.2 Forward 
sequencing primer. Plasmids or PCR amplicons were purified using Qiagen kits. DNA 
sequencing requirements are described in section 2.15. A total of 17 sequencing reactions were 
performed. Each of the inserts contained a unique sequence (Fig 3.7), and the Forward 
(complement) and Reverse primer sequences were present (shown in red and blue, respectively).  
From this small set of sequencing reactions, it was clear that a notable proportion of T-
rich sequences were present. However, a position-by-position inspection of the 62 nt random 
cassette showed no observable bias for a given nt position. This may be a reflection of the 
synthesis chemistry, in which a small intrinsic bias during synthesis led to an oligonucleotide 
pool with a higher T content. 
Preliminary Experiment II – Primer Walking Experiment 
Given the result from Preliminary Experiment I, a further experiment was devised to test the 
‘randomness’ of the oligonucleotide library; this did not rely on DNA sequencing, but on 
interrogating the identity of the first nucleotide at either end of the 62 nt random cassette. 
This was designated a limited ‘primer-walking’ experiment and used eight modified 
primers (Fig 3.8A F1A, F1C, F1G, F1T, R1A R1C, R1G and R1T), four for each end of the 
cassette. The principle of this experiment involved combining one of the unmodified SELEX 
primers (Forward or Reverse Fig 3.2A) with one of the primer-walking primers (for example, 
F1A. Fig 3.8A). The modified primer sequences were simply shifted one nucleotide in the 
3’direction, with the 3’-terminal base being either A, T, C or G. Using these primer sets it was 
possible to probe the first position of the random region of the synthesised pool. This process 
relies on the discrimination for correct base-pair formation that Taq DNA polymerase 
demonstrates: a 3’ terminal mismatch greatly reduces the efficiency of Taq DNA polymerase to 
bind and elongate a primer-template complex (Ayyadevara et al. 2000).
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5’CGCAAGCATAAAGTGTAAAGGGTTATTATTGTATTGTTGTGTTTTCAATGGTTGCCCTCACTTAGGTGTGGTTTGAAAATGTACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTTGCTCCTCATTTTTGTACTTGTTTGCTGTCTTCTTTCCTCGTGTCCGTGAGTTACGCTGTGACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTTGTTGTATTGCTTTTTTTGTCTATTGAAAATATGTGTTCTACCTGGTATTGTTTTTGTTCTACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTATGTTTCAGTCTCATGATTTTGTTAATTTGACGCTTGTGTATTGTGTTTTTTGCTTTTGACACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTGTGGCGTCTAAATTGGTTTGTGTTTTATGTTTTATGTAATTCGAGCTGCTGTATTCGGTCGACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGATTTTGTGAGTTGCATTTTTTACTGCATTGTTTCATACTATTGGTCATTTGGCCTTTTACTCACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGGTTGATGTTTTCAAATTCTTTGTATGGGATTTGTTGTTGTCTTGGAGAGGTTCTTCTGGGTGACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGATTATCTGATATTCTTTGCTTTCTTTTGATTTCAAATTGGTATGTTCCATTTACTTGTGTCCACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTTTTATGTTAAATTATTTGTTTTTTGTTTGTATTCTTTTATAGGAACGCTCTGTCTGTGAGCACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTTCCCTCTGTGTTTGGATAAACCTTTTTTATTTATGTGTTGGTATGGTTGGAAATTCGAAGTACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGAGGATTGTTAGTATGTTCTGTTTATAATTTTTGTTGGCATGGATTTATTACTGTACGCTCTCACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGCGCCCTTTTAGTGGCTGGCGCAAAATATCTTCGGATCCCCTTGTCCAACCAGATTAATCGAAACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGTTCTCTCATTTAGGACCCTAGTAAGTCATCATTGGTGTTTAAATGCCACCCCGAAGAAACCGACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGCCTAGAAATGTCTATGATTGGTCCACTAAAGTTGATTAAATCGACTCCTAAATCCGCGCGATACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGAGGGCATTAGAGGTTTAATTTTGTATGGCAAGGTACTCCCGATCTTAATGGATGGCCGGAAGACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGCATCTGATGTTACCCGGGTTGAGTTAGTGTCGAGCTCGCGGAACTATTGCATGAGTAGAGATACTTTCACCAGCGTTTCT3’ 
5’CGCAAGCATAAAGTGTAAAGCGCAGCCACCTATCGCCTGAAAGCCAGTCGGCGTTAAGGAGTGCTCTGTCCAGGACAACACGACTTTCACCAGCGTTTCT3’ 
 
Figure 3.7. A selection of insert sequences from the cloned randomised library of oligonucleotides. Sequences of the SELEX reverse primer are shown in Red and the sequence 
complementary to SELEX forward primer are shown in Blue. All are 100 nt in length with a 62 nt unique central sequence.
Reverse SELEX primer     Random pool sequence                 Forward primer (complement) 
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A total of eight primer combinations were tested, four at each end of the random cassette. 
Since one modified primer was synthesised for each of the possible nucleotides, each of these 
selective oligonucleotides could theoretically amplify one quarter of the possible potential 
sequences in the random pool. This will be true only if the pool is unbiased or all nucleotides 
are represented at these terminal positions; this is equivalent to testing 2 out of the 62 possible 
positions. The assumption made is that these two positions are statistically representative of the 
other 60 positions. A quantitative form of this experiment could be done using q-PCR. 
PCR amplifications were made using master-mixes where possible and equal volumes 
were loaded on an agarose gel (Fig 3.8B). A positive control reaction was performed using the 
unmodified SELEX PCR primer set (Lane 6, 100 bp). Every combination of unmodified + 
selective primers was used (Lanes 1-4 and 8-11, 99 bp in size). A no-template negative control 
was also included (Lane 13). Successful amplification of all the eight modified primer sets was 
observed, along with the positive control (Lane 6). These amplicons showed that there was no 
observable difference between band intensities for each of the 4 nucleotides at both positions. 
Since all the possible DNA nucleotide variants are found at the 5’ and 3’ terminal positions of 
the random central region, we concluded that there was sufficient diversity in the pool to move 
ahead with SELEX. This is the first of three modified primer experiments described in this 
thesis. All of these work by designing selective primers which selectively amplify 
subpopulations of sequences within larger populations of template molecules. 
Preliminary Experiment III – ssDNA Production 
The next preparatory experiment was to observe the ability of the asymmetric PCR reaction to 
create ssDNA. The asymmetric PCR conditions described in section 2.5.2 were first reported in 
(Liang et al. 2007), where they were shown to generate ssDNA from a plasmid template. 
However it must be shown that the same reaction will also generate ssDNA from templates used 
in this Cell-SELEX protocol; the important feature being that they amplify a much shorter 
template than reported in Liang et al. 2007.  Published literature showed that a  
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Primers to Interrogate Random Pool 
F1A – GAAACGCTGGTGAAAGTA – 18mer 
F1C – GAAACGCTGGTGAAAGTC – 18mer 
F1G – GAAACGCTGGTGAAAGTG – 18mer 
F1T – GAAACGCTGGTGAAAGTT – 18mer 
 
R1A -  GCAAGCATAAAGTGTAAAA – 20mer 
R1C -  GCAAGCATAAAGTGTAAAC – 20mer 
R1G -  GCAAGCATAAAGTGTAAAG – 20mer 
R1T -  GCAAGCATAAAGTGTAAAT – 20mer 
  
 
 
 
 
 
 
 
 
 
Figure 3.8. Using PCR to interrogate the oligonucleotide library A.  The modified primer sequences used 
to amplify subpopulations of the randomised oligonucleotide library. 3’ terminal nucleotides are shown 
in blue and red. B. 2% (w/v) agarose gel stained with ethidium bromide showing the PCR amplification 
of different sub-populations of the randomised pool of 100mers. Lanes 1, 2, 3 & 4) Show the amplification 
of subpopulations where the 3’ nucleotide of the randomised section is a T, G, C and A respectively. 5) 
Gene Ruler 100 bp DNA ladder supplied by Thermo-Fisher. 6) PCR amplification of the randomised pool 
with unmodified primers. 7) Gene Ruler 100 bp DNA ladder supplied by Thermo-Fisher. 8, 9, 10 & 11) 
Show the PCR amplifications of sub-population where the 5’ nucleotide of the random section is an A, C, 
G and T respectively, 12) BLANK 13) PCR no template control. In every lane (except markers) a constant 
volume of PCR reaction (8 μl) and loading dye (2 μl) were loaded. 40 cycles of PCR were performed in 
all cases with 53 °C annealing temperature. Primer sequences and notation shown first in Table 2.3. 
A. 
1           2           3           4            5           6           7           8           9          10        11          12          13 
T          G           C          A           M           -          M          A          C           G         T            -          NTC 
B. 
5’ - end 3’ - end 
100 bp 
1 kbp 
300 bp 
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primer ratio of 10:1 would generate a balance between single-strand product yield and duplex 
by-product (Tabarzad et al. 2014). Therefore, PCR reactions with a symmetric (1:1) or 
asymmetric (1:0.1) ratio of Reverse: Forward primer were conducted. These were analysed using 
D-PAGE (2.10.3) and shown in Fig 3.9A. Lanes 2 and 3 show symmetric PCR reactions with 
and without template, respectively. Lanes 4 and 5 show asymmetric PCR reactions with and 
without template, respectively. SYBR Gold was used to visualise the gel due to the dye’s 
increased sensitivity to ssDNA when compared to ethidium. 
The results of D-PAGE analysis (Fig 3.9A) indicated that there was indeed a difference 
between the symmetric and asymmetric PCR forms.  The amount of ssDNA synthesised during 
asymmetric PCR depended on the relative concentrations of the primers used; these were 0.4 
µM Reverse and 0.04 µM Forward respectively in lane 4. Symmetric PCR (lane 2) suggests 
exponential amplification of both DNA strands, whereas asymmetric PCR (lane 4) indicates a 
curtailed exponential phase followed by a primer-extension phase only. Once a primer had been 
completely consumed by the reaction, only linear amplification of the remaining target strand 
was possible.  
As these PCR amplifications used a randomised population of molecules as the target 
template, the products will also contain a diverse range of species. This most likely explains why 
the population of molecules does not migrate as a discrete band but as a population of molecules 
distributed over an area. All the molecules should be 100 nt in length; however, the different 
nucleotide compositions will cause rates of migration to differ. 
The primer molecules on this gel do migrate as a defined band. This is due to their 
defined sequence. As the primers also are shorter, they appear fainter on the gel as each molecule 
interacts with fewer fluorescent stain molecules and gives a weaker signal. Although the bands 
representing the PCR product appear brighter they cannot exceed the concentration of the primer 
molecules. 
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Figure 3.9. Asymmetric PCR A. 15% (w/v) Denaturing PAGE stained with SYBR Gold showing 1) NEB 
50 bp DNA ladder (denatured) 2) Symmetric PCR product of random pool amplification (1:1 ratio of 
Forward : Reverse). 3) No-template PCR control of Symmetric (1:1) PCR. 4) Asymmetric (1:10) PCR 
product of random pool amplification. 5) No-template PCR control of Asymmetric (1:10) PCR 6) NEB 
50 bp DNA ladder (denatured). 5 µl loaded in each lane. 40 PCR cycles were performed. B. Pixel 
densitometry analysis of the PCR products in Lanes 2 and 4. Electrophoretic mobility is shown on the x 
axis and pixel density is shown on the y axis. Quantification of the pixel counts was performed using 
ImageJ software; the percentage of counts in each band is shown relative to the total counts for both 
strands. 
A. 
B. 
    1            2            3            4            5            6 
100 nt 
20 nt 
18 nt 
Symmetric  
PCR product 
Asymmetric  
PCR product 
51.8% 48.2% 
72.5% 27.5% 
104 
 
The two populations of molecules within the PCR product represent the “top” and 
“bottom” strand of the duplex. Lanes 3 and 5 are the symmetric and asymmetric no-template 
control reactions respectively, and show the primer molecules used in the PCR reactions running 
further down the gel. The unused primers are separated as they differ in length by two 
nucleotides. The smaller of the two primers is the one depleted in asymmetric PCR and this can 
be observed in the gel (in lane 5 the smallest band is depleted when compared to lane 3). The 
relative intensity of each separated strand was quantified by densitometry (Fig 3.9B). For 
Symmetric PCR these showed intensities of 51.8% and 48.2% for the two strands. For 
Asymmetric PCR, these showed intensities of 72.5% and 27.5% for the two strands. Since the 
reduced concentration primer was the 18-mer Forward strand it was evident from the 
Asymmetric PCR lane that the forward primer synthesised the faster migrating (lower) strand in 
the gel. Asymmetric PCR had a lower total yield than the symmetric PCR shown by a smaller 
area under the curve in Fig3.9B. Two clearly defined peaks were not observed and this was 
likely due to the random nucleotide cassette which will cause each molecule to have a unique 
molecular weight. 
The two strands were observed to migrate at slightly different rates in D-PAGE 
conditions. This may be due to combination of factors such as small changes in net charge, 
molecular mass and structural differences causing different hydrodynamic radii. For example, 
relating to the molecular mass, 38 of the 100 nt were of fixed sequence. When compared these 
gave a fixed mass of 11645.7 Da for the slower migrating evolving strand and 11707.7 Da for 
the complementary strand. Also, the different functional groups and charges in these fixed 
nucleotides on each strand may cause the differential migration on a denaturing gel. Overall, 
these experiments demonstrated that asymmetric PCR using a 1:0.1 ratio of Reverse primer to 
Forward primer was able to generate ssDNA for use in SELEX.  
 
 
105 
 
Preliminary Experiment IV – Primer Specificity Experiments 
It was next necessary to demonstrate using bioinformatics and experimentally that the 
primer sequences used in this chapter do not amplify any region of the E.coli genome. This was 
essential, as genome-derived nucleic acids from the target cells were present during the 
amplification of the bound population of evolving molecules. Any cross-reactivity caused by the 
endogenous E.coli nucleic acids could have caused the appearance of false positives (which is 
why the pUC19 positive PCR control was essential) and contaminant nucleic acids may compete 
with the bound synthetic nucleic acids and impede the SELEX process.  
Therefore, the primer sequences were firstly vetted against the genome and a range of 
common plasmids of E.coli using BLAST. No significant complete complementary sequences 
were found for either the forward or reverse SELEX primers. Secondly, PCR experiments were 
also performed in order to demonstrate that amplification occurred only when the synthetic 
nucleic acids are present (Fig 3.10).  A live-cell PCR experiment was performed using different 
strains of E.coli. These PCR reactions were designed to demonstrate that bacterial genomic DNA 
is not sufficient to initiate a PCR reaction. Four PCR reactions were set up using different E.coli 
bacterial colonies as templates. As shown in Fig 3.10, only the bacterial colony transformed with 
a recombinant plasmid (containing one of the defined sequences from preliminary experiment 
I) showed a positive PCR amplification (lane 3). E.coli transformed with pAT153 (lane 2) did 
not show a positive PCR band. Likewise untransformed E.coli DH5α or JM109 (lanes 4 and 5 
respectively) did not show a PCR product. This demonstrated the specificity of the SELEX 
primers.  
Preliminary Experiment V – Target Cell Viability 
All the preliminary experiments described so far validated the nucleic acids used in 
the SELEX process. The final validation experiment before SELEX was started was to  
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Figure 3.10 Test for false-positive PCR amplification. 2% (w/v) agarose gel stained with ethidium 
bromide. 1) NEB 50 bp Ladder 2) SELEX primer PCR with E.coli HB101 cells containing the plasmid 
pAT153 3) SELEX primer PCR with E.coli DH5α transformed with the pJET1.2 cloning vector 
containing a randomised target sequence 4) SELEX primer PCR with untransformed E.coli DH5α cells 
5) SELEX primer PCR with E.coli JM109 cells (no plasmids). 40 PCR cycles were performed. 
 
  
    1               2                3               4                5   
50 bp 
100 bp 
150 bp 
250 bp 
1.35 kbp 
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Figure 3.11 Viability test of E.coli HB101. A. Oil immersion light microscopy of Gram-stained E.coli 
HB101:pAT153 x1000 magnification. B. Oil immersion light microscopy of E.coli HB101:pAT153 after 
the cells had been incubated in 1 ml dH2O for ten minutes with gentle agitation and centrifuged at 8,000 
g for three minutes (simulating the SELEX binding and separation conditions used in each round). Both 
panels show bright field microscopy and staining of target cells. 
A. 
B. 
10 μm 
10 μm 
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ensure that the bacterial cells were alive and intact during the SELEX process. This was done 
using white light, bright-field microscopy combined with Gram staining (Fig 3.11) (Gram, 
1884). Fig 3.11A shows a population of E.coli HB101 before centrifugation; Fig 3.11B shows a 
similar population after centrifugation in pure water (8,000 g for 3 mins). Centrifugation and 
Gram-staining light microscopy experiments were performed in order to ensure firstly that the 
cells were indeed Gram negative Bacilli, and secondly that the cells remain intact during the 
SELEX procedure. Figure 3.11 shows that the target cells are indeed Gram negative and also 
that the cells survive the in vitro selection procedure.  
These five preliminary experiments demonstrated the following: (1,) that the “naïve” 
pool of nucleic acids was indeed random, as determined by cloning and DNA sequencing; (2,) 
that the first and last nucleotides of the 62 nt cassette were unbiased, as determined by primer 
walking; (3,)  Both the symmetric and asymmetric PCRs function as expected and asymmetric 
PCR generated ssDNA, as determined by D-PAGE analysis; (4,) Endogenous E.coli nucleic 
acids (DNA or RNA)  do not cause false positive PCRs; (5,)  The target cells do indeed survive 
the selection and partition procedures intact, as determined by Gram staining. Once all these 
preliminary control experiments had been performed it was possible to begin applying selective 
pressure to the pool of nucleic acid molecules. 
 
3.4. SELEX Method I 
 
It has been suggested that approximately 1014 different sequences are required to begin in vitro 
evolution (Lorsch & Szostak, 1996). However, the first  successful SELEX ever experiment 
performed still only had a maximum of 48 ( 65,536) potential sequences (Tuerk & Gold, 1990). 
Given the large number of possible target sites on the E.coli surface and their highly 
heterogenous nature it was decided to use a very large number of potential starting sequences. 
Therefore, 3 μl of 100 μM randomised oligonucleotides (approx. 1.807 x 1014 molecules) were 
initially amplified in three separate 50 μl asymmetric PCR reactions. This allowed an increase 
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in the total number of any given sequence and additional mutations to occur within the pool; the 
products of these reactions were then combined and taken to the first round of selection. 
SELEX was performed according to the strategy outlined in Figure 3.1 and section 2.9.1. 
The library of oligonucleotides was incubated with a colony of E.coli HB101 resuspended in 1 
ml of dH2O for 10 minutes with gentle agitation. This mixture was then centrifuged at 8,000 g 
for 3 minutes. The unbound fraction of the molecules remaining in free solution was removed 
and discarded. The cellular pellet (containing a small portion of bound sequences) was then 
resuspended in 100 µl of dH2O and 1 µl of this was used in symmetric PCR reactions.  
During the first part of the PCR cycle, the bound molecules were eluted from the cells 
by heating the cells to 95 °C in the thermocycler for 5 minutes, killing the cells and rapidly 
denaturing nucleases. Symmetric amplification was then performed and the bound fraction of 
the library was exponentially enriched. Agarose gel electrophoresis was used to observe the 
amplified DNA with positive and negative controls for each amplification step. Selected 
molecules then underwent asymmetric PCR to allow regeneration of mainly the single strand. 
These single strands were pooled together and then used in the next round of in vitro selection.  
This cycle was repeated 15 times. A selection of results from cycles 1, 5, 6, 12, 14 is 
shown in Fig 3.12. All the PCR conditions shown in the panels of Fig 3.12 are identical. The 
only difference is the nature and composition of the evolving pool of nucleic acids. Fig 3.12 
gives insight into the progressing stages of evolving populations of DNA molecules. Samples 
were taken from each amplification stage (lanes 2-4). These were accompanied by pUC19 
positive controls and no-template negative controls (lanes 5 and 6 respectively). Fig 3.12 also 
shows the emergence of PCR products that migrated above the 100 bp position on agarose gels. 
These aberrant PCR products developed between the first and fourth rounds of SELEX. At first 
it was thought that these smearing species were nucleic acids from the bacterial cells; however, 
it was later found that the smear was created even when no bacterial cells were present in the 
amplification mixture. 
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Figure 3.12 Symmetric PCR amplifications from the evolving SELEX pool. Each panel shows a 1 % 
(w/v) agarose gel of the PCR amplification steps from different rounds of whole cell SELEX stained with 
ethidium bromide. 1) DNA ladder. 2 to 4) Separate symmetric PCR amplifications (5 μl loadings) of the 
selected pool of molecules. 5) pUC19 positive PCR control. 6) no template PCR control. A panel showing 
the Wide-Range DNA ladder (50 – 10,000 bp) supplied by Clontech is shown. In all cases 40 PCR cycles 
were performed. 
 
B. 
B 
   1           2           3           4           5           6             1              2               3                4              5              6          
Round 1 Round 12. 
Round 5 
Round 6. 
Round 14 
100 bp 
100 bp 
100 bp 
100 bp 
100 bp 
100 bp 
2 kbp 
2 kbp 
2 kbp 
2 kbp 
2 kbp 
2 kbp 
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Figure 3.13 Comparison of the enriched and original pools. 2% (w/v) agarose gel stained with ethidium 
bromide showing the symmetric PCR amplification of the enriched pool of molecules (Round 15) and the 
initial pool of molecules. 1) Gene Ruler 100 bp DNA ladder supplied by Thermo-Fisher 2) Symmetric 
PCR product of the enriched pool of molecules (5 μl loading) 3) Symmetric PCR of the initial randomised 
pool of molecules (5 μl loading). In both cases 40 PCR cycles were performed. 
 
 
 
       1                  2                 3                                
1 kbp 
100 bp 
200 bp 
500 bp 
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Figure 3.14 Analysis of evolved PCR products. 10% (w/v) N-PAGE stained with ethidium bromide 
showing the symmetric PCR amplification of the enriched pool of molecules. Lanes 1 and 9) Gene Ruler 
100 bp DNA ladder supplied by Thermo-Fisher 2, 4, 6, 8) blank.  3, 5, 7) Symmetric PCR of the selected 
pool of molecules (5 μl loading) (The SELEX samples used in this gel are the same as those used in Fig 
3.13) 40 PCR cycles were performed.  
   1        2       3        4       5        6       7        8       9   
1 kbp 
100 bp 
200 bp 
300 bp 
500 bp 
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After 15 rounds of binding and enrichment the population of enriched molecules which 
were amplified by symmetric PCR and appeared to show a large range of electrophoretic 
mobilities, giving a broad ‘smear’ which is centred well above the 100-mer original pool (Fig 
3.13 lane 2). The most probable explanation for the broad range of DNA mobility is variation in 
DNA lengths across the population. Also, secondary structures may be present which produce a 
smear if in an equilibrium between folded and unfolded states. Alternatively, this abnormal 
migration could have been caused by the selected molecules having an affinity for the 
polysaccharide agarose matrix as there are polysaccharide components of E.coli cell walls. 
Therefore the evolved pool of molecules was analysed using N-PAGE and the same broad range 
of molecular weights was observed (Fig 3.14. lanes 3,5 and 7). This suggests the abnormal 
migration was likely caused by variation in DNA length and not an affinity to the gel matrix. 
The appearance of high molecular weight PCR products during SELEX was a gradual process. 
In the early rounds of SELEX (before round 3), no smearing was apparent on agarose gels. 
Amplification of randomised DNA sequences may cause SELEX by-products. A number of 
putative mechanisms for aberrant PCR amplifications will be discussed in a Chapter 5. These 
proposed mechanisms may result in the transition from the original 100 nt randomised 
oligonucleotide to larger molecules with additional primer sequences or high numbers of primer 
binding sites.  
  The high molecular weight smear was found to have a very low cloning efficiency, 
which may be a function of long/structured DNA. To investigate this smearing, it was found that 
the ratio of PCR template to PCR primers played an important role in the size of the products 
created. Adjusting this ratio by changing either of these factors could be used to produce smaller 
PCR products with higher cloning efficiencies. This is shown in Fig 3.15 in which three serial 
dilution experiments of PCR templates were conducted. The three templates were individual 1 
µl samples from the 15th round of SELEX. Dilutions of 102, 105, 10 8 were performed. These 
showed a progressive decrease in smearing.  As the template dilution factor increased, the smear 
of molecules shown in Figure 3.15 was reduced, becoming a defined band at 100 bp in length.  
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These ~100bp bands were cloned with much higher efficiency, and sequencing data were 
obtained.   
3.5. Cloning and Sequencing of the enriched pool of molecules 
 Molecular cloning of the 108-fold template-diluted PCR products (40 cycles, 53 °C 
annealing) by blunt-ended ligation was performed according to the protocols described 
previously in this chapter (2.11). PCR analysis of recombinant plasmids showed that the cloning 
had been successful in all cases. Fig 3.16A shows twelve successful colony PCR amplifications 
of individual cloned selected molecules (lanes 2-13) with an uncontaminated no-template 
control (lane 14). Amplified regions of the recombinant cloning vectors (~200 bp) containing 
the inserted DNA molecules were purified and sent for sequencing. Colony PCR products were 
sequenced using the forward and reverse pJET1.2 sequencing primers. The evolving strand was 
identified by reading the sequence downstream of the reverse SELEX primer. The reverse primer 
was the primer in excess during asymmetric PCR. Analysis of the resultant sequences showed 
that the SELEX primers were found to be conserved in the evolved pool of molecules. This 
indicated that the cloned molecules were descended from the original randomised 
oligonucleotide.  
Fig 3.16B gives the sequencing results from 35 individual clones. These collectively 
produced 24 unique putative aptamer sequences as 15 of the 35 clones had multiple 
representations within the pool. The table of sequences is ranked according to frequency of 
occurrence. The second observation was that all the sequences were significantly shorter than 
the original 62 nt cassette (as shown in the starting pool (Fig 3.7)). The modal sequence had a 
frequency of 6 and was also the longest sequence having 37 nt in the central region. The second 
most frequent sequence was observed 4 times and was 23 nt in length. The third and fourth most 
successful sequence shad a frequency of 3 and 2 respectively. The remaining 20 sequences were 
represented once. 
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Figure 3.16 SELEX Method I Results. Screening for recombinant plasmids by PCR. A. 1% (w/v) agarose 
gel stained with ethidium bromide showing the colony PCR amplification using the pJET1.2 primers of 
recombinant plasmids containing inserts from the enriched pool of molecules. Lanes 1 &15) 2-Log DNA 
Ladder (0.1-10.0 kb) supplied by NEB. Lanes 2-13) PCR products from separate recombinant plasmids. 
Lane 14) PCR no template control. B. Table showing the sequences extracted from the enriched pool of 
molecules shown in order of frequency.  All these sequences were found between correct primer sequences 
and are the “evolving” strand. Highly similar sequences are shown in bold with mismatching single 
nucleotides shown in red. Molecules which were selected for further functional analysis in later chapters 
have been named *3.1 and *3.2. 
# Evolving strand sequence (5’ to 3’) Clone number Frequency 
S1.1 GGTATGGGTGCCGTTACAGTGTGGGGTATGCCTGTGT 11 19 21 22 23 31 6 
S1.2 GGAACACGGCGTGATTGCGGCCT 12 14 15 20 4 
S1.3 GGGCTGCATGGGTGTTCTGTGT 16 17 18 3 
S1.4 GGGCAGTCTCTGTAGGCTTAGTGTTCTGTGT 28 29 2 
S1.5 GGGTGGGCTGTCCTGTGT 1 1 
S1.6 GGTGAATAGTGGCCCCTATGTGCTCTGT 2 1 
S1.7 GGGCTGACCACGTGCT 3 1 
S1.8 GGGAAGGATGCACCTGCTGTGGT 4 1 
S1.9 GGGTCACACGGCATTGT 5 1 
S1.10 GGACTGCGGAGTGGTTGTGTCGTGT 6 1 
S1.11 GGGGCTGGGGTGTTGCTGGCTCTGT 7 1 
S1.12 GGACCAGGCGCTCGTTGT 8 1 
S1.13 GGAGCACGGCGTGATTGCGGCCT 9 1 
S1.14 GCACTGCTGCTCGTACTGT 10 1 
S1.15 GGCGCCCCTTACCATTGCGCTGCTGT 13 1 
S1.16 CAAAGTGTTTAGGGTTGTGTCT 24 1 
S1.17 GGCAAATCGTAAAACTAAGCCCCACTCCTGCT 25 1 
S1.18 GGTGTTGCTATACGTGT 26 1 
S1.19 GGCAGTTGT 27 1 
S1.20 GATGTCACTGTGTTCTGTCC 30 1 
S1.21 GGTGTCCAATTGCCCTGTCT 32 1 
S1.22 GGAGCCGTGCATGCT 33 1 
S1.23 GGGCTTGTTGT 34 1 
S1.24 GGGCTTGTTTTGTCCGT 35 1 
B. 
A.   1        2       3       4       5        6      7        8       9      10     11     12     13     14      15         
M                                                                                                                               M 
100bp 
1 kbp 
3 kbp 
*3.1 
*3.2 
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 In information theory (and recent aptamer publications), the Levenshtein edit distance 
is the minimum number of deletions, substitutions or insertions that must occur within a 
sequence in order to modulate it to another specified sequence (Levenshtein, 1966). This concept 
is applied to pools of nucleic acid sequences of different lengths in order to determine the 
sequence similarity within the pool (Alam et al. 2015). In the set of variable length sequences 
shown in Fig 3.16B two sequences (indicated in bold with substituted nucleotide in red) had a 
Levenshtein distance of 1, meaning it would only require one mutation to convert one to the 
other. This indicated that these two sequences are highly likely to be related and may require 
either purine at this position; however, the A form is 4x more abundant than the G form. 
Sequences with higher frequencies can be said to have a Levenshtein distance of 0, as they are 
independent observations of the same sequence and require no insertions, deletions or 
substitutions to mutate into themselves. 
 Using the sequencing data acquired and shown in Fig 3.16B it was possible to design 
new modified PCR primers which could specifically amplify one of the twenty-four sequences 
observed. This was done to verify that the DNA molecules observed after cloning and 
sequencing were indeed representative of the selected pool of molecules shown in Fig 3.13. 
Modified PCR primer sets were therefore designed to amplify three of the observed sequences 
in Fig 3.16B. These were Sequence number 6 (F6S2 and R6S2 for Clone number 2), Sequence 
number 12 (F6S8 and R6S8 for Clone number 8) and Sequence number 1 (F6S11 and R6S11 
for Clone numbers 11, 19, 21, 22, 23, 31). These sequences, and the sequences of the primers 
used to amplify them are described in Fig 3.17A. Whereas the last primer modifying experiment 
(described in Fig. 3.8) shifted the primer annealing positions only one nucleotide into the central 
random sequence (thereby selectively amplifying one quarter of the randomised pool of 
sequences), these new primers were both shifted six nucleotide positions into the central region 
and therefore were highly selective for far fewer sequences.   
Fig 3.17B shows the results of these selective amplicon primer shifting experiments. 
Lane 2, as seen before (Figs 3.13 -3.15) shows a smear, characteristic of the symmetric   
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Forward primers (18 nt) Reverse primers (20 nt) Sequence to be amplified 
Forward Reverse All 
5’AGAAACGCTGGTGAAAGT3’ 5’CGCAAGCATAAAGTGTAAAG3’ - 
F6S2 R6S2 Clone 2 
5’GCTGGTGAAAGTACAGAG3’ 5’CATAAAGTGTAAAGGGTGAA3’ GGTGAATAGTGGCCCCTATGTGCTCTGT 
F6S8 R6S8 Clone 8 
5’GCTGGTGAAAGTACAACG3’ 5’CATAAAGTGTAAAGGGACCA3’ GGACCAGGCGCTCGTTGT 
F6S12 R6S12 Clone 11 
5’GCTGGTGAAAGTACACAG3’ 5’CATAAAGTGTAAAGGGTATG3’ GGTATGGGTGCCGTTACAGTGTGGGGTATGCCTGTGT 
B. 
A. 
Figure 3.17 Extraction of unique sequences from a complex pool of sequences. A. A table showing the PCR primer 
sets used in these experiments and the sequences to be amplified. Modified sequences downstream of the forward 
primer (and complementary sequences) are shown in blue. Modified sequences downstream of the reverse primer are 
shown in red. B. A 2% (w/v) agarose gel stained with ethidium bromide. Showing in lanes 1 &10) Gene Ruler 100 
bp DNA ladder supplied by Thermo Fisher, 2) Symmetric amplification using unmodified primers of the selected 
(and diluted) pool of molecules, 3) The NTC for the unmodified primers, 4) Symmetric PCR amplification of the 
sequence of Clone 2 (54 bp), 5) NTC for the Clone 2 primer set, 6) Symmetric PCR amplification of the sequence of 
Clone 8 (44 bp), 7) NTC for the Clone 8 primer set, 8) Symmetric PCR amplification of the sequence of Clone 11 
(63 bp), 9) NTC for the Clone 11 primer set. 40 PCR cycles were performed with 53 °C annealing temperatures. 
 
 
  1       2        3      4       5      6      7       8       9      10     
 M      -      NTC     2      NTC      8     NTC       11    NTC        M 
100bp 
1 kbp 
200bp 
500bp 
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amplification (with unmodified SELEX primers) of the 103 fold diluted selected pool of 
molecules. This acts as a positive control PCR and is accompanied by a no-template control 
(lane 3). The remaining lanes (4-9) show the three individual primer shifting experiments. 
The expected lengths of each PCR amplicon were different for each primer set because the 
target sequences to be amplified were of different lengths. The target for amplification in each 
case was a 103-fold dilution of the selected pool of molecules. All PCRs were identical in every 
component except the sequence of the PCR primers. Clone 2 sequence was 28 nt long and 
therefore would create an amplicon of 54 bp if amplified correctly. Clone 8 sequence was 18 nt 
long and therefore would create an amplicon of 44 bp if amplified correctly. Clone 11 sequence 
was 37 nt long and therefore would create an amplicon of 63 bp if amplified correctly. These 
were observed as expected in Fig 3.17B lanes 4, 6 and 8 respectively alongside no-template 
controls (lanes 5, 7 and 9). This result indicated that the complex smear of different molecules 
does indeed contain or is comprised of the sequences observed after dilution, cloning and 
sequencing.  
3.6. SELEX Method I Conclusions 
During this chapter, Cell-SELEX using live bacterial colonies and asymmetric PCR was 
performed. Prior to this, a number of preparatory, control and optimisation experiments were 
performed. Fifteen rounds of SELEX were completed. The pool of ssDNA sequences was 
enriched. Several observations were made, including the emergence of variation in length of the 
molecules in the evolving pool. Another surprising result was the conserved sequence of 
nucleotides in the selected pool of molecules. 
The first SELEX experiments involved selecting a single sequence from various RNA 
sequences (Tuerk & Gold, 1990). In this example, there was an expected “wild-type” optimal 
sequence. The evolving pool of molecules converged upon this known sequence. Recent 
developments in the fields of high-throughput next-generation sequencing and bioinformatics 
have allowed researchers to observe how many different sequences are converging on an optimal 
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binding sequence as the sequences evolve (Alam et al. 2015). When selecting sequences to bind 
to simple targets, there may be a few unique optimal structures to bind to the target. These 
include the common-sequence pseudoknot motifs that bind to, and inhibit HIV reverse 
transcriptase proteins (Jaeger et al.1998; Kensch et al. 2000), and the common emergence of G-
quadruplex forming sequences in the evolution of DNA-zymes (Zhu et al. 2012). Some 
sequences become more predominant in evolving pools, depending on which SELEX protocols 
are used. For example, a review of membrane filtration selection methods found that this method 
of separating bound and unbound molecules often caused a G-bias (Ozer et al. 2014) and RNA 
SELEX has been shown to reduce the number of A-moieties in evolved selected sequences 
(Thiel et al. 2011). Raising aptamers against TATA-box-binding proteins will also cause 
sequences with TATA-box-like sequences to evolve (Miropolskaya & Kulbachinskiy, 2015). 
However, due to the complex and heterogeneous nature of the bacterial cell surface, no “wild-
type” consensus sequence was expected.  
 No published works have used comparable protocols to those described in this chapter. 
However, other groups do not observe truncation of sequences when performing Cell-SELEX 
using bacterial cells (Kim et al. 2014). Some variation in length is observed in molecular 
evolution experiments; however, this is normally limited to the insertion or deletion of a single 
additional nucleotide to the evolving cassette (Ellington et al. 1997; Lee et al. 2004). Throughout 
the development of small molecule SELEX, it was rare for consensus sequences to emerge, even 
when the target presented very few possible epitopes (Wang et al. 1995). This may have been 
due to the relatively limited number of sequences which could be recorded using cloning and 
sequencing technology at the time. As previously mentioned, modern sequencing and 
bioinformatics techniques have increased the number of evolving molecules which can be 
observed in a single experiment, meaning consensus sequences are more likely to be seen (Alam 
et al. 2015). 
Dilution of the template molecules prior to PCR amplification of the selected pool of 
molecules can reduce the observed molecular weights of the PCR products (Fig 3.15) and 
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amplifying the pool with selective primers also causes the creation of a band rather than a smear. 
Throughout the SELEX protocols, the evolving pool of molecules has replicated using the 
unmodified SELEX primers. During this experiment, the selective pressure of the modified 
primers allows only a single sequence to replicate. This validates the sequences observed after 
cloning and sequencing. Cell SELEX Method I had yielded a number of putative aptamer 
candidates for further investigation. Another method of bacterial live-cell SELEX was now 
developed. 
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Chapter 4: Cell-SELEX using Bacterial Cell 
Cultures and Lambda Exonuclease 
4.1. Introduction and Rationale 
A different SELEX strategy was designed which significantly improved upon the previously 
described method. A new method of single-strand DNA regeneration with a significantly higher 
yield of ssDNA was required. Lambda (λ)-exonuclease digestion has been used as a single strand 
regeneration mechanism since 2006 (Jones & White, 2006). This enzymatic ssDNA regeneration 
method reduces the number of PCR amplifications required per round of SELEX (as it would 
replace the asymmetric PCR method). The λ-exonuclease method was chosen after attempting 
magnetic bead separation and denaturing gel separation for ssDNA regeneration, both of which 
yielded low quantities of ssDNA. A number of other improvements were incorporated into the 
new method (SELEX Method II).  
These included: (1) a redesigned 100 nt random library with a 5’ HEX group for 
visualisation; (2) binding reactions performed in  1×PBS rather than water; (3) an increased 
number of wash steps to improve binding stringency; (4) heat-killing the cells after the selection 
step and incorporating phenol-chloroform and ethanol precipitation steps to stop cellular debris 
and potential inhibitors entering the PCR amplification processes; (5) increasing the number of 
separate parallel symmetric PCR reactions from three to twelve for every round of SELEX; (6) 
use of λ-exonuclease for ssDNA regeneration; (7), two separate PCR purification steps 
performed per round of SELEX.  
SELEX was performed using phosphate buffered saline (1×PBS, pH 7.2) (Table 2.2) 
instead of deionised water, though light microscopy indicated that cells remained intact in pure 
water. The rationale was to reduce the osmotic stress on the bacterial cells. It also provided 
cations which may allow a greater diversity of ssDNA structures to form. Further analysis of the 
literature indicated that the number of dead bacterial cells during cell SELEX should be 
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minimised in order to increase affinity for living cells only (Avci-Adali & Wendel, 2010). The 
bacterial colony live-cell PCR method (SELEX Method I) was therefore replaced by a late-log 
phase culture SELEX method (SELEX Method II). Published SELEX papers also indicated that 
the number of rounds of SELEX could be reduced from fifteen to eight, as eight rounds is 
sufficient to allow directed molecular evolution. Cloning and sequencing strategies were shown 
to be effective in SELEX Method I and were therefore unaltered for SELEX Method II. Cloning 
and sequencing would however be performed for every round of SELEX and the initial random 
pool, to monitor the progression of sequence evolution. 
4.2. SELEX Method II Overview and Strategy 
A detailed description of the methods used in this chapter may be found in section 2.9.2. A 
fluorescently labelled 100 nt (5’ HEX) ssDNA randomised library was synthesised by ADTbio 
and HPLC-purified. The sequences of the primers were changed from those used in SELEX 
Method I to prevent cross-contamination of sequences from the previous chapter and to increase 
the selectivity (Tm) of the primers. The PCR protocol annealing temperature was increased from 
53˚C to 62˚C and the number of cycles of PCR was reduced from 40 to 30 to prevent exhaustion 
of primers and dNTPs. Also, the number of parallel individual PCR reactions was increased 
from three to twelve to maintain diversity of sequences and increase evolving population size. 
Although SELEX Method II differs from the previously described method in a number of ways, 
the target remains the same strain of antibiotic-resistant E.coli HB101 pAT153. These bacterial 
cells however were not taken from a colony but were extracted from late-logarithmic phase 
cultures (1 ml of LB broth culture) when OD600 = 0.45. This ensured that a minimum number of 
dead cells entered the selection stages. 
 The DNA sequences used in this SELEX system are described in Table 2.4 of Chapter 
2. The new primer sequences were designed to incorporate recognition sequences for the EcoRI 
and BamHI Type II restriction endonucleases. The rest of the primer sequences were designed 
by adding random nucleotides either side of the restriction sites resulting in a final length of 25 
nt each. The primer sequences were then checked against the E.coli genome and pAT153 
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plasmids using BLAST. The extension of the primer sites from 18 nt and 20 nt to 25 nt each 
consequently reduced the number of randomised nucleotides within the cassette from 62 to 50. 
Although this does reduce the possible sequence variability of the random pool, sufficient 
potential variation remains to initiate SELEX as 450 >> 1014 (Lorsch & Szostak, 1996). 
 The new nucleotide pool and PCR primers used in this method were assessed in the 
same way to the one described in SELEX Method I. The phenomena observed in the previous 
chapter, including the development of high molecular weight SELEX by-products and the 
truncation of selected nucleic acid sequences, were also studied using this new SELEX system. 
This determined if the phenomena were an artefact of the nucleic acids used in the previous 
SELEX method or were common by-products of both these experiments (and perhaps molecular 
evolution in general). The formation of “aberrant” PCR products during molecular evolution has 
been reported in published work (Shao et al. 2011). As before, a number of preliminary 
experiments were performed to ensure that the new SELEX nucleic acid system was functioning 
correctly. 
4.3. SELEX Preparation and Preliminary Experiments 
Preliminary Experiment I – PCR Optimisation 
The first stage was to examine the purity and length of the new primers and 100 nt random pool. 
Four 25 nt primers were synthesised and tested. These were called ‘HEX’, ‘TOP’, ‘PHOS’ and 
‘BOT’. The “HEX” and “TOP” primers had the same 25 nt sequence, differing only by the 
presence or absence of a 5’ hexachlorofluorescein (HEX) group. The “PHOS” and “BOT” 
primers had the same 25 nt sequence and differed only by the presence or absence of a 5’-
phosphate group. During SELEX Method II, the HEX/PHOS primer set was used. The 
TOP/BOT primer set was used only for final cloning of putative aptamer candidates as using 
modified primers would reduce cloning efficiency. The “HEX” and “PHOS” primers were used 
to fluorescently label and to protect one strand of the duplex PCR product, while allowing the 
other to be digested by λ-exonuclease (2.14). These are shown in Figure 4.1A on a 15% (w/v) 
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N-PAGE, with 70 ng per lane. The HEX oligonucleotide (lane2) has a greater mass, so runs 
slower than the PHOS oligo (lane 3), with the two unlabelled primers running slightly faster still 
(lanes 4 and 5). Lane 6 shows the HEX-labelled 100 nt random library, which runs as a single 
band (though it contains a large number of diverse ssDNA sequences). Finally, PCR (30 cycles, 
62 ˚C annealing temperature) was performed using each combination of primer sets 
(HEX/PHOS, HEX/BOT, TOP/PHOS, TOP/BOT), shown in lanes 7-10 respectively. These 
used the new randomised library as a template to ensure correct amplification of 100 bp 
amplicons. Analysis of the unpurified PCR products (5 µl) indicated that all the possible primer 
combinations could successfully amplify a PCR product at 100 bp. Some higher molecular 
weight bands were observed further up the gel and these may be due to mis-priming within the 
random pool cassette (investigated subsequently and also in Chapter 5).  
Importantly, the 5’ modifications to the primer sequences did not inhibit the PCR amplification 
of the pools of molecules. The small differences in electrophoretic mobility can be accounted 
for by the presence/absence of the HEX and PHOS groups. PCR composition and protocols are 
shown in Tables 2.7 and 2.8. Figure 4.1B shows a 2% (w/v) agarose gel with the same unpurified 
PCR samples (HEX/PHOS, HEX/BOT, TOP/PHOS, TOP/BOT) and a no-template control in 
lane 6. This confirmed that the PCR products were single bands, with slight variations in 
migration that matched their molecular weights. Larger PCR products are seen in the N-PAGE 
gel (Fig 4.1A) but not in the agarose-ethidium gel (Fig 4.1B). This possibly was due to increased 
sensitivity of SYBR GOLD when compared to ethidium ions.  
Preliminary Experiment II – PCR Primer to PCR Template Ratio Experiments. 
The previously described SELEX experiments in Chapter 3 indicated that the concentration 
of PCR primers to PCR template ratio played an important role in determining how the evolving 
pool of molecules amplified. High molecular weight products were observed when a high 
template to PCR primer ratio was used (Fig 3.15). To study this phenomenon further, a number 
of experiments were performed which adjusted the template and primer concentrations of PCR 
amplifications. These experiments gave additional information on the effect described in  
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Figure 4.1 Analysis of new PCR primers and PCR products. A. 15% (w/v) N-PAGE stained with 
SYBR Gold. Lane 1) NEB 50 bp Marker. 2) HEX Primer. 3) PHOS Primer. 4) TOP Primer. 5) BOT 
Primer. 6) Random pool 100 nt. 7) PCR product using HEX and PHOS primers. 8) PCR product using 
HEX and BOT primers. 9) PCR product using TOP and PHOS primers. 10) PCR product using TOP 
and BOT primers. B. 2% (w/v) agarose gel stained with ethidium bromide. . Lane 1) NEB 50 bp 
Marker 2) PCR product using HEX and PHOS primers. 3) PCR product using HEX and BOT primers. 
4) PCR product using TOP and PHOS primers. 5) PCR product using TOP and BOT primers. 6) NTC. 
(30 cycles, 62 ˚C annealing temperature was used for all PCRs) 
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Chapter 3 where dilution of the PCR template caused the formation of lower molecular weight 
amplicons. For the first of these experiments (described in Fig 4.2A and Fig 4.2B) the primer 
concentration (0.4 μM of both primers) and master mix was kept constant while the template 
concentration was serially diluted. Template concentrations ranged from 40 nM to 0.04 yM (mo-
lar concentrations were calculated using Nanodrop UV spectroscopy and the average expected 
molecular weight of a 100 nt single stranded random library). Very low concentrations of tem-
plate molecules were achieved by performing serial dilutions on stock template concentrations. 
It was expected that at very low concentrations, no template molecules would be present in the 
reaction mixture meaning that the reaction would not be any different from a no-template control 
(NTC). Analysis of PCR products by N-PAGE demonstrated that lower template concentrations 
created lower molecular weight PCR products (~100 bp), and high template concentrations cre-
ated high molecular weight PCR products (>> 100 bp). This finding is in accordance with the 
observations in Chapter 3. Below a certain threshold (between 40 fM and 40 aM) the template 
concentration was too low to be detected and amplified by PCR.  
Once the transition point had been found using 1000-fold dilutions of template concentration 
(Fig 4.2A lane 4) a more gradual set of dilutions was performed to observe the nature of the 
transition from a smear to a band (Fig 4.2B). These experiments demonstrated that there is a 
continuous transition between “correct” PCR products at 100 bp and higher molecular weight 
“aberrant” products (Fig 4.2B lanes 2-9). 
Fig 4.2B was quantified using ImageJ pixel densitometry, and the relative proportion of 
>100 bp products and 100 bp bands for each concentration of template was measured. Fig 4.2C 
shows a graphical representation of this quantitation where percentage proportion of smear and 
band is shown as a function of primer to template ratio. These experiments corroborate the 
observed effects of PCR template dilution seen in the previous chapters. In both cases dilution 
of the template concentration reduced the average size of the amplicon from a smear to a sharp 
band, (please see Fig 3.15 and Fig 4.2B). These experiments show similar effects even with 
different PCR primers, target sequences and PCR protocols.  
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Figure 4.2 Template concentration dilution PCR. A. 12.5% (w/v) N-PAGE stained with ethidium bromide. 
Lane 1) 100 bp – 3 kbp ladder from VWR. 2) PCR with 40 nM random 100 nt template. 3) 40 pM template. 4) 
40 fM template. 5) 40 aM template. 6) 40 zM template. 7) 40 yM template. 8) 0.04 yM template. 9) NTC. B. 
12.5% (w/v) N-PAGE stained with Ethidium bromide. Lane 1) 100 bp – 3 kbp ladder from VWR. 2) PCR with 
40 pM random 100 nt template. 3) 20 pM template. 4) 10 pM template. 5) 5 pM template. 6) 2.5 pM template. 
7) 1.25 pM template. 8) 625 fM. 9) 312.5 fM template concentration. 10) NTC. The two black lines indicate 
the template range expanded from Fig 4.2A into 4.2B. C. Graphical representation of the quantitation of Fig 
4.2B showing the percentage proportion of smear and band on the y-axis and the number of primer molecules 
per template molecule on the x-axis. 
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Preliminary Experiment III– PCR Primer to PCR Template Ratio Experiments II. 
The next stage of these experiments kept the template concentration constant (40 fM , which 
gave a 100 bp band as shown in Fig 4.2A lane 4) while adjusting the concentration of the primers 
from 4 μM to 0.1 μM. The results of this experiment are shown in Fig 4.3A and 4.3B. Lanes 2-
7 correspond to primer concentrations of 4, 2, 1, 0.4, 0.2, 0.1 µM and demonstrate that at high 
primer concentrations a clear 100 bp PCR product is formed. Lower concentrations (lanes 6 and 
7) showed that increasing the primer concentration decreased the molecular weight of the PCR 
products amplified (Fig 4.3 lanes 2-4) and decreasing the primer concentration increased the size 
of the PCR products amplified (Fig 4.3 lanes 6 and 7).  
The combination of these two observations (specifically that decreasing template 
concentration and increasing primer concentration have similar effects) indicates that a high 
primer to template ratio causes amplification of low molecular weight products and a low primer 
to template ratio allows the synthesis of higher molecular weight products. The high molecular 
weight “aberrant” PCR products may therefore be caused by inter-template annealing or intra-
template folding (and subsequent extension) during PCR amplifications. Increasing the relative 
primer concentration increases the probability that a template molecule will encounter a primer 
and amplify correctly. The experiment described in Fig 4.3 where the primer concentration is 
effectively titrated against a constant template concentration is equivalent to using molecular 
crowding of HEX/PHOS primers to increase the probability of correct PCR amplification.  
The HEX-labelled PCR primer appeared magenta (Fig 4.3C) as the 6-hexachlorofluorescein 
(Fig 2.7B) molecule absorbs green light (Fig 2.8). The different concentrations of the HEX 
primer were clearly seen in Fig 4.3C.  
Fig 4.3A & 4.3B are the same gel but were visualised in different ways. Fig 4.3A used only 
the fluorescence of HEX to visualise the gel. The increasing concentration of the HEX primer 
could clearly be seen (Indicated by the HEX arrow). After green wavelength (523 nm) 
fluorescence analysis the gel was stained using SYBR gold. The subsequent visualisation using 
blue wavelength fluorescence allowed unlabelled DNA molecules to be observed (specifically  
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Figure 4.3 Primer concentration PCR. A. 15 % (w/v) N-PAGE visualised using HEX fluorescence 
(535 nm excitation). Lane 1) NEB 50 bp Ladder. 2) PCR reaction with 4 μM HEX/PHOS primers. 3) 
2 μM primers. 4) 1 μM primers. 5) 0.4 μM primers. 6) 0.2 μM primers. 7) 0.1 μM primers. 8) NTC 
with 0.4 μM primers.  B. The same gel as shown in Fig 4.3A after staining and blue wavelength 
visualisation with SYBR Gold.  
 
 
 
A. 
 1       2       3       4       5        6       7       8   
HEX 
100 bp 
B. 
 1       2       3       4       5        6       7       8   
100 bp 
PHOS 
HEX 
50 bp 
500 bp 
 131 
 
the 50 bp NEB DNA marker and the PHOS primer). Overall, the preliminary experiments de-
scribed in this section were important in order to characterise the necessary conditions for effec-
tive PCR amplification of a random pool, including the requirement for a high primer:template 
ratio. The template concentration of PCR reactions during SELEX is a result of the proportion 
of bound molecules following selection and therefore is an experimental variable which cannot 
be controlled. Therefore in all SELEX Method II amplification stages the final primer concen-
tration was at least 0.4 µM. These HEX/PHOS PCR amplifications created duplex PCR products 
with one phosphorylated strand and one HEX-labelled strand. These duplexes were used as sub-
strates for the enzyme λ-exonuclease for the regeneration of ssDNA. 
4.4. λ-Exonuclease Digestion of DNA 
The new method of ssDNA regeneration was tested and optimised. Lambda (λ)-λexonuclease 
digestion was chosen over magnetic bead and denaturing gel separation as it gave the highest 
yield of ssDNA (data not shown). Originally taken from Enterobacteriaphage lambda and 
expressed in Escherichia coli, this highly processive exonuclease catalyses the removal of 5´ 
mononucleotides from duplex DNA. The preferred substrate is 5´-phosphorylated double 
stranded DNA, although it will also degrade single-stranded and non-phosphorylated substrates 
at a reduced rate (Dapprich, 1999; Conroy et al. 2010; Lim et al. 2012).  
Each monomer of the homotrimer is 226 amino acids in length and has a mass of 25,909 
Da. The subunits interact to form a toroidal structure (Fig 4.4A) which creates a funnel through 
which DNA is passed and hydrolysed. The reaction requires Mg2+ which is provided in the 
reaction buffer containing 2.5 mM MgCl2 (Table 2.2). λ-exonuclease degrades different 
substrates at different rates depending on the 5’ chemical groups (Mitsis & Kwagh, 1999) and 
the sequence of nucleotides being digested (Perkins et al. 2003; Conroy & Moreland, 2010).  λ 
-exonuclease functions at approximately 12 nt (4 nm)  per second when digesting a single strand 
from a duplex. The crystal structure of the mutant exonuclease co-crystallised with a duplex 
DNA substrate suggests that the enzyme proceeds using a ratchet mechanism (Zhang & Bell, 
2011). 
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SDS-PAGE analysis of the recombinant protein was performed (Fig 4.4B). This shows 
three loadings of recombinant λ-exonuclease (NEB) of 8, 4, 2 µl of a 5 U/µl stock of enzyme. 
SDS-PAGE analysis showed a single band migrating near to 25 kDa, with a slight shadow band 
underneath. This apparent molecular weight corresponds well to the theoretical subunit mass of 
the enzyme. The observation of a single band would be expected as the homo-trimer structure 
would break down under the denaturing conditions and migrate as one band. This gel also shows 
that the enzyme preparation was sufficiently pure. 
A system was designed which would facilitate optimal single-stranded DNA recovery 
from a HEX/PHOS PCR duplex. One strand (the PHOS strand) was 5’ phosphorylated to 
encourage digestion by the enzyme while the other (evolving) strand was protected from 
digestion by the addition of a blocking 5’ chemical group. The blocking agent was decided to 
be a 5’ HEX group, which would, as already shown, also allow visualisation of the DNA. Fig 
4.5A shows the structure of λ-exonuclease with dsDNA. The 5’ HEX group was proposed to 
sterically interfere with the enzyme accessing the 5’ terminal nucleotides.  
FAM was also suggested as another possible chemical blocking group which could 
protect the evolving strand. HEX was chosen over FAM as HEX could be excited using green 
LASER light whereas FAM was excited by blue LASER light. This meant that FAM and SYBR 
Gold would be excited by the same LASER.  
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A. 
3 x 25,909 Da. 
Figure 4.4 The toroidal structure of λ-exonuclease. A. Representation of the crystal structure of λ-
exonuclease (Kovall & Matthews, 1997) (PDB 1AVQ); different subunits are shown in cyan, magenta 
and yellow. B. 15% (v/w) SDS-PAGE analysis of λ-exonuclease Lane 1) NEB Blue Protein Standard 
2) – 3) 8 μl loading of λ-exonuclease 4) – 5) 4 μl loading of λ-exonuclease 6) – 7) 2 μl loading of λ-
exonuclease 8) – 9) NEB Blue Protein Standard. Stained with protein safe stain, destained overnight 
and visualised using white light transilluminaiton. 
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An experiment was performed to test the selective ability of the exonuclease to digest 5’ 
phosphorylated ssDNA and 5’ hydroxylated ssDNA at different rates. Time-course exonuclease 
digestions were performed on phosphorylated and non-phosphorylated oligonucleotides 
(sequences in figure legend). The results are shown in Fig 4.5B. This gel shows enzymatic 
digestion of two substrates over the course of 30 minutes (lanes 1 to 5 and 6 to10). This 
experiment demonstrated that the enzyme digested the 5’ phosphorylated substrate at a much 
higher rate than the un-phosphorylated strand. Both these substrates were short single-stranded 
DNA molecules (Fig 4.5B). Fig 4.5B demonstrates that although ssDNA is not the optimal 
substrate for λ-exonuclease after 5 minutes of 5 U digestion the phosphorylated oligonucleotide 
had almost been completely digested (Fig 4.5B lane 3) whereas the 5’ hydroxyl oligonucleotide 
was still present after half an hour (Fig4.5B land 10). Although this experiment does demonstrate 
the activity of λ-exonuclease, in SELEX Method II λ-exonuclease was required to selectively 
digest one strand of a 100 bp DNA duplex. 
 A number of experiments were performed to demonstrate the exonuclease’s ability to 
digest one strand of duplex substrates with different sequences. dsDNA would be the substrate 
to digest during SELEX. Therefore representative individual sequences (similar to those that 
would be found in SELEX Method II) were required for digesting assays. Therefore the initial 
pool of random sequences was PCR-amplified using unmodified (TOP/BOT) primers and 
symmetric PCR (Table 2.4, Section 2.5.1). These 100 bp duplex PCR products were purified 
using Qiagen PCR purification kits (2.6.2).  These purified PCR products were ligated into the 
pJET1.2 cloning vector and transformed into competent E.coli DH5α cells. This process mirrors 
the cloning of the previous initial random pool nucleic acid library described in Chapter 3, prior 
to SELEX Method I (Section 3.3 Figs 3.4 & 3.7). Individual clones containing unique 
recombinant DNA sequences were harvested, transferred to clone libraries and plasmids from 
individual clones were isolated. These recombinant plasmids were checked for correct insert 
recombination by BglII digestion (similar to the data shown in Fig 3.5, data not shown).  
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A. 
 1       2      3       4       5       6       7      8       9     10 
5’ Phosphorylated 22 mer 5’ Hydroxyl 23 mer 
 Time (m):  0       1      5      10     30      0       1      5      10    30 
Figure 4.5 The mechanisms of action and activity of λ-exonuclease A. The structure of λ-exonuclease 
co-crystallised with a double-stranded dodecamer (PDB 3SLP). B. 15% (w/v) D-PAGE stained with 
SYBR gold analysis of λ-exonuclease time-course digestions of two ssDNA substrates. The 5’ Phos-
phorylated substrate had the sequence 5’Phos-AATTCGAGCTCGGTACCCGGGG3’ the 5’ Hydroxyl 
substrate had the sequence 5'CGACTCACTATAGGGAGAGCGGC3’. Substrate concentrations were 
equalised at 90 nM and 100 μl reaction 5U enzyme digests were performed. 10 μl samples were taken 
and mixed with 10 μl STOP buffer to denature the enzyme. Time-points were 0, 1 minute, 5 minutes, 
10 minutes and 30 minutes. 
 
22 nt 
23 nt 
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These individual extracted nucleic acid sequences were used as the template (0.1 nM 
concentration) in symmetric HEX/PHOS PCR reactions. The master-mix reactions also 
contained 5 μl of [α-32P] dATP (0.37 MBq/µl : 3.3 µM ). Radiolabelling PCR protocols are 
described in section 2.5.4 and allowed easy visualisation of both DNA strands. The Taq 
polymerase enzyme incorporated [α-32P] dATP (a β emitter) into the backbone of both DNA 
strands at random “A” locations. (Wherever there was an adenine in the sequence there was a 
probability it would carry a heavy phosphorus isotope.) These PCR reactions were purified by 
GE Healthcare microspin columns (2.6.4). A number of PCRs were performed using different 
plasmids with unique insert sequences (12 in total). This process created a number of different 
radio-labelled 100 bp PCR duplexes where the “TOP” or “evolving” strand was 5’ HEX labelled 
and the “BOT” strand was 5’-phosphorylated (Fig 4.6A). The concentration of these DNA 
substrates was calculated by Nanodrop UV spectroscopy and adjusted to 70 µM. Two 17 μl 
samples were then taken from each unique PCR product. To each sample a 2 μl volume of 10 × 
λ-exonuclease buffer (Table 2.2) was added. To one of the two samples for each PCR product a 
1 μl volume (5U) of λ-exonuclease was added, and to the other 1 μl of water was added. Both 
the enzyme digest and the control sample were incubated at 37 ˚C for two hours. A cartoon 
representation of the digestion of duplex DNA is shown in Fig 4.6B. After the incubation time 
was completed, a 10 μl sample of all the digestions and control reactions was taken and 
combined with a 10 μl volume of STOP buffer (Table 2.2). This mixture was heated to 95 ˚C 
for 5 minutes before being analysed by 15% (w/v) D-PAGE (Fig 4.6C). A 45 cm Bio-Rad 
sequencing gel was used. The gel was pre-run at 80 W for an hour to allow the gel to reach 50 
˚C. Samples were taken from heating and loaded onto the gel. The gel was run for 2 hours at 60 
W. The gel was then removed and wrapped in Saran-Wrap. A phosphorimaging cassette was 
used to expose the gel onto an imaging plate for 24 hours. After this time the imaging plate was 
carefully removed and analysed using a Fujifilm FLA-5000 image analyser. A section of one of 
the resultant images is shown in Fig 4.6C.  
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22 nt 
Figure 4.6 λ-exonuclease digestion of radiolabelled DNA duplexes A. A representation of a 
HEX/PHOS DNA duplex. B. A representation of λ-exonuclease digestion of a HEX/PHOS DNA du-
plex. C. An exposed imaging plate showing a section of a 45 cm 15% (v/w) D-PAGE. Odd-numbered 
lanes show undigested (U) 32P labelled PCR duplexes and even-numbered lanes show digested (D) 
PCR duplexes. The sequences of the central randomised regions of each sequence are described below. 
Sequences of the HEX and PHOS primers are found in Table 2.4. Strand 1 is Hex-labelled and pro-
tected and Strand 2 is phosphorylated and is digested by λ-exonuclease. 
Lanes 1&2- TATGAGAACCGGGGCGGCGTCGTGATTTGGTACGGGTTCGATGGGACGAA 
Lanes 3&4- AGTCGGAGCGAAGACAGCGTCTGAATGAGTGATCGTTGGGCGGAGCTAGT 
Lanes 5&6- ATCGGTCGAGGCTTGCGGTCAGGTTCTAGGCAGCCGGGTTAACTGTAAGT 
Lanes 7&8- CCGCCTTAGTGGGCTTGTGAGGAAAAAGGAGCGAGGGCCGCCGCCGGTTT 
Lanes 9&10- GCGACTTCCGGCCGCCGCGCGTGGGAGTTACATGATGGGGGGTTGATGCA 
Lanes 11&12- CGGATTAGGCGGGGGGCGAGGGTGGAATCTGGTCATCGGCCGAAGCGAGG 
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This shows six unique sequences before (U) and after (D) digestion by λ-exonuclease. 
The heat and chaotropic agents of the denaturing gel caused the duplex to separate into two 
bands. One of these bands (the faster migrating band, most likely corresponding to the phos-
phorylated strand) was removed by digestion by the exonuclease while the other remained intact 
after digestion. Twelve unique DNA sequences were analysed in this way. Six different sample 
sequences are shown in Fig 4.6C. This result indicated that the enzyme was indeed capable of 
degrading one strand while the other strand remained intact. (To the author’s knowledge this 
mechanism of strand protection using chemical blocking is a novel development in SELEX 
ssDNA regeneration methods.) Following on from this observation, a time-course nuclease di-
gestion was performed (Fig 4.7A). A control experiment was also included. This control exper-
iment studied the removal of the 5’ phosphate from the end of the digested strand. Two different 
DNA duplex substrates were digested simultaneously; one HEX/PHOS substrate and one 
HEX/BOT substrate. Symmetric PCR reactions were performed on a diluted sample of the ran-
domised library of sequences (10 fM) (Tables 2.4, 2.7 & 2.8).  
Three separate PCR amplifications were performed with the HEX/PHOS primer com-
bination and three with the HEX/BOT primer combination. The PCR reactions were purified 
using Qiagen spin columns. Samples were resuspended in water and concentrations measured 
using Nanodrop UV spectroscopy. The resultant phosphorylated and un-phosphorylated DNA 
duplexes were digested in separate 100 μl reactions with 5 U λ-exonuclease (described in section 
2.14). Reactions were incubated at 37 ˚C as described above. A 10 μl sample was taken from 
both ongoing reactions at 0, 2, 5, 10 and 30 minutes. These extracted samples were mixed with 
STOP buffer to halt the reaction by denaturing the enzyme. Time-points were analysed by D-
PAGE (Fig 4.7A). A 10 cm NOVEX gel tank was used. The gel was visualised using green 
wavelength fluorescence to determine which of the observed bands was labelled with HEX. 
After this the gel was stained with SYBR Gold to visualise the non-fluorescing DNA molecules. 
Lanes 1-5 show the gradual removal of the phosphorylated strand. In contrast, lanes 6-10 show  
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Figure 4.7 Removal of the phosphorylated strand from the duplex. A. 15% (w/v) D-PAGE showing 
time-course λ-exonuclease digestions of phosphorylated PCR products in lanes 1-5 and non-phosphor-
ylated PCR products in lanes 6-10. Gel was visualised using SYBR GOLD and blue light fluorescence. 
B. The bands of lanes 1-5 were quantified using ImageJ and the proportional percentage of each DNA 
species was plotted as a factor of time. The graph shows the rapid and complete removal of the phos-
phorylated, the partial removal of the primers. Black lines indicate which lanes are quantified. 
 
 
A. 
B. 
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very little change when the phosphorylation on the strand is missing. This corroborates the result 
observed in Figs 4.5B and Fig 4.6B.There is also a band containing some remaining primer 
sequences lower down the gel. λ-exonuclease will also degrade the PHOS primer at a slower 
rate than the phosphorylated duplex (as ssDNA is degraded slower than dsDNA). It will not 
degrade the HEX primer as the 5’ end is protected. This was observed on the gel as the band 
containing the primers was not as rapidly depleted as the phosphorylated duplex band and did 
not go to completion. The HEX modification therefore protects the evolving 100 nt strand and 
the HEX primer. 
 Fig 4.7B shows a quantitation of band intensity for all the bands observed in lanes 1-5 
of Fig 4.7A. Band densitometry was measured using ImageJ. Results are plotted as relative per-
centage proportion of each species in each lane as a function of time. The graph shows the com-
plete depletion of the phosphorylated strand and the increasing proportion of the protected strand 
as time progressed. 
 Fig 4.7 demonstrates that the exonuclease activity of the enzyme is greatly enhanced by 
phosphorylation of the target strand. It also demonstrates that the HEX-labelled strand evades 
degradation in both DNA duplexes. This result demonstrated that λ-exonuclease digestion is an 
effective method of ssDNA recovery for SELEX.  
 In both Chapters 3 and 4 of this thesis, the development of higher than expected molec-
ular weight PCR products has been observed when PCR-amplifying random (and selected) se-
quences of ssDNA. As has previously been described, the formation of high molecular weight 
products can be prevented by a number of different methods; firstly, dilution of the template 
(Fig 3.15 & 4.2); secondly, increasing the primer concentration (Fig 4.3); and thirdly, increasing 
the selectivity of the primers (Fig 3.17). Published experiments have demonstrated that emulsion 
PCR is also an effective way of increasing the correct amplification of template molecules (Shao 
et al. 2011).  
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 An experiment was performed which analysed the effects of λ-exonuclease digestion on 
“aberrant” high molecular weight PCR products. Another time-course exonuclease digestion of 
HEX/PHOS and HEX/BOT random sequence PCR products was performed. Random pool PCR 
amplification was performed with a 0.4 μM primer concentration and a 40 pM template concen-
tration. In previous experiments this had generated a smear of high molecular weight PCR prod-
ucts (Fig 4.2B). These high molecular weight PCR products were purified using a QiaQuick 
microspin method and HEX/PHOS and HEX/BOT products were digested in two separate 100 
μl λ-exonuclease reactions (5U λ-exonuclease). 8 μl samples were taken from both ongoing re-
actions at 0, 1, 5, 10, 15, 20, 30, 40 mins and 1hour time-points and placed in an equivalent 
volume of STOP buffer to halt the reaction. These mixed samples were heated and analysed by 
15% D-PAGE. The initial 100 nt HEX-labelled random pool was used as a reference size marker.  
 Fig 4.8 shows that over time, λ-exonuclease caused a reduction of high molecular 
weight smearing and an accumulation of a 100 nt strand. The effect was seen mainly with 
HEX/PHOS primer-amplified substrates. This finding indicated that the high molecular weight 
smear may be comprised of repeating concatameric units of 100 nt monomers. It may also indi-
cate that the longer, higher molecular weight PCR products are digested faster, as the enzyme 
can continually digest one long strand rather than hopping between shorter substrates. (For ex-
ample, once attached to the 5’ terminal nucleotide, one enzyme could digest a single 1 kbp sub-
strate faster than ten individual 100 bp substrates.) 
This demonstrates that the smear of high molecular weight PCR products was converted 
back to a 100 bp band by digestion with λ-exonuclease (Fig 4.8A) The mechanisms of how this 
occurs is yet unknown. However the presence of a 5’ phosphate group on one of the PCR primers 
used to create the high molecular weight PCR products greatly increases the rate at which the 
smear is digested (Fig 4.8B). Repeated use of λ-exonuclease as the method of single-stranded 
recovery may prevent the accumulation of “aberrant” high molecular weight PCR products dur-
ing SELEX. 
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A. 
B. 
100 nt 
100 nt 
Figure 4.8 λ-exonuclease digestion of high molecular weight PCR products. A. 15% (w/v) D-PAGE 
showing time-course λ-exonuclease digestions of HEX/PHOS (single strand phosphorylated) high 
molecular weight PCR products. B. 15% (w/v) D-PAGE showing time-course λ-exonuclease diges-
tions of HEX/BOT (neither strand phosphorylated) high molecular weight PCR products. In both cases 
the gels were visualised using green wavelength fluorescence. The marker used in both cases is the 
initial randomised library of 100 nt HEX-labelled oligonucleotides (Lane 1). 
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4.5. SELEX Method II 
SELEX was performed according to the strategy outlined in Section 2.9.2 and Fig 2.6B. 50 μl 
of 33.94 μM HEX-labelled 100 nt randomised library was thermally equilibrated and used to 
begin SELEX. A 1 ml sample of late-log phase E.coli HB10: pAT1531 growth was centrifuged 
(8,000 g, 3 mins) and resuspended in 1 ml of 1× PBS (pH 7.2). To this, the fluorescent initial 
pool of molecules was added. This was mixed with gentle agitation for half an hour. The sample 
was centrifuged and the supernatant was removed and stored separately. The pellet containing 
the bound fraction was fully resuspended in 1 ml of 1× PBS (pH 7.2), centrifuged as above, and 
the supernatant was removed. This wash step was repeated two additional times; in all cases the 
wash supernatant was stored separately. The cell pellet was finally resuspended in 100 μl of 
dH2O. That concluded the separation of the bound and free sequences for one round of SELEX. 
It was no longer necessary for the cells to be alive. Cells were heat-killed at 95 ˚C for 5 minutes. 
Phenol-chloroform extraction was performed to remove cellular debris and proteins. This was 
followed by ethanol precipitation and resuspension in 100 μl of dH2O.  
 Twelve 1 μl samples of this selected pool were used as templates in separate but identical 
HEX/PHOS PCR amplifications. Samples (5 μl) of each of these PCR reactions were analysed 
by N-PAGE to ensure correct amplification of positive reactions and negative no-template 
controls.  The products of these reactions were purified using Qiaquick microspin columns. 
Samples were eluted using dH2O. The eluates of these columns were pooled together and the 
first 7 μl sample was taken (A 2 μl fraction of this sample was used for Nanodrop UV 
spectrophotometry. The remaining 5 μl was saved for later analysis by D-PAGE.) 
The remaining PCR products were digested by λ-exonuclease to regenerate the single 
strand. Buffer and enzyme were added giving a final concentration of 1× exonuclease buffer and 
5 U of exonuclease per 100 μl reaction. After 2 hours at 37˚C the sample was heat-killed at 70 
˚C for 10 minutes. The completed reaction was again purified using Qiaquick microspin 
columns. Samples were eluted using dH2O. The eluates of these columns were pooled together 
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and the second 7 μl sample was taken. A 2 μl fraction of this sample was used for Nanodrop UV 
spectrophotometry. The remaining 5 μl was saved for analysis by D-PAGE. The purified single 
stranded fluorescent DNA that had not been taken for sampling was melted and cooled slowly 
and then used to initiate the next round of SELEX.  
Samples had been taken after PCR amplification and after λ-exonuclease digestion for 
each round of SELEX. These samples were analysed using D-PAGE. The results of this D-
PAGE analysis are shown in Fig 4.9. Samples from every SELEX round were visible (Each 
SELEX round is shown with the names S1–S7 in lanes 2 to 9 and 12 to 19). The initial HEX-
labelled random library of molecules was used as a 100 nt size marker. Samples taken after 
amplification showed two bands at 100 nt and bands containing primer sequences. The second 
sample from each round of SELEX showed the removal of the lower band and the primer band. 
This indicates (assuming that the samples were representative of the majority of molecules in 
the evolving SELEX pool) that the SELEX Method II protocol had successfully amplified the 
selected pools of molecules and recovered the single strands at each round of SELEX.           
Fig 4.9 shows the development of the SELEX pool over all 8 cycles of SELEX.  Initially 
the observed products were all “correct” (i.e. 100 nt in length); however, as the pool evolved, 
higher molecular weight products were observed. Unlike the evolution of molecules described 
in Chapter 3; these selected pools of molecules formed discrete higher molecular weight bands 
at approximately 125 nt and 150 nt (Fig 4.9 lanes 16 to19). The evolving populations of 
molecules were splitting into groups of molecules with different apparent lengths.  These higher 
molecular weight products were observed after 6 rounds of SELEX had been completed. 
After D-PAGE analysis of the evolving pools of molecules had been completed, pools 
of sequences form each round of SELEX were PCR-amplified using TOP/BOT unmodified 
primers and prepared for cloning and sequencing. Methods of cloning and sequencing were as 
described in Chapter 3.
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Figure 4.9. Analysis of the evolving pools of molecules. 15% (w/v) D-PAGE analysis of each round of SELEX. Lanes 1 and 11 show the 100 nt HEX-
labelled randomised library marker (120 ng). Lane 2 shows the post-amplification sample from SELEX round 1 (S1). Lane 3 shows the post-nuclease 
digestion sample from SELEX round 1.  SELEX round 2 is shown in Lanes 4 and 5 and so on until SELEX round 8 in lanes 18 and 19. Lanes 10 and 
20 are blank. D-PAGE was visualised using SYBR gold and blue wavelength fluorescence.
  1     2    3     4    5     6    7    8     9   10           11   12  13  14   15  16   17  18  19   20  
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4.6. Cloning and Sequencing 
Selected pools of molecules from each round were used as the template (1 μl volume variable 
concentration) in standard TOP/BOT primer set symmetric PCR reactions (30 cycles, 62 ˚C 
annealing temperature). Samples from these reactions were analysed by N-PAGE (Fig 4.10, 
lanes 2 to 9). These PCR products were purified using Qiaquick columns. After purification, 
samples were measured using UV Nanodrop spectrophotometry. Approximate molar 
concentrations were assigned to each amplified pool of molecules (assuming an average length 
and molecular weight of 100 nt). Purified samples were diluted to similar concentrations. 
Cloning of purified inserts was performed according to the previously described protocols. Heat 
shock transformation was performed with appropriate no-insert and no-plasmid control 
experiments. Transformed bacterial colonies were transferred into clone libraries for each round 
of SELEX. Recombinant plasmids were harvested by automated QiaCube plasmid preparation. 
Isolated plasmids from every round were divided into two aliquots. One was sent for 
sequencing, and the other was stored in a library of recombinant plasmids. A minimum of twelve 
separate plasmids were sent for sequences from each round of SELEX. The sequencing data 
from the eighth and final round of SELEX are shown in Fig 4.11A and B. Putative aptamer 
sequences were identified by reading the sequences immediately downstream of the sequence 
of the HEX primer (the strand protected from λ-exonuclease digestion). 
As Fig 4.10 indicates, some of the PCR products sequenced were above 100 bp in length. 
Sequencing of the plasmids containing the cloned sequences indicated that the directed 
molecular evolution of the sequences had caused the addition of extra PHOS primer sequences 
Fig 4.11 B. These findings will be discussed at greater length in Chapter 5. Fig 4.11 A indicates 
that, unlike during SELEX Method I, little to no truncation of the evolving sequences had 
occurred. Although one sequence was observed on two occasions, the selected pool of molecules 
appeared to be more heterogeneous than the evolved pool of molecules described in the previous 
chapter. Sequencing Data from SELEX rounds 1-7 are shown in Appendix IV. 
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  1     2      3     4     5     6      7     8     9   10                                     
100 bp 
Figure 4.10 Preparation for cloning every round of SELEX. 15% (w/v) N-PAGE stained with SYBR 
Gold and visualised using blue wavelength fluorescence. Showing in Lane 1) NEB 50 bp DNA ladder 
2) TOP/BOT primer amplification of the selected sequences from SELEX Method II Round 1. 3) 
Round 2. 4) Round 3. 5) Round 4. 6) Round 5. 7) Round 6. 8) Round 7. 9) Round 8. 10) No template 
control PCR. 
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Fig 4.11.A.twenty-eight ≥101 nt sequences of selected DNA molecules from the 8th round of SELEX Method II. HEX/TOP and PHOS/BOT complement sequences are 
shown.  Sequences have been given unique identifying codes (S2.1 to S2.34.) Sequence S2.1 is shown in bold as it was isolated from two separate clones (Frequency = 2).  
The sequences taken and synthesised for later analysis were given the names 4.1, 4.2, 4.3 and 4.4 these sequences are indicated above. 
 
S2.1 5’GCGACCCAAGGAATTCTGCTGAAGGGGACCCGCCAGGTTCAGGGCAGAGGTTTGTAGCGACGAAGTACGCCGCAACATCGTACCGGATCCGTCACCAGCC3’4.1* 
S2.2 5’GCGACCCAAGGAATTCTGCTGAAGGGCGCTAGCGAGCAGTCAGCACGTTTAGTGCACTGTATGGACATCAGCACACATCGTACCGGATCCGTCACCAGCC3’ 
S2.3 5’GCGACCCAAGGAATTCTGCTGAAGGCGGGCGGCGTGTCACACCAGGCTTTCGATTCCTTGCTGGTTCGGGTTGTGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.5 5’GCGACCCAAGGAATTCTGCTGAAGGCGGCGGGGAGGTTGGCTCATCATGGCTCTACTGACTGCGCCTGGGTAGCTCATCGTACCGGATCCGTCACCAGCC3’ 
S2.6 5’GCGACCCAAGGAATTCTGCTGAAGGAGGGCGGTGAACGGATAGACGCGGCGGTTAGAGTTGGTAGCCACGTGCAACATCGTACCGGATCCGTCACCAGCC3’ 
S2.7 5’GCGACCCAAGGAATTCTGCTGAAGGTATAGGTTCGACTGCCAAACAGCCGAGGACGGGTAATTGAGGGTCCCGAGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.8 5’GCGACCCAAGGAATTCTGCTGAAGGTCAACTTTCTCACTGTACAGAATGGGGATAGTTTATGCGGGTTTTGTAAGCATCGTACCGGATCCGTCACCAGCC3’4.3* 
S2.9 5’GCGACCCAAGGAATTCTGCTGAAGGGGGATGGGGGGAAGGACGAGAAGGGGAAGAACAGAGGGGATCAAGGTAGACATCGTACCGGATCCGTCACCAGCC3’ 
S2.105’GCGACCCAAGGAATTCTGCTGAAGGCGATTGGGGGGAGAGAACCGCGCGAATCGTCCTAGGCGTCGTGCGTATCAGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.115’GATACCCAAGGAATTCTGCTGAAGGGGGAAGCATGCTATCTTTGGACGCGTCGGAGACACGACTGCGTCTCTTGCCATCGTACCGGATCCGTCACCAGCC3’4.2* 
S2.125’GCGACCCAAGGAATTCTGCTGAAGGCCGAGCAGTGGTGTTACCCTCATTCACACCGCTGCTAGCTGACCTAACCTCATCGTACCGGATCCGTCACCAGCC3’ 
S2.145’GCGACCCAAGGAATTCTGCTGAAGGTGTGGGGGAGGGGCATACTATTTGTTCACGCCACAGCGCATCACTGGCCGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.155’GCGACCCAAGGAATTCTGCTGAAGGCTGGGTATGAGAAAACAACGGGTGGAAACTGTAGTTACCCTATCTTTTCCCATCGTACCGGATCCGTCACCAGCC3’ 
S2.165’GCGACCCAAGGAATTCTGCTGAAGGGCGCTACGTTGATGGCCCTTTGAGAGGGCCTCGTAGTGAAAATTGCTGGCCATCGTACCGGATCCGTCACCAGCC3’4.4* 
S2.175’GCGACCCAAGGAATTCTGCTGAAGGGCATGGCCAGGTTACGCCAGTAAGCGAAACGGAAAGTGGCCTCGACGTTGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.185’GCGACCCAAGGAATTCTGCTGAAGGGCGGAAAGTATGCCTGAAGACGTCCTAGTGCGCCAGCTAGCATACTGGGGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.195’NCGACCCAAGGAATTCTGCTGAAGGGAGGCCTGCACACGGAATCCAGCTTCCATAGGGGATGTGGGGGGTGGGGGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.215’GCGACCCAAGGAATTCTGCTGAAGGGCAGTGTGTTGCCCTGAGCCCGGTTTTCTGACGGGAATGCTTGCGTTGTGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.225’GCGACCCAAGGAATTCTGCTGAAGGCAAACGTCGTGCATGATAGATGGCGTGCGCGTGGCGAGGGCAAGCGAGGTCATCGTACCGGATCCGTCACCAGCC3’ 
S2.245’GCGACCCAAGGAATTCTGCTGAAGGAGCGGGGGGGTCACTAAGCGTGGTGGTGCGAGGGACAAGGTTTGGGCAGACATCGTACCGGATCCGTCACCAGCC3’ 
S2.255’GCGACCCAAGGAATTCTGCTGAAGGAGTGGGCCGTCGTGTGTCAGCGAGACCCCTTCAGGCGTTATGGTGGGTTGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.265’GCGACCCAAGGAATTCTGCTGAAGGAAGAGGGAGGGGTAAAGTCGAATCGACGAGTGCGGTTGTCCTTTGTTGAGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.285’GCGACCCAAGGAATTCTGCTGAAGGCGGTTAGCTGTTGTAAGTTACCTTGAATTCCGCACGTCCACATCCACGGACATCGTACCGGATCCGTCACCAGCC3’ 
S2.305’GCGACCCAAGGAATTCTGCTGAAGGACAGGCTGATCAGGCTCCATTCTTCTTCCCATCTCTGCTCTGCTATGCAGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.315’GCGACCCAAGGAATTCTGCTGAAGGGGCCGTGCACGTGGCGAGGCATTGTGCGTGGGCGAAGATAACTAGGGAACCATCGTACCGGATCCGTCACCAGCC3’ 
S2.335’GCGACCCAAGGAATTCTGCTGAAGGTTTGAGAGGTTGTGCCTATGACCAGGGTGTTGCTACTGCTTAGTGGTAGGCATCGTACCGGATCCGTCACCAGCC3’ 
S2.345’GCGACCCAAGGAATTCTGCTGAAGGTGTGGCGGCTTGAAATTTGGTCGTTTGCGCCGATGAGACTAGGCCCTTCCCATCGTACCGGATCCGTCACCAGCC3’  
 
HEX/TOP primer    Selected central sequence          PHOS/BOT primer (complement) 
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         Fig 4.11.B. The seven >101nt sequences isolated from the 8th round of SELEX Method II. HEX/TOP and PHOS/BOT complement sequences are shown
Sequences with 1 additional PHOS/BOT primer sequence 
 
S2.4  5’GCGACCCAAGGAATTCTGCTGAAGGGTTCACTGGTTGACCAGTGGGGCATCCCCTGACCTGGTTTGCTCACGGGGCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCC3’ 
 
S2.13 5’GCGACCCAAGGAATTCTGCTGAAGGGGCTGTGCCGGTCTTCCTTCGGATGTGCGTACAGGGGTGGAGCGGAAGGGCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCC3’ 
 
S2.23 5’GCGACCCAAGGAATTCTGCTGAAGGTAGGTGTTAGCGGCGGAGCATAGAGCCAGTATTGGCCAAATATTTCTGGCCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCC3’ 
 
S2.29 5’GCGACCCAAGGAATTCTGCTGAAGGCAACAGGTCCGCGCGTTAGAAAACCCAAGGTGTTGGATGGTCACGGCCAGCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCC3’ 
 
 
Sequences with 2 additional PHOS/BOT primer sequence 
 
S2.20 5’GCGACCCAAGGAATTCTGCTGAAGGTGTAGGCGGTGATAATGCTTTTCATCCTTGGAACATTCGTGCAGCAGGGGCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCCCATCGTACCGGATCCGTCACCAGCC3’ 
 
S2.32 5’GCGACCCAAGGAATTCTGCTGAAGGAGCCCAGCAAAATCGCCGTATTTGGAAAAGCTGCTCTCGAGAGTCTTGGACATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCCCATCGTACCGGATCCGTCACCAGCC3’ 
 
Sequence with 3 additional PHOS/BOT primer sequences 
 
S2.27 5’GCGACCCAAGGAATTCTGCTGAAGGGGTGGTCATGTTACCGGAAGTGAGACGCGAATTGTGGGAGTGGCCGCCTCCATCGTACCGGATCCGTCACCAGCC 
CATCGTACCGGATCCGTCACCAGCCCATCGTACCGGATCCGTCACCAGCCCATCGTACCGGATCCGTCACCAGCC3’ 
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4.7. SELEX Method II Conclusions 
Fig 4.10 lane 9 shows that multiple bands were present in the amplified round 8 pool of 
molecules. These samples when cloned were shown to contain DNA molecules of differing 
lengths. The lengths of these molecules corresponded to the bands observed, with the majority 
of the molecules sequenced falling at 100 nt (or 101 nt); however, some molecules were 125 nt, 
150 nt or 175 nt. These molecules had accumulated extra PHOS primer sequences. It could be 
speculated that this phenomenon is a by-product of the λ-exonuclease single strand recovery 
process. This effect has not been seen in any published SELEX experiments using λ-exonuclease 
thus far (Lim et al. 2012). Upon sequencing, one DNA molecule had been sampled twice. This 
may indicate that the pool of molecules in round eight is more homogeneous than previous 
rounds of the evolving pool of molecules. More sequencing data are required to corroborate this 
conclusion. The pool of molecules does not appear to be as homogeneous as the final pool 
described in Chapter 3. The data shown in Fig 4.11 A are comparable to other Cell-SELEX 
experiments performed using similar techniques (Cibiel et al. 2011). 
 Sequences from SELEX Method II rounds 1-7 are shown in Appendix IV. All of these 
sequences have been processed using bacterial selection, meaning any one of these sequences 
could potentially be an effective aptamer. 
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Chapter 5: Molecular Evolution of DNA during 
SELEX Methods I & II 
5.1. Introduction 
Throughout SELEX Methods I and II, DNA molecules have been subjected to selective pressure; 
specifically to bind to E.coli HB101:pAT153 and to reproduce. A number of unexpected 
observations were made during the evolutionary process. Some of these were in accordance with 
previously described phenomena. The first recorded cases of human directed molecular 
evolution (described in section 1.4.8) reported that the evolving pool of molecules reduced in 
size from over 4217 nt to only 218 nt (Pace & Spiegelman, 1967; Levisohn & Spiegelman, 1969; 
Kashiwagi & Yomo, 2011). Further experimentation showed that continuing molecular 
evolution would eventually reduce the sequence further to the minimum replicating unit of just 
48 nt, which represents the minimum binding site for the Qβ replicase enzyme (Oehlenschläger 
& Eigen, 1997). This complete removal of all “genetic” information (other than the structures 
required for replication) represents the pinnacle of efficiency and replicative fitness for the Qβ 
replication system. Truncation of nucleic acid sequences is therefore a well-documented process. 
In Chapter 3 the diminution of evolving sequences was observed when compared to the initial 
randomised library from which the pool evolved (from 62 nt to 9 nt). Similar diminution was 
not observed during the evolution of molecules in Chapter 4.  
 These observations are linked to the ability of these shorter polymer molecules to 
replicate faster and require fewer resources (monomers) to complete replication. This shows that 
smaller molecules are higher in replicative fitness than longer counterparts. The chemistry of 
replicating biopolymers therefore creates a “genetics paradox”. If evolution favours the shorter 
biopolymers, how is it that long complex genomes could evolve at all? Recent publications have 
shown that in some conditions larger molecules have a replicative advantage over shorter 
counterparts (Kreysing et al. 2015). 
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 In both SELEX Methods I & II, DNA sequences were also augmented, often with the 
addition of primer sequences. Aberrant augmented sequences from SELEX Method I are shown 
below and the sequences from SELEX Method II are shown in Fig 4.11B and Appendix IV). 
This complexity emerged from a number of different potential mechanisms. Experimental 
results which demonstrate this complexity and proposed accompanying evolutionary 
mechanisms will be discussed in the following sections. 
 In the 1997 Science article “Ribozymes in Wonderland” Andrew Ellington and 
colleagues noted that mechanisms had been discovered by which evolving nucleic acid 
molecules could augment themselves by ligation and diminish themselves by splicing (Ellington 
& Bull, 1997). 
5.2. Aberrant SELEX Products from SELEX Method I 
SELEX Method I used 15 cycles of Symmetric and Asymmetric PCR to evolve nucleic acid 
ligands to the cell surface of E.coli HB101 pAT153. This gives a theoretical maximum of 1,225 
replications (15 symmetric and 15 asymmetric PCRs each with 40 cycles plus 25 cycles of pre-
cloning PCR (assuming one replication per PCR cycle)) for any sequence in the evolving pool. 
This is 4.62 times as many replications when compared to SELEX Method II with 265 
theoretical replications (8 symmetric PCRs each with 30 cycles and 25 cycles of pre-cloning 
PCR reactions). This may explain the truncation of sequences observed in Fig 3.16B, but not in 
Fig 4.11. A high number of replications would allow a higher number of deletion mutations 
which would lead to the stepwise diminution of sequence length. These shorter sequences would 
have increased replicative fitness and would eventually dominate the pool of molecules. 
Truncation of these regions between forward and reverse primer sequences could have occurred 
by one of two mechanisms, the stepwise deletion mechanisms, or the binding of one of the 
primer sequences within the central variable region. Annealing of either the forward or reverse 
primers within the central variable region of the evolving pool of molecules would lead to an 
immediate truncation event as the PCR amplicon created by this primer configuration would not 
replicate the complete molecule but only a portion. This is a one-step mechanism for the efficient 
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truncation of DNA molecules. It may also be possible that DNA sequences may self-splice or 
be spliced by other molecule with deoxyribozyme activity. It is impossible to say which of these 
mechanisms was responsible for the diminution of sequence length in SELEX Method I, though 
it is likely to be a combination of all these mechanisms. In these proposed truncation mechanisms 
the flanking primer sequences would be completely conserved. Any insertion, deletion or 
substitution mutations within the primer sequences would reduce the ability of the sequences to 
replicate. A sequence with a sufficiently mutated primer binding sequence would lose the ability 
to replicate by the normal PCR method and would theoretically go extinct. However, there may 
be a number of additional mechanisms by which highly structured nucleic acids may replicate 
that may not require PCR primers. 
 Intra- and intermolecular mispriming events may cause DNA structures with free 3’ 
ends to form which may be extended by Taq polymerase. These structures are caused by 
complementary intramolecular or intermolecular sequences. The intermolecular 
complementarity between a primer and an evolving strand produces a “correct” 3’ terminus 
which causes the full extension of the template strand producing a complete duplex PCR 
product. Fig 5.1A shows the correct primer-induced elongation of a target sequence. 
 The intramolecular hairpin priming mechanism may produce an amplicon greater than 
the original length of the template strand. This mechanism only requires one strand and is 
therefore a primer-free elongation mechanism. The central variable sequence region may contain 
a sequence which is partially complementary to the 3’ end of the same molecule. This may cause 
a hairpin to form which would allow unimolecular elongation. A diagram of this mechanism is 
shown in Fig 5.1B. 
 Intermolecular mispriming is another primer-free mechanism for extension of one or 
more nucleic acid strands. Sometimes describes as “jumping PCR”, this mechanism involves 
one complete strand forming complementary Watson-Crick base pairings with another strand 
which induce one or more free 3’ ends ready for enzymatic amplification. A schematic of this 
mechanism is shown in Fig 5.1C. 
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A. 
B. 
C. 
D. 
E. 
Figure 5.1 Correct and aberrant replicative mechanisms possible during the amplification of random 
sequences. A. Primer-induced replication of a sequence (Primer shown in red). B. Primer-free exten-
sion of a structured nucleic acid sequence leading to a primer sequence duplication event. C. Intramo-
lecular mispriming of two nucleic acid template sequences leading to the incorporation of additional 
primer sites. D. A duplex DNA molecule where one strand forms a secondary structure may lead to 
aberrant extension and addition of a primer site. E. A primer dimer leading to extension. 
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Another form of intermolecular mispriming may occur when one strand of a DNA duplex 
forms a secondary structure while still remaining partly complementary to a partner strand. The 
structure-forming strand may create a free 3’ end which would allow elongation. This is shown 
in Fig 5.1D. 
These “aberrant” PCR amplification mechanisms described above may lead to the 
incorporation of additional primer sites into the evolving strand. A sequence with more than one 
forward and one reverse primer site may have an advantage as this may increase the chances of 
successful amplification. These favourable sequence patterns may come to dominate the pool of 
evolving sequences as these abnormal PCR products may have higher replicative fitness. The 
primer sequences themselves may form dimers which could be extended. These multi-primer 
concatamers may then go on to initiate replication and become incorporated into evolving 
sequences. Primer dimers are described in Fig 5.1E. 
The above described replication and extension mechanisms could be responsible for the 
formation of the high molecular weight PCR products during SELEX Method I (Shown in Fig 
3.12 and 3.13). In Chapter 3, template dilution PCR was used to create short PCR amplicons 
with high cloning efficiencies. Attempting to perform a molecular cloning reaction using the 
smear as a target insert resulted in very few recombinant colonies, that is, a low ligation 
efficiency. These cloned inserts of the undiluted mixture of molecules from SELEX Method I 
reveal information as to the nature of the high molecular weight PCR products observed in 
SELEX. They also shed light on the effectiveness of template dilution PCR in reducing the 
length of PCR amplicons. 
Only two species (from separate colonies and different cloning reactions) were isolated 
during the cloning and transformation of the undiluted high molecular weight PCR products 
amplified from the final round of SELEX Method I. These are shown in Fig 5.2. The first shown 
in Fig 5.2A is 321 nt in length and contained forward and reverse primer sequences on both 
strands. It also contained an overlapping self-complementary reverse primer sequence. This 
therefore suggested that either strand can act as a template to either primer. 
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6.  
 
 
 
 
  
A. 
B. 
Figure 5.2 Isolated sequences from the undiluted evolving pool of molecules from SELEX Method I. A. A 321 nt 
sequence isolated from the 15th round of SELEX, showing in the schematic, the reverse primer in red and the 
forward primer in blue. In the sequence itself, the forward primers are shown in blue (light blue for the sequence 
itself and dark blue for the complement), and the reverse primer is shown in red (red for the sequence and orange 
for the complement). Overlapping reverse primer and primer complement sequences are shown in purple. B. A 744 
nt sequence isolated from the 15th round of SELEX, showing in the schematic, the reverse primer in red and the 
forward primer in blue  and the same in the sequence itself. Both sequences are 5’ to 3’. 
 
 
 
 
 
 
5’ 
3’ 
5’ 
3’ 
Aberrant clone I : 321 nt sequence 
Aberrant clone II : 744 nt sequence 
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SELEX Method I used asymmetric PCR as a method of single-stranded DNA generation. 
One of the primers was depleted, meaning that one of the resources required to complete 
replication (the forward primer) was scarce and the other (the reverse primer) was abundant. The 
sequences seen in Fig 5.2 may represent structures adopted by the evolving pool of molecules 
to adapt to this primer discrepancy. The asymmetric PCR method applies selective pressure to 
the pool of molecules. The molecules adapt to the lack of one primer by incorporating multiple 
primer binding sites and therefore increasing the likelihood of encountering the depleted primer.  
Fig 5.2A shows a sequence where the forward and reverse SELEX primers can bind to and 
initiate amplification of either strand. Whereas the initial random pool 100 nt could only be 
amplified by one primer, these evolved structures have bypassed this and can be amplified by 
either. The self-complementary reverse primer sequence in Aberrant clone I, could form a 
snapback hairpin structure. The reverse primer could therefore initiate replication of both strands 
of the duplex from this point (shown in purple). The reverse primer is the more abundant primer 
in asymmetric PCR. This primer-hairpin structure is in the centre of five reverse primer 
sequences able to amplify either strand of the DNA duplex. These primer sites are either 
overlapping or separated by only two or three nucleotides. 
The larger SELEX product shown in Fig 5.2B showed higher order patterns. Repeating units 
of primer sequences were observed along the length of the molecule. Multiple consecutive 
reverse primer binding sequences lead to a forward primer binding sequence. This observation 
indicates that the molecule has adapted to the primer ratios used during SELEX amplification. 
Much like when Sol Spiegelman directed the evolution of the Qβ RNA genome to adapt to 
the lack of cytosine residues (Levisohn & Spiegelman, 1969), these molecules are the product 
of directed evolution where one primer has been depleted. The main finding, specifically the 
incorporation of additional primer sites, was not a phenomenon only observed in SELEX 
Method I; the refined SELEX method II also produced molecules with additional primer binding 
sequences, however in comparison the products of SELEX method II were more ordered and 
the accumulation of these additional sequences progresses with each round of SELEX. 
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5.3. Aberrant SELEX Products from SELEX Method II 
SELEX Method II used cloning and sequencing to analyse every single round of in vitro 
selection. Unlike SELEX Method I, little to no truncation of randomised central sequences was 
observed during SELEX Method II.  The elimination of the asymmetric PCR step reduced the 
competition for primer resources and the adaptations observed in Fig 5.2 were not seen.  
 Additional primer sequences were accumulated by the concatamerisation of the 
PHOS/BOT primer sequence. This phenomenon explains the observations of increasing size 
PCR products in Fig 4.9 and Fig 4.10. Sequencing data from each round of SELEX indicated 
that, while the population of molecules initially only consisted of 100 bp molecules containing 
one HEX/TOP and one PHOS/BOT primer per sequence, the pool eventually evolved to contain 
a number of 125 bp, 150 bp and 175 bp sequences. Examples of these augmented sequences are 
shown in Fig 5.3A. Concatameric primers were first observed in SELEX round 5. The final (8th) 
round of SELEX included sequences with 1, 2, 3 and 4 PHOS/BOT primer sequences. Only the 
PHOS/BOT primer site was duplicated, never the HET/TOP primer sequence. It may be that the 
free 5’-phosphate on the PHOS primer facilitated the concatamerisation. The 5’ HEX group on 
the HEX primer may be preventing primer concatamerisation. Repeated heating and cooling 
during PCR amplification and the electron-dense phospate group may allowed additional phos 
primers to bind to the 5’ end of the evolving biopolymer.  
The sequences containing multiple primers may have had an evolutionary advantage as 
it increased the chances of successful replication. The accumulation of PHOS/BOT primer sites 
can be observed in Fig 4.11 B and Fig 5.3B. As SELEX progresses, the number of additional 
primer sites increases. This is another example of how in some situations larger nucleic acid 
sequences may have an evolutionary advantage over shorter counterparts. This therefore may 
provide a mechanism by which nucleic acids can overcome the “genetics paradox” as described 
by Kreysing et al. 2015. It may be that other aberrant PCR products were created but these were 
either not observed or were out-competed by these sequences.  
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Figure 5.3 Accumulation of phosphorylated primers during SELEX Method II. A. Examples of sequences from 
SELEX round 8 showing the restriction site sequences. The XhoI, XbaI and BglII restriction sites are all part of the 
pJET1.2 blunt cloning vector (Fig 2.2B). The EcoRI and BamHI restriction sites are found in the HEX/TOP and 
PHOS/BOT primers respectively (Table 2.4). Sequences with 1, 2, 3 and 4 PHOS/BOT primer sequences are shown 
and a sequence where the cloned 100 bp sequence was inserted the other way around. (See Fig 4.11 B and Appendix 
IV for sequences.) B. This graph shows the percentage proportion of the sequences with one or more primer se-
quences for every round of SELEX. Longer aberrant PCR products were observed in the later rounds of SELEX. 
(See Fig 4.11 and Appendix IV for sequences.) 
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5.4. Development of Homogeneity in SELEX Method I and II 
In both SELEX Methods I and II, multiple clones containing the same sequence were observed. 
In SELEX Method I, 35 clones yielded 24 individual sequences (Fig 3.16). SELEX Method II 
yielded 34 sequences from 35 clones (Fig 4.11). In contrast to this, other research groups have 
sampled 99 sequences in the final round of selection against B.anthracis spores and observed no 
identical sequences (Bruno & Carrillo, 2012). The nature of complex multi-epitope targets does 
not normally allow significant homogeneity to emerge during SELEX (Vant-Hull et al. 1998).  
 A research group in Korea, raising aptamers against E.coli performed 10 rounds of 
SELEX, and 28 sequences were isolated from 28 clones, (Kim et al. 2013). This is comparable 
to the 15 rounds performed in SELEX Method I and the 8 rounds performed in SELEX Method 
II, where identical clones were observed in both cases. More clones were sequenced in this thesis 
(35 in both cases compared to 28 in the Korean study). Another study where aptamers were 
raised against Listeria sp. performed 6 rounds of selection and two rounds of counter selection. 
This yielded 10 unique sequences from 13 clones. Three of the sequences were observed twice 
(Suh et al. 2014). A study by Savory et al. in 2014 sampled 35 transformants from 6 rounds of 
SELEX against E.coli, yielding 29 individual sequences (Savory et al. 2014). 
 The findings of this thesis are congruent with the findings of the above-listed studies. 
Enrichment of DNA sequences during Cell-SELEX can be observed in the isolation of identical 
sequences. The comparatively high homogeneity of sequences found in SELEX Method I may 
be due to the high number of SELEX rounds performed. Variation in the length of sequences 
was also observed in the above listed studies. The highly truncated sequences evolved in SELEX 
Method I may also be due to the high number of SELEX rounds performed. This is comparable 
with the molecular evolution of nucleic acid experiments performed on the Qβ RNA genome 
(Oehlenschläger & Eigen, 1997). 
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6. Chapter 6: Analysis of Evolved Sequences 
6.1. Analysis of Individual Selected Sequences 
All the sequences isolated in both SELEX Method I and Method II were analysed using a number 
of software packages. These programs were used to identify trends in the evolving pool of nucleic 
acids. The products of SELEX Method I and Method II were analysed with and without attached 
primer regions. There is no consensus in the literature as to whether the flanking primer regions are 
required for aptamers to function (Cowperthwaite & Ellington, 2008).  
The number of nucleotides of each selected sequence was measured alongside the 
percentage of G-C nucleotides and the theoretical Tm of the strands. The number of each nucleotide 
in each selected strand was also noted and tabulated. Secondary structure analysis was performed 
using mfold structural prediction software (Zuker, 2003). These programs create a number of 
possible 2D secondary structure predictions, also known as an ensemble. The average minimum free 
energy (measured as ΔG) of each ensemble is given and reflects the stability of each nucleic acid 
sequence adopting a particular structure (Manthey, 2005). These structural predictions were 
performed using two algorithms; the first allowed for G-T interactions, the second did not. ΔG 
values were originally given in kcal⋅mol−1 and were converted to kJ⋅mol−1 The G-quadruplex 
propensity was ascertained by using the Quadruplex forming G-rich sequences (QGRS) program 
webservers (Kikin et al. 2006). QGRS gives a nucleic acid sequence a score out of 105 representing 
the likelihood that the sequence will form a G-quadruplex structure. QGRS scores were taken for 
all the evolved sequences. The molecular weights of all the sequences with and without primers 
were calculated and theoretical extinction coefficient for each sequence calculated. These data were 
tabulated and shown in Tables 6.1 to 6.4. Table 6.1 and 6.2 show the data from Chapter 3 SELEX 
Method I without and with primers respectively, and Tables 6.3 and 6.4 show the data from SELEX  
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SELEX Method I – Selected sequence parameters- without primer sequences 
 Frequency nt Tm (°C) CG% A T C G 
Molecular 
weight 
 (g⋅mol-1) 
Molar extinction coef-
ficient  (L⋅mol−1⋅cm−1) 
ΔG 
(No G-T) 
(kJ⋅mol−1) 
ΔG 
(G-T) 
(kJ/⋅mol−1) 
QGRS 
score 
S1.1 6 37 83.1 56.8 4 12 5 16 11554.5 353400 -25.56 -57.70 7 
S1.2 4 23 79.8 65.2 4 4 6 9 7105.6 216300 -16.99 -34.14  
S1.3 3 22 72.7 59.1 1 8 3 10 6844.5 202000 -11.17 -27.15  
S1.4 2 31 72.9 51.6 3 12 5 11 9595.3 288100 -17.95 -35.44  
S1.5 1 18 66.8 66.7 0 6 3 9 5593.7 163500 -8.83 -19.33  
S1.6 1 28 73.6 53.6 4 9 6 9 8626.6 261400 -10.25 -29.83  
S1.7 1 16 64.5 68.8 2 3 5 6 4898.2 145500 -9.71 -16.19  
S1.8 1 23 74.4 60.9 4 5 4 10 7160.7 221100 -13.77 -21.21  
S1.9 1 17 63.9 58.8 3 4 4 6 5226.4 161800 -7.95 -12.43  
S1.10 1 25 76.1 60 2 8 3 12 7816.1 237800 -11.21 -26.74  
S1.11 1 25 80.4 68 0 8 4 13 7808.1 224300 -13.10 -53.72 14 
S1.12 1 18 69.3 66.7 2 4 5 7 5531.6 165900 -4.44 -10.04  
S1.13 1 23 81.7 69.6 3 4 6 10 7121.6 214200 -17.15 -35.44  
S1.14 1 19 62.5 57.9 2 6 6 5 5770.8 167100 -7.24 -16.28  
S1.15 1 26 82 65.4 2 7 10 7 7890.1 222800 -22.18 -34.69  
S1.16 1 22 60.1 40.9 4 9 2 7 6811.5 212300 -5.15 -8.33  
S1.17 1 32 76.9 50 10 6 11 5 9722.4 301900 -9.33 -22.43  
S1.18 1 17 51.8 47.1 2 7 2 6 5247.5 161700 -5.86 -9.92  
S1.19 1 9 24.6 55.6 1 3 1 4 2769.9 86500 -0.71 -0.25  
S1.20 1 20 58.6 50 2 8 5 5 6090 180800 -5.23 -10.96  
S1.21 1 20 66.6 55 2 7 6 5 6075 177600 -4.90 -18.49  
S1.22 1 15 63 66.7 2 3 4 6 4609 139100 -7.49 -11.97  
S1.23 1 11 39.7 54.5 0 5 1 5 3394.3 99400 -1.09 -1.63  
S1.24 1 17 61.7 52.9 0 8 3 6 5214.4 149400 -3.22 -26.78  
 
Table 6.1. Data from the twenty-four sequences isolated from the 15th round of SELEX Method I 
without flanking primer sequences. Sequences are shown in order of frequency of observation. ΔG 
values were originally given in kcal⋅mol−1; these were converted to kJ⋅mol−1. 
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SELEX Method I – Selected sequence parameters - with primer sequences 
 Frequency nt Tm (°C) CG% A T C G 
Molecular 
weight (g⋅mol−1) 
Molar extinction coeffi-
cient  (L⋅mol−1⋅cm−1) 
ΔG 
(No G-T) 
(kJ⋅mol−1) 
ΔG 
(G-T) 
(kJ/⋅mol−1) 
QGRS 
score 
S1.1 6 75 90.5 49.3 16 22 14 23 721600 23262 -54.56 -111.92 7 
S1.2 4 61 90.5 50.8 16 14 15 16 584500 18813 -49.62 -81.84  
S1.3 3 60 88.5 48.3 13 18 12 17 570200 18552 -38.91 -80.92  
S1.4 2 69 86.8 46.4 15 22 14 18 656300 21303 -40.21 -95.06  
S1.5 1 56 87.6 50 12 16 12 16 531700 17301 -38.70 -71.55  
S1.6 1 66 87.4 47 16 19 15 16 629600 20334 -44.02 -92.09  
S1.7 1 54 87.3 50 14 13 14 13 513700 16606 -41.25 -68.12  
S1.8 1 61 88.8 49.2 16 15 13 17 589300 18868 -43.22 -85.06 8 
S1.9 1 55 87 47.3 15 14 13 13 530000 16934 -33.05 -60.25  
S1.10 1 63 89.3 49.2 14 18 12 19 606000 19524 -37.07 -76.82  
S1.11 1 63 90.6 52.4 12 18 13 20 592500 19516 -44.06 -96.27 19 
S1.12 1 56 88 50 14 14 14 14 534100 17239 -34.98 -69.20  
S1.13 1 61 91.2 52.5 15 14 15 17 582400 18829 -45.90 -83.81  
S1.14 1 57 86 47.4 14 16 15 12 535300 17478 -38.99 -80.92  
S1.15 1 64 90.9 51.6 14 17 19 14 591000 19598 -57.57 -99.33  
S1.16 1 60 84 41.7 16 19 11 14 580600 18519 -33.26 -64.98  
S1.17 1 70 87.8 45.7 22 16 20 12 670100 21430 -39.16 -79.91  
S1.18 1 55 83.3 43.6 14 17 11 13 529900 16955 -33.10 -65.02  
S1.19 1 47 82.3 44.7 13 13 10 11 454700 14478 -30.08 -48.99  
S1.20 1 58 86.3 44.8 14 18 14 12 548100 17798 -38.41 -73.81  
S1.21 1 58 86.8 46.6 14 17 15 12 545800 17783 -49.08 -85.44  
S1.22 1 53 87.1 49.1 14 13 13 13 507300 16317 -30.96 -62.80  
S1.23 1 49 83.3 44.9 12 15 10 12 467600 15102 -34.14 -53.85  
S1.24 1 55 85.7 45.5 12 18 12 13 517600 16922 -34.02 -65.35  
 
  
Table 6.2. Data for the twenty-four sequences isolated from the 15th round of SELEX Method I with 
flanking primer sequences. Sequences are shown in order of frequency of observation. 
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Method II without and with primers respectively. Twenty-four sequences were shown from round 
15 of SELEX Method I and 34 sequences were shown from SELEX Method II. 
Analysis of the selected sequences from SELEX Method I (Tables 6.1 and 6.2) showed the 
great diversity of sequence length and therefore molecular weight and Tm. Although the molecules 
contained a high proportion of G nucleotides, very few of the sequences had high QGRS scores, 
which would indicate that the sequences were unlikely to form G-quadruplex structures. This may 
be because these putative aptamers were raised in water (as opposed to PBS in SELEX Method II) 
which lacked the monovalent cations required for quadruplex formation. Sequences 5, 11, 23 and 
24 do not contain A residues in the evolving central section and yet contain all the A residues in the 
fixed sequence flanking primer sections. Several other sequences contain only a small number of A 
residues (Thiel et al. 2011). 
Mfold structural predictions which allowed G-T base pairing produced more stable theoret-
ical ensembles than those without. G-T pairings like those described in Fig 1.5B could possibly 
stabilise secondary structures by increasing the number of possible hydrogen bond formations. The 
longer sequences with the primer sequences attached gave more stable ΔG predictions as there were 
more nucleotides available to form possible structures. All the sequences from SELEX Method II 
were longer than those from SELEX Method I (except the aberrant ones described in Chapter 5). 
The modal sequence from SELEX Method I however was the longest observed sequence. The longer 
sequences produced during SELEX Method II gave more stable (and therefore more negative ΔG) 
structural predictions. QGRS mapping of the sequences of SELEX Method II also yielded a higher 
proportion of sequences able to form G-Quadruplex structures. Some sequences were notable as the 
QGRS predictions suggested there may be two independent G-quadruplex forming sequences adja-
cent to one another within the selected sequence. These sequences are shown with the two QGRS 
scores.  
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SELEX Method II – Selected sequences - without primer sequences 
 Frequency nt Tm (°C) CG% A T C G 
Molecular 
weight 
 (g⋅mol−1) 
Molar extinction 
coefficient  
(L⋅mol−1⋅cm−1) 
ΔG 
(No G-T) 
(kJ⋅mol−1) 
ΔG 
(G-T) 
(kJ/⋅mol−1) 
QGRS 
score 
S2.1 2 50 92 60 12 8 12 18 15526.1 490300 -39.54 -71.00 18 
S2.2 1 50 88.8 54 13 10 13 14 15420 485300 -49.25 -79.45  
S2.3 1 50 94.9 62 4 15 13 18 15439 449600 -31.67 -69.71  
S2.4 1 50 93.3 62 6 13 14 17 15417 455800 -61.55 -100.83 8 
S2.5 1 50 92.8 64 6 12 13 19 15482 457600 -38.87 -86.23 21 
S2.6 1 50 91.9 60 12 8 9 21 15646.2 500300 -39.50 -63.18 15 
S2.7 1 50 88.6 56 13 9 11 17 15525.1 494200 -47.40 -70.00  
S2.8 1 50 80.2 40 12 18 7 13 15476.1 485700 -23.97 -51.00  
S2.9 1 50 88.9 58 18 3 3 26 15915.4 542400 -10.25 -17.49 31 
S2.10 1 51 93.5 62.7 10 9 12 20 15862.3 494200 -43.01 -75.35  
S2.11 1 50 90.9 58 9 12 13 16 15434 466900 -58.95 -90.17  
S2.12 1 50 87.5 56 10 12 18 10 15217.9 454900 -59.79 -87.28  
S2.13 1 50 94.4 66 6 11 10 23 15627.1 473400 -41.13 -82.09 21 
S2.14 1 50 93.5 60 9 11 13 17 15459 469800 -35.73 -78.62 20 
S2.15 1 50 80.6 44 14 14 10 12 15424.1 486800 -31.51 -57.40  
S2.16 1 50 89.5 56 9 13 11 17 15489.1 469900 -58.49 -102.05  
S2.17 1 50 91.1 58 13 8 12 17 15510.1 488500 -38.79 -70.42  
S2.18 1 50 88.2 58 12 9 12 17 15501.1 485200 -40.08 -71.46  
S2.19 1 50 94.5 66 9 8 10 23 15654.2 485900 -43.68 -88.95 38 
S2.20 1 50 88.4 50 10 15 9 16 15503.1 477900 -28.24 -59.71  
S2.21 1 50 93 58 5 16 11 18 15478 455400 -45.90 -79.04  
S2.22 1 50 95 62 11 8 10 21 15622.2 489600 -51.51 -80.75 16 
S2.23 1 50 85.5 50 12 13 9 16 15521.1 489000 -35.35 -62.13  
S2.24 1 50 94.3 64 10 8 7 25 15758.3 498900 -30.96 -62.51 10, 20 
S2.25 1 50 93.2 62 6 13 11 20 15537.1 471200 -35.61 -69.83  
S2.26 1 50 87.1 52 12 12 6 20 15666.2 502300 -30.84 -62.51  
S2.27 1 50 92.1 60 9 11 10 20 15579.1 482400 -31.84 -91.09  
S2.28 1 50 86.9 50 11 14 14 11 15312 470900 -27.78 -56.57  
S2.29 1 50 91.9 58 13 8 13 16 15470.1 486300 -39.37 -64.14 19 
S2.30 1 50 87 52 8 16 17 9 15189.9 445000 -28.58 -53.18  
S2.31 1 50 93.3 62 11 8 10 21 15622.2 489200 -48.99 -74.98  
S2.32 1 50 87.8 50 14 11 12 13 15419.1 484800 -29.20 -61.09  
S2.33 1 50 84 50 8 17 7 18 15565.2 477700 -36.40 -73.55  
S2.34 1 50 91.6 56 7 15 12 16 15431 458400 -34.43 -72.47  
 
Table 6.3. Data for the thirty-four sequences isolated from the 8th round of SELEX Method II with 
no flanking primer sequences. Sequences are shown in order of frequency of observation. Sequences 
with more than one QGRS predicted sequence are shown with two QGRS scores. The 5’ putative 
quadruplex-forming sequence is shown first. 
 166 
 
SELEX Method II – Selected sequences – with single flanking primer sequences 
 Fre-quency nt 
Tm 
(°C) CG%
 A T C G 
Molecu-
lar 
weight  
(g⋅mol−1) 
Molar attenu-
ation 
 coefficient  
(L⋅mol−1⋅cm−1) 
ΔG 
(No G-T) 
(kJ⋅mol−1) 
ΔG 
(G-T) 
(kJ/⋅mol−1) 
QGRS 
score 
S2.1 2 100 95 60.5 24 15 30 31 30878.7 959100 -82.47 -158.20 17 
S2.2 1 100 95 57 25 18 30 27 30808 955800 -82.63 -155.81  
S2.3 1 100 95 61 16 23 30 31 30826.9 920500 -91.04 -185.39 10 
S2.4 1 100 95 61 18 21 31 30 30804.9 926600 -106.23 -189.20 12, 12 
S2.5 1 100 95 62 18 20 30 32 30869.9 929900 -85.86 -171.63 21 
S2.6 1 100 95 60 24 16 26 34 31034.1 970500 -93.68 -176.69 18 
S2.7 1 100 95 58 25 17 28 30 30913 966200 -83.14 -154.93  
S2.8 1 100 94.1 50 24 26 24 26 30864.1 957700 -65.10 -147.11  
S2.9 1 100 95 59 30 11 20 39 31303.3 1012900 -55.86 -147.61 31, 8 
S2.10 1 101 95 61.4 22 17 29 33 31250.2 965100 -84.14 -173.38 11 
S2.11 1 100 95 57 22 21 29 28 30821 944200 -90.75 -159.33 6 
S2.12 1 100 95 58 22 20 35 23 30605.8 927200 -88.91 -159.58  
S2.13 1 100 95 63 18 19 27 36 31015 944200 -91.63 -178.70 12, 21 
S2.14 1 100 95 60 21 19 30 30 30847 941800 -78.03 -159.16 20 
S2.15 1 100 94.6 52 26 22 27 25 30812 958800 -79.45 -151.21 9 
S2.16 1 100 95 58 21 21 28 30 30877 941800 -100.83 -184.14  
S2.17 1 100 95 59 25 16 29 30 30898 959300 -80.92 -151.50 12 
S2.18 1 100 95 59 24 17 29 30 30889 956000 -85.19 -168.53  
S2.19 1 100 95 62.5 21 16 27 36 31021.8 956500 -92.68 -180.25 38 
S2.20 1 100 95 55 22 23 26 29 30891 949900 -73.26 -153.76 10 
S2.21 1 100 95 59 17 24 28 31 30866 926200 -94.06 -168.82  
S2.22 1 100 95 61 23 16 27 34 31010.1 961900 -89.24 -167.28 16 
S2.23 1 100 95 55 24 21 26 29 30909 962100 -79.62 -167.57 15 
S2.24 1 100 95 62 22 16 24 38 31146.2 969100 -88.07 -182.67 18, 20 
S2.25 1 100 95 61 18 21 28 33 30925 941700 -85.77 -174.56 11 
S2.26 1 100 95 56 24 20 23 33 31054.2 972800 -66.99 -145.18 17 
S2.27 1 100 95 60 21 19 27 33 30967 954300 -76.94 -163.55 11 
S2.28 1 100 95 55 23 22 31 24 30699.9 941500 -69.66 -157.74  
S2.29 1 100 95 59 25 16 30 29 30858 957200 -83.68 -164.10 19 
S2.30 1 100 95 56 20 24 34 22 30577.8 915500 -60.00 -135.73 12 
S2.31 1 100 95 61 23 16 27 34 31010.1 961100 -80.04 -156.94 11 
S2.32 1 100 95 55 26 19 29 26 30807 955000 -67.36 -145.73  
S2.33 1 100 95 55 20 25 24 31 30953.1 949700 -76.15 -159.41  
S2.34 1 100 95 58 19 23 29 29 30818.9 931500 -68.62 -156.73 12 
 
Table 6.4. Data for the thirty-five sequences isolated from the 8th round of SELEX Method II with 
flanking single primer sequences. Sequences are shown in order of frequency of observation. 
Sequences with more than one QGRS predicted sequence are shown with two QGRS scores. The 5’ 
putative quadruplex-forming sequence is shown first. Sequences with more than one PHOS/BOT 
sequence were truncated to 100 nt. 
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Unlike the sequences from SELEX Method I, the sequences displayed in Tables 6.3 and 6.4 
show very little diversity in sequence length. Sequence S2.10 has acquired an insertion of 1 nt. This 
may be due to directed molecular evolution or a misreading of the sequencing data. Although anal-
ysis of individual sequences yielded interesting insights to the composition of the selected pool of 
molecules, collective analysis of the group of sequences could yield additional information. 
6.2. Collective Alignment Analysis of Selected Sequences 
 Multiple sequence alignments allowed trends in the population of evolved molecules from 
both SELEX Methods to be observed. Sequences were aligned using Geneious R8 software 
packages. Sequences were aligned with and without the flanking primer regions. Alignments 
revealed the highly conserved nature of the primer regions. Sequences from SELEX Method I were 
of different lengths. Alignment parameters were chosen which would allow sequences of different 
lengths to be compared (low gap formation penalty). Comparative analysis of the 24 sequences 
revealed that in all but one case the nucleotide immediately downstream of the reverse primer 
sequence was a G and in all but one other case the nucleotide immediately upstream of the forward 
primer complement sequence was a T. Both exceptions were C residues. 
The alignment patterns of sequences isolated form SELEX Method I are shown in Fig 6.1A, 
and sequences from SELEX Method II are shown in Fig 6.1B. SELEX Method I yielded a 
population of molecules with variable lengths but highly similar nucleotide patterns at the 5’ and 3’ 
ends of the variable central nucleotide regions. This would indicate that this particular configuration 
of nucleotides gave the evolving sequences some kind of selective advantage. This could include 
either increased fitness of replication or binding (or both). It also implied that the sequences were 
somehow related. The sequencing and primer walking experiments described in Fig 3.7 and Fig 3.8 
demonstrated that the terminal random nucleotides of the original random pool were unbiased. These 
nucleotides had therefore become more homogeneous in response to the selective pressure of 
SELEX. 
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A. 
B. 
Figure 6.1. Nucleotide sequence alignments of selected oligonucleotides from both SELEX Methods. 
A. The consensus and identity measurements of the selected twenty-four sequences from SELEX 
Method I. The consensus shows the most popular nucleotide at any position (including no nucleotide). 
Identity measurements were shown in green for 100% similarity. Sequences are shown 5’ to 3’ and the 
5’ 20-mer reverse primer and 18-mer forward primer complement are shown. B. The thirty-four 
sequences isolated from SELEX Method II. The 5’ 25 mer TOP primer and the 3’ 25 mer BOT primer 
were also identified. In both cases, G is shown in yellow, A in red, C in blue and T in green. Nucleotides 
are identified with standard International Union of Pure and Applied Chemistry (IUPAC) notation. 
Primer sequences in brackets. The sequence of the SELEX primers corresponding to the above 
indicated positions are: 
a   5’CGCAAGCATAAAGTGTAAAG 3’   Reverse primer 
b   5’ACTTTCACCAGCGTTTCT 3’   Forward primer inverse complement 
c  5’GCGACCCAAGGAATTCTGCTGAAGG 3’ Top Primer 
d 5’CATCGTACCGGATCCGTCACCAGCC 3’  Bot Primer inverse complement 
 
 
 
 
a
. 
b
. 
c
. 
 a
. 
d
. 
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 In addition to the alignments, similarity of each sequence to each other sequence was meas-
ured. Alignments were performed using only the central nucleic acid sequences without the flanking 
primer regions. These similarity values were made into a matrix. The matrix for the selected se-
quences from SELEX Method I is shown in Fig 6.2 and the sequences from SELEX Method II are 
shown in Fig 6.3. The similarity matrix for SELEX Method I highlighted the similarity of sequence 
2 and sequence 13 as these sequences only differ by one nucleotide. Sequences 19 and 23 showed 
64% similarity. Both these sequences were very short, with 9 and 11 nucleotides respectively. Be-
sides these exceptions, no other sequences exceeded 60% similarity.  In Fig 6.3, the highest sequence 
similarities were observed between sequences 14 and 20 (46%), sequences 9 and 24 (45%) and 
sequences 8 and 19 (43%). No sequences from SELEX Method II exceeded 46% similarity. 
 Using the data from Fig 6.1A, it was possible to design a primer-walking experiment. Pri-
mers were designed which would amplify molecules which shared the 5’ and 3’ conserved nucleo-
tide patterns in the selected pool of molecules from SELEX Method I. Primer sets were designed 
(F1A, F2, F3, R1G R2 and R3) where one primer would be the standard unselective SELEX primer 
and the other would be selective. The selective primer sequences were shifted 1, 2 or 3 nucleotides 
into the central region. Positive unselective PCR amplification of the selected pool was performed 
alongside no template PCR controls. Fig 6.4A shows the modified sequence primers with a positive 
integer indicating how many nucleotides the sequence has shifted. The original SELEX primers are 
also shown. Selective 3’ nucleotides are shown in red. Fig 6.4B demonstrates that gradually increas-
ing the selectivity of the primers decreased the amount of smearing seen on the gel. Symmetric PCR 
using the unselective SELEX primers (lane 5) gave the characteristic smearing of PCR products. 
Increasing the selectivity of either primer decreased the apparent molecular weight of the PCR prod-
ucts produced. The effect was more apparent with the forward primer (lanes 6, 7, and 8). A similar 
experiment could not be performed with the products of SELEX Method II as a similar nucleotide 
consensus was not observed. 
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 Forward primers (18 nt) Reverse primers (20 nt) 
 
F 5’ AGAAACGCTGGTGAAAGT 3’ 5’ CGCAAGCATAAAGTGTAAAG 3’ R 
F1A 5’ GAAACGCTGGTGAAAGTA 3’ 5’ GCAAGCATAAAGTGTAAAGG 3’ R1G 
F2 5’ AAACGCTGGTGAAAGTAC 3’ 5’ CAAGCATAAAGTGTAAAGGG 3’ R2 
F3 5’ AACGCTGGTGAAAGTACA 3’ 5’ AAGCATAAAGTGTAAAGGGA 3’ R3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
 1         2        3        4          5        6        7         8         9         10 
M     R1G     R2     R3        ±       F3       F2    F1A      M      NTC 
20bp 
100bp 
200bp 
300bp 
Figure 6.4. Primer walking experiments on the selected pool of molecules from SELEX Method I. A. The 
unmodified SELEX primers from SELEX Method I and the modified primers designed to amplify sub-populations 
of the selected pool of molecules from the 15th round of SELEX. Selective nucleotides are shown in red. B. 2% 
(w/v) agarose gel stained with ethidium bromide. Showing in Lane 1) O’range 20 bp DNA ladder supplied by 
Thermo Fisher; 2, 3, 4) Symmetric PCR product where the reverse PCR primer has been shifted 1, 2 and 3 
nucleotides respectively. 5) Positive PCR control with unmodified SELEX primers. 6, 7, 8) Symmetric PCR 
product where the forward PCR primer has been shifted 3, 2 and 1 nucleotides respectively. 9) O’range 20 bp 
DNA ladder supplied by Thermo Fisher. 10) NTC. All are 5 μl loadings. 
 
 
 
 
40bp 
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6.3. Selection of Sequences for Confocal Microscopy 
Oligonucleotide sequences were selected for further analysis. This selection was based on 
a number of different criteria. The modal sequences from SELEX Methods I & II were 
chosen for analysis. This was done as sequences with higher frequencies of observation 
were more abundant in the selected pool (assuming an unbiased selection process). 
Sequences which formed a higher proportion of the selected pool of molecules would 
therefore be “fitter” than sequences which only appeared infrequently. This fitness may 
represent either high binding affinity to the target cells or higher replicative ability. In 
addition, multiple copies of the same sequences from different observations verified 
sequence fidelity. Recent advances in next generation sequencing (NGS) combined with 
new computer programmes (FASTAptamer) automatically rank millions of NGS reads 
according to frequency. These new programs also calculate the Levenshtein distance 
between every single sequencing read and combine these to find seed sequences in large 
sample sizes (Levenshtein, 1966; Alam, & Burke, 2015). This technology allows millions 
of sequencing results to be compared. 
 The second criterion by which sequences were selected for further analysis was 
sequence read quality. Any sequences with ambiguous sequencing results were eliminated. 
Sequences with the highest quality sequencing reads were chosen for further analysis. This 
was done to ensure that the molecules synthesised for further experimentation were truly 
representative of the sequences found in the evolved pool of molecules. 
 A number of control experiment sequences were also chosen. These sequences acted 
in contrast to the evolved oligonucleotide sequences. The fluorophore used in the confocal 
microscopy experiments was HEX, as this molecule was present in SELEX Method II and 
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it has a sufficiently high quantum yield. It was therefore necessary to perform control 
experiments to determine that all 5’-HEX labelled oligonucleotides do not bind to cells. The 
25 nt 5’-HEX-labelled primer was one of the oligonucleotides chosen to act as a control. 
The randomised starting pool of HEX-labelled oligonucleotides from SELEX Method II 
was the second control experiment. This was done to compare the evolved sequences to the 
progenitor molecules from which they were evolved. This was also done to ensure that all 
100 nt 5’ HEX-labelled oligonucleotides do not exhibit cell binding activity. This also 
demonstrated that any cell binding observed was an evolved characteristic. Finally a single 
sequence taken from the initial unevolved pool of oligonucleotides was taken and used as 
an additional non-binding control experiment. As each round of SELEX from SELEX 
Method II was sequenced, each was given a number between 1 and 8. The sequencing of 
the initial randomised pool was given the name Round 0.  
In addition to these negative control experiments, a number of positive control 
experiments were performed. Sequences were taken from published work of other research 
groups. These have a reported affinity to E.coli cells. The first, (named Oligo K) was taken 
from a Korean group. This was a 45 nt ssDNA sequence with a published KD of 12.4 nM 
when binding to E.coli. The strains of E.coli used by this group were taken from the Korean 
Collection for Type Cultures (KCTC 2571) (Kim et al. 2013; Kim et al. 2014). The second, 
(named Oligo J) positive control sequence was a G-rich 24 nt sequence from a research 
group collaboration between Tokyo and Brighton. This sequence had a reported affinity to 
E.coli NSM59 (KD = 110 nM) and a lesser affinity to E.coli DH5α (KD = 880 nM) (Savory 
et al. 2014). Both these positive control sequences were synthesised alongside the selected  
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Name  Sequence (5’ to 3’) 
Negative control sequences. 
HEX 
Primer 
5’ HEX GCGACCCAAGGAATTCTGCTGAAGG 
HEX Pool 5’ HEX GCGACCCAAGGAATTCTGCTGAAGG (N)50 CATCGTACCGGATCCGTCACCAGCC 
Round 0 5’ HEX ACAAGAACACTATTTGCTGACGCAACGTGCGGAGGATTTCTCGGGAGCGG 
Fluor  
control 
5’ FAM CCAAAAGCACCACACACCCCACGCAAAAACAAGTTTTTGCTATTTTCTTTATA 
Evolved sequences SELEX Method I 
Oligo 3.1 5’ HEX CGCAAGCATAAAGTGTAAAGGGTATGGGTGCCGTTACAGTGTGGGGTATGCCTGTGT 
Oligo 3.1a - ACACAGGCATACCCCACACTGTAACGGCACCCATACC 
Oligo 3.1s 5’ HEX ATCCGGGTGGGTTTGGGGTTTGAGGTACGAGGTTTCC 
Oligo 3.2 5’ HEX CGCAAGCATAAAGTGTAAAGGGAACACGGCGTGATTGCGGCCT 
Oligo3.2a 5’ HEX AGAAACGCTGGTGAAAGTAGGCCGCAATCACGCCGTGTTCC 
Evolved sequences SELEX Method II 
Oligo 4.1 5’ HEX GGACCCGCCAGGTTCAGGGCAGAGGTTTGTAGCGACGAAGTACGCCGCAA 
Oligo 4.1s 5’ HEX CTCCAAGCGCCTCTTGGTGCGAAAGGGAGCAAGCGGGGTGAGACATAGCC 
Oligo 4.2 5’ HEX GGGAAGCATGCTATCTTTGGACGCGTCGGAGACACGACTGCGTCTCTTGC 
Oligo 4.2s 5’ HEX CGTACCTGGTCGGTGGTTCATGCGTCCGGATAATCGGTTCAACCGGCAAG 
Oligo 4.3 5’ HEX TCAACTTTCTCACTGTACAGAATGGGGATAGTTTATGCGGGTTTTGTAAG 
Oligo 4.3s 5’ HEX TTAAGGTGAGGTCCATGGGACGTCACTATTATTTAGAAGCATTTCTGTGT 
Oligo 4.4 5’ HEX GCGCTACGTTGATGGCCCTTTGAGAGGGCCTCGTAGTGAAAATTGCTGGC 
Oligo 4.4s 5’ HEX AAGGGTGGTGTGCCCTACCTTAGTACCGGCTGTGTATGGTCGACGAGATC 
Positive control sequences 
Oligo K 5’ HEX ACTTAGGTCGAGGTTAGTTTGTCTTGCTGGCGCATCCACTGAGCG 
Oligo Ks 5’ HEX GTGCGTCGTCGATAGTTAGCATGTGGTGCATCGGCTTCCGTCAAT 
Oligo J 5’ HEX GGCATAGCTGCCGGGAGGGGGGGG 
Oligo Js 5’ HEX GGGCAGGGAGGGGCGCTGTAGCGG 
Table 6.5 The sequences taken forward to be analysed by laser scanning confocal microscopy (LSCM). 
“HEX Primer” and “HEX Pool” are taken from Table 2.4. “Round 0” is a sequence taken at random from 
SELEX Method II initial pool. “Fluor control” was donated by Dr Darren Gowers. “Oligo 3.1 and 3.2” 
are taken from Fig 3.16 B. “Oligos 4.1, 4.2, 4.3, and 4.4” are shown in Fig 4.11A. “Oligo K” is taken from 
(Kim et al. 2013) and “Oligo J” is taken from (Savory et al. 2014). All other oligos are complementary or 
scrambled sequences. 
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sequences from SELEX Method I & II. A table of oligonucleotides synthesised for confocal 
microscopy is shown above. Each of the evolved sequences used in confocal microscopy (Chapter 
7) also had a “scrambled control”. These had the same G, A, T & C composition but the nucleotides 
were rearranged in a random order. This was done to determine that the observation of binding is 
due to the sequence-specific formation of structures by the putative aptamers. Sequences were 
scrambled using an online webserver. The scrambled control oligonucleotides are noted with an “s” 
after the sequence name. Another set of control oligonucleotides were the “annealing” control 
oligonucleotides. The structure of a ssDNA molecule can be disrupted and changed by annealing 
complementary strands to the sequence making dsDNA. These control oligonucleotides were 
annealed to the evolved strands and the duplex molecules were used in confocal microscopy 
experiments to determine if binding had been diminished. Oligonucleotides designed to anneal to a 
sequence were noted with an “a” after the name.The previously published oligonucleotides were 
also scrambled. The 45-mer was named Oligo K and the 25-mer was named Oligo J. A Fluorescein 
control was also used. This oligonucleotide was used to observe the effects of different LASER 
wavelengths on cells. It also acted as another non-binding control fluorescent sequence. Sequences 
were synthesised with 5’ primer regions for SELEX Method I and with no flanking primer regions 
for SELEX Method II. This was done primarily because shorter sequences reduce the number of 
synthesis by-products and give higher purity and also to reduce the cost of synthesis. All these 
sequences were synthesised by either ADTBio, Eurogentec or Invitrogen with as high purity as 
possible (Selective Precipitation Optimized Process (SePOP), Reversed phase high purity liquid 
chromatography (RP-HPLC) or Polyacrylamide Gel Electrophoresis (PAGE) purification methods 
were used.) Mfold structural predictions were performed for all sequences and a selection are shown 
in Fig 6.5. Many SELEX papers include mfold structural predictions for selected sequences (Song 
et al.2011; Suh et al.2014). A 15% (w/v) N-PAGE gel showing the annealing of Oligo 3.1 and Oligo 
3.1a is shown in Fig 6.6. Annealing was performed in 0.1 × PBS using 5 μM solutions of each 
oligonucleotide.  
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Figure 6.5. A selection of mfold structural predictions. Mfold structural predictions were performed using 
Vienna webservers. The Matthews 2004 DNA model was used. MFE structural prediction was selected and the 
theoretical temperature was set to 25 ˚C. 
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Figure 6.6. Annealing of complementary oligonucleotides. 15% (w/v) N-PAGE stained with SYBR Gold showing 
in lane 1) A 2 μl loading of 5 μM Oligo 3.1 in 0.1 × PBS (133 ng) 2) A 2 μl loading of 5 μM Oligo 3.1a in 0.1 × 
PBS (90 ng). 3) A 2 μl loading of 2.5 μM annealed Oligo 3.1/Oligo3.1a duplex in 0.1 × PBS (110 ng). Marker 
lane was run on the same gel but not adjacent to lanes 1,2 and 3. Lane M) NEB low range DNA ladder. 
 Marker is lowmvpsv 
 
 
 
 
 1           2            3   
Oligo 3.1 
Oligo 3.1 / 3.1a 
duplex 
Oligo 3.1a 
50 bp 
100 bp 
 M   
25 bp 
766 bp 
200 bp 
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Chapter 7: Binding Analysis of Radioactively and 
Fluorescently Labelled Oligonucleotides 
The purpose of this chapter was to analyse the binding of labelled oligonucleotides to live E.coli 
HB101: pAT153 cells. In all cases where the term E.coli HB101 is used in this chapter, the cells 
are transformed with the pAT153 plasmid (E.coli HB101: pAT153). Binding analysis was 
performed using laser scanning confocal microscopy (LSCM) of fluorescently labelled 
oligonucleotides and living cells. A second method used radiolabelled single DNA strands. 
 LSCM has previously been used to analyse the binding of selected aptamers against 
breast cancer cells (Li et al. 2014) and lung cancer cells (Kunii et al. 2011). LSCM has also been 
used in the analysis of aptamer binding to prokaryotic cells, including Listeria. sp (Suh et al. 
2014) and Escherichia coli (Kim et al.2013). These experiments are sometimes, but not always 
coupled with a more quantitative form of analysis. Flow Cytometry would be an example of a 
common quantitative technique used to analyse fluorescent aptamer binding (Meyer et al. 2013). 
Radiolabelled nucleic acid assays are more common in RNA-SELEX experiments; examples 
include the selection of RNA aptamers against Shiga toxin (Challa et al. 2014) and Ricin 
(Hesselberth et al. 2000). 
7.1. Sample Preparation  
Cultures of E.coli HB101:pAT153 and DH5α (containing no plasmid) were prepared by taking 
colonies from LB agar plates and inoculating LB broth under aseptic conditions. These cultures 
were incubated with agitation at 37 ˚C until the culture reached an optical density of 0.45 at 600 
nm. The cells from 1 ml of culture were then harvested by centrifugation (8,000 g for 3 mins). 
These cells were used in aptamer binding assays. 
Oligonucleotides were prepared by diluting fluorescently labelled oligonucleotide stock 
solutions (at 10 μM, 50 μM or 100 μM) to a desired concentration (typically between 0.05 μM 
and 30 μM). DNA sequences evolved during SELEX Method I (Oligo 3.1 and 3.2) were 
resuspended and diluted into water as this was the medium in which SELEX was performed. 
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DNA sequences from SELEX Method II were resuspended in water and later made up to a final 
concentration of 1 × PBS as this was the medium in which SELEX Method II was performed. 
Binding experiments using Oligo J were performed in 1 × TBS as this was the medium of binding 
and SELEX in the published paper (Savory et al. 2014) and Oligo K binding experiments were 
performed in 1 × PBS (Kim et al. 2013).  
All oligonucleotide solutions were thermally equilibrated by heating the samples to 95 
˚C for 5 minutes; samples were then allowed to cool slowly. Complementary oligonucleotide 
sequences were also mixed in equimolar quantities and annealed to create duplex DNA 
molecules in solution (as described in section 2.16). These oligonucleotide solutions were used 
to resuspend the cell pellets taken from liquid cultures described above. Cells were gently and 
fully resuspended by pipetting (LB E.coli culture OD600nm= 0.45  ≈ 107 cells /ml) (Sezonov & 
D’Ari, 2007). Cells were initially incubated with oligonucleotides for ten minutes at room 
temperature with gentle agitation; however, this was later extended to forty minutes as this gave 
greater fluorescent signal strength. 
 Initially, the volume of fluorescent oligonucleotide solution used to resuspend the cells 
was 100 μl. This was later reduced to 10 μl as similar results were attained while much less 
oligonucleotide was required. Following incubation, cells and supernatant were separated by 
centrifugation (8,000 g for 3 mins). Cells were resuspended, and washed in 100 μl of buffer 
(Water, 1× PBS or 1 × TBS). The cells were centrifuged again and the wash was removed. The 
cells were resuspended in a different volume of buffer depending on the method of analysis.  
The results of these fluorescent aptamer binding reactions were analysed by LASER 
scanning confocal microscopy (LSCM). For this method the washed cell pellet was resuspended 
in 10 μl of the appropriate binding buffer. A 7 μl sample of this cell suspension with fluorescent 
bound fraction was placed onto a clean glass microscope slide and covered with a cover slip. 
The edges of the clover slip were then sealed with nail varnish. These were then taken 
immediately for LSCM. The majority of cell binding experiments were done using this 
technique. 
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7.2. Laser Scanning Confocal Microscopy Setup 
Microscope slides were viewed using a Zeiss 710 confocal microscope. A combination of bright-
field, white light and laser scanning microscopy was used. Bright-field microscopy was used to 
observe cells and fluorescence was observed using laser light. A 514 nm LASER was used to 
observe HEX fluorescence; this was combined with a 536 nm filter. Fluorescein was observed 
using a 488 nm LASER with a 512 nm filter. Images were acquired using ×40, ×63 and ×100 
objective lenses. LASER intensity was limited to prevent the 5 W argon-ion LASER overheating 
and damage to the samples. Image averaging was used so that each image was a combination of 
up to 16 individual readings. White light intensity was adjusted to correspond to the objective 
lenses. Lenses with higher magnifying power focus on a smaller area, meaning less white light 
enters the microscope. White light intensity was therefore increased with magnifying power to 
ensure that the E.coli cells remained visible. For the ×40, ×63 and ×100 objective lenses oil 
immersion light microscopy was used. Fresh immersion oil was applied directly to the coverslip.  
A number of z-stack and time-course experiments were performed. For these the z-
dimension depth of field was controlled by the pinhole aperture. The z-dimension field of view 
(for LASER pathway detection) was set to be 1 μm. The length in μm of the x and y dimensions 
of the field of view were also recorded in all cases. Z-stack experiments were performed by 
picking focus points above and below the optimal cell focus. The microscope then proceeded to 
take image slices every 1 μm through the sample, and these were then accumulated to create 3D 
images. Time-course experiments were set up by focusing the microscope and images were 
taken every second. All these images were recorded as .lsm files and viewed using ZEN 
software, LSM image browser or image J (2.17). Processed images were then exported as 16-bit 
.tif image files. The emissions observed with HEX fluorescence were false coloured magenta. 
The emissions observed with Fluorescein fluorescence were false coloured green. 
7.3. Laser Scanning Confocal Microscopy  
7.3.1. Negative Control Experiments 
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A number of experiments were performed to ensure firstly that the untreated E.coli cells alone 
did not produce any kind of fluorescent signal. These experiments were also used to eliminate 
the possibility that the cells would scatter light and create a false positive result. Cells were 
harvested as described above, cells were centrifuged and washed (no fluorescent oligonucleotide 
was added). These untreated live cells were viewed to ensure that no auto-fluorescence occurred. 
Negative control experiments were performed on the strains HB101: pAT153 and DH5α both in 
water, TBS and PBS. 
 Bright-field, z-stack confocal microscopy of E.coli HB101: pAT153 in water (Fig 7.1A) 
and in PBS (Fig 7.1B) was performed. No auto-fluorescence was observed. Similar experiments 
were performed on the DH5α and JM109 strains. Both the 488 nm and 514 nm LASER 
frequencies were used. In all cases no fluorescent signal was observed. These control 
experiments also demonstrated that in all buffers the cells remained intact during the 
oligonucleotide binding procedure. Z-stacks were performed to determine the optimal focal 
plane. If no fluorophores are present then the LASER light will not red-shift in frequency 
because it is reflected by the filter away from the detector. Only LASER light which is shifted 
to beyond 536 nm reaches the detector and produces a signal. As no fluorophore was present, 
no signal was detected. As the Z-stack function takes a series of images over time, it was possible 
to observe some cell motility as each image was taken.   
 Having established that the cells did not auto-fluoresce, the next step was to proceed to 
treating the cells with non-binding fluorescently labelled molecules. The first molecules to be 
assessed in this way were the initial library of randomised HEX-labelled oligonucleotides and 
the single sequence taken from the sequencing of the initial naïve pool of sequences. E.coli 
HB101: pAT153 cells were prepared as described above and were incubated with 1 μM, 10 μM 
and 30 μM concentrations of HEX-labelled oligonucleotides. Results from these binding 
experiments  
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 Figure 7.1 LSCM negative control experiments. A. A sample of E.coli HB101 in water, viewed with a 514 
nm LASER and bright field microscopy B. A sample of E.coli HB101 in 1× PBS, viewed with a 514 nm 
LASER and bright field microscopy. In both cases fluorescence signal is shown in magenta and bright-field 
signal is shown in grayscale. x and y = 85.02 μm, z = 3.7 μm. The × 100 objective was used. (× 1000 total). 
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are shown in Fig 7.2. For these experiments the × 40 objective was used, giving a greater field 
of view (212.55 μm2). This was done to increase the number of cells viewed at any one time. 
Fig 7.2A shows a binding experiment with E.coli HB101 and 10 μM of the “Round 0” unevolved 
HEX-labelled oligonucleotide (Sequence named “Round 0” in the negative control sequences 
section of Table 6.5). The harvested cells were stained with the oligonucleotide in PBS for 40 
minutes. These cells were then washed and viewed using LSCM. Fig 7.2A shows no localised 
staining of E.coli cells. A similar result was found for cells stained with the 100 nt random pool 
of oligonucleotides (Table 2.4) (10 μM shown in Fig 7.2B) (Sequence also shown in the negative 
control sequences section of Table 6.5). Although no staining of cells was observed at 1 μM, 10 
μM or 30 μM, increasing the concentration of the fluorophore did increase the amount of 
background fluorescence. This background signal was not localised to the cells but was 
distributed evenly across the field of view. These experiments demonstrated that the “naïve” 
unevolved molecules do not appear to interact with the living E.coli. The homogeneous single 
sequence “Round 0” does not appear to bind to cells, and neither does the heterogeneous pool 
of sequences “Random pool”. This indicates that any strong binding should not be an inherent 
characteristic of the initial pools, but as the result of directed molecular evolution. Following on 
from these “naïve” sequence experiments the HEX primer experiments were performed. A 
binding interaction was performed as described above with the HEX-labelled primer (10 μM). 
Again, no binding was observed (Fig 7.3A). The final negative control experiment was the 
“Fluor control”. The sequence of this fluorescently labelled ssDNA molecule is shown in Table 
6.5. As this molecule contains a different fluorophore it was viewed sing a different LASER and 
filter combination. Fluorescence from these fluorophores was displayed with green false 
colouring rather than the magenta used for HEX. As with the previous experiments no cell 
specific binding was observed (Fig 7.3B). Having concluded the negative control experiments, 
it was determined that all the strains of cells in all the possible binding buffers did not auto-
fluoresce. It was also demonstrated that fluorescent oligonucleotide molecules which had not 
been subjected to directed molecular evolution did not appear to bind to cells. These “naïve”   
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Figure 7.2 LSCM negative control experiments. A. E.coli HB101 in PBS stained with 10 μM HEX-labelled 
“Round 0” oligonucleotide, viewed with a 514 nm LASER and bright field microscopy B. E.coli HB101 in 
PBS stained with 10 μM HEX-labelled “Random pool” oligonucleotides, viewed with a 514 nm LASER 
and bright field microscopy. In both cases fluorescence signal is shown in magenta and bright-field signal 
is shown in grayscale. x and y = 212.55 μm, z = 10 μm. The × 40 objective was used. (× 400 total). 
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Figure 7.3 LSCM negative control experiments. A. E.coli HB101 in PBS stained with 10 μM HEX-labelled 
primer viewed with a 514 nm LASER and bright field microscopy. Fluorescence is shown in magenta B. 
E.coli HB101 in PBS stained with 10 μM Fluor-labelled oligonucleotide viewed with a 488 nm LASER and 
bright field microscopy. Fluorescence is shown in Green. In both cases bright-field data are shown in 
greyscale. x and y = 212.55 μm The × 40 objective was used. (× 400 total). 
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sequences were the HEX-labelled original library of molecules, the single sequence taken from 
the original library of molecules, the HEX primer and the Fluor control sequence. None of these 
sequences demonstrated any affinity to the E.coli. Following this, the evolved sequences from 
SELEX Method I were tested. 
7.3.2. LSCM Analysis of Evolved Sequences from SELEX Method I 
The most abundant sequence from the 15th round of SELEX Method I (Fig 3.16) was given the 
name Oligo 3.1. The second most frequently observed sequence was given the name Oligo 3.2. 
These sequences were synthesised alongside scrambled sequences (Oligo 3.1s) and 
complementary oligonucleotides designed to anneal to the putative aptamer sequences to disrupt 
the structure (Oligo 3.1a and 3.2a). LSCM binding experiments were performed at a range of 
concentrations. As SELEX Method I was performed using water as the binding medium, these 
experiments were also performed in water in order to match the conditions under which the 
putative aptamers were raised. Oligo 3.1 contained the 37 nt selected sequence with the 20 nt 5’ 
reverse primer sequence resulting in a 57 nt sequence with a 5’ HEX modification. Binding 
experiments were performed at 50 nM, 250 nM, 500 nM, 1 μM, 5 μM, 10 μM, 20 μM and 30 
μM concentrations of fluorescent oligonucleotide. Experiments were performed using E.coli 
HB101 cells prepared as described above. Fig 7.4 shows the results of an Oligo 3.1 (10 μM) 
binding experiment in water using E.coli HB101. As confocal microscopy allows focusing of 
LASER light onto very narrow focal planes the best confocal images of these live bacterial cells 
were gained when the cells were aligned onto a 2D plane orthogonal to the z-dimension. These 
could be the upper cover slip or the lower glass slide. The free bacterial cells were not fixed, so 
being suspended in water were able to move with pedesis or convection currents; these could be 
caused by the movement of the glass slide or pressure applied by the oil immersion objective 
lenses. Bubbles would occasionally form between the upper and lower glass surfaces. Fig 7.4 
shows that Oligo 3.1 stained all E.coli HB101 cells in this field of view. Fig 7.5 shows the same 
binding conditions, but with a lower magnifying objective used to increase the number of cells 
in the field of view. Fig 7.5 also used a z-stack to find the optimal focal plane. 
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Figure 7.4 LSCM imaging of Oligo 3.1 co-localised to E.coli HB101 in water. This combined image shows 
bright field data in grayscale and fluorescent signal is shown in magenta. x and y = 85.02 μm. A 514 nm 
LASER was used in combination with a 536 nm filter. The × 100 objective was used. (× 1000 total). 
 
 
 
 
E.coli 
HB101 
cell 
Water Air bubble 
y 
10 μM 
HEX 
Oligo3.1 
E.coli 
HB101 
Water 
 189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
y 
z 
Figure 7.5 LSCM imaging of Oligo 3.1 co-localised to E.coli HB101 in water. This combined image shows 
bright field data in grayscale and fluorescent signal is shown in magenta. A 514 nm LASER was used in 
combination with a 536 nm filter. x and y = 212.55 μm, z = 22 μm. The × 40 objective was used. (× 400 
total). 
 
 
 
 
10 μM 
HEX 
Oligo3.1 
E.coli 
HB101 
Water 
 190 
 
Auto-fluorescence and HEX-mediated non-specific binding having been eliminated, 
Oligo 3.1 exhibited cell-specific co-localisation at 10 μM staining concentration. From this 
observation, two additional experiments were performed to establish that the binding was 
dependant on the sequence of the oligonucleotide and the structure of the molecule. The first of 
these experiments involved disrupting the sequence of the nucleobases monomers within the 
polymer. Thus Oligo 3.1s was a scrambled version of the binding section of Oligo 3.1 (Oligo 
3.1s Table 6.5). Fig 7.6A shows the LSCM results of a binding experiment using the scrambled 
Oligo 3.1 (10μM). Reordering the sequence of nucleobases in the oligonucleotide appears to 
completely inhibit the ability of the molecule to co-localise to the E.coli HB101 cells.  
The second control experiment disrupted the structure of the ssDNA molecule by 
annealing a complementary nucleic acid sequence in order to make dsDNA. Oligo 3.1a (Table 
6.5) is complementary to the formally random region of Oligo 3.1. Equimolar quantities of these 
molecules were annealed together. A binding reaction was performed using a 10 μM solution of 
incomplete duplex molecules. (Oligonucleotides were annealed in 0.1 × PBS and were purified 
using GE microspin columns, and buffer was exchanged into water for the binding reaction.) 
Results from the Oligo 3.1 – Oligo 3.1a complex are shown in Fig 7.6B. These control 
experiments demonstrate that localisation of Oligo 3.1 to E.coli HB101 cells can be disabled by 
scrambling the sequence of nucleobases and annealing complementary oligonucleotides. This 
demonstrated that cell localisation is a characteristic of the single-stranded aptamer sequence 
alone. 
 Oligo 3.1 was able to stain every cell within a field of view (Fig 7.4 and Fig 7.5). A 
fluorescence quantification method was devised which would allow the fluorescence signal 
(measured in fluorescence pixel intensity per cell) from every cell in a field of view to be 
counted. This method of fluorescence quantification is described in Fig 7.7. Mean fluorescent 
pixel intensity per cell increased with the concentration of Oligo 3.1 used in the staining 
procedure.  
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Figure 7.6 LSCM imaging of inactivated Oligo 3.1 and E.coli HB101 in water. A. Bacterial cells stained 
with 10 μM Oligo 3.1s. x and y = 212.55 μm, z = 18 μm.  B. Bacterial cells stained with 10 μM Oligo 
3.1 –Oligo 3.1a complex. x and y = 212.55 μm. This combined image shows bright field data in grayscale 
and fluorescent signal is shown in magenta. A 514 nm LASER was used in combination with a 536 nm 
filter. The × 40 objective was used. (× 400 total). 
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Figure 7.7 Fluorescence Quantification of LSCM images. (Example image Oligo 3.1, 10 µM concentration) 
A. 
The original multi-channel LSCM z-stack image (.lsm file) Example data showing Oligo 3.1 at 10 µM with 
E.coli HB101: pAT153. 
B. 
A single focal plane from the z-stack image was selected and the fluorescence channel (Channel 1) was 
extracted to a new file. The new file was “de-speckled” to remove background pixels. 
C. 
Using ImageJ, the threshold parameters were set. These identify the background, unstained cells and stained 
cells according to fluorescent intensity. 
D. 
The “Analyse particle” function was used to identify all regions of fluorescent intensity that fall between 
the previously identified thresholds. Only particles with an area between 2 and 10 μm2 are selected. This 
removed cell clusters and cell fragments. 
E. 
The selected particles were compared back to the original image to ensure they represented a fair proportion 
of the stained cells with a clear range of intensity. Thresholds were adjusted until a representative sample 
was identified. 
F. 
The mean intensity of the fluorescent pixels within the area of each cell was quantified. A large number of 
cells may be quantified in a single count. In this example image 713 cells were quantified. Each counted 
cell is given a number, an area, an average fluorescent pixel intensity, a minimum pixel intensity and a 
maximum fluorescent pixel intensity. Examples of generated data are shown (706 -713). 
G. 
Using this technique, mean fluorescent pixel intensity measurements were made for LSCM images from a 
range of concentrations of Oligo 3.1. Over 200 individual cells from multiple experiments were quantified 
for each concentration. The Mean fluorescent pixel intensity per cell was plotted as a function of [Oligo 
3.1]. Error bars indicating 2 σ around the mean are also shown. 
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 Oligonucleotide 3.2, the second most abundant sequence from SELEX Method I, did 
not localise to E.coli HB101: pAT153 cells. A very small proportion of the cells stained with 
Oligo 3.2 gave a small fluorescent signal. This may indicate that Oligo 3.2 required the 3’ 
flanking forward primer complement in order to bind to cells. It may also mean that Oligo 3.2 
only binds to a specific site on the E.coli cell surface, so only low intensity fluorescence per cell 
would be observed (Fig 7.8A).  
Binding experiments were performed with Oligo 3.2. These binding experiments were 
similar to those described above. Results from these binding experiments are shown in Fig 7.8A. 
Oligo 3.2a is a fluorescently labelled complementary oligonucleotide to Oligo 3.2. These were 
annealed to create a duplex DNA molecule with two 5’ HEX fluorophores. Oligo 3.2a was 
originally intended to disrupt binding of Oligo 3.2; however, as Oligo 3.2 showed no binding, 
the duplex Oligo 3.2 – Oligo 3.2a complex was used as another fluorescently labelled control 
DNA molecule, to demonstrate that. E.coli did not uptake the fluorescent stain. The results of 
these binding experiments are shown in Fig 7.8B. As no binding was observed using LSCM, the 
binding of Oligo 3.2 was not quantitated and analysed further (using the method described in 
Fig 7.7). Both Fig 7.8A and 7.8B show negative binding results. Fig 7.8 B shows little 
fluorescence. Indeed the duplex molecule used as a stain in Fig 7.8 B contained two HEX 
chemical groups and should therefore produce twice the fluorescence signal per molecule. 
Single-stranded Oligo 3.2 may not bind because (to save on the cost of synthesis) it is 
not a complete sequence, or the molecule may also require other factors to bind co-operatively. 
This is surprising as Oligo 3.2 was the second most abundant sequence from SELEX Method I. 
In summary Oligo 3.1 co-localised to E.coli HB101 cells in water. This interaction was 
interrupted by scrambling the sequence of the oligonucleotide and by annealing complementary 
oligonucleotides. The fluorescence of the cells observed using LSCM increased with increasing 
concentration of fluorescent oligonucleotide. In contrast, Oligo 3.2 did not demonstrate co-
localisation to E.coli HB101. Fluorescent signals were quantified as described above (Fig 7.7). 
No fluorescent signal was observed.  
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Figure 7.8 LSCM imaging of Oligo 3.2 or Oligo 3.2- Oligo3.2a complexes and E.coli HB101 in water. A.   Bacterial 
cells stained with 10 μM Oligo 3.2. x and y = 212.55 μm, z = 19 μm.  B. Bacterial cells stained with 10 μM Oligo 
3.2 – Oligo 3.2a duplex. x and y = 212.55 μm.  These combined images show bright field data in grayscale and 
fluorescent signal is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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7.3.3. LSCM Analysis of Evolved Sequences from SELEX Method II 
Four oligonucleotide sequences were tested from the final SELEX round of SELEX Method II. 
These were named Oligos 4.1(The modal sequence of SELEX Method II), 4.2, 4.3 and 4.4. Each 
of these was synthesised with a scrambled oligonucleotide control (4.1s, 4.2s, 4.3s and 4.4s 
respectively). All sequences are listed in Table 6.5. 
OLIGO 4.1 and OLIGO 4.1s 
Fluorescently labelled oligonucleotide binding experiments were performed at 1 μM, 5 μM, 10 
μM, and 30 μM concentrations of oligonucleotide. As SELEX Method II used 1 × PBS pH 7.2 
as the binding buffer, LSCM experiments were also performed in this buffer. Oligo 4.2s is an 
oligonucleotide with the same length and G, A, T, C composition of oligo 4.2 with the order of 
nucleotides randomised. Oligo 4.1 demonstrated cell localisation at 1 μM, 5 μM, 10 μM and 30 
μM, though only a small proportion of cells were stained. The number of cells giving off a 
fluorescent signal never exceeded 5% of the cells in any field of view. Increasing the 
Concentration of fluorescent oligonucleotide used to stain the cells did not increase the number 
of fluorescent cells. At higher concentrations of Oligo 4.1 and 4.1s the amount of background 
fluorescence increased. 
It was possible to disable this binding by scrambling the sequence of the oligonucleotide. 
The scrambled oligo control experiments shows no cell localisation at equivalent concentrations 
to those described above. Fig 7.9A shows E.coli HB101 cells stained with 1 μM Oligo 4.1 and 
Fig 7.9B shows E.coli HB101 cells stained with 10 μM Oligo 4.1. Fig 7.10A shows E.coli 
HB101 cells stained with 30 μM Oligo 4.1 and Fig 7.10B shows E.coli HB101 cells stained with 
10 μM Oligo 4.1s. In all cases the same LASER wavelength and filters were used and the same 
objective lenses. The reason why this oligonucleotide would interact with a small proportion of 
cells and not others is not yet known. This may indicate some kind of selective discrimination, 
or it may be that the fluorescent cells are different to the non-fluorescent cells (alive or dead) or 
may be at different stages of division or expressing different surface morphologies. 
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Figure 7.9 LSCM imaging of Oligo 4.1 and E.coli HB101 in PBS. A.   Bacterial cells stained with 1 μM 
Oligo 4.1. x and y = 212.55 μm, z = 22 μm.  B. Bacterial cells stained with 10 μM Oligo 4.1 x and y = 
212.55 μm z = 18 μm.  These combined images show bright field data in grayscale, and fluorescent signal 
is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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Figure 7.10 LSCM imaging of Oligo 4.1 and 4.1s with E.coli HB101 in PBS. A.   Bacterial cells stained 
with 30 μM Oligo 4.1. x and y = 212.55 μm, z = 22 μm.  B. Bacterial cells stained with 10 μM Oligo 4.1s 
x and y = 212.55 μm z = 8 μm.  These combined images show bright field data in grayscale, and fluorescent 
signal is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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OLIGO 4.2 and OLIGO 4.2s 
When compared to Oligo 4.1, Oligo 4.2 stained a higher proportion of the E.coli HB101 cells 
under similar conditions. Various concentrations of fluorescent oligonucleotide were tested. 
These ranged from 1 μM to 20 μM. Cell localisation of fluorescent signal was observed for Oligo 
4.2 but not for the scrambled control Oligo 4.2s at equivalent concentrations. The number of 
cells stained in any field of view did not reach totality. 
Fig 7.11(i)A and Fig 7.11(i)B show the cell localisation of Oligo 4.2 at 10 μM 
concentration of fluorescent oligonucleotide (panel A). This localisation is disrupted by 
scrambling the sequence of the oligonucleotide (panel B). Both these images were taken from 
the optimal focal plane of 100 μm z-stack experiments. These z-stacks were performed as 
bacterial cells would frequently adhere to the top cover slip and the microscope slide or would 
be suspended between the two surfaces. This created a complex 3D environment where cells 
would move in and out of the optimal focal plane of the LASER. These large z-stack experiments 
were performed to ensure as many cells as possible would pass through the focal plane. 
OLIGO 4.3 and OLIGO 4.3s 
Oligo 4.3 showed similar staining patterns to oligo 4.2 and 4.1. All three of these evolved nucleic 
acid sequences stain a portion of the cells in every field of view. The proportion of stained cells 
did not increase with increasing concentration of fluorescent stain. Staining of individual cells 
was observed with all the selected oligonucleotides from SELEX Method II. This apparent 
binding was disrupted in all cases by scrambling the oligonucleotides. 
 Fig 7.11(ii)A shows an orthogonal view of a z-stack view of E.coli HB101 cells in 
1×PBS stained with 10 μM Oligo 4.3. Fig 7.11(ii)B shows a single image of E.coli HB101 cells 
in PBS stained with 10 μM Oligo 4.3s. Binding experiments were performed at 1 μM, 5 μM, 10 
μM, 20 μM and 30 μM of both oligonucleotides. Again the number of fluorescent cells with 
localised fluorescent signal did not reach totality.  
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Figure 7.11(i) LSCM imaging of Oligo 4.2 and 4.2s with E.coli HB101 in PBS. A.   Bacterial cells 
stained with 10 μM Oligo 4.2. B. Bacterial cells stained with 10 μM Oligo 4.2s. Both images were 
taken from 100 μm z-stacks (z dimension not shown to save space). x and y = 212.55 μm z = 100 μm.  
These combined images show bright field data in grayscale and fluorescent signal is shown in 
magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
 
 
 
x 
y 
A. 
x 
y 
B. 
10 μM 
HEX 
Oligo 4.2 
E.coli 
HB101 
1×PBS 
10 μM 
HEX 
Oligo 4.2s 
E.coli 
HB101 
1×PBS 
 201 
 
  
x 
y 
A. 
x 
y 
B. 
z 
Figure 7.11(ii) LSCM imaging of Oligo 4.3 and 4.3s with E.coli HB101 in PBS. A.   Bacterial cells 
stained with 10 μM Oligo 4.3. x and y = 212.55 μm z = 20 μm. B. Bacterial cells stained with 10 
μM Oligo 4.3s. x and y = 212.55 μm. These combined images show bright field data in grayscale, 
and fluorescent signal is shown in magenta. A 514 nm LASER was used in combination with a 536 
nm filter.  
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OLIGO 4.4 and OLIGO 4.4s 
Unlike the previously described oligonucleotides from SELEX Method II, Oligo 4.4 
demonstrated total staining of E.coli HB101 in PBS. This staining was dependent on the 
concentration of fluorescent Oligo 4.4 used. At low concentrations (<8 μM) only partial staining 
of cells was observed. The proportion of cells stained increased with the increasing concentration 
of Oligo 4.4. at concentrations above 8 μM, total staining of E.coli HB101 was observed. 
 Binding experiments at 1 μM, 2 μM, 3 μM, 4 μM, 5 μM, 6 μM, 7 μM, 8 μM and 10 μM 
were performed in order to observe and document this transition from partial to total staining. 
Fig 7.12A shows a typical image taken from the optimal focal plane of a 22 μm z-stack. This 
image shows a low proportion of cells with localised fluorescent signal. The z-stack ensured that 
the cells not showing any fluorescent signal are indeed non-fluorescent and not just out of the 
optimal focal plane. Fig 7.12B shows a typical transitional image of Oligo 4.4 partially staining 
E.coli HB101. At 5 μM, Oligo 4.4 produced a combination of stained and unstained cells.  
 Increasing the concentration of fluorescent oligonucleotide increased the proportion of 
cells stained. Fig 7.13A and B show higher concentration staining of E.coli HB101. These 
images used a lower magnification objective lens in order to maximise the number of cells in 
the field of view. Both Fig 7.13A and Fig 7.13B show total staining of the cells in the field of 
view. The scrambled DNA control was also performed. Importantly, binding of oligo 4.4s was 
not observed at comparable concentrations Fig 7.14. 
 The proportion of cells with localised fluorescent signal was quantitated for all of the 
oligonucleotides taken from SELEX Method II. This was done to observe the different patterns 
of binding of each oligonucleotide. Images were quantified by using the ImageJ program 
described above, or simply by asking volunteers to count the number of cells in a field of view 
and also the number of cells that were “pink”.  These quantitations will be discussed in section 
7.4.  
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Figure 7.12 LSCM imaging of Oligo 4.4 with E.coli HB101 in PBS. A.   Bacterial cells stained with 
2 μM Oligo 4.4. x and y = 85.02 μm z = 22 μm. B. Bacterial cells stained with 5 μM Oligo 4.4. x 
and y = 85.02 μm. These combined images show bright field data in grayscale and fluorescent signal 
is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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Figure 7.13 LSCM imaging of Oligo 4.4 with E.coli HB101 in PBS. A.   Bacterial cells stained with 8 
μM Oligo 4.4. B. Bacterial cells stained with 10 μM Oligo 4.4. In both images x and y = 212.55 
μm. These combined images show bright field data in grayscale, and fluorescent signal is shown in 
magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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Figure 7.14 LSCM imaging of Oligo 4.4s with E.coli HB101 in PBS. A.   Bacterial cells 
stained with 10 μM Oligo 4.4s. x and y = 212.55 μm. This combined image show bright field 
data in grayscale and fluorescent signal is shown in magenta. A 514 nm LASER was used in 
combination with a 536 nm filter.  
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7.3.4. LSCM Analysis of Aptamer Sequences from the Literature  
In addition to the molecules raised by SELEX Methods I and II, molecules from published works 
were also tested (Kim et al, 2013; Savory et al, 2014). These acted as positive controls for 
binding experiments. The sequences of Oligos J, Js, K and Ks are shown in Table 6.5. 
OLIGO J and OLIGO Js 
Fluorescent oligonucleotide binding experiments were performed for Oligo J and Oligo Js in 1 
× TBS. The cell strain used was E.coli DH5α. This aptamer was originally raised against a 
uropathic strain of E.coli; however, the authors also reported a comparatively weak affinity to 
the DH5α strain (Savory et al., 2014).  Partial staining of DH5α cells was observed (Fig 7.15A). 
This staining was not observed with the scrambled oligonucleotide control at equivalent 
concentrations (Fig 7.15B). this control experiment was not performed in the published paper. 
OLIGO K and OLIGO Ks 
Fluorescent oligonucleotide binding experiments were performed for Oligo K and Oligo Ks in 
1 × PBS. The cell strain used was E.coli HB101 (Kim et al. 2014). Very weak staining was 
observed (Fig 7.16A). Again, this staining was not observed with scrambled oligonucleotide 
controls at equivalent concentrations (Fig 7.16B). 
7.3.5. LSCM Analysis of Evolved Sequences and Human Cells  
In order to work as a therapeutic agent, the E.coli binding agents must not also show any cross-
reactivity to human cells. Control experiments were performed using immortalised Human 
Embryonic Kidney 293 (HEK293) cells taken from cell culture. These cells (A gift from Mr J. 
Chamberlain in the S. Kolstoe research group.) were resuspended from culture media into PBS 
and Oligonucleotide binding experiments were performed as above. The centrifugation was 
reduced from 8,000 g for 3 mins to 1,000 for 10 minutes to ease the stress on the cells. 
 All the oligonucleotides were screened for binding to HEK293 cells. Fig 7.17 shows the 
results for Oligos 3.1 and 4.4. No affinity for human cells was observed.  
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Figure 7.15 LSCM imaging of Oligos J and Js with E.coli DH5α in TBS. A.  Bacterial 
cells stained with 10 μM Oligo J. x and y = 134.90 μm. B.  Bacterial cells stained with 
10 μM Oligo Js x and y = 212.55 μm. These combined images show bright field data in 
grayscale, and fluorescent signal is shown in magenta. A 514 nm LASER was used in 
combination with a 536 nm filter.  
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Figure 7.16 LSCM imaging of Oligos K and Ks with E.coli HB101 in PBS. A.  Bacterial cells 
stained with 10 μM Oligo K. x and y = 212.55 μm. B.  Bacterial cells stained with 10 μM Oligo Ks 
x and y = 212.55 μm. These combined images show bright field data in grayscale, and fluorescent 
signal is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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Figure 7.17 LSCM imaging of Oligos 3.1 and 4.4 with HEK293 cells. A.  HEK293 cells stained 
with 10 μM Oligo 3.1 B.  HEK293 cells stained with 10 μM Oligo 4.4. In both cases x and y = 
212.55 μm. These combined images show bright field data in grayscale, and fluorescent signal 
is shown in magenta. A 514 nm LASER was used in combination with a 536 nm filter.  
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7.3.6. LSCM Analysis of Evolved Sequences and Elongated E.coli cells.  
E.coli is a highly responsive pathogen. It responds to environmental cues to maximise survival 
and reproduction. One mechanism used by pathogenic E.coli is to elongate to form a filamentous 
state (Errington, 2013). It is believed that this state is formed by pathogenic cells in response to 
hydrodynamic stress (Justice & Hultgren, 2006). It may also aid in the pathogen’s evasion of the 
immune system (Andersen et al. 2012). This elongated filamentous state of E.coli was 
sometimes induced by the fluorescent oligonucleotide binding assay. Oligo 4.1 showed partial 
cell localisation to these elongated forms of E.coli (Fig 7.18). 
7.4. Quantitation of LSCM results 
Selected oligonucleotide sequences interacted differently with target cells. For example, Oligo 
3.1 stained all cells and increasing the concentration increased the cell fluorescent intensity of 
each cell in a field of view, whereas Oligo 4.4 also stained all cells but only at concentrations 
above 8 μM. Oligo 3.1 was quantified using the fluorescent quantification process described 
above (Fig 7.7). SELEX Method II sequences were quantified by counting the proportion of 
stained and unstained cells for each concentration. Data from quantifications were analysed 
using GraFit software and are presented in Fig 7.19. 
 Fig 7.19A shows the data for the increasing fluorescent intensity of stained bacterial 
cells as a function of HEX-labelled Oligo 3.1 concentration. Fig 7.19 B to E show the proportion 
of stained target cells as a function of HEX-labelled oligonucleotide concentration. Fig 7.19F 
shows a table of the capacity, KDapp, and sample sizes for Oligo 3.1 and Oligo 4.4. These two 
molecules demonstrated binding to all target cells in a field of view (totality). All the 
oligonucleotides shown in Fig 7.19 demonstrated, cell-specific fluorescence localisation. Oligo 
4.1, Oligo 4.2 and Oligo 4.3 did not reach totality at these concentrations (Fig 7.19B, C and D).   
Ifold-predicted minimum free energy 3D structures of Oligo 3.1 (Fig 7.20A) and Oligo 4.4 (Fig 
7.20B) are shown. Ifold predicts a kinked hairpin structure for Oligo 3.1 and a hairpin structure 
for Oligo 4.4. These structures are speculative. Further study is needed.  
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Figure 7.18 LSCM imaging of Oligo 4.1 with elongated E.coli HB101 cells in PBS. Bacterial 
cells stained with 10 μM Oligo 4.1. x and y = 212.55 μm z = 10 μm. This combined image 
shows bright field data in grayscale, and fluorescent signal is shown in magenta. A 514 nm 
LASER was used in combination with a 536 nm filter.  
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The reported KDapp measurements shown in Fig 7.19 F cannot be directly compared with 
the reported dissociation constants reported in other bacterial cell-SELEX published works. A 
table containing publications of Bacterial Cell-SELEX experiments is shown in Appendix I. 
These publications have used a range of binding assays. The apparent dissociation constants 
achieved in this thesis are greater than those described in other published works; meaning that 
the aptamers have an apparent lower affinity for the target cells. This may be due to differences 
in the experimental procedures used to determine the affinities. LSCM may be a less sensitive 
method of determining affinity than flow cytometry or filter partitioning and quantitation. Other 
bacterial SELEX publications have reported KD values in the nano-molar range (Appendix I); 
whereas, the apparent dissociation constants of the molecules in this thesis has been measured 
in the micro-molar range (Fig 7.19 F).  
 LSCM has been used by other research groups to characterise the binding properties of 
aptamers to bacterial cells. In one study (Suh et al. 2014), aptamer sequences were isolated 
which only bound to between 10 % and 44 % of bacterial cells in a population. This is similar 
to the results described above, where only a small fraction of cells fluoresced under experimental 
conditions. This study also observed partially stained cells, that is, only a fraction of each stain 
was fluorescing. The cause of this partial binding, both among bacterial populations, and partial 
staining of individual cells remains unknown. This may be the cause of the apparently low 
affinity observed in this thesis.  
 Some of the molecules isolated in this thesis do have a higher affinity to the target cells 
than scrambled sequence equivalents. It is also important to state that the apparent affinities 
reported for Oligo K (Kim et al. 2013) and Oligo J (Savory et al. 2014) could not be replicated 
using LSCM in this thesis. This may be due to the different cell strains used in the case of Oligo 
K (HB101: pAT153 rather than KCTC 2571). Differences in sample preparation may have also 
changed the outcome of these experiments.  
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 Capacity 
50% 
(KD
app) 
Sample size 
(n) 
Oligo 3.1 81.27 3.35 μM 
Min 222 / 
Max 711  
Oligo 4.4 100 6.69 μM 
Min 1070 / 
Max 2784 
A. B. 
C. D. 
E. 
Figure 7.19 Quantitation of binding from LSCM data. A. Graph showing increasing fluorescent intensity 
of stained bacterial cells as a function of HEX-labelled Oligo 3.1 concentration. The blue line represents a 
fitted ligand binding curve. This curve gives an estimated maximum capacity of 81.27 fluorescent pixel 
intensity units and a KDapp of 3.35 μM. B. Graph of the proportion of fluorescing cells in a field of view as 
a function of concentration of Oligo 4.1. The y-axis is split. The blue line represents a straight line fit. C. 
Graph of the proportion of fluorescing cells in a field of view as a function of concentration of Oligo 4.2. 
As the proportion of cells stained never reaches totality the maximum capacity is limited to 24.7%. D. 
Graph of the proportion of fluorescing cells in a field of view as a function of concentration of Oligo 4.3 
The y-axis is split. The blue line represents a straight line fit.  E. Graph of the proportion of fluorescing 
cells in a field of view as a function of concentration of Oligo 4.4. The blue line is a fitted co-operative 
binding curve. This curve gives a 100% maximum capacity and a KDapp of 6.7 μM F. A table showing the 
capacity, KDapp, and sample sizes for Oligo 3.1 and Oligo 4.4. 
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Figure 7.20 Ifold-predicted minimum free energy structures. A. Oligo 3.1. B. Oligo 4.4. 
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7.5. Radiolabelled Binding Assay 
A library of 108 sequenced plasmids was created at the end of SELEX Method II. Each of these 
plasmids contained a different nucleic acid sequence from one of the rounds of SELEX Method 
II. Radiolabelled ssDNA molecules were created as described in section 4.4 (Fig 4.6). These 
known nucleic acid sequences were labelled during PCR using [α-32P] dATP incorporation. 
They were then digested using λ exonuclease. Three sequences were chosen from the first round 
of SELEX, three from the fourth round of SELEX and three from the eighth round of SELEX. 
10 % of the radio-labelled sample was taken and set aside as a known concentration control. 
 The remaining radio-labelled ssDNA molecules were incubated (at RT for 40 mins) in 
a suitable buffer with living E.coli HB101 cells (prepared as above). The cells were centrifuged 
(as above) and the supernatant with the unbound species was removed. The cells were then 
washed twice in buffer (100 μl). Each of these washes was retained for later quantification. 
Finally the cells were resuspended in 100 μl of buffer. All samples were mixed inside a 
scintillation tube with 2 ml of scintillation fluid. Samples were quantified using a Lab Logic 
300SL Liquid Scintillation Counter.  
 Radioactivity for each sample was measured and recorded as counts per minute. Fig 
7.21A shows the raw counts per minute for each of the fractions of each tested sequence. It also 
shows the scintillation fluid (SF control), water (H2O control), 1 × PBS (PBS control), growth 
media (LB control) and cells in buffer only control (Cells). Fig 7.21B shows the graphical 
representation of the scintillation data acquired for each sequence. The counts per minute (c.p.m) 
of the cells in buffer alone has been subtracted as background from all readings. As the ‘10% 
control count’ experiments do not equal one tenth of the total counts observed, it was clear that 
this experiment required further optimisation. It most likely should be repeated with higher 
numbers of cells until all the radioactive signal is accounted for.   
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Figure 7.21 Quantifications of binding using radioactivity. A. Scintillation data from radiolabelled 
oligonucleotide live cell binding experiments, Data are given in counts per minute. B. Graphical 
representation of the Data shown in Fig 7.20A. The counts per minute of Cells and Buffer only control have 
been subtracted as background. The sequences from the library of selected sequences are shown below. 
 
R1S1 TATGAGAACCGGGGCGGCGTCGTGATTTGGTACGGGTTCGATGGGACGAA  
R1S2 AGTCGGAGCGAAGACAGCGTCTGAATGAGTGATCGTTGGGCGGAGCTAGT  
R1S3 ATCGGTCGAGGCTTGCGGTCAGGTTCTAGGCAGCCGGGTTAACTGTAAGT  
  
R4S1 CCGCCTTAGTGGGCTTGTGAGGAAAAAGGAGCGAGGGCCGCCGCCGGTTT  
R4S2 GCGACTTCCGGCCGCCGCGCGTGGGAGTTACATGATGGGGGGTTGATGCA  
R4S3 CGGATTAGGCGGGGGGCGAGGGTGGAATCTGGTCATCGGCCGAAGCGAGG  
  
R8S1 GGGAAGCATGCTATCTTTGGACGCGTCGGAGACACGACTGCGTCTCTTGC  
R8S2 CGGCGGGGAGGTTGGCTCATCATGGCTCTACTGACTGCGCCTGGGTAGCT  
R8S3 CGATTGGGGGGAGAGAACCGCGCGAATCGTCCTAGGCGTCGTGCGTATCA  
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Chapter 8: Discussion 
The main findings of this thesis can be divided into three main areas. The first contribution to 
knowledge are the evolved molecules themselves and their potential uses as the basis for 
therapeutic and diagnostic agents. The second is the information gained which give insight into 
the mechanisms of evolution of DNA molecules, and how populations of replicating chemicals 
adapt to evolutionary selective pressure.  The final contributions were the two methods 
developed for the directed evolution of cell specific nucleic acid ligands. Both SELEX Methods 
I and II can be applied to any potential new target and both methods have raised DNA molecules 
that demonstrated localisation to the target cells in controlled binding experiments. These 
findings contribute to the emerging field of nucleic acid therapeutics.  
 
8.1. Novel ssDNA Sequences which Interact with Gram Negative Bacteria. 
The two SELEX Methods described in this thesis have generated a large number of potential 
new sequences that may interact with pathogenic organisms. Published articles have indicated 
that only one round of directed evolution (selection, and amplification) is required to generate 
specific ligands to a range of diverse cellular and molecular targets (Nitsche et al. 2007; 
Lauridsen et al. 2012). This indicates that in addition to the 24 unique sequences observed in the 
final round of SELEX Method I and the 34 sequences observed in the final round of SELEX 
Method II, the 75 evolved ssDNA sequences from SELEX Method II rounds 1-7 may also 
exhibit a strong interaction with the target organisms or similar pathogenic species. 
 Six of the sequences from the final rounds of both SELEX Methods have been tested 
for interactions with the target organisms. Of these sequences, one showed no interaction with 
the target cells in fluorescence binding studies. This may be a true sign of no affinity to the 
target, or it may be due to the sequence being incomplete as the sequence was synthesised with 
no forward primer complement region. This was done to save costs. A potential further 
experiment would be to repeat these binding experiments with a complete sequence.  
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The other sequence from SELEX Method I that was analysed with LSCM demonstrated 
an interaction with the target cells. This interaction showed dose-responsive characteristics. A 
higher concentration of fluorescent oligonucleotide gave each stained cell a higher fluorescent 
signal. This interaction could also be disrupted by rearranging the sequence of the 
oligonucleotide and by annealing complementary oligonucleotides to disrupt the structure. Two 
of the sequences evolved during SELEX Method I have been assayed for binding to E.coli 
HB101. Twenty-two unique sequences remain to be tested.  
The shortest of these ssDNA sequences is only 9 nt in length without primer regions, 
and 47 nt with flanking primer sequences. It has previously been demonstrated in published 
works that very small nucleic acid sequences may exhibit high affinities or catalytic activities 
(Anderson & Mecozzi, 2005; Turk et al. 2010; Yarus, 2011). The observation of these severely 
diminished sequences was attributed to these sequences requiring fewer monomers to complete 
replication and therefore requiring less time and fewer resources to replicate. This increased 
replicative fitness would give an evolutionary advantage to these molecules over larger species. 
The question remains however; if 9 nt evolved sequences are found in the pool then why do 37 
nt sequences persist? It could be speculated that the shorter sequences could have better 
replicative fitness whereas the larger molecules maintain their position in the evolving pool by 
binding to the target with high affinity. Another possibility is that shorter sequences may have 
an advantage when interacting with the target cells. Shorter sequences may access structures 
which larger sequences could not. Shorter sequences may also be taken up into cells at a higher 
rate. Cell-internalising aptamers have previously been reported (Chu, & Levy, 2006; Hernandez 
et al. 2013). 
Any of the evolved sequences from this thesis may have bacteriostatic or bactericidal 
properties. If the sequences interrupt cell-wall synthesis or block vital bacterial cellular 
functions, they could prove to be therapeutically interesting non-toxic novel antimicrobial 
agents. In further experiments, ideally all of the selected sequences would be assayed for 
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antimicrobial activity. Even if the molecules are not innately antibiotics, there are a number of 
mechanisms by which nucleic acid ligands could be used in antimicrobial therapies. 
In May 2015 a group (including Nobel laureate Kary Mullis) working at University of 
California San Diego School of Medicine, in collaboration with researchers at Altermune 
Technologies in Irvine, CA, published a paper where a G-quadruplex-forming DNA aptamer 
against group A Streptococcus (GAS) was used to redirect an immune response. A galactose-α-
1,3-galactosyl-β-1,4-N-acetyl-glucosamine (α-Gal)-conjugated DNA aptamer  was used to 
attach α-Gal to the cell surface (M1 protein) of the pathogenic bacterium. This chemical signal 
was then identified by the anti-α-Gal human antibodies. It was demonstrated that this aptamer 
flagging of bacterial cells could redirect mouse and human antibodies to the pathogen. The 
aptamer conjugated to the 5’ α-Gal modification was shown to increase the rate of phagocytosis 
of Streptococcus cells when compared to randomised DNA controls and aptamers without the 
5’ α-Gal modification (Kristian et al. 2015). It would be possible and simple to replace the anti-
GAS aptamer used with any of the sequences raised in this thesis. This may allow an immune 
response to be redirected against E.coli. 
Pathogen-specific binding agents could also be used to extract bacterial cells directly 
from the blood-stream. Aptamers linked to magnetic beads could be used to clean the blood in 
a form of extracorporeal sepsis therapy (Kang et al. 2014). 
The field of DNA origami and nanotechnology generates many innovative and varied 
structures made entirely of DNA building blocks. These structures, or DNA-conjugated 
magnetic nanoparticles could be used to create self-assembling adhesion constructs. Adhesion 
constructs have been created to induce adhesion between bladder carcinoma cells (Li et al. 
2014). Similar constructs have induced adhesion between phospholipid vesicles (Shimobayashi 
et al. 2015). Could an E.coli-specific intercellular adhesion molecule be created from the 
sequences evolved in this thesis? 
Further experiments are required to define the nature of the interaction between the 
ssDNA sequences raised in this thesis and the target bacterial cells. The molecular target of the 
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aptamers must be identified. This could be done by cross-linking the target to an immobilised 
aptamer, lysing the cells, and performing a crude extraction. Any molecules bound (protein, 
carbohydrate or lipid) to the aptamer could then potentially be identified by Mass Spectroscopy. 
Once the molecule had been identified, this could lead to intermolecular interaction studies such 
as Surface Plasmon Resonance and Electrophoretic Mobility Shift Assays. 
The affinity of the aptamers to the cells could be identified by Flow Cytometry. This 
would give precise measurements for the amount of fluorescently labelled oligonucleotides 
bound to and dissociated from the living cells. These experiments are the next essential step in 
understanding the interaction between these oligonucleotides and the target. Flow Cytometry 
has been used in a number of Cell SELEX publications, and is becoming the standard technique 
for establishing the binding kinetics of cell-targeting nucleic acids (Wang & Ding, 2009; Meyer 
et al. 2013; Suh et al. 2014). 
It is possible that the molecules isolated in this sequence of experiments may act as 
bactericidal or bacteriostatic agents. This could be done by interrupting the bacterial cell wall 
metabolism (Johnson et al. 2013) or by binding to vital cell wall components such as outer 
membrane proteins (Joshi et al. 2009; Koebnik, et al. 2000). 
8.2. Insights into Molecular Evolution of DNA 
This thesis focused on the responses of DNA to selective pressure. SELEX is simple 
combinatorial chemistry with the addition of evolution (Ahmad & Soh, 2012). Manipulating 
evolutionary pathways in this way allows functional molecules to evolve without understanding 
either how the molecule works or the nature of the target substance. SELEX can therefore be 
described as unintelligent design. 
In Chapter 5 of this thesis, the anomalous and unexpected results from SELEX Method 
I and SELEX Method II were discussed and possible mechanisms for the development of these 
phenomena were proposed. SELEX Method I yielded molecules much greater than the expected 
length. The evolutionary process had caused complexity to emerge. From standard building 
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blocks highly complex molecules developed. This reflects the findings published this year where 
under some conditions larger nucleic acids have evolutionary advantages over shorter ones 
causing populations to lengthen over time (Kreysing & Braun, 2015). The structure of these 
highly complex sequences may give clues as to how small nucleic acid sequences concatamerise 
into much larger molecules. This in turn may help solve the genetics paradox relating to how 
genomes emerge from genes. 
The addition of primer sites observed as SELEX Method II progressed may be a 
testament to the inherent selfishness of competing nucleic acids. As the evolving sequences 
recruit priming nucleic acids to improve replicative fitness, they also give themselves 
evolutionary advantages over competitors. This strategy forces the entire population to adapt to 
these new conditions as an arms race ensues and the number of consecutive primer sequences 
escalates. This also gives insight into the strategies used by DNA in response to selective 
pressure. Further experimentation into these phenomena could establish if under similar 
conditions the same strategies are used. Does evolution happen the same way twice?  
The conserved nucleotides at the 5’ and 3’ end of the central cassette of the selected 
molecules in SELEX Method I indicate that these sequences may be in some way connected. 
Did these nucleobases develop by convergent evolution? Or are they evidence of some kind of 
founder effect? Are they descendants from an ancestor molecule? The use of next generation 
sequencing and large sample size sequencing technology could possibly shed light on these 
processes. High throughput analysis of millions of evolving sequences may give the answer to 
these questions in the near future (Alam et al. 2015). 
Both SELEX Methods I and II yielded sequence-specific binding molecules. SELEX 
Method II used fewer rounds of selection. SELEX Method I yielded a more heterogeneous pool 
of selected sequences. Both SELEX Methods yielded aberrant sequences. SELEX Method II 
allowed sequencing data to be extracted from every round of selection.  
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8.3. Development of SELEX Methods. 
Two SELEX Methods have been described. When nucleic acid SELEX protocols are described 
in published literature (and online) they are usually divided into sections, such as: Selection 
stages, Amplification stages, and Single strand recovery stages (Lee & Ellington, 2004). The 
HEX/PHOS λ exonuclease system of single strand recovery described in SELEX Method II is a 
significant improvement upon existing technologies. The addition of a 5’ protecting agent to the 
evolving strand is novel, and facilitates complete removal of the complementary strand without 
the evolving strand also being digested and therefore removed from the evolving pool of 
molecules (Avci-Adali et al. 2010; Marimuthu et al. 2012). 
Increasing the number of individual PCR amplifications per round of SELEX is also a 
notable improvement. The completed template rehybridisation effect plays an important role in 
maintaining population diversity in amplifying pools of selected molecules (Mathieu-Daudé et 
al. 1996). Further investigation is required into how PCR amplification affects evolving 
populations of molecules.  
Importantly, these described SELEX Methods can be applied to any type of living cell 
or tissue (that can survive centrifugation). Aptamers can be raised to tissues (Liu et al. 2012), 
and these SELEX  procedures can rapidly yield specific nucleic acid ligands. SELEX itself can 
also be automated to improve both rapidity and reproducibility of selection procedures (Eulberg, 
et al. 2005; Stoltenburg et al 2007; Ding et al. 2008; Paegel & Joyce, 2008). SELEX could be 
performed on tissues from patient biopsies and samples which could lead to same-day 
development of tissue and patient specific nucleic acid ligands.  
8.4. Future Work 
As this project continues, new binding analysis methods have been developed using 
centrifugation and cell partitioning, followed by N-PAGE fluorescent oligonucleotide 
quantitation. These new analytical methods are yielding promising new binding data for selected 
oligonucleotides. The next step would be to characterise the binding affinities of all the 
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molecules isolated during this course of investigation, and to test them, both for bacterial 
affinities to a range of bacterial species, and for bactericidal properties. Circular Dichroism 
projects are beginning to determine structural data regarding the molecules isolated in this thesis. 
Flow Cytometry would be an ideal future experiment, as it would elucidate and quantify the 
binding affinities of multiple aptamers isolated from SELEX Methods I and II. Improvements 
could be made to both these SELEX Methods. A new evolutionary study could be performed 
which incorporated later generation sequencing technology to greatly increase the number of 
aptamer species analysed. This would also eliminate the need for cloning and transformations. 
Automated SELEX systems could also be incorporated to raise novel aptamers more efficiently. 
The molecules from this thesis could be incorporated immediately into emerging aptamer-based 
therapeutic technologies including extra-corporeal blood cleansing (Kang et al. 2014) and 
immune system recruitment (Kristian et al. 2015). There are a great variety of potential 
applications for these novel aptamer sequences. 
This thesis began by describing the chemical nature of DNA and RNA molecules. All 
life can be reduced to specific configurations of these nucleobases. The immense complexity 
that can develop from varying sequences of nucleic acids is astounding. This complexity is 
massively increased with the addition of new nucleobase analogues and chemical modifications. 
The powerful mixture of combinatorial chemistry and evolutionary pressure will lead to the 
development of many fantastic advances in molecular medicine.  
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Appendices 
Appendix I 
Table AI : List of published unique nucleic acid aptamers, partially adapted from Stoltenburg 
& Strehlitz, 2007. The citations for each reference are given in a separate appendix references 
list (see end of Appendices). 
Target for aptamer selection Type of aptamer KD References  
Inorganic components    
Zn2+ RNA 1.2 mmol/L Ciesiolka et al. (1995) 
Ni2+ RNA 0.8–29 μmol/L Hofmann et al. (1997) 
Small organic molecules    
Ethanolamine DNA 6–19 nmol/L Mann et al. (2005)  
Theophylline RNA 100 nmol/L Jenison et al. (1994)  
Malachite green RNA 1 μmol/L Grate and Wilson (2001) 
Organic dyes RNA 100–600 μmol/L Ellington and Szostak (1990) 
 DNA 33–46 μmol/L Ellington and Szostak (1992) 
Sulforhodamine B DNA 190 nmol/L Wilson and Szostak (1998) 
Hematoporphyrin DNA 1.6 μmol/L Okazawa et al. (2000) 
Ricin toxin DNA 58–105 nmol/L Tang et al. (2006)  
Cholic acid DNA 5–67.5 μmol/L Kato et al. (2000)  
4<comma>4′-Methylenedianiline RNA 0.45–15 μmol/L Brockstedt et al. (2004) 
Dopamine RNA 2.8 μmol/L Mannironi et al. (1997) 
Cocaine DNA n.s.a Stojanovic et al. (2000) 
Nucleotides and derivatives    
Adenine RNA 10 μmol/L Meli et al. (2002)  
ATP (adenosine) RNA 0.7–50 μmol/L Sassanfar and Szostak (1993) 
Adenosine/ATP DNA 6 μmol/L Huizenga and Szostak (1995) 
ATP RNA 4.8–11 μmol/L Sazani et al. (2004)  
Xanthine RNA 3.3 μmol/L Kiga et al. (1998)  
cAMP RNA 10 μmol/L Koizumi and Breaker (2000) 
Cofactors      
Coenzyme A RNA n.s.a Saran et al. (2003)  
Cyanocobalamin RNA 88 nmol/L Lorsch and Szostak (1994) 
Riboflavin RNA 1–5 μmol/L Lauhon and Szostak (1995) 
FMN RNA 0.5 μmol/L Burgstaller and Famulok (1994) 
FAD RNA 137–273 μmol/L Burgstaller and Famulok (1994) 
NAD RNA n.s.a Burgstaller and Famulok (1994) 
 RNA 2.5 μmol/L Lauhon and Szostak (1995) 
S-adenosyl methionine RNA n.s.a Burke and Gold (1997) 
S-adenosyl homocysteine RNA 0.1 μmol/L Gebhardt et al. (2000) 
Biotin RNA 5 μmol/L Wilson et al. (1998) 
Nucleic acids     
TAR RNA element of HIV-1 DNA 50 nmol/L Boiziau et al. (1999)  
 RNA 20–50 nmol/L Duconge and Toulme (1999) 
 DNA 50 nmol/L Sekkal et al. (2002)  
Yeast phenylalanine tRNA RNA 12–26 nmol/L Scarabino et al. (1999) 
E.coli 5S RNA RNA 6–12 μmol/L Ko et al. (1999)  
 RNA 3 μmol/L Ko et al. (2001)  
Amino acids     
l-Arginine RNA 330 nmol/L Geiger et al. (1996)  
 DNA ∼2.5 mmol/L Harada and Frankel (1995) 
l-Citrulline RNA 62–68 μmol/L Famulok (1994)  
l-Valine RNA 12 mmol/L Majerfeld and Yarus (1994) 
l-Isoleucine RNA 1–7 mmol/L Lozupone et al. (2003) 
 RNA 200–500 μmol/L Majerfeld and Yarus (1998) 
d-Tryptophan RNA 18 μmol/L Famulok and Szostak (1992) 
l-tyrosinamide DNA 45 μmol/L Vianini et al. (2001)  
l-histidine RNA 8–54 μmol/L Majerfeld et al. (2005) 
Carbohydrates      
 
 
  
Cellobiose DNA 600–nmol/L Yang et al. (1998)  
Target for aptamer selection Type of aptamer KD References  
Sialyl Lewis X RNA 0.085–10 nmol/L Jeong et al. (2001)  
Chitin DNA n.s.a Fukusaki et al. (2000) 
Sialyllactose DNA 4.9 μmol/L Masud et al. (2004)  
Sephadex DNA n.s.a Srisawat et al. (2001) 
Antibiotics     
Kanamycin A RNA ≤300 nmol/L Lato et al. (1995)  
Kanamycin B RNA 180 nmol/L Kwon et al. (2001)  
Streptomycin RNA n.s.a Wallace and Schroeder (1998) 
Neomycin RNA ∼100 nmol/L Wallis et al. (1995)  
Tobramycin RNA 2–3 nmol/L Wang and Rando (1995) 
Lividomycin RNA ≤300 nmol/L Lato et al. (1995) 
Moenomycin A RNA 300–400 nmol/L Schürer et al. (2001)  
Tetracycline RNA 1 μmol/L Berens et al. (2001)  
Chloramphenicol RNA 25–65 μmol/L Burke et al. (1997)  
Peptides and proteins    
T4 DNA polymerase RNA 5–30 nmol/L Tuerk and Gold (1990) 
α-Thrombin DNA 200 nmol/L Bock et al. (1992)  
 RNA <1–4 nmol/L White et al. (2001)  
Bovine thrombin RNA 164–240 nmol/L Liu et al. (2003)  
Neurotensin receptor NTS-1 (rat) RNA 0.37 nmol/L Daniels et al. (2002)  
Immunglobulin E DNA 23–39 nmol/L Mendonsa and Bowser (2004) 
 RNA 30–35 nmol/L Wiegand et al. (1996) 
 DNA 10 nmol/L Wiegand et al. (1996) 
Interferon-γ RNA 2.7 nmol/L Kubik et al. (1997)  
MCP-1 (mouse) RNA 180–370 pmol/L Rhodes et al. (2001)  
PDGF DNA 0.1 nmol/L Green et al. (1996)  
VEGF RNA 0.1–2 nmol/L Jellinek et al. (1994)  
 RNA 0.05–0.13 nmol/L Ruckman et al. (1998) 
HIV-1 integrase RNA 10–800 nmol/L Allen et al. (1995)  
HIV-1 RT RNA ∼5 nmol/L Tuerk et al. (1992)  
 DNA ∼1 nmol/L Schneider et al. (1995) 
 DNA 180–500 pmol/L Mosing et al. (2005)  
HIV-1 nucleocapsid protein RNA 0.84–1.4 nmol/L Kim et al. (2002)  
TTF1 DNA 3.3–67 nmol/L Murphy et al. (2003)  
HGF DNA 19–25 nmol/L Saito and Tomida (2005) 
Streptavidin RNA 7 nmol/L Tahiri-Alaoui et al. (2002) 
 RNA 70–200 nmol/L Srisawat and Engelke (2001) 
 DNA 57–85 nmol/L Stoltenburg et al. (2005) 
l-Selectin DNA 1.8–5.5 nmol/L Hicke et al. (1996)  
Taq DNA polymerase DNA 0.04–9 nmol/L Dang and Jayasena (1996) 
Prion protein (PrPc) RNA 0.1–1.7 nmol/L Proske et al. (2002)  
PrPSc fibrils RNA 23.4 nmol/L Rhie et al. (2003)  
rPrPc RNA n.s.a Weiss et al. (1997)  
rPrPc DNA n.s.a Takemura et al. (2006) 
C5 protein RNA 2–5 nmol/L Biesecker et al. (1999) 
Hepatitis C virus RdRp DNA 1.3/23.5 nmol/L Jones et al. (2006)  
Hepatitis C virus NS3 RNA n.s.a Kumar et al. (1997)  
Hepatitis C virus NS3 helicase DNA 140 nmol/L Zhan et al. (2005)  
ppERK2/ERK2 RNA 4.7/50 nmol/L Seiwert et al. (2000)  
Protein kinase C delta DNA 122 nmol/L Mallikaratchy et al. (2006) 
RNase H1 DNA 10–80 nmol/L Pileur et al. (2003)  
Tumour marker MUC1 DNA 0.1–34 nmol/L Ferreira et al. (2006) 
GnRH l-RNA 190 nmol/L Leva et al. (2002)  
 l-DNA 45 nmol/L   
Vasopressin l-DNA 1.2 μmol/L Williams et al. (1997) 
Amyloid peptide βA4(1-40) RNA 29–48 nmol/L Ylera et al. (2002)  
Microcystin DNA 1 mmol/L Nakamura et al. (2001) 
Complex structures     
Anthrax spores DNA n.s.a Bruno and Kiel (1999) 
Differentiated PC12 cells DNA n.s.a Wang et al. (2003)  
Transformed YPEN-1 endothelial cells/pigpen DNA n.s.a Blank et al. (2001)  
U251 glioblastoma cells/tenascin-C DNA 150 nmol/L Daniels et al. (2003)  
 RNA 5 nmol/L Hicke et al. (2001)  
Live African trypanosomes RNA 60 nmol/L Homann and Göringer (1999) 
Jurkat T cell leukemia RNA n.s.a Lee and Lee (2006)  
Trypanosoma cruzi RNA 40–400 nmol/L Ulrich et al. 2002 
Leukemia cells CCRF-CEM DNA 0.8–229 nmol/L Shangguan et al. (2006) 
 
    
Table A II : List of published unique nucleic acid aptamers currently undergoing clinical trials 
adapted from (Sun et al.) 
 
Table A III : List of published unique nucleic acid aptamers raised against bacterial cells. The 
citations for each reference are given in a separate appendix references list (see end of 
Appendices). 
Target  Type of Aptamer  KD Reference 
E.coli  KCTC 2571 DNA 12.4-25.2 nM (Kim et al. 2013) 
E.coli NSM59 DNA 110 nM (Savory et al. 2014) 
E. coli O157:H7 RNA - (Lee et al. 2012) 
Listeria sp. DNA 106.4 nM (Suh et al. 2014) 
Bacillus anthracis 
(spores) 
DNA - (Bruno and Carrillo) 
Streptococcus 
pyogenes 
DNA 9 – 10 nM (Hamula et al. 2011) 
Salmonella 
typhimurium 
DNA - (Jyoti et al. 2011) 
 
 
  
Appendix II 
Markers and Standards 
 
  
2-Log DNA Ladder 
(0.1-10.0 kb) 
supplied by NEB  
 
High molecular 
weight Plasmid 
marker 500 bp to 
10 kbp 
50 bp Ladder 
supplied by NEB 
Gene Ruler 100 bp 
DNA ladder 
supplied by Thermo-
Fisher 
100 bp - 3 kbp DNA 
ladder supplied by 
VWR 
AccuLadder 1 kb 
DNA Size Marker 
supplied by Bioneer 
Wide-Range DNA 
ladder (50 – 10,000 
bp) supplied by 
Clontech 
Blue protein 
standard Broad 
range supplied by 
NEB 
O’range 20 bp DNA 
ladder supplied by 
Thermo Fisher 
Scientific 
Low-Range Ladder 
supplied by NEB 
Appendix III 
Plasmid Sequences – pAT153 - GenBank: L08853.1 
        1 ttctcatgtt tgacagctta tcatcgataa gctttaatgc ggtagtttat cacagttaaa 
       61 ttgctaacgc agtcaggcac cgtgtatgaa atctaacaat gcgctcatcg tcatcctcgg 
      121 caccgtcacc ctggatgctg taggcatagg cttggttatg ccggtactgc cgggcctctt 
      181 gcgggatatc gtccattccg acagcatcgc cagtcactat ggcgtgctgc tagcgctata 
      241 tgcgttgatg caatttctat gcgcacccgt tctcggagca ctgtccgacc gctttggccg 
      301 ccgcccagtc ctgctcgctt cgctacttgg agccactatc gactacgcga tcatggcgac 
      361 cacacccgtc ctgtggatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 
      421 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 
      481 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 
      541 actgttgggc gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct 
      601 caacctacta ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgaccgat 
      661 gcccttgaga gccttcaacc cagtcagctc cttccggtgg gcgcggggca tgactatcgt 
      721 cgccgcactt atgactgtct tctttatcat gcaactcgta ggacaggtgc cggcagcgct 
      781 ctgggtcatt ttcggcgagg accgctttcg ctggagcgcg acgatgatcg gcctgtcgct 
      841 tgcggtattc ggaatcttgc acgccctcgc tcaagccttc gtcactggtc ccgccaccaa 
      901 acgtttcggc gagaagcagg ccattatcgc cggcatggcg gccgacgcgc tgggctacgt 
      961 cttgctggcg ttcgcgacgc gaggctggat ggccttcccc attatgattc ttctcgcttc 
     1021 cggcggcatc gggatgcccg cgttgcaggc catgctgtcc aggcaggtag atgacgacca 
     1081 tcagggacag cttcaaggat cgctcgcggc tcttaccagc ctaacttcga tcactggacc 
     1141 gctgatcgtc acggcgattt atgccgcctc ggcgagcaca tggaacgggt tggcatggat 
     1201 tgtaggcgcc gccctatacc ttgtctgcct ccccgcgttg cgtcgcggtg catggagccg 
     1261 ggccacctcg acctgaatgg aagccggcgg cacctcgcta acggattcac cactccaaga 
     1321 attggagcca atcaattctt gcggagaact gtgaatgcgc aaaccaaccc ttggcagaac 
     1381 atatccatcg cgtccgccat ctccagcagc cgcacgcggc gcatctcggg cagcgttggg 
     1441 tcctggccac gggtgcgcat gatcgtgctc ctgtcgttga ggacccggct aggctggcgg 
     1501 ggttgcctta ctggttagca gaatgaatca ccgatacgcg agcgaacgtg aagcgactgc 
     1561 tgctgcaaaa cgtctgcgac ctgagcaaca acatgaatgg tcttcggttt ccgtgtttcg 
     1621 taaagtctgg aaacgcggaa gtcagcgctc ttccgcttcc tcgctcactg actcgctgcg 
     1681 ctcggtcgtt cggctgcggc gagcggtatc agctcactca aaggcggtaa tacggttatc 
     1741 cacagaatca ggggataacg caggaaagaa catgtgagca aaaggccagc aaaaggccag 
     1801 gaaccgtaaa aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca 
     1861 tcacaaaaat cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca 
     1921 ggcgtttccc cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg 
     1981 atacctgtcc gcctttctcc cttcgggaag cgtggcgctt tctcatagct cacgctgtag 
     2041 gtatctcagt tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt 
     2101 tcagcccgac cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca 
     2161 cgacttatcg ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg 
     2221 cggtgctaca gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt 
     2281 tggtatctgc gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc 
     2341 cggcaaacaa accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg 
     2401 cagaaaaaaa ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg 
     2461 gaacgaaaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 
     2521 gatcctttta aattaaaaat gaagttttaa atcaatctaa agtatatatg agtaaacttg 
     2581 gtctgacagt taccaatgct taatcagtga ggcacctatc tcagcgatct gtctatttcg 
     2641 ttcatccata gttgcctgac tccccgtcgt gtagataact acgatacggg agggcttacc 
     2701 atctggcccc agtgctgcaa tgataccgcg agacccacgc tcaccggctc cagatttatc 
     2761 agcaataaac cagccagccg gaagggccga gcgcagaagt ggtcctgcaa ctttatccgc 
     2821 ctccatccag tctattaatt gttgccggga agctagagta agtagttcgc cagttaatag 
     2881 tttgcgcaac gttgttgcca ttgctgcagg catcgtggtg tcacgctcgt cgtttggtat 
     2941 ggcttcattc agctccggtt cccaacgatc aaggcgagtt acatgatccc ccatgttgtg 
     3001 caaaaaagcg gttagctcct tcggtcctcc gatcgttgtc agaagtaagt tggccgcagt 
     3061 gttatcactc atggttatgg cagcactgca taattctctt actgtcatgc catccgtaag 
     3121 atgcttttct gtgactggtg agtactcaac caagtcattc tgagaatagt gtatgcggcg 
     3181 accgagttgc tcttgcccgg cgtcaacacg ggataatacc gcgccacata gcagaacttt 
     3241 aaaagtgctc atcattggaa aacgttcttc ggggcgaaaa ctctcaagga tcttaccgct 
     3301 gttgagatcc agttcgatgt aacccactcg tgcacccaac tgatcttcag catcttttac 
     3361 tttcaccagc gtttctgggt gagcaaaaac aggaaggcaa aatgccgcaa aaaagggaat 
     3421 aagggcgaca cggaaatgtt gaatactcat actcttcctt tttcaatatt attgaagcat 
     3481 ttatcagggt tattgtctca tgagcggata catatttgaa tgtatttaga aaaataaaca 
     3541 aataggggtt ccgcgcacat ttccccgaaa agtgccacct gacgtctaag aaaccattat 
     3601 tatcatgaca ttaacctata aaaataggcg tatcacgagg ccctttcgtc ttcaagaa 
  
Plasmid Sequences – pJET1.2 - GenBank: EF694056.1 
        1 gcccctgcag ccgaattata ttatttttgc caaataattt ttaacaaaag ctctgaagtc 
       61 ttcttcattt aaattcttag atgatacttc atctggaaaa ttgtcccaat tagtagcatc 
      121 acgctgtgag taagttctaa accatttttt tattgttgta ttatctctaa tcttactact 
      181 cgatgagttt tcggtattat ctctattttt aacttggagc aggttccatt cattgttttt 
      241 ttcatcatag tgaataaaat caactgcttt aacacttgtg cctgaacacc atatccatcc 
      301 ggcgtaatac gactcactat agggagagcg gccgccagat cttccggatg gctcgagttt 
      361 ttcagcaaga tatctttcta gaagatctcc tacaatattc tcagctgcca tggaaaatcg 
      421 atgttcttct tttattctct caagattttc aggctgtata ttaaaactta tattaagaac 
      481 tatgctaacc acctcatcag gaaccgttgt aggtggcgtg ggttttcttg gcaatcgact 
      541 ctcatgaaaa ctacgagcta aatattcaat atgttcctct tgaccaactt tattctgcat 
      601 tttttttgaa cgaggtttag agcaagcttc aggaaactga gacaggaatt ttattaaaaa 
      661 tttaaatttt gaagaaagtt cagggttaat agcatccatt ttttgctttg caagttcctc 
      721 agcattctta acaaaagacg tctcttttga catgtttaaa gtttaaacct cctgtgtgaa 
      781 attgttatcc gctcacaatt ccacacatta tacgagccgg aagcataaag tgtaaagcct 
      841 ggggtgccta atgagtgagc taactcacat taattgcgtt gcgctcactg ccaattgctt 
      901 tccagtcggg aaacctgtcg tgccagctgc attaatgaat cggccaacgc gcggggagag 
      961 gcggtttgcg tattgggcgc tcttccgctt cctcgctcac tgactcgctg cgctcggtcg 
     1021 ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta tccacagaat 
     1081 caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta 
     1141 aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag catcacaaaa 
     1201 atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac caggcgtttc 
     1261 cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc ggatacctgt 
     1321 ccgcctttct cccttcggga agcgtggcgc tttctcatag ctcacgctgt aggtatctca 
     1381 gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc gttcagcccg 
     1441 accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga cacgacttat 
     1501 cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta ggcggtgcta 
     1561 cagagttctt gaagtggtgg cctaactacg gctacactag aaggacagta tttggtatct 
     1621 gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga tccggcaaac 
     1681 aaaccaccgc tggtagcggt ggtttttttg tttgcaagca gcagattacg cgcagaaaaa 
     1741 aaggatctca agaagatcct ttgatctttt ctacggggtc tgacgctcag tggaacgaaa 
     1801 actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc tagatccttt 
     1861 taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact tggtctgaca 
     1921 gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt cgttcatcca 
     1981 tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta ccatctggcc 
     2041 ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta tcagcaataa 
     2101 accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc gcctccatcc 
     2161 agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat agtttgcgca 
     2221 acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt atggcttcat 
     2281 tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg tgcaaaaaag 
     2341 cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca gtgttatcac 
     2401 tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta agatgctttt 
     2461 ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg cgaccgagtt 
     2521 gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact ttaaaagtgc 
     2581 tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg ctgttgagat 
     2641 ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt actttcacca 
     2701 gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga ataagggcga 
     2761 cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc atttatcagg 
     2821 gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa caaatagggg 
     2881 ttccgcgcac atttccccga aaagtgccac ctgacgtcta agaaaccatt attatcatga 
     2941 cattaaccta taaaaatagg cgtatcacga ggcc 
 
 
 
Plasmid Sequences – pUC19 - GenBank: M77789.2 
        1 gcgcccaata cgcaaaccgc ctctccccgc gcgttggccg attcattaat gcagctggca 
       61 cgacaggttt cccgactgga aagcgggcag tgagcgcaac gcaattaatg tgagttagct 
      121 cactcattag gcaccccagg ctttacactt tatgcttccg gctcgtatgt tgtgtggaat 
      181 tgtgagcgga taacaatttc acacaggaaa cagctatgac catgattacg ccaagcttgc 
      241 atgcctgcag gtcgactcta gaggatcccc gggtaccgag ctcgaattca ctggccgtcg 
      301 ttttacaacg tcgtgactgg gaaaaccctg gcgttaccca acttaatcgc cttgcagcac 
      361 atcccccttt cgccagctgg cgtaatagcg aagaggcccg caccgatcgc ccttcccaac 
      421 agttgcgcag cctgaatggc gaatggcgcc tgatgcggta ttttctcctt acgcatctgt 
      481 gcggtatttc acaccgcata tggtgcactc tcagtacaat ctgctctgat gccgcatagt 
      541 taagccagcc ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct tgtctgctcc 
      601 cggcatccgc ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt cagaggtttt 
      661 caccgtcatc accgaaacgc gcgagacgaa agggcctcgt gatacgccta tttttatagg 
      721 ttaatgtcat gataataatg gtttcttaga cgtcaggtgg cacttttcgg ggaaatgtgc 
      781 gcggaacccc tatttgttta tttttctaaa tacattcaaa tatgtatccg ctcatgagac 
      841 aataaccctg ataaatgctt caataatatt gaaaaaggaa gagtatgagt attcaacatt 
      901 tccgtgtcgc ccttattccc ttttttgcgg cattttgcct tcctgttttt gctcacccag 
      961 aaacgctggt gaaagtaaaa gatgctgaag atcagttggg tgcacgagtg ggttacatcg 
     1021 aactggatct caacagcggt aagatccttg agagttttcg ccccgaagaa cgttttccaa 
     1081 tgatgagcac ttttaaagtt ctgctatgtg gcgcggtatt atcccgtatt gacgccgggc 
     1141 aagagcaact cggtcgccgc atacactatt ctcagaatga cttggttgag tactcaccag 
     1201 tcacagaaaa gcatcttacg gatggcatga cagtaagaga attatgcagt gctgccataa 
     1261 ccatgagtga taacactgcg gccaacttac ttctgacaac gatcggagga ccgaaggagc 
     1321 taaccgcttt tttgcacaac atgggggatc atgtaactcg ccttgatcgt tgggaaccgg 
     1381 agctgaatga agccatacca aacgacgagc gtgacaccac gatgcctgta gcaatggcaa 
     1441 caacgttgcg caaactatta actggcgaac tacttactct agcttcccgg caacaattaa 
     1501 tagactggat ggaggcggat aaagttgcag gaccacttct gcgctcggcc cttccggctg 
     1561 gctggtttat tgctgataaa tctggagccg gtgagcgtgg gtctcgcggt atcattgcag 
     1621 cactggggcc agatggtaag ccctcccgta tcgtagttat ctacacgacg gggagtcagg 
     1681 caactatgga tgaacgaaat agacagatcg ctgagatagg tgcctcactg attaagcatt 
     1741 ggtaactgtc agaccaagtt tactcatata tactttagat tgatttaaaa cttcattttt 
     1801 aatttaaaag gatctaggtg aagatccttt ttgataatct catgaccaaa atcccttaac 
     1861 gtgagttttc gttccactga gcgtcagacc ccgtagaaaa gatcaaagga tcttcttgag 
     1921 atcctttttt tctgcgcgta atctgctgct tgcaaacaaa aaaaccaccg ctaccagcgg 
     1981 tggtttgttt gccggatcaa gagctaccaa ctctttttcc gaaggtaact ggcttcagca 
     2041 gagcgcagat accaaatact gttcttctag tgtagccgta gttaggccac cacttcaaga 
     2101 actctgtagc accgcctaca tacctcgctc tgctaatcct gttaccagtg gctgctgcca 
     2161 gtggcgataa gtcgtgtctt accgggttgg actcaagacg atagttaccg gataaggcgc 
     2221 agcggtcggg ctgaacgggg ggttcgtgca cacagcccag cttggagcga acgacctaca 
     2281 ccgaactgag atacctacag cgtgagctat gagaaagcgc cacgcttccc gaagggagaa 
     2341 aggcggacag gtatccggta agcggcaggg tcggaacagg agagcgcacg agggagcttc 
     2401 cagggggaaa cgcctggtat ctttatagtc ctgtcgggtt tcgccacctc tgacttgagc 
     2461 gtcgattttt gtgatgctcg tcaggggggc ggagcctatg gaaaaacgcc agcaacgcgg 
     2521 cctttttacg gttcctggcc ttttgctggc cttttgctca catgttcttt cctgcgttat 
     2581 cccctgattc tgtggataac cgtattaccg cctttgagtg agctgatacc gctcgccgca 
     2641 gccgaacgac cgagcgcagc gagtcagtga gcgaggaagc ggaaga 
  
Appendix IV 
Full insert sequences from SELEX Method II Rounds 1-7 
1   
   
GCGACCCAAGGAATTCTGCTGAAGGGCAGTGGTTAGNTCTTTTTCCTGGGTTATCAAGTCAGGGGGGGTAGGTCACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCCGATAAGCTGCTTGGGTGTTGCGGACATTTAGTCTAAAGTGCTAGTTGGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGAAACTGGTACCCATTTCCGGGGGAGACTCTATATCCAGGGCTGCTTACCTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTTGGGGACAGCCGATCAAGTTTGGTAGGAATGCAACTAAACACGGCCCGTCATCGTACCGGATCCGTCACCAGAT 
GCGACCCAAGGAATTCTGCTGAAGGAGTCGGAGCGAAGACAGCGTCTGAATGAGTGATCGTTGGGCGGAGCTAGTCATCGTAACCGGATCCGTCACCAGC 
GCGACCCAAGGAATTCTGCTGAAGGTATCAATGGTGTATGGGTAGCCATGCGGGTGGTATGTGGTGGACTGGCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTATGAGAACCGGGGCGGCGTCGTGATTTGGTACGGGTTCGATGGGACGAACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGATCGGTCGAGGCTTGCGGTCAGGTTCTAGGCAGCCGGGTTAACTGTAAGTCATCGTACCGGATCCGTCACCAGCC 
2   
GCGACCCAAGGAATTCTGCTGAAGGGCGGAGTGTGTCTTATCGTGAGAGTGGCCCTTGGGAGTGGGGGGTGTACACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGGGGGTCTGGGAGTTGACGAAAGTGTGGAGGCGTTGACGCGAGTACCCTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGTGCAAAGTGCGCGCGAGATACTGAAGAGTATGGTTTACGACGGTGGGACCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCGGTCGTTGACGGAGGGTGGCCTGCTGGGGTCAAGGATTTGCGGATAGGCCATCGTACCGGATCCGTCACCAGCC 
3   
GCGACCCAAGGAATTCTGCTGAAGGTTTCGCCGGGGAGTGTATAGGGCATGCGGGTTAGGGACGCGGTCGGCGGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCTCTTGGGGGCTGGGGTTATATTGACACGAGGTACAGAGTGCGAGGACACCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGTATATGAATGGCAAAGTGTCCCGTCGGAGCGCGACTCGACTAGTGGGTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCATGGAACGAAACGATAGAGCGCTTTGGTCTTATCGGGGTCTTGTAGGCACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGAGATAAGCGAAAAGCCTATAGACGTATTGAGTGTTACATACGGAATTTNCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCTGGTGGTGCTTGCTCGTTCGACTTAGAAGTCAGGGTTGGGAGTGTAACACATCGTACCGGATCCGTTACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCAGCGGGTAAGGGATGTATCGGAGGAGAGACAAGTGTGCCTTGGCTGACATCGTACCGGATCCGTCACCAGCC 
4   
GCGACCCAAGGAATTCTGCTGAAGGCCGCCTTAGTGGGCTTGTGAGGAAAAAGGAGCGAGGGCCGCCGCCGGTTTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCATTGCGATGCTGTTTTTACTTGGAGCCGGGTTAGCTGGTGCCAGTGTGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGTATAGCGTGAAGGTCTAGTTCGATGAAGGGAATCAGTTGTATATACACCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGGTCTGTGCCAGGCCCCTTGGTCGCGGGCTTAGTCTATAATGTAGACGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGAACTGGGGAGGATTGGTTAATTACTATTCGTGGCACGTGACTAGGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGAGCTTGAGGCGTACGACCATGCAGAGTGAAAGCTAAGTTTACGGACAGAGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCGGATTAGGCGGGGGGCGAGGGTGGAATCTGGTCATCGGCCGAAGCGAGGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGATGTCACGTCAGGACGAGTGAGCGGGAGATATGTGCTTTAACGCGCCGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGATAGAAGAGTGAGCAGAGGATGGATGAGTAGGTGGTGCGTGCATAAAGCCATCGTACCGGATCCGTCACCAGCA 
GCGACCCAAGGAATTCTGCTGAAGGCCAATAGGNGCGAGAGTCGGAACGTCGGTTTTGTGAAATCGTCGTCCTTCACATCGTACCGGATCCGTCACCAGCC 
5   
GCGACCCAAGGAATTCTGCTGAAGGAAGTGTGGAAGAGGGTCTCACAAGAAGCATTGAGTGATGACGAGGGCAGCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGCTGGCGAGCGTAGTGAGCGTGGCGGGCGATGTGGGTGAGTACTAGGACCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCGGCTGAGTGGCCATAGTGGGTTACTTTTTCGGCCAGGAGGTTAATAGTTCATCGTACCGGATCCGTCACCAGCC 
GCGACCNNAGGAATTCTGCTGAAGGGGGCCCGGCGATGGTCTCAAAGGGAGTACGCACAAGGAGGTTTAACCTGGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCGCCAAGGGGTAGAAGCTGAGTGGGCGCTTACGTATATATAGTGGTTAGCCATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGCTTCGCTGTGGCTCCACTACAGAGTTTAAACTAGGCTGAACTTAGGCAACCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGTGTCGAGGGACCAGTGACCGCAATGCACGGTCGAATTGATGTCGTTGCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGCACCCTATCCCCTCAGGTGGGTAACGATTAAGTGCCCTATGCGGAGCTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGTCGGATACGACACGTGCTAGTAATTGGCGCTCTGTACGACCAAGGCATCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTAGCACTAAAGTGCAATCCGCGATTCTAATCAGGAGAGTGGAAGGTTTGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGTATATAGCCGCGCGTTGGAAGGCAGGTCACGTGTGGGCCTCAGCTGGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGAGGAGTGTCCGATGCGAGTCCTCCATAGAGCGCTATGCGGTCGTCTAGGCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTTAGGGGCAAGGAAAGTTTCTTGGTAGGCGCTGGTTCTCGGTGGGGAGGCCATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGGGATAGGCGTTCAAGCTTCATCGTTGCAGGCCAAGTTCTTTTTGGGAGAGCATCGTACCGGATCCGTCACCAGCC 
6   
GCGACCCAAGGAATTCTGCTGAAGGCCCATGATATGTTTGAGGAAGGCACCGATTGCCGAGGCTATCGGATTGTTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCTGCTTGACGGCCGGGGGTGAGTAGTGTGCTGGTACACTGCCGGTAGGGTCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCATGGATATTGAGCTTCGCTAGGGAGAGGGTTTATGTTCCTGGTGAGCTGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGTGCGTTGGccGATGGTGTCGTtaACGTGTTCAGATTATGACGTATGGGTCATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGGCATGATGACGCCTGGGCGTACTGCAGGAATGGCAACTGTATGCCAGCTTCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGAGACAGGGGATGTGTATGTCACGGCCCGTGCTTAATGGAGACTAGTGGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGCCAGGTCAGCAAGCGAGAGCGGGGCTAAGCGCCTTGTGAGAGGGAGCACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGGGAGACATGGGCGTCAGAAGGCTCTATTAGTCTGTGCTTTCGGCGCGCATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGCCGCGAAGAGAAAGGGGAGATGAGGAGGACACTGGGGCAGTGTTGGCTAGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGATCGACANTACGGAGTGTGGCNGCAGCTGNNTATNGGTCNCAACNNTCNGCATCGTACCGGATCCGTCACCAGCC 
7   
GCGACCCAAGGAATTCTGCTGAAGGACACGTGAGAGGTGGTGTACAGGAAGCGAGCGTCGCATATGATCAGATTGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGTGGCAGGGTATGCGCGCCGCGGCGCCGGCCATCTCCCCAACATAGCTGACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGNGGANGCGCCGTCCACTTGCTCTCGTCGGGAACGGGTGGGTTCGCCCGGCCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGAAGTTGGCCGGGCTTGCTGTCGAGAGGGTTGTGTTGGGGTGGTCACAAACATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGCACTTGTGTTTATGTATGCGTCGGTCTGCCCGTGCGAGCACATGTTGGTACATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGTGCAGTCCAAAGATGAGGCGAATAGGAGCAGCGGTCGGAACGATAAGACCATCGTACCGGATCCGTCACCAGCC+Phos 
GCGACCCAAGGAATTCTGCTGAAGGGCCGGCGGTTCATTCCAGGTACGCACGGGCAGTGGCTAGGGGGCAGCAGGCATCGTACCGGATCCGTCACCAGCC 
GCGACCCAAGGAATTCTGCTGAAGGGGACCCGCCAGGTTCAGGGCAGAGGTTTGTATGGACGAAGTACGCCGCAACATCGTACCGGATCCGTCACCAGCC 
 
 
 
 
   
Appendix References 
 
Citations for Tables AI and AIII 
 
Allen, P., Worland, S., Gold, L., “Isolation of high-affinity RNA ligands to Hiv-1 integrase from a random pool.”   
        Virology 209, (1995): 327–336. 
 
Berens, C., Thain, A., Schroeder, R., “A tetracycline-binding RNA aptamer.”  Bioorg. Med. Chem. 9, (2001): 2549–2556. 
 
Biesecker, G., Dihel, L., Enney, K., Bendele, R.A., “Derivation of RNA aptamer inhibitors of human complement C5.”  
         Immunopharmacology 42, (1999): 219–230. 
 
Blank, M., Weinschenk, T., Priemer, M., Schluesener, H., “Systematic evolution of a DNA aptamer binding to rat brain tumor  
         microvessels— selective targeting of endothelial regulatory protein pigpen.” J. Biol. Chem.276, (2001): 16464–16468. 
 
Bock, L.C., Griffin, L.C., Latham, J.A., Vermaas, E.H., Toole, J.J., “Selection of single-stranded DNA molecules that bind and 
inhibithuman thrombin” Nature 355, (1992): 564–566. 
 
Boiziau, C., Dausse, E., Yurchenko, L., Toulme, J.J., “DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element 
form RNA-DNA kissing complexes.” J. Biol. Chem. 274, (1999): 12730–12737. 
 
Brockstedt, U., Uzarowska, A., Montpetit, A., Pfau, W., Labuda, D., “In vitro evolution of RNA aptamers recognizing carcinogenic 
aromatic amines.” Biochem. Biophys. Res. Commun. 313, (2004): 1004–1008. 
 
Bruno, J.G., Kiel, J.L., “In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection.” Biosens. 
Bioelectron. 14, (1999): 457–464. 
 
Bruno, John G., and Maria P. Carrillo. “Development of Aptamer Beacons for Rapid Presumptive Detection of Bacillus Spores.” Journal 
of Fluorescence 22, (2012): 915–924.  
 
Burgstaller, P., Famulok, M., “Isolierung von RNA Aptameren für biologische Cofaktoren durch in-vitro Selektion.” Angew. Chem. 106, 
(1994): 1163–1166. 
 
Burke, D.H., Gold, L., “RNA aptamers to the adenosine moiety of Sadenosyl methionine: structural inferences from variations on a theme 
and the reproducibility of SELEX.” Nucleic Acids Res. 25, (1997): 2020–2024. 
 
Burke, D.H., Hoffman, D.C., Brown, A., Hansen, M., Pardi, A., Gold, L., “RNA aptamers to the peptidyl transferase inhibitor 
chloramphenicol.” Chem. Biol. 4, (1997): 833–843. 
 
Burke, D.H., Scates, L., Andrews, K., Gold, L., “Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus 
(HIV-1) reverse transcriptase.” J. Mol. Biol. 264, (1996): 650–666. 
 
Burke, D.H., Willis, J.H., “Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX.” RNA 4, 
(1998): 1165– 1175. 
 
Ciesiolka, J., Gorski, J., Yarus, M., “Selection of an RNA domain that binds Zn2+.”  RNA 1, (1995): 538–550. 
 
Dang, C., Jayasena, S.D., “Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR.” 
J. Mol. Biol. 264, (1996): 268–278. 
 
Daniels, D.A., Chen, H., Hicke, B.J., Swiderek, K.M., Gold, L., “A tenascin-C aptamer identified by tumor cell SELEX: systematic 
evolution of ligands by exponential enrichment.” Proc. Natl. Acad. Sci. U. S. A. 100, (2003): 15416–15421. 
 
Daniels, D.A., Sohal, A.K., Rees, S., Grisshammer, R., “Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, 
NTS-1.” Anal. Biochem. 305, (2002): 214–226. 
 
Duconge, F., Toulme, J.J., “In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR 
RNA element of HIV-1.” RNA-A 5, (1999): 1605–1614. 
 
Ellington, A.D., Szostak, J.W., “In vitro selection of RNA molecules that bind specific ligands.” Nature 346, (1990): 818–822. 
 
Ellington, A.D., Szostak, J.W., “Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures.” 
Nature 355, (1992): 850– 852. 
 
Famulok, M., “Molecular recognition of amino-acids by RNA–aptamers— an L-citrulline binding RNA motif and its evolution into an 
L-arginine binder.” J. Am. Chem. Soc. 116, (1994): 1698–1706. 
 
Famulok, M., Szostak, J.W., “Stereospecific recognition of tryptophan agarose by in vitro selected RNA.” J. Am. Chem. Soc. 114, (1992): 
3990–3991. 
 
Ferreira, C.S.M., Matthews, C.S., Missailidis, S., “DNA aptamers that bind to MUC1 tumour marker: design and characterization of 
MUC1-binding single-stranded DNA aptamers.” Tumor Biol. 27, (2006): 289–301. 
Fukusaki, E., Kato, T., Maeda, H., Kawazoe, N., Ito, Y., Okazawa, A., Kajiyama, S., Kobayashi, A., “DNA aptamers that bind to 
chitin.” Bioorg. Med. Chem. Lett. 10, (2000): 423–425. 
 
 
Gebhardt, K., Shokraei, A., Babaie, E., Lindqvist, B.H., “RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation 
dependency, and comparison with anti-S-adenosylhomocysteine antibody.” Biochemistry 39, (2000) 7255–7265. 
 
Geiger, A., Burgstaller, P., von der Eltz, H., Roeder, A., Famulok, M., “RNA aptamers that bind L-arginine with sub-micromolar 
dissociation constants and high enantioselectivity.”  Nucleic Acids Res. 24, (1996): 1029– 1036. 
 
Grate, D., Wilson, C., “Inducible regulation of the S-cerevisiae cell cycle mediated by an RNA aptamer–ligand complex.” Bioorg. Med. 
Chem. 9, (2001): 2565–2570. 
 
Green, L.S., Jellinek, D., Jenison, R., Ostman, A., Heldin, C.H., Janjic, N., “Inhibitory DNA ligands to platelet-derived growth 
       factor B-chain.” Biochemistry 35, (1996): 14413–14424. 
 
Hamula, Camille L A, X Chris Le, and Xing-Fang Li. “DNA Aptamers Binding to Multiple Prevalent M-Types of  
       Streptococcus Pyogenes.” Analytical chemistry 83.10 (2011): 3640–3647.  
 
Harada, K., Frankel, A.D., “Identification of two novel arginine binding DNAs.” EMBO J. 14, (1995): 5798–5811. 
 
Hicke, B.J., Marion, C., Chang, Y.F., Gould, T., Lynott, C.K., Parma, D., Schmidt, P.G., Warren, S., “Tenascin-c aptamers 
       are generated using tumor cells and purified protein.” J. Biol. Chem. 276, (2001): 48644–48654. 
 
Hicke, B.J., Watson, S.R., Koenig, A., Lynott, C.K., Bargatze, R.F., Chang, Y.F., Ringquist, S., Moon-McDermott, L., Jennings, S.,  
        Fitzwater, T., Han, H.L., Varki, N., Albinana, I., Willis, M.C., Varki, A., Parma, D., “DNA aptamers block L-selectin function 
in vivo. Inhibition of human lymphocyte trafficking in SCID mice.” J. Clin. Invest. 98, (1996): 2688–2692. 
 
Hirao, I., Harada, Y., Nojima, T., Osawa, Y., Masaki, H., Yokoyama, S., “In vitro selection of RNA aptamers that bind 
 to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA.” Biochemistry 43, (2004): 3214– 3221. 
 
Hofmann, H.P., Limmer, S., Hornung, V., Sprinzl, M., “Ni2+-binding RNA motifs with an asymmetric purine-rich internal 
      loop and a G-A base pair.” RNA 3, (1997): 1289–1300. 
 
Homann, M., Göringer, H.U., “Combinatorial selection of high affinity RNA ligands to live African trypanosomes.”  
Nucleic Acids Res. 27, (1999): 2006– 2014. 
 
Huizenga, D.E., Szostak, J.W., “A DNA aptamer that binds adenosine and ATP.” Biochemistry. 34, (1995): 656–665. 
 
Jellinek, D., Green, L.S., Bell, C., Janjic, N., “Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth 
factor.” Biochemistry 33, (1994.) 10450–10456. 
 
Jenison, R.D., Gill, S.C., Pardi, A., Polisky, B., “High-resolution molecular discrimination by RNA.” Science 263, (1994): 1425–1429. 
 
Jeong, S., Eom, T., Kim, S., Lee, S., Yu, J., “In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell 
adhesion” Biochem. Biophys. Res. Commun. 281, (2001): 237–243. 
Jones, L.A., Clancy, L.E., Rawlinson, W.D., White, P.A., “High-affinity aptamers to subtype 3a hepatitis C virus polymerase display 
genotypic specificity.” Antimicrob. Agents Ch. 50, (2006): 3019–3027. 
 
Jyoti, Anurag et al. “Identification of Environmental Reservoirs of Nontyphoidal Salmonellosis: Aptamer-Assisted  
       Bioconcentration andSubsequent Detection of Salmonella Typhimurium by Quantitative Polymerase Chain 
       Reaction.” Environmental Science and Technology 45.20 (2011): 8996–9002.  
 
Kato, T., Takemura, T., Yano, K., Ikebukuro, K., Karube, I., “In vitro selection of DNA aptamers which bind to 
       cholic acid.” Biochim. Biophys. Acta 1493, (2000): 12–18. 
 
Kiga, D., Futamura, Y., Sakamoto, K., Yokoyama, S., “An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine 
recognition.” Nucleic Acids Res. 26, (1998): 1755–1760. 
 
Kim, S.J., Kim, M.Y., Lee, J.H., You, J.C., Jeong, S., “Selection and stabilization of the RNA aptamers against the human 
immunodeficiency virus type-1 nucleocapsid protein.” Biochem. Biophys. Res. Commun. 291, (2002): 925–931. 
 
Kim, Yeon Seok et al. “Isolation and Characterization of DNA Aptamers against Escherichia Coli Using a Bacterial  
       Cell-Systematic Evolution of Ligands by Exponential Enrichment Approach.” Analytical biochemistry 436.1 (2013): 22–8.  
 
Ko, J., Lee, Y., Park, I., Cho, B., “Identification of a structural motif of 23S rRNA interacting with 5S rRNA.” 
        FEBS Lett. 508, (2001): 300–304. 
 
Ko, J.H., Cho, B., Ahn, J.K., Lee, Y., Park, I., “Probing the functional motifs of Escherichia coli 5S rRNA in relation to 16S rRNA using 
a SELEX experiment.” Br. Kor. Chem. Soc. 20, (1999): 1335–1339. 
 
Koizumi, M., Breaker, R.R., “Molecular recognition of cAMP by an RNA aptamer.” Biochemistry 39, (2000): 8983–8992. 
 
Kubik, M.F., Bell, C., Fitzwater, T., Watson, S.R., Tasset, D.M., “Isolation and characterization of 20-fluoro-, 20-amino-, and 20-
fluoro/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding.” J. Immunol. 159, (1997): 259–267. 
 
Kumar, P.K.R., Machida, K., Urvil, P.T., Kakiuchi, N., Vishnuvardhan, D., Shimotohno, K., Taira, K., Nishikawa, S., “Isolation of RNA 
aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.” Virology 237, (1997): 270–
282. 
 
Kwon, M., Chun, S.M., Jeong, S., Yu, J., “Invitro selection of RNA against kanamycin B.” Mol. Cells 11, (2001): 303–311. 
 
   
Lato, S.M., Boles, A.R., Ellington, A.D., “In-vitro selection of RNA lectins—using combinatorial chemistry to interpret ribozyme 
evolution.” Chem. Biol. 2, (1995): 291–303. 
 
Lato, S.M., Ellington, A.D., “Screening chemical libraries for nucleicacid-binding drugs by in vitro selection: a test case with lividomycin.” 
Mol. Div. 2, (1996): 103–110. 
 
Lauhon, C.T., Szostak, J.W., “RNA aptamers that bind flavin and nicotinamide redox cofactors.”  J. Am. Chem. Soc. 117, (1995): 1246–
1257. 
 
Lee, Y.J., Lee, S.W., “Invitro selection of cancer-specific RNA aptamers.”  J. Microbiol. Biotechnol. 16, (2006): 1149–1153. 
 
Lee, Young Ju et al. “In Vitro Selection of Escherichia Coli O157:H7-Specific RNA Aptamer.” Biochemical and Biophysical Research 
Communications 417 (2012): 414–420. 
 
Leva, S., Lichte, A., Burmeister, J., Muhn, P., Jahnke, B., Fesser, D., Erfurth, J., Burgstaller, P., Klussmann, S., “GnRH binding RNA and 
DNA Spiegelmers: a novel approach toward GnRH antagonism.” Chem. Biol. 9, (2002): 351–359. 
 
Liu, X.M., Zhang, D.J., Cao, G.J., Yang, G., Ding, H.M., Liu, G., Fan, M., Shen, B.F., Shao, N.S., “RNA aptamers specific for bovine 
thrombin.” J. Mol. Recognit. 16, (2003): 23–27. 
 
Lorsch, J.R., Szostak, J.W., “In vitro selection of RNA aptamers specific for cyanocobalamin.” Biochemistry 33, (1994): 973–982. 
 
Lozupone, C., Changayil, S., Majerfeld, I., Yarus, M., “Selection of the simplest RNA that binds isoleucine.”  
RNA 9, (2003): 1315–1322. 
 
Majerfeld, I., Puthenvedu, D., Yarus, M., “RNA affinity for molecular Lhistidine; genetic code origins.” J. Mol. Evol. 61, (2005): 226–
235. 
 
Majerfeld, I., Yarus, M., “Isoleucine: RNA sites with associated coding sequences.” RNA 4, (1998): 471–478. 
 
Majerfeld, I., Yarus, M., “An RNA pocket for an aliphatic hydrophobe.” Nat. Struct. Mol. Biol. 1, (1994): 287–292. 
 
Mallikaratchy, P., Stahelin, R.V., Cao, Z.H., Cho, W.H., Tan, W.H., “Selection of DNA ligands for protein kinase C-delta.” Chem. 
Commun. (2006): 3229–3231. 
 
Mann, D., Reinemann, C., Stoltenburg, R., Strehlitz, B., “In vitro selection of DNA aptamers binding ethanolamine.” Biochem. Biophys. 
Res. Commun. 338, (2005): 1928–1934. 
 
Mannironi, C., DiNardo, A., Fruscoloni, P., TocchiniValentini, G.P., “In vitro selection of dopamine RNA ligands.”  Biochemistry 36, 
(1997): 9726–9734.  
 
Masud, M.M., Kuwahara, M., Ozaki, H., Sawai, H., “Sialyllactose-binding modified DNA aptamer bearing additional functionality by 
SELEX.” Bioorg. Med. Chem. 12, (2004): 1111–1120. 
 
Meli, M., Vergne, J., Decout, J.L., Maurel, M.C., “Adenine-aptamer complexes - A bipartite RNA site that binds the adenine nucleic 
base.” J. Biol. Chem. 277, (2002): 2104–2111. 
 
Mendonsa, S.D., Bowser, M.T., “In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis.” Anal. 
Chem. 76, (2004): 5387–5392. 
 
Mosing, R.K., Mendonsa, S.D., Bowser, M.T., “Capillary electrophoresis SELEX selection of aptamers with affinity for HIV-1 reverse 
transcriptase.” Anal. Chem. 77, (2005): 6107–6112. 
 
Murphy, M.B., Fuller, S.T., Richardson, P.M., Doyle, S.A., “An improved method for the in vitro evolution of  
       aptamers and applications in protein detection and purification.” Nucleic Acids Res. 31 (2003): e110. 
 
Nakamura, C., Kobayashi, T., Miyake, M., Shirai, M., Miyake, J., “Usage of a DNA aptamer as a ligand targeting  
       microcystin.” Mol. Cryst. Liquid Cryst. 371, (2001): 369–374. 
 
Okazawa, A., Maeda, H., Fukusaki, E., Katakura, Y., Kobayashi, A., “In vitro selection of hematoporphyrin  
       binding DNA aptamers.” Bioorg. Med. Chem. Lett. 10, (2000): 2653–2656. 
 
Pan, W., Craven, R.C., Qiu, Q., Wilson, C.B., Wills, J.W., Golovine, S., Wang, J.F., “Isolation of virus-neutralizing RNAs from a large 
pool of random sequences.” Proc. Natl. Acad. Sci. U. S. A. 92, (1995): 11509–11513. 
 
Pileur, F., Andreola, M.L., Dausse, E., Michel, J., Moreau, S., Yamada, H., Gaidamakov, S.A., Crouch, R.J., Toulme, J.J., Cazenave, C., 
“Selective inhibitory DNA aptamers of the human RNase H1” Nucleic Acids Res. 31, (2003):  5776–5788. 
 
Proske, D., Gilch, S., Wopfner, F., Schatzl, H.M., Winnacker, E.L., Famulok, M., “Prion-protein-specific aptamer 
       reduces PrPSc formation.” Chembiochemistry 3, (2002): 717–725. 
 
Rhie, A., Kirby, L., Sayer, N., Wellesley, R., Disterer, P., Sylvester, I., Gill, A., Hope, J., James, W., Tahiri-Alaoui, A.,   
 “Characterization of 20-fluoroRNA aptamers that bind preferentially to disease-associated conformations of  prion protein and 
inhibit conversion.” J. Biol. Chem. 278, (2003): 39697–39705. 
Rhodes, A., Deakin, A., Spaull, J., Coomber, B., Aitken, A., Life, P., Rees, S., “The generation and characterization of antagonist RNA 
aptamers to human oncostatin M.” J. Biol. Chem. 275, (2000): 28555–28561. 
  
Rhodes, A., Smithers, N., Chapman, T., Parsons, S., Rees, S., “The generation and characterisation of antagonist RNA aptamers to MCP-
1.” FEBS Lett. 506, (2001): 85–90. 
 
Ringquist, S., Jones, T., Snyder, E.E., Gibson, T., Boni, I., Gold, L., “High affinity RNA ligands to Escherichia coli ribosomes and 
ribosomal protein S1: comparison of natural and unnatural binding sites.” Biochemistry 34, (1995): 3640–3648. 
 
Ruckman, J., Green, L.S., Beeson, J., Waugh, S., Gillette, W.L., Henninger, D.D., Claesson-Welsh, L., Janjic, N., “20-fluoropyrimidine 
RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF(165))—inhibition of receptor 
binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain.” J. Biol. Chem. 
273, (1998): 20556–20567. 
 
Saito, T., Tomida, M., “Generation of inhibitory DNA aptamers against human hepatocyte growth factor.” DNA Cell Biol. 24, (2005): 
624–633. 
 
Sampson, T., “Aptamers and SELEX: the technology.” World Patent Inf. 25, (2003): 123–129. 
 
Saran, D., Frank, J., Burke, D.H., “The tyranny of adenosine recognition among RNA aptamers to coenzyme A.”  
BMC Evol. Biol. (2003): 3-26.  
 
Sassanfar, M., Szostak, J.W., “An RNA motif that binds ATP.” Nature 364, (1993): 550–553. 
 
Savory, Nasa et al. “Selection of DNA Aptamers against Uropathogenic Escherichia Coli NSM59 by Quantitative PCR Controlled Cell-
SELEX.” Journal of Microbiological Methods 104 (2014): 94–100. Web. 
 
Sazani, P.L., Larralde, R., Szostak, J.W., “A small aptamer with strong and specific recognition of the triphosphate of ATP.” J. Am. Chem. 
Soc. 126, (2004): 8370–8371. 
 
Scarabino, D., Crisari, A., Lorenzini, S., Williams, K., Tocchini-Valentini, G.P., “tRNA prefers to kiss.” EMBO J. 18, (1999): 4571–4578. 
 
Schneider, D.J., Feigon, J., Hostomsky, Z., Gold, L., “High-affinity ssdna inhibitors of the reverse-transcriptase of type-1 human-
immunodeficiencyvirus.” Biochemistry 34, (1995): 9599–9610. 
 
Schu¨rer, H., Stembera, K., Knoll, D., Mayer, G., Blind, M., Forster, H., Famulok, M., Welzel, P., Hahn, U., “Aptamers that bind to the 
antibiotic moenomycin A.” Bioorg. Med. Chem. 9, (2001): 2557–2563. 
 
Seiwert, S.D., Nahreini, T.S., Aigner, S., Ahn, N.G., Uhlenbeck, O.C., “RNA aptamers as pathway-specific MAP kinase inhibitors.” Chem. 
Biol. 7, (2000): 833–843. 
 
Sekkal, D., Dausse, E., Di Primo, C., Darfeuille, F., Boiziau, C., Toulme, J.J., “In vitro selection of DNA aptamers against the HIV-1 TAR 
RNA hairpin.” Antisense Nucleic Acid Drug Dev. 12, (2002): 265–274. 
 
Shangguan, D., Li, Y., Tang, Z.W., Cao, Z.H.C., Chen, H.W., Mallikaratchy, P., Sefah, K., Yang, C.Y.J., Tan, W.H., “Aptamers evolved 
from live cells as effective molecular probes for cancer study.” Proc. Natl. Acad. Sci. U. S. A. 103, (2006): 11838–11843. 
 
Srisawat, C., Engelke, D.R., “Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins.”  RNA 7, (2001): 632–
641. 
 
Stojanovic, M.N., de Prada, P., Landry, D.W., “Fluorescent sensors based on aptamer self-assembly.” J. Am. Chem. Soc. 122, (2000) : 
11547– 11548. 
 
Stoltenburg, R., Reinemann, C., Strehlitz, B., “FluMag-SELEX as an advantageous method for DNA aptamer selection.” Anal. Bioanal. 
Chem. 383, (2005): 83–91. 
 
Stoltenburg, Regina, Christine Reinemann, and Beate Strehlitz. “SELEX-A (r)evolutionary Method to Generate High-Affinity Nucleic 
Acid Ligands.” Biomolecular Engineering 24.4 (2007): 381–403.  
 
Suh, Soo Hwan et al. “Selection and Characterization of DNA Aptamers Specific for Listeria Species.” Analytical Biochemistry 459 
(2014): 39-45 
 
Tahiri-Alaoui, A., Frigotto, L., Manville, N., Ibrahim, J., Romby, P., James, W., “High affinity nucleic acid aptamers for streptavidin 
incorporated into bi-specific capture ligands.” Nucleic Acids Res. 30, (2002): e45. 
 
Takemura, K., Wang, P., Vorberg, I., Surewicz, W., Priola, S.A., Kanthasamy, A., Pottathil, R., Chen, S.G., Sreevatsan, S., “DNA aptamers 
that bind to PrPC and not PrPSc show sequence and structure specificity.”  Exp. Biol. Med. 231, (2006): 204–214. 
 
Tang, J.J., Xie, J.W., Shao, N.S., Yan, Y., “The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection 
methods.” Electrophoresis 27, (2006): 1303–1311. 
 
Tuerk, C., Macdougal, S., Gold, L., “RNA pseudoknots that inhibit humanimmunodeficiency-virus type-1 reverse-transcriptase.” Proc. 
Natl. Acad. Sci. U. S. A. 89, (1992): 6988–6992. 
 
Ulrich, H., Magdesian, M.H., Alves, M.J.M., Colli, W., “In vitro selection of RNA aptamers that bind to cell adhesion receptors of 
Trypanosoma cruzi and inhibit cell invasion.” J. Biol. Chem. 277, (2002): 20756–20762. 
 
   
Vianini, E., Palumbo, M., Gatto, B., “In vitro selection of DNA aptamers that bind L-tyrosinamide.” Bioorg. Med. Chem. 9, (2001): 2543–
2548. 
 
Wallace, S.T., Schroeder, R., “In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination 
between antibiotics.” RNA 4, (1998): 112–123. 
 
Wallis, M.G., von Ahsen, U., Schroeder, R., Famulok, M., “A novel RNA motif for neomycin recognition.” Chem. Biol. 2, (1995): 543–
552. 
 
Wang, C., Zhang, M., Yang, G., Zhang, D., Ding, H., Wang, H., Fan, M., Shen, B., Shao, N., “Single-stranded DNA aptamers that bind 
differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment.” J. Biotechnol. 
102, (2003): 15–22. 
 
Wang, Y., Rando, R.R., “Specific binding of aminoglycoside antibiotics to RNA.” Chem. Biol. 2, (1995): 281–290. 
 
Weiss, S., Proske, D., Neumann, M., Groschup, M.H., Kretzschmar, H.A., Famulok, M., Winnacker, E.L., “RNA aptamers specifically 
interact with the prion protein PrP.” J. Virol. 71, (1997): 8790–8797. 
 
White, R., Rusconi, C., Scardino, E., Wolberg, A., Lawson, J., Hoffman, M., Sullenger, B., “Generation of species cross-reactive 
aptamers using ‘‘toggle’’ SELEX.” Mol. Ther. 4, (2001): 567–574. 
 
Wiegand, T.W., Williams, P.B., Dreskin, S.C., Jouvin, M.H., Kinet, J.P., Tasset, D., “High-affinity oligonucleotide ligands to human 
IgE inhibit binding to Fc epsilon receptor I.” J. Immunol. 157, (1996): 221–230. 
 
Williams, K.P., Liu, X.H., Schumacher, T.N., Lin, H.Y., Ausiello, D.A., Kim, P.S., Bartel, D.P., “Bioactive and nuclease-resistant L-
DNA ligand of vasopressin.” Proc. Natl. Acad. Sci. U. S. A. 94, (1997): 11285–11290. 
 
Wilson, C., Nix, J., Szostak, J., “Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot.” 
Biochemistry 37, (1998): 14410–14419. 
 
Wilson, C., Szostak, J., “In vitro evolution of a self-alkylating ribozyme.” Nature 374, (1995): 777–782. 
 
Wilson, C., Szostak, J.W., “Isolation of a fluorophore-specific DNA aptamer with weak redox activity.” Chem. Biol. 5, (1998): 609–617. 
 
Yang, Q., Goldstein,I.J., Mei, H.Y., Engelke, D.R., “DNA ligands that bind tightly and selectively to cellobiose.” Proc. Natl. Acad. Sci. 
U. S. A. 95, (1998): 5462–5467. 
 
Ylera, F., Lurz, R., Erdmann, V.A., Furste, J.P., “Selection of RNA aptamers to the Alzheimer’s disease amyloid peptide.” Biochem. 
Biophys. Res. Commun. 290, (2002): 1583–1588. 
 
Zhan, L.S., Zhuo, H.L., Wang, H.Z., Peng, J.C., Wang, Q.L., “Screening and characterization of aptamers of hepatitis C virus NS3 
helicase.” Progr. Biochem. Biophys. 32, (2005): 245–250. 
 
 
 
UPR16 – August 2015                                                                      
 
FORM UPR16 
Research Ethics Review Checklist 
 
Please include this completed form as an appendix to your thesis (see the 
Postgraduate Research Student Handbook for more information 
 
 
 
Postgraduate Research Student (PGRS) Information 
 
 
Student ID: 
 
395206 
 
PGRS Name: 
 
 
Robert Michael Nicholas Gowland 
 
Department: 
 
 
SOBS 
 
First Supervisor: 
 
Darren Gowers 
 
Start Date:  
(or progression date for Prof Doc students) 
 
 
1.10.10 
 
Study Mode and Route: 
 
Part-time
 
Full-time 
  

 
 
 
 
MPhil  
 
PhD 
 
 
 
 
 
 
 
MD 
 
Professional Doctorate 
 
 
 
 
 
 
 
Title of Thesis: 
 
 
Directed Molecular Evolution of Novel DNA Aptamers Raised Against an Antibiotic 
Resistant Escherichia coli. 
 
 
 
Thesis Word Count:  
(excluding ancillary data) 
 
 
55848 
 
 
 
If you are unsure about any of the following, please contact the local representative on your Faculty Ethics Committee 
for advice.  Please note that it is your responsibility to follow the University’s Ethics Policy and any relevant University, 
academic or professional guidelines in the conduct of your study 
Although the Ethics Committee may have given your study a favourable opinion, the final responsibility for the ethical 
conduct of this work lies with the researcher(s). 
 
 
 
UKRIO Finished Research Checklist: 
(If you would like to know more about the checklist, please see your Faculty or Departmental Ethics Committee rep or see the online 
version of the full checklist at: http://www.ukrio.org/what-we-do/code-of-practice-for-research/) 
 
 
a) Have all of your research and findings been reported accurately, honestly and 
within a reasonable time frame? 
 
 
YES 
NO    
 
 
 
 
 
b) Have all contributions to knowledge been acknowledged? 
 
 
YES 
NO    
 
 
 
 
 
c) Have you complied with all agreements relating to intellectual property, publication 
and authorship? 
 
YES 
NO    
 
 
 
 
 
d) Has your research data been retained in a secure and accessible form and will it 
remain so for the required duration?  
 
YES 
NO    
 
 
 
 
 
e) Does your research comply with all legal, ethical, and contractual requirements? 
 
 
YES 
NO    
 
 
 
 
      
 
Candidate Statement: 
 
 
I have considered the ethical dimensions of the above named research project, and have successfully 
obtained the necessary ethical approval(s) 
 
 
Ethical review number(s) from Faculty Ethics Committee (or from 
NRES/SCREC): 
 
 
N/A 
 
If you have not submitted your work for ethical review, and/or you have answered ‘No’ to one or more of 
questions a) to e), please explain below why this is so: 
 
 
No ethical issues were raised by departmental review. 
 
 
   
UPR16 – August 2015                                                                      
Signed (PGRS): 
 
 
 
Date: 29.03.2016 
 
 
 
Rob Gowland 
